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Abstract 
 
Nuclear Magnetic Resonance (NMR) is a phenomenon in which certain nuclei in 
the presence of a magnetic field and radiofrequency (RF) radiation emit a 
certain amount of signal at a frequency equal to that of the RF radiation. 
Proton Magnetic Resonance Spectroscopy (1H-MRS) is an NMR technique capable 
of measuring the chemical composition, often referred to as metabolites, of 
the human body non-invasively and in vivo. It is commonly used as a research 
tool in the investigation of neurological disorders such as multiple sclerosis, 
brain tumors, stroke, clinical depression, and schizophrenia. Accurate 
quantification of the metabolites of interest requires a reference standard of 
known and fixed concentration.  
 
Brain tissue water has been previously reported to have a fairly constant and 
known concentration, and so has been suggested to be a suitable reference 
concentration in absolute quantitative 1H-MRS of the human brain. In practice, 
however, it is challenging to measure the actual tissue water concentration; 
hence, some studies choose to use estimates of tissue water concentration 
from the literature. These literature values are usually averages from a healthy 
study group. There are however indications that brain tissue water content 
could vary widely in certain disease conditions such as in brain tumors and 
inflammation. In such situations, absolute metabolite quantification using the 
literature estimates of tissue water content will be inaccurate while the 
measurement of cerebral water content using the available techniques will be 
impractical for the patients due to scanning time considerations. It is therefore 
necessary to develop a technique that can be used to quantify both the 
reference water and metabolite concentrations, simultaneously without 
subject tolerance issues.  
 
The main objective of this thesis was to investigate the response of water NMR 
signal from human brain tissue under various measurement conditions using the 
single-voxel 1H-MRS technique. As part of the investigation, the thesis also 
focused on the development of methods for the absolute quantification of 
cerebral water and metabolite concentrations.  
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A standard 1H-MRS water-suppressed acquisition on the General Electric (GE) 
MR scanner acquires some unsuppressed-water spectra at the beginning of the 
PRESS pulse sequence. Using the Spectroscopy Analysis by GE (SAGE) software 
package (version 7), this thesis developed methods to optimise the 
unsuppressed-water and suppressed-water signals from which, respectively, 
cerebral water and metabolite concentrations were estimated.    
 
The unsuppressed-water signal response characteristics were investigated in 
experiments at 3 T that involved: 1) variation of the MRS voxel position over a 
three-dimensional RF field within an eight-channel head coil; 2) measurement 
of the relaxation times of brain tissue water using standard saturation recovery 
and multi spin-echo MRS techniques; 3) measurement of brain tissue water 
content in peripheral inflammation; and 4) estimation of the BOLD effect on 
the water spectral peak. 
 
The stability of the MR scanner used for all the investigations was assessed. 
Over the project period, the worst precision measurements of the scanner (for 
both water and metabolite signals) were observed to be about 12 % and 26 % in 
serial phantom and human studies, respectively. The MRI/MRS scanner was 
therefore found to measure water and metabolite signals with good precision, 
both in vivo and in vitro.  
 
By recording the water NMR signal responses at various locations within the 
phased-array head coil, RF sensitivity profile (voxel position-dependent) 
equations of the head coil were obtained. The coordinates of any in vivo voxel 
could be substituted into an appropriate profile equation to estimate an 
unsuppressed-water signal area that could be used as a reference signal to 
quantify brain tissue water content. This novel technique of quantifying 
cerebral water content is superior to the previous techniques of performing 
multi-echo unsuppressed-water signal acquisitions. The method does not 
require extra unsuppressed-water acquisitions, or corrections for variations in 
the sensitivity of the eight-channel head coil as both the in vivo and reference 
signals are acquired from the same voxel position.  
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Brain tissue water content was subsequently quantified accurately using the 
newly developed method of referencing. In frontal brain voxels, the average 
water content, WC of grey matter, GM was found to be higher than that of 
white matter, WM (GM/WM WC ± SE = 46.37 ± 2.58/42.86 ± 2.46 mol/kg; p = 
0.02); parietal voxels also showed a similar comparison (GM/WM WC ± SE = 
37.23 ± 1.70/34.14 ± 2.02 mol/kg; p = 0.03). These findings were consistent 
with previous reports of cerebral water content. For regions of mixed 
proportions of grey and white matter tissues, the average water contents of 
each tissue type considered separately (by voxel segmentation) and together 
were found to compare with literature estimates. Using data from five voxel 
positions, average brain tissue water content was observed to be uniformly 
distributed across the human brain by one-way ANOVA (p = 0.60), and did not 
vary significantly with gender (p > 0.05) and age (p > 0.05).  
 
For the first time, cerebral water content was observed in this thesis to remain 
fairly constant in psoriatic arthritis, a peripheral inflammatory condition (one-
way ANOVA, p = 0.63). Among five brain metabolites quantified in the psoriasis 
patients, only the mean concentration of creatine, Cr was found to be 
significantly lower in the frontal grey matter voxels of the patients, PsA 
compared to healthy controls, HC at baseline (PsA/HC ± SE = 6.34 ± 0.38/7.78 ± 
0.38 mM/kg; p = 0.01) and post-TNF-α blockade medication (PsA/HC ± SE = 
6.69 ± 0.25/7.78 ± 0.38 mM/kg; p = 0.03). None of the metabolite 
concentrations, including Cr (p = 0.27), changed significantly with medication. 
The condition of PsA was not observed to affect the mood of the patients, as 
indicated by their BDI scores. The significant finding of Cr concentration 
alteration in psoriatic arthritis thus suggests that Cr may not be a reliable 
denominator in studies of psoriasis that express the metabolite levels as ratios.      
 
The T1 and T2 relaxation times of water and the metabolites were measured in 
the prefrontal grey matter (T1/T2 ± SE = 1574 ± 61/147 ± 6 ms) and bilateral 
Hippocampi (T1/T2 ± SE; left = 1475 ± 68/178 ± 83 ms, right = 1389 ± 58/273 ± 
98 ms). The relaxation time estimates for the metabolites were in agreement 
with literature values; relaxation times for water however were measured for 
the first time in those regions and at 3 T. The measured relaxation times were 
used to correct the water and metabolite signals for relaxation effects during 
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their absolute quantification, and could as well serve the same purpose in 
future studies. 
 
There is increasing interest in the BOLD response of cerebral metabolites and 
water during tasks. This thesis thus also assessed changes in brain tissue 
metabolite and water contents while a subject experienced a visual stimulus. 
In the presence of the visual stimulus, the BOLD effects on the metabolite and 
water spectral peaks were found to be comparable, as has been observed in 
previous studies. For the first time, this thesis further investigated the impact 
of temporal resolution (determined by NEX) on the amount of the BOLD signal 
acquired from cerebral water and metabolites. In a single visual activation 
paradigm, the BOLD effect resulted in increased water peak area which 
differed significantly between NEX values of 2 and 8 (p < 0.01); this observation 
also was true for NAA and Glu. The findings thus suggest that temporal 
resolution of the MRS data could result in significant differences in the results 
of functional MRS studies. 
 
In conclusion, by its detailed investigations of the water signal characteristics 
and newly developed methods for the absolute quantification of cerebral water 
and metabolite concentrations, this thesis has corroborated the suitability of 
the brain tissue water signal as a reference and has also improved on the 
accuracy of quantitative MRS using the endogenous water signal as a reference 
standard. The techniques presented in this thesis can thus be applied in future 
1H-MRS brain studies where the endogenous unsuppressed-water signal is 
required.  
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 Chapter 1: Introduction 
 
 
1.1 Overview of MR Spectroscopy as Applied in this 
Thesis  
 
 1.1.1 Advances in MR Spectroscopy  
 
    
Historically, Magnetic Resonance Spectroscopy (MRS) was an analytical method 
in Chemistry that was used for the identification and quantification of chemical 
species in samples. In clinical practice, presently, it is a non-invasive research 
tool that provides in vivo information about the chemical composition and 
metabolism of a part of the human body under investigation. In vivo MRS is 
basically a complementary method to diagnostic imaging and can be used, for 
example, in the detailed analysis of primary and secondary brain tumours and 
metabolic diseases [1]. Clinical MRS is a relatively new and advanced technique 
of in vivo Nuclear Magnetic Resonance (NMR).  
 
 
The NMR effect of a nucleus was discovered in 1938 by Isidor Isaac Rabi (Nobel 
Prize 1944) [2]. NMR in condensed matter was first achieved in 1946 
simultaneously by two independent groups led by  Felix Bloch of Stanford 
University [3] and Edward Mills Purcell of Harvard University [4] (Nobel Prize 
1952). At this time, NMR was only experimental until in the 1950s when the 
creation of a one-dimensional NMR image was first described by Herman Carr 
[5]. The application of Fourier analysis to NMR by Richard Ernst in 1966 (Nobel 
Prize 1991) [6] dramatically improved the efficiency of NMR imaging. In 1973, 
Paul Lauterbur (Nobel Prize 2003) expanded on Carr’s technique and generated 
the first NMR images (of water filled tubes) in 2D and 3D using gradients [7]. 
Lauterbur later published the first cross-sectional NMR image of a living mouse 
in 1974 [8]. The first NMR image of a human body part (the finger) was 
acquired by Peter Mansfield of the University of Nottingham, England in 1976 
[9]. During his research on the analytical properties of NMR, Raymond 
Damadian created the world’s first whole-body NMR imaging machine in 1972 
[10]. Damadian and his colleagues subsequently performed the first whole-body 
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NMR imaging scan of a human being in 1977 [11]. Peter Mansfield and his team 
again developed a mathematical technique to speed up NMR imaging scan 
times and to also improve the NMR image quality in 1978 [12].  
  
 
The first NMR Spectroscopy experiments, observing the 31P nucleus, were 
reported in 1973 by Moon and Richards [13] who determined intact red blood 
intracellular pH from chemical shift differences and in 1974 by Hoult and 
colleagues [14] who first studied intact, excised rat hind leg. NMR Spectroscopy 
at this time was originally concerned with identifying chemical compounds in 
samples and there was no spatial information contained in the data (i.e. it was 
not associated with NMR imaging) [1]. NMR Spectroscopy therefore developed 
separately from NMR imaging on different machines at that time. During the 
1980s, Paul Bottomley of General Electric (GE) research centre, New York 
developed the first whole-body clinical NMR imaging and spectroscopy scanner 
at 1.5T. In 1985, Bottomley performed the first localised in vivo proton (1H) 
NMR Spectroscopy in the human brain on their 1.5T NMR imaging/spectroscopy 
scanner [15].  
 
Despite its high natural abundance of 99.985 % and having the greatest NMR-
sensitivity [16, 17], previous NMR Spectroscopy experiments could not study 
the 1H nucleus because its presence in vivo is predominantly in water whose 
concentration is in the order of about 104 larger than the concentrations of the 
metabolites of interest. Suppression of the solvent, including lipid, signal thus 
became essential but remained a challenge [15]; consequently limiting the 
early in vivo NMR Spectroscopy studies to the 31P nucleus when, in practice, it 
is the 1H NMR spectrum that is altered in almost all neurological disorders [18].  
 
The 1985 pioneering 1H-NMR Spectroscopy study by Bottomley et al was further 
refined by Frahm et al in 1987 who published [19] the various metabolites 
detected in vivo with 1H-NMR Spectroscopy; this was then followed by the work 
of Narayana and colleagues who in 1989 also published the first paper [20] on 
quantification of the metabolites detected by 1H-NMR Spectroscopy in the 
human brain. 
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Since these studies, improvements have been made in modern clinical NMR 
imaging/spectroscopy scanners especially related to higher field strengths for 
imaging and spectral localisation. These advances have aided the proliferation 
of the use of 1H-NMR Spectroscopy in examining various pathologies in the 
human body. In particular, neurological pathologies that have been studied 
with 1H-NMR Spectroscopy include stroke [21], multiple sclerosis [22], brain 
tumours [23], Alzheimer’s disease [24], dementia [25], schizophrenia [26], 
bipolar disorders [27], and major depression [28]. Later on, in vivo NMR 
imaging was renamed MRI (Magnetic Resonance Imaging) whereas in vivo NMR 
Spectroscopy was renamed MRS (Magnetic Resonance Spectroscopy) by US 
radiologists to prevent the public being alarmed with the term “nuclear” [1]. 
The term “nuclear” was also reported to be constantly and erroneously 
associated with Nuclear Medicine. Thus, in subsequent discussions in this 
thesis, MRI and MRS will be used for NMR imaging and NMR Spectroscopy 
respectively. 
 
  
1.1.2 MR Spectroscopy in Practice 
  
 
MRI provides anatomical information by using pulsed static magnetic fields to 
record spatially encoded signals from protons in a localised region of the body 
while MRS uses magnetic field gradients to gain information on the spatial 
distribution of nuclei within a specific anatomical region of the body. In 
practice, MRS is guided by an MRI localised anatomical region to acquire signals 
from chemical species (usually called metabolites) which contain either 
protons (1H) or any one of the other NMR-sensitive nuclei such as 13C, 31P and 
19F. Thus, a typical MRS examination of any anatomical region is preceded by 
the MRI acquisition of that region using the MR scanner (Figure 1.1a). For 
instance, all the in vivo experiments in this thesis were performed in the 
human brain, and so MRI of the brain was acquired in each case before MRS 
localisation; all MRS localisations were performed using the phased-array head 
coil (Figure 1.1b). The MRS localised region is called a volume element or 
voxel. Two MRS localisation techniques are available: single-voxel MRS (SV-
MRS) and MRS imaging (MRSI). Both techniques are discussed in detail in section 
2.2.4. MRS data may be evaluated either by visual inspection [29] or 
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quantification [1] of the spectra. This thesis will however focus on quantitative 
SV 1H-MRS examination of the human brain. 
   
 
 
          
 
 
 
 
 
Figure 1.1: A clinical whole-body MRI scanner(a) equipped with a phased-array head coil (b) 
used to acquire MRI of the brain (c) and to localise spectra to the frontal region of the brain 
(d). The patient rests their head on the padding in the head coil (e). 
 
1.1.3 Overview and Objective of this Thesis  
 
 
The utility of MRS lies in the accurate quantification of the metabolite spectra. 
Quantified spectrum in this sense will make it possible for MRS data 
interpretation to be objective, reproducible and comparable between studies. 
In addition, spectral quantification will enhance the reliability of MRS and 
(c) 
(a) 
(b) 
(d) 
(e) 
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enable the direct evaluation of biological changes in disease progression and 
recovery following treatment [1, 30].  
 
In brain studies, most of the regions of interest are commonly small and 
curved. This means that in SV-MRS, spectra will have to be localised to smaller 
voxels (typically 1 cm3 cuboid or cube) at the expense of poorer signal-to-noise 
ratio (SNR). The use of larger voxel sizes to increase SNR on the other hand will 
mean that spectra will be contaminated by signals originating from outside the 
region of interest and/or cerebrospinal fluid (CSF). Signal contribution to the 
acquired MRS signal by CSF is usually referred to as the partial volume effect 
(PVE). The use of larger voxel sizes without PVE correction (PVEC) will result in 
inaccuracies of the quantified concentrations [1].  
 
In quantitative MRS, the area under each spectral peak is proportional to the 
concentration of the metabolite they represent [31]. However, these spectral 
areas largely depend on the T2 relaxation times of protons in the chemical 
structures of the metabolites. Depending on the spectral acquisition 
parameters used, the spectral areas (and hence the calculated concentrations) 
could be over- or underestimated. To minimise this error arising from 
relaxation effects, the relaxation times for the respective metabolites are used 
to deduce correction factors for relaxation effect correction (REC).  The final 
result of the REC method is that each spectral peak area is appropriately 
adjusted for signal losses it might have suffered due to the relaxation effects.  
 
Concentration estimates in quantitative MRS can be expressed in two ways: 
ratio and absolute units (details in section 4.1.1). In either units of expression, 
a standard concentration is required. The absolute quantification method was 
implemented in this thesis. In the absolute unit expression, the standard 
concentration is usually known (either by assumption or from a separate 
measurement). This known standard concentration in millimolar (mM) units is 
then used to convert the metabolite peak area unit from arbitrary to 
concentration units. The unit conversion process is usually in two stages (see 
equation 1.4): firstly, the ratio of the spectral peak areas (after PVEC and REC) 
of the metabolite and the standard solution is evaluated; secondly, this ratio is 
multiplied by the mM standard concentration. Thus, after the second step, the 
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concentration of the metabolite is obtained in mM units. The rationale for this 
thesis was the practical assessment of a chosen standard concentration for its 
suitability in absolute quantitative SV-MRS. 
  
The requirement of the standard concentration is that its value should remain 
fairly constant over time. Such a standard concentration could either be an 
external solution or an internal metabolite within brain tissue (details in 
section 4.1.2). Water within brain tissue was used as the reference 
concentration in this thesis (chapter 7). However, the focus of this thesis was 
not only on the development of methods of absolute quantification of cerebral 
water content (chapter 6) and metabolite concentrations (chapter 7). The main 
focus, and theme, of this thesis was the investigation of the NMR response 
characteristics of cerebral water under different experimental situations: RF 
coil sensitivity profiling (chapter 4), relaxation time measurements (chapter 5), 
assessment of regional distribution of cerebral water content (chapter 6), 
peripheral inflammation (chapter 7), and visual stimulation (chapter 8). These 
experimental conditions were chosen for two reasons: firstly, they represent 
some of the most common clinical situations encountered in human MRS 
studies. Secondly, they were thought to be potential ways by which substantial 
changes in the cerebral water signal could be obtained (i.e. the water NMR 
signal was likely to be more sensitive, or respond, to how those conditions 
changed in the experiments). 
  
The development of absolute quantitative methods (for cerebral water and 
metabolites) aspects of this thesis also involved the use of the water signal, 
measured in vitro and in vivo. All experiments in this thesis were performed 
using the phased-array coil (Figure 1.1b). Most of the recent clinical MRI 
scanners are equipped with this type of head coil to improve signal-to-noise 
ratio of MRI [32]. However, the implication of these coils for SV-MRS is that 
metabolite signal intensities are affected by the relative position of each 
receiver coil element from the SV-MRS localised region [1]. This RF coil 
response characteristics was made use of in this thesis: the RF response 
profiles (plots of the water spectral peak areas) for various voxel positions 
were deduced mathematically from in vitro experiments (chapter 4) such that 
each profile equation was a function of voxel position.  
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The RF response profiles provided information on the NMR response 
characteristics of water, in vitro and at the same time were used to calculate 
reference water signal areas for in vivo acquisitions (by substitution of the in 
vivo voxel coordinates into the deduced RF profile equations). The calculated 
in vivo water signal area (from the equations) was then used as a reference 
signal in the quantification of cerebral water content (chapters 6 and 7). 
 
From the same acquisition and voxel position, metabolite and water signal 
areas were obtained in vivo. Using the water signal as a reference 
concentration, the concentrations of the metabolites were calculated (chapter 
7). Such an absolute quantitative method was not affected by the non-uniform 
RF response characteristics of the phased-array coil, circumventing the need 
for signal non-uniformity correction.  
 
The objective of this thesis was to investigate how cerebral water NMR signal 
varies in response to various experimental conditions in order to ascertain its 
suitability as a reference concentration in novel absolute quantitative methods 
developed herein. This thesis therefore is a cohesive body of work that seeks to 
corroborate or otherwise previous studies that have suggested the use of 
cerebral water as a suitable standard concentration.  
 
Since this thesis focuses on brain tissue water content, it is necessary to discuss 
the biological significance of water in cellular tissue function (section 1.2) and 
its relevance in MRI (section 1.3) and quantitative MRS (section 1.4).  
 
1.2 The Role of Water in Neurophysiology 
  
  
This section aims to discuss only the role of water in tissue function, focusing 
on the human brain. Even though the emphasis is on the brain, the underlining 
role played by water discussed here is not limited to only brain tissues but is 
applicable to the whole body.  
Water is the most abundant substance in, and the most important component 
of, the human body.  It comprises about three quarters of the human mass and 
is a major component in every cell. The unique structure of water (i.e. its 
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bipolar ends) gives it properties that enable it to play many biological roles. 
Primarily, the presence of water is that which provides life for cells and 
consequently living organisms. This is because its involvement in 
photosynthesis produces oxygen that we breathe and utilise for all life 
sustaining processes that occur at the cellular level. Water within cells plays 
important roles in metabolism, excretion, temperature regulation and 
structural support. It is therefore an element of extreme importance 
supporting all physiological activities of living cells. For this reason, the body 
has an adaptive mechanism (involving the secretion of hormones by the 
pituitary glands that signal the kidneys to reabsorb water) to maintain constant 
cellular tissue water content so that too much water does not leave the body. 
When the body lacks water, brain cells and other neurons shrink and 
biochemical processes involved in cellular communication slow down. A 
constant tissue water content is thus critical because dehydration, even as 
little as 2 % loss of body weight, results in impaired physiological (e.g. 
visuomotor tracking, psychomotor speed and thermoregulatory responses) and 
performance (e.g. mood, cognition and physical activity level) responses; and 
the body can collapse when water loss approaches 7 % [33-37]. However, the 
lowest levels of dehydration that produce significant effects on cognitive 
performance and mood have not been established [25]. 
The human brain is about 77-78 % water [38] which is distributed within the 
brain cells and also bathes the cells. This intra and extra cellular water 
distribution provides a medium for communication among all the brain cells 
and also gives structure and shape to the cells. Nutrients and other important 
substances required for cell function are then transported in the water medium 
by diffusion or osmosis between the cells.  This process of communication 
between the cells is only possible when what is being transported is water 
soluble [39].  
Within the water molecule, the charge distribution is such that one end of the 
molecule is slightly negative while the other end is slightly positive (section 
2.2.6.1); water is therefore said to be polarised. This charge distribution within 
the water molecule gives it an electrical conducting property. Thus, the 
electrical potential of water makes it a reactant in intracellular reactions. 
40 
 
Being a reactant in this case, it helps in the formation of electrical pathways 
through which signals and other ions are conducted between the brain neurons. 
The electrical pathway further links the various parts of the body to the central 
nervous system (which includes the brain) through nerve formations. This link 
provides a communication channel to conduct impulses between the brain and 
other parts of the body.   
The energy required for the normal functioning of the brain comes from 
nutrients that are dissolved in water first, before being transported by blood to 
the brain tissue. Enzymes, hormones and coenzymes that aid the breakdown 
process of the nutrients (i.e. amino acids, carbohydrates, vitamins and 
minerals) are also dissolved in water. By the process of hydrolysis, the cells 
then use water to separate a phosphate group from adenosine triphosphate 
(ATP) or an analogue of ATP such as guanosine triphosphate (GTP) in the 
nutrients to produce energy [40] as illustrated by the following equations:   
ATP + H2O = Energy + ADP + Inorganic Phosphate                      (Eq. 1.1)  
GTP + H2O = Energy + GDP + Inorganic Phosphate                                 (Eq. 1.2) 
 
This is the same mechanism by which the major excitatory neurotransmitter 
called glutamate is produced:  
Glutamine + H2O = Glutamate + NH4+                                                  (Eq. 1.3)  
Glutamate is considered to be the major mediator of excitatory signals in the 
central nervous system and is involved in most aspects of normal brain function 
including cognition, memory and learning [41]. 
As the energy is utilised by the brain, heat and other waste products (such as 
carbon dioxide) are produced. The presence of water within and around the 
brain cells provides a ‘heat sink’ or cooling medium to help (the 
hypothalamus/pituitary gland) in the regulation of the core brain temperature; 
and to also serve as a solvent for the waste products. As a solvent containing 
the waste substances, water is directly or indirectly involved in their transport 
to their points of excretion. 
 
41 
 
1.3 The Relevance of Tissue Water in MRI 
   
MRI produces images whose intensities reflect the intrinsic NMR characteristics 
of tissues. The NMR characteristics of tissues that define contrast in the MR 
image are related to proton density, relaxation (T1 and T2), flow and diffusion 
of tissue water. It is the amount of binding of tissue water that produces the 
differences in T1 and T2 relaxation times between tissues [1]. By manipulating 
these characteristics of tissue water in a desired way (using the MR scanner), 
various contrasts can be produced in MR imaging as discussed in the following 
subsections. All the contrast types discussed in these subsections were 
produced in the MRI acquisitions of this thesis. 
 
1.3.1 Proton Density 
     
Proton density MRI relies mainly on protons (i.e. 1H atoms) in free water within 
tissue. This is because these are the only protons that contribute to the MR 
signal. The concentration of MRI-visible protons in a tissue, relative to that in 
the same volume of water at the same temperature is referred to as the proton 
density (PD) of the tissue [1]. By using a short echo time (TE) and a long 
repetition time (TR), a PD-weighted MR image (Figure 1.2) can be generated, 
with intensity related to tissue water content. In the brain, where most mobile 
protons are in water, the PD image provides a direct measure of tissue water 
content [1]. PD-weighted image intensity thus increases with oedema, 
inflammation or demyelinating disease since any one of these conditions 
increases tissue water content within the affected location [42]. 
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Figure 1.2: A PD-weighted axial MR image of the brain 
 
1.3.2 Proton Relaxation 
   
  
Free water protons are in constant random motion and in the process may 
either lose energy to their surroundings or change their interactions with one 
another. The energy loss process is measured by a time-constant called T1 
relaxation time (section 2.1.2.1), whereas the change in interaction process is 
measured by a time-constant called T2 relaxation time (section 2.1.2.2). Both 
processes occur simultaneously but independently of each other. The T1 and T2 
relaxation times of tissue water protons are very essential to MRI. This is 
because both relaxation times help define contrast in MRI: for example, using 
particular values of TE and TR, increased MR signal will be acquired from 
tissues with longer T2 relaxation times; decreased signal will be acquired from 
those tissues with longer T1 relaxation times. An MR image may thus be T2-
weighted, T1-weighted or it may have a contrast generally defined by a 
combination of the two with other tissue NMR characteristics such as proton 
cross-relaxation, flow or diffusion. When both TR and TE are short, a T1-
weighted contrast (Figure 7.1a) is produced, whereas both long TR and TE will 
produce a T2-weighted contrast (Figure 7.1b). 
  
1.3.3 Tissue-bound Protons 
    
In addition to the free water protons, biological tissues also contain a specific 
pool of protons bound in macromolecules (usually proteins). These 
macromolecular protons however cannot directly contribute to the MR signal 
43 
 
because they have very short T1 relaxation times due to their constrained 
motion – i.e. the protons have a short relaxation time compared to the time 
required to make an NMR measurement. They have a wider range of Larmor 
frequencies than free water protons. Therefore MRI of a tissue with a large 
pool of these bound water protons could involve exciting only the tissue at a 
frequency slightly greater or lesser than the Larmor frequency of the free 
protons; the excitation pulse does not directly affect those protons in free 
water. Repeated delivery of the off-resonant radiofrequency pulses to the 
tissue saturates the magnetization of the bound protons from where it (i.e. the 
magnetisation) is transferred to free protons nearby by a cross-relaxation 
process. The free water protons then mirror, in magnitude, the 
macromolecular content of the tissue being studied. This process by which 
water serves as a ‘transcription medium’ for MR imaging of macromolecules is 
called Magnetisation Transfer (MT) imaging (Figure 1.3). The concentration of 
macromolecules and their interaction with free water defines the contrast in 
MT imaging (Figures 1.4a-b). 
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Figure 1.3: Generation of magnetisation transfer contrast (MTC) in MT Imaging 
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Figure 1.4: Axial MRI of the same subject acquired with the MT pulse switched OFF (a) and 
ON (b) 
Note that white matter (WM) tissue is brighter in the MT OFF than in the MT ON image. This is 
because WM tissue is made up mainly of myelin which has a lot of water trapped in sheaths. It 
is this bound water content of the WM tissue that makes it respond more to the MT effect 
compared to grey matter tissue.   
 
1.3.4 BOLD Contrast 
 
 
Blood plasma is the component of blood that normally holds the blood cells. It 
is almost 92 % water by volume and 8 % of proteins, metabolites and ions. It 
serves as the main medium for transportation of materials including 
oxygenated blood in the body [40]. Blood flow could therefore be seen as being 
due to plasma, which is water. Regional blood flow is closely related to neural 
activity, and produces a sensitive MR imaging contrast mechanism which 
dependends on blood oxygen level, known as blood oxygen level dependent 
(BOLD) contrast. Neural activity causes blood to become deoxygenated; this 
creates a susceptibility difference between vessels carrying this blood and their 
surrounding tissue. Such susceptibility differences cause a decrease in the MR 
proton signal due mainly to pseudo-relaxation (dephasing) process measured by 
a time constant denoted by T2*(more in section 8.1.1). Thus in a T2*-weighted 
MR image, the presence of deoxygenated blood (which is paramagnetic) in 
vessels causes pixels containing those vessels to appear darker. Upon neural 
activity, there is an increased supply or flow of oxygenated blood (which is 
diamagnetic) to vessels and so the T2*-weighted image becomes brighter in 
(a) (b) 
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those pixels containing these vessels (Figure 8.3a-b). This type of MR imaging 
that relies on the BOLD contrast mechanism is called functional MRI (fMRI).  
 
  
1.4 The Relevance of Tissue Water in MRS 
 
 
For in vivo MRS, water provides the medium for all the biochemical reactions 
involving the metabolites being studied. Mobility of the metabolite molecules 
makes MRS feasible, and these molecules are mobilised by water (section 1.2). 
The mobility of the metabolite molecules depends on the nature of their 
chemical bonds; the relative mobility in turn influences how the molecules 
interact with one another. For a given metabolite, its position on the 
frequency axis is determined by the degree of shielding of its protons by 
neighbouring atoms; whereas the interaction of its molecules determines the 
splitting of its spectral peak. A certain number of protons in the molecular 
structure of each metabolite determines the intensity of the spectral peak of 
that metabolite (details in sections 2.2.1-2). In particular, the frequency 
positions of the spectral peaks are unique and specific to each metabolite, and 
are therefore used in the identification of the metabolites. 
 
Aside from the major role water plays in MR spectral peak characterisation and 
identification as mentioned above, it is also relevant mostly in spectral 
processing and quantification in MRS. In the following subsections, the 
relevance of water in MRS that have been applied in this thesis are discussed; 
only MRS thermometry (section 1.4.2) has not been applied in this thesis but 
has been discussed in order to introduce the concept of brain temperature 
measurements using the MRS technique. This would then make it clearer when 
MRS thermometry is suggested as one of the possible research areas where the 
methods developed in this thesis could be applied (see section 9.3.2).    
   
1.4.1 Reference Standard 
 
 
Tissue water contributes a large quantifiable peak in the MR spectrum 
(Figure1.5) that can be used as an internal reference standard to quantify the 
metabolites. In most MRS studies, the unsuppressed-water signal is acquired 
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separately (from the metabolite spectra) for this purpose. However, as in this 
thesis, it is also possible to acquire both the reference water and metabolite 
spectra at the same time (section 2.3.1.3). These two acquisition methods use 
the water peak area together with the molar concentration of tissue water 
(~55.51 mol/L) in a model to estimate the metabolite concentrations. 
Generally, such models take the form: 
 
[Metabolite] = Ametabolite/Astandard x (Correction factors) x [Standard]     (Eq. 1.4) 
 
In this model, [Metabolite] is the estimated metabolite concentration, Ametabolite 
is the area under the metabolite peak whose concentration is to be estimated, 
Astandard is the area under the water peak which is the reference standard and 
[Standard] is the concentration in molar units of pure water which is 
approximately 55.6 mol/L [31]. The correction factors may vary depending on 
the errors that are more likely to affect the measurements and so these may 
vary depending on the study.          
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Figure 1.5: MR Spectrum showing the large residual water peak after its suppression 
The figure also illustrates the importance of suppressing the water signal: the metabolites of 
interest have a signal more than one hundred times smaller than that of the water peak, and 
without water suppression will be poorly resolved.  
 
1.4.2 MRS Thermometry 
  
 
The water peak is relevant in non-invasive and in vivo brain temperature 
measurement using MR Spectroscopy. This technique depends on the effect of 
temperature on the water proton chemical shift [43, 44].Temperature drifts 
affect the local magnetic field strength experienced by the water protons in 
their chemical environment. A change in magnetic field strength local to the 
water protons results in a shift in the water peak resonance frequency. This is 
manifested in a ‘displacement’ of the water peak from its normal position on 
the frequency axis of the MR spectrum (Figure 1.6). Cady et al [43] 
investigated this temperature-dependent frequency shift in the brains of 
anaethetised, ventilated new-born piglets, and subsequently estimated the 
Metabolite signals 
Large water signal 
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brain temperature in six new-born human infants using the NAA peak as a 
reference in the following equation:  
 
T = 286.9 - 94(∆H2O – δNAA)                                                               (Eq. 1.5) 
 
In equation 1.5, T is the estimated temperature in degree Celsius, ∆H2O is the 
measured frequency offset of the water peak and δNAA is the chemical shift of 
the reference NAA peak, which is 2.01 ppm.  
 
 
 
 
Figure 1.6: Temperature-dependent frequency shift of the water peak 
Blue line: normal chemical shift of the water peak relative to the NAA peak; green line: 
frequency offset from the reference NAA peak. The new frequency of the water resonance 
peak (green line) is denoted by ∆H2O, and the chemical shift of NAA denoted by δNAA 
 
 
1.4.3 Eddy current correction 
 
 
MR Spectroscopy uses magnetic field gradients to spatially define a voxel to 
which spectra are localised (sections 2.2.3.2-3). Rapid switching of the 
magnetic field gradients (which occurs in every localisation pulse sequence) 
 
Water peak offset 
Reference NAA peak 
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induces eddy currents in the magnetic cryostat. This causes a transient 
distortion of the magnetic field which consequently causes time-dependent 
shifts of the resonance frequency in the selected volume. The effect of eddy 
currents on MRS is that they result in a distorted or poorly resolved spectrum in 
the frequency domain [45, 46].  
 
The eddy current correction procedure involves the use of the unsuppressed- 
water signal as a reference for the water-suppressed signals (i.e. the 
metabolites). Usually, the unsuppressed-water peak is acquired by using the 
same spoiler gradients as the metabolite spectrum and so will be affected by 
the same distortions. Practically, the metabolite signal is divided by the phase 
factor of the water signal for each data point in the time-domain by the 
following derivation [46]:  
 
The received signal, A(t) after phase-sensitive detection, can be described as a 
complex parameter with real part AR(t) and imaginary part AI(t), and phase 
Φ(t). The real and imaginary entities can be described together as a magnitude 
AM(t) as shown in the following equations: 
 
A(t) = [AR(t) + iAI(t)] e
iΦ(t) = AM(t) e
iΦ(t)                                             (Eq. 1.6) 
 
The transmitter frequency on the MR scanner is tuned to the water resonance 
frequency. Therefore, the time-dependent phase component of the water 
signal (w) is only caused by eddy currents as follows (i.e. modifying equation 
1.6): 
 
Aw = AM,w(t) e
iΦw(t), where Φw(t) = Φeddy(t)                                        (Eq. 1.7) 
The metabolite spectra are water-suppressed. Therefore, the phase of their 
signal, Φs(t) is the sum of the required spectral information, Φreq(t) and the 
effect of eddy currents, Φeddy(t): 
Asuppressed = AM,s(t) e
iΦs(t), where Φs(t) = Φreq(t) + Φeddy(t)                 (Eq. 1.8)  
 
Dividing the suppressed signal (i.e. equation 1.8) by the phase factor of the 
water signal (in equation 1.7) results in the cancellation of the effect of eddy 
currents as shown in the following equation: 
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Acorrected = AM,s(t) e
iΦs(t)/ eiΦw(t)                                                         (Eq. 1.9) 
 
Hence Acorrected = AM,s(t) e
iΦreq(t), the Fourier transform of which yields a 
spectrum without eddy current effects in the frequency domain. The resulting 
spectrum is also simultaneously phase-corrected with good spectral resolution. 
 
1.4.4 Signal Weighting in Phased-Array Coil Data 
Combination 
  
 
Further to eddy current and phase correction, the unsuppressed-water is also 
of relevance in the determination of signal weights for signal combination in 
phased-array head coils. In an N-channel head coil, the weighting factors are 
determined by [46-48]: 
 
 
 
 
                                                                                                                      (Eq. 1.10) 
 
 
where Aw,k is the maximum  amplitude of the time-domain unsuppressed-water 
signal (obtained by fitting an exponential decay to the data) and Aw,l is the 
unsuppressed-water signal from the individual coil elements.   
 
The subsequent summation procedure used by the N-channel head coil 
combines the individual phase-corrected spectra, Acorrected by using the 
weighted sum in equation 1.9: 
 
 
                                                                               (Eq. 1.11) 
 
 
Asum therefore becomes the amplitude of the localised metabolite signals 
recorded from the MRS voxel. In this thesis, an 8-channel head coil was used; 
therefore N = 8 in equations 1.10 and 1.11.  
 
 
 
Aw, l ∑ Aw, k / Wk = 
l = 1 
N 
N 
k = 1 
Asum(t) =  ∑ Wk·Acorrected, k (t) 
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1.5 Structure and Outline of this Thesis 
 
 
 
The body of this thesis is structured into nine chapters under three main 
sections: background to MRS with regards to the study theme (chapters 1-2), 
experimental results (chapters 3-8), and general conclusions (chapter 9). The 
six results chapters are presented in the format of a typical peer reviewed 
scientific paper (i.e. introduction, methods, results and discussion, and 
summary/conclusions). 
 
An outline, with brief descriptions, of each chapter contained in this thesis is 
as follows:     
 
• Chapter 1; Overview of in vivo MR Spectroscopy, theme of this thesis, its 
objective, structure, and chapter outline. 
 
• Chapter 2; Principles of NMR as applied to MRS, biological significance of 
the MR spectra, analysis of the MR spectra, statistical methods used in 
this thesis, and ethical issues in the human studies of this thesis. 
 
• Chapter 3; Longitudinal reproducibility MRS studies measuring the 
precision of the 1H-MRS signal area estimates, in vitro and in vivo. 
 
• Chapter 4; RF coil sensitivity mapping using the unsuppressed-water 
signal acquired from a phantom.  
  
• Chapter 5; Measurement of brain tissue, metabolite and water relaxation 
times; partial volume correction by voxel localisation, registration and 
segmentation. 
 
• Chapter 6; Quantification of cerebral water content, its assessment by 
brain region, tissue type, gender and age; comparison between MT ratios 
(as measured by MT imaging) and water content (as measured by MRS) of 
the same brain regions.  
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• Chapter 7; Assessment of the changes (compared to controls) in cerebral 
water and metabolite concentrations in psoriatic arthritis. 
 
• Chapter 8; Study of the BOLD changes in cerebral water and metabolite 
resonances during sustained visual stimulation of the visual cortex.  
  
• Chapter 9; Novel contributions of this thesis, methodological limitations, 
and some suggested extensions of this work.  
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Chapter 2: Background 
 
        
 
This chapter introduces the fundamental concepts of Nuclear Magnetic 
Resonance and their application to Magnetic Resonance Spectroscopy (MRS). 
The chapter aims to provide an explanation of: MRS data acquisition, 
interpretation and biological significance of the MR spectra. The chapter 
therefore is of relevance to the understanding of the MRS results presented in 
the subsequent chapters of this thesis.  
 
2.1 Principles of Nuclear Magnetic Resonance 
 
 
Nuclear Magnetic Resonance (NMR) is a physical phenomenon that depends on a 
property called spin, which is possessed by some atomic nuclei. Atomic nuclei 
that contain odd number of protons and/or of neutrons have an intrinsic spin. 
Examples of such nuclei are 1H, 6Li, 7Li, 13C, 14N, 15N, 17O, 19F, 23Na, 31P, 35Cl, and 
39K. Any such nucleus with an intrinsic spin also has a magnetic property and is 
theoretically NMR-sensitive: it is affected by external magnetic fields and 
electromagnetic waves. Such a nucleus must also have a high natural 
abundance and gyromagnetic ratio to generate a large NMR signal. Hydrogen-1 
(1H) is the most commonly studied NMR nucleus due to its high natural 
abundance (99.984 %), high NMR-sensitivity (100 %) and high gyromagnetic ratio 
(26.75 x 10-7 rad/T sec)[17].The 1H atom has only one proton but no neutrons, 
and so is often simply referred to as a “proton”. 
 
The principle of NMR usually involves two sequential steps: 
 
1. The alignment of the magnetic nuclear spins in an external, static 
magnetic field, B0 
 
2. The perturbation of this alignment of the nuclear spins by the use of an 
electromagnetic radiofrequency (RF) pulse. The frequency of the RF pulse 
depends on the nucleus being studied and the strength of B0. 
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The resulting response to these two sequential steps by the nuclear spins, µi is 
the phenomenon that is exploited in Magnetic Resonance Imaging (MRI) and 
Spectroscopy (MRS).  
 
2.1.1 Origin of the NMR Signal 
 
2.1.1.1 Alignment of Magnetic Spins in B0 
 
 
A proton has a positive charge and also rotates about its axis. As a rotating 
mass with an electrical charge, it has magnetic moment and angular 
momentum.  
 
In the presence of an external magnetic field B0, the magnetic moment 
experiences a torque. At the same time, it tries to align with or against the 
direction of B0 (in the case of spin, I = 1/2). As a result, it precesses about the 
axis of B0 at a rate that is proportional to the strength of the applied magnetic 
field. The rate of precession is called the Larmor frequency, which is given by 
the Larmor equation: 
 
ω = γB0                                                                                           (Eq. 2.1) 
 
where ω is the Larmor frequency in megahertz (MHz), B0 is the strength of the 
applied magnetic field in tesla (T) and γ is the gyromagnetic ratio, a constant 
specific to a particular nucleus.  
 
In the absence of an external magnetic field however, a population of protons 
are randomly oriented and there is no net magnetisation (Figure 2.1(A)). When 
exposed to a strong magnetic field B0, the protons tend to align parallel or 
anti-parallel to B0 [for I=1/2, where I is the intrinsic spin of the nucleus] 
(Figure 2.1(B)). The parallel alignment is slightly preferred as it is equivalent to 
spins residing in a lower energy level. 
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Figure 2.1: Alignment of NMR-sensitive spins in the case of I = 1/2 
(A) Spins are randomly aligned in the absence of an external magnetic field but each precesses 
about its axis; (B) When an external magnetic field, B0 is applied, some spins align parallel 
while others align antiparallel to the field. Spins in each alignment resonate in phase with each 
other. Those spins aligned parallel to the field create a net magnetisation, M0.  
 
 
If NP and NA are respectively the numbers of protons in the parallel and anti-
parallel orientations, then the equilibrium populations are given by the 
Boltzmann distribution: 
 
NP/NA = exp(ħω/kT) ≈ 1 + ħω/kT                                                       (Eq. 2.2) 
 
where k is Boltzmann’s constant, ħ is Plank’s constant and T is absolute 
temperature. The fractional excess of protons aligned with B0 is then given by: 
 
(NP-NA)/NA ≈ ħω/kT = ħγB0/kT                                                          (Eq. 2.3) 
 
This fractional excess of protons creates a small collective net equilibrium 
magnetisation M0 which points along the axis of B0. M0 is called the longitudinal 
magnetisation and is the source of the NMR signal. As it has both magnitude 
and direction, the longitudinal magnetisation is considered to be a vector 
visualised in a rotating frame of reference (Figure 2.2). This frame of reference 
has three mutually orthogonal axes, represented by x/, y/ and z/. B0 points in 
the z/-direction and so the longitudinal magnetisation M0 being parallel to B0 
also points in the z/-direction while precessing at a frequency of ω.    
 
M0 B0 
(A) (B) 
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Figure 2.2: Equilibrium magnetisation, M0 aligned parallel to the B0 field in the rotating 
frame of reference 
  
 
2.1.1.2 Irradiation of the B0-aligned Spins with an RF 
Pulse 
 
In order to measure M0, a radiofrequency (RF) field of amplitude B1 is applied 
perpendicularly to B0 (Figure 2.3). The applied RF field oscillates in phase with, 
and at the same rate ω as, the precessing nuclear magnetic moments, µi and 
introduces energy into the spin system. Viewed from the laboratory frame, the 
equilibrium magnetisation, M0 (i.e. the total of the individual µi) lies along the 
+z-axis parallel to B0 in the Cartesian coordinate system. B1 on the other hand 
could be aligned with the laboratory x-axis and can be resolved into two 
components rotating in opposite directions about the z-axis:  one of these 
becomes the required B1 field, in phase with the precessing magnetisation, 
while the other appears to rotate at 2ω relative to the magnetisation, and can 
usually be ignored. 
 
The required B1 field causes M0 to tip away from its parallel position with B0 
toward the transverse plane, and to execute a spiral path, as shown in Figure 
2.3; this is known as excitation. The excitation energy of B1 required to cause 
the tipping of each µi (making up M0) is given by: 
 
∆E = ħγB0                                                                                                                                        (Eq. 2.4) 
 
B0 x/ y
/
 
z/ 
M0 
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If the duration and strength of B1 are sufficient to tip M0 through 90
o, a 
transverse magnetisation will be created and M0 will now lie in the xy-plane 
where it will be denoted by Mxy. This is known as a 90
o or pi/2 pulse. 
Alternatively, if M0 is tipped right over onto the –z direction, this is called a 
180o, pi or inversion pulse. Generally, the RF pulse which rotates the 
longitudinal magnetisation, M0 by an angle of α
ο is called a αο RF pulse. The RF 
pulse angle is normally 90o or 180o in most conventional pulses. Nonetheless, 
low flip angle gradient echo techniques, such as SPGR, are becoming common.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: The B1 field oscillates at the same Larmor frequency as the protons and tips the 
longitudinal magnetisation, M0 into the transverse plane, causing it to execute a spiral 
path. 
M0 is denoted by Mxy in the transverse or xy-plane. This is illustrated in the laboratory frame of 
reference where the three axes are x, y and z and not x/, y/ and z/. 
 
 
When the RF pulse is switched off, M0 continues to precess about B0, describing 
a cone of half-angle α, called the flip angle, as shown in Figure 2.4. For any RF 
pulse, B1 of duration tp, the flip angle is described as: 
 
α = γB1tp                                                                                          (Eq. 2.5) 
 
 
B1 
 z  
M0 
B0 
Mxy 
x 
y  
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Figure 2.4: The longitudinal magnetisation in the absence of B1 describes a cone of half-
angle, α along the z-axis and is now denoted by Mz in the laboratory frame of reference. 
   
# 
2.1.1.3 Generation of the NMR Signal 
 
 
B1 is often called the radiofrequency (RF) field because ω/2pi normally lies 
between 1 MHz and 500 MHz. The B1 field for NMR experiments is generated by 
applying a voltage, oscillating at ω, to the terminals of a suitable RF coil 
surrounding the sample. Whenever the transverse magnetisation Mxy is created 
by the application of B1, it rotates about the z-axis (Figures 2.3-4). This has the 
effect of an electrical generator and induces an alternating voltage of the 
same frequency as the Larmor frequency, ω in a receiver coil. This induced 
voltage is the NMR signal. The strength of this resulting NMR signal can be 
increased by decreasing the temperature T of the study sample (though 
impractical in humans) or increasing the applied magnetic field strength B0 
(equation 2.3) or increasing the flip angle of the RF pulse up to 90ο. The NMR 
signal is then collected and processed with sensitive receivers and computers 
to generate an MR image or spectrum.  
  
 
α 
 z  
Mz 
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2.1.2 Relaxation of the NMR Signal  
 
 
The applied RF field normally disturbs the equilibrium state of the spin system. 
However, as soon as the RF pulse is switched off, the spin system tries to re-
establish equilibrium. The return to equilibrium of the spin system causes the 
NMR signal to gradually decay (Figure 2.5) due to the loss of transverse 
magnetisation with time. This type of decaying signal obtained in the absence 
of the B1 field is called a Free Induction Decay (FID). The processes that 
determine the return to equilibrium of both longitudinal and transverse 
magnetisation are called “spin-lattice” and “spin-spin” interactions, 
respectively. These two processes cause T1 (or spin-lattice) relaxation and T2 
(or spin-spin) relaxation respectively, and are exponential in nature with time 
constants T1 and T2. These two time constants are important for tissue and 
spectral characterisation in MRI and MRS.  
 
 
 
Figure 2.5: Free induction decay (FID) following a 90o excitation pulse 
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  2.1.2.1 T1 Relaxation 
 
 
 
 
 
 
 
 
 
Figure 2.6: Return of the bulk magnetisation to its equilibrium magnetisation, M0 due to 
spin-lattice relaxation with time constant T1.  
The thin blue arrows represent the individual spins, µi making up the equilibrium 
magnetisation, Mo (thick blue arrow). The thick red arrow represents the longitudinal 
magnetisation, Mz recovering monoexponentially towards its initial equilibrium value of Mo 
(from left to right). The last diagram on the right shows the point at which Mz has recovered 
fully to Mo (i.e. Mz = Mo). 
 
 
Spin-lattice or T1 relaxation describes the transfer of energy from the spin 
system to its surroundings, otherwise known as the lattice [32]. The energy 
transfer process causes the longitudinal magnetisation, Mz to gradually recover 
exponentially towards its initial equilibrium value Mo (Figure 2.6). Thus T1 
relaxation is also known as longitudinal relaxation or T1 recovery, described by 
the monoexponential equation: 
 
Mz(t) = M0[1 - exp(-t/T1)]                                                                  (Eq. 2.6) 
 
where Mz(t) is the longitudinal magnetisation at time t, M0 is the equilibrium 
magnetisation and T1 is the longitudinal relaxation time. 
 
The T1 rate constant depends on the strength of the applied magnetic field B0, 
tissue composition, structure, molecular motion and surroundings. Protons in 
different tissues and metabolites therefore have different T1 recovery rates. 
For instance, at 1.5 T, the T1 relaxation time of grey matter tissue is about 
1138 ms whereas that of white matter tissue is about 649 ms [49].  
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  2.1.2.2 T2 Relaxation 
 
 
 
 
 
 
 
 
 
 
Figure 2.7: Loss of phase coherence between neighbouring magnetic moments, µi due to 
spin-spin relaxation causes an exponential decay of the transverse magnetisation, Mxy with 
time constant T2. 
The thick blue arrow represents the transverse magnetisation, Mxy which, due to the T2 
relaxation effect, experiences loss in phase coherence among its component spins, µi (light 
blue arrows); this results in the fanning out of the individual spins, µi while Mxy decays 
exponentially to zero (from left to right).  
 
 
T2 relaxation describes the loss in phase coherence between neighbouring spins 
with time. Each spin experiences the external magnetic field, B0. However, one 
spin affects the other by slightly altering the magnetic field experienced by the 
second spin. The precession rate of the second spin will change slightly, 
causing an increase or decrease in its phase relative to the first spin. Thus, 
these dipole-dipole interactions cause the precession rates of the individual 
spins to vary slightly. The result is that they lose phase coherence (i.e. they no 
longer precess at the same rate as before) and the resultant transverse 
magnetisation Mxy decays gradually to zero as shown in Figure 2.7. The 
relaxation process can be described by the exponential equation: 
 
Mxy(t) = M0,xy exp(-t/T2)                                                                    (Eq. 2.7)  
   
where Mxy(t) is the transverse magnetisation at time t, M0,xy is the initial 
transverse magnetisation (immediately after the RF pulse) and T2 is the 
transverse relaxation time. 
 
This type of relaxation involves energy exchange among only the spins and so is 
called spin-spin relaxation.  
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Spin-spin relaxation time depends on the molecular environment of the spins, 
and so T2 varies between tissues. Free molecules (i.e. spins) in fluids influence 
the phase of each other less than if they were close to one another as in solids. 
Thus, spins in fluids take longer to dephase than those in solids. Fluids 
therefore mostly have longer T2 relaxation times than solids. For instance, in 
tumours where there is more unbound water than in normal tissues, spins take 
longer to dephase. Therefore at 1.5 T, in white matter tissue, lesions have 
longer T2 relaxation times (e.g. 165 ms) compared to normal tissue (98 ms) 
[49].  
 
T1 and T2 relaxation occur simultaneously but are independent of each other. 
Nonetheless, the dephasing of the spins occurs much faster than the recovery 
of longitudinal magnetisation. For this reason, longitudinal magnetisation can 
never be re-established until all the transverse magnetisation has decayed 
away [32]. Hence for a given tissue, T2 is usually about a tenth of T1.The T1 and 
T2 values of CSF however are close at a given field strength: for example, T1 = 
3302 ms and T2 = 2269 ms at 0.15 T [50]. 
  
 
2.1.2.3 T2* Relaxation 
 
 
Intrinsic inhomogeneities caused by the magnetic field generator and by the 
person being examined also contribute to dephasing of the spins [32]. The rate 
of the signal decay caused by these field inhomogeneities is even faster than 
that caused by T2. This second type of decay (or “pseudo-relaxation”) occurs 
with the time constant T2*, which is typically always shorter than T2. The 
observed rate of decay of the NMR signal due to T2* is described as: 
 
1/T2* = 1/T2 + γ∆B0                                                                           (Eq. 2.8) 
 
where ∆B0 is the amount of variation of the applied magnetic field strength 
over the region occupied by the study sample. 
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The T2* effect is more pronounced at tissue borders, particularly at air-tissue 
interfaces, or may be induced by local magnetic fields (e.g. from iron 
particles).  
 
2.1.3 Methods of Measuring Relaxation 
 
 
Measurement of the T1 and T2 relaxation times involves the use of a series of 
RF pulses. These pulses are applied sequentially at predefined time intervals in 
order to produce varying signal intensities with respect to the time intervals. 
Such a group of applied RF pulses is known as a “pulse sequence”. The most 
common pulse sequences for measuring T1 and T2 relaxation times are 
described in the following subsections. These sequences have been used in this 
thesis for the estimation of relaxation times of brain tissue and metabolites 
(chapter 5).  
 
2.1.3.1 Measurement of T1 Relaxation Time 
 
 
The inversion recovery pulse sequence (Figure 2.8) is used for measuring T1 
relaxation time. It comprises of a 180o pulse, followed after an inversion time, 
TI by a 90o pulse.  
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Figure 2.8: The inversion recovery experiment viewed from the rotating frame of 
reference, x/, y/, z/.  
A 1800 pulse inverts the equilibrium magnetisation into the –z/ plane (a-b). After a time delay 
called the inversion time, TI some amount of signal recovers along the +z/-axis by the T1 
recovery process (c). At the end of the TI time, a 900 pulse is applied to tip any recovered 
longitudinal magnetisation, Mz into the transverse plane; precession of this transverse 
magnetisation, Mxy generates an FID which is the measurable NMR signal (d).    
 
  
The 180o pulse inverts the longitudinal magnetisation onto the –z/ axis such that 
its Mz component has an initial value of –M0 (b). During the inversion time, TI 
the magnetisation recovers towards its equilibrium value of +M0 along the z/ 
axis (c). After the application of the 90o pulse, any Mz component recovered 
(along the z/ axis) is converted into transverse magnetisation, Mxy (d). The 
magnitude and sign of the resulting FID indicates how far the magnetisation 
had recovered along the z/ axis during the TI time (Figure 2.9). 
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Figure 2.9: A plot of the intensity of the recovered magnetisation, Mz versus time, t in the 
inversion recovery experiment. 
At t = 0, the 1800 inversion pulse ends; at t = TI following the inversion pulse, the 90o 
excitation pulse is applied, converting Mz into a transverse magnetisation and generating an FID 
whose intensity is proportional to Mz(TI). Three curves are shown for samples with different T1 
relaxation times: the sample with the shortest T1 (blue line) will appear brightest in an MR 
image because its magnetisation recovers fastest to a large, positive value at t = TI.   
 
  
 
 
By a least-square curve fit (similar to those of Figure 2.9) of the signal 
intensities, S versus their corresponding TI times, T1 can be estimated from the 
exponential equation:  
 
S α Mz(TI) = M0  [1 – 2exp(-TI/T1)]                                                        (Eq. 2.9)  
       
where M0 is the equilibrium magnetisation equivalent to the proton density of 
the sample. 
 
For the T1 measurements in this thesis, the inversion recovery experiment was 
implementable on the MR scanner by varying the repetition time (TR). Signal 
intensity, Mz was therefore a function of TR as follows:  
 
Mz(TR) = M∞ x [1 – exp(-TR/T1)]                                                        (Eq. 2.10) 
 
where M∞ is the signal intensity at the longest possible TR time. 
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2.1.3.2 Measurement of T2 Relaxation Time 
 
 
The spin echo pulse sequence (Figure 2.10) is used to measure T2 relaxation 
time. It comprises a 90o pulse, followed after a time delay of TE/2 by a 180o 
pulse.  
  
                                                                 
                                                                       
 
 
 
 
 
                                                                                                  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.10: The spin-echo experiment viewed from a rotating frame of reference 
A 90o excitation pulse (in the x/-direction) generates an FID in the transverse plane at time 
TE/2 (a). Some spins precess faster (red arrow) than others (blue arrow); this creates a phase 
difference between them (b). After another time delay of TE/2, a 1800 inversion pulse (in the 
y/-direction) inverts the spins (c) such that the faster precessing spins catch up with the slower 
precessing spins (d). The spins intersect (black arrow) at time TE (i.e. TE/2 + TE/2) where the 
maximum spin echo signal is recorded (e).  
 
 
The 90o pulse flips the magnetisation vector, M0 onto the y/ axis (a), where the 
component vectors making up M0 are caused to dephase with respect to one 
another by spin-spin interaction (b). Following the application of the 180o 
pulse, after the waiting time of TE/2, the “fan” of magnetisation vectors is 
90ox 
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flipped over along the –y/ axis (c). The initial dephasing process after the 90o 
pulse is now exactly reversed and the vector sum of the rephrasing 
magnetisation vectors reaches a maximum at time TE, at the centre of an echo 
signal (d). In this case, instead of the initial FID after the 90o pulse, it is rather 
the spin echo signal after the 180o pulse that is acquired (e), the amplitude, S 
of which is given by: 
 
  S = S0 exp(-TE/T2)                                                                           (Eq. 2.11)                 
  
where S0 is the initial amplitude of the FID generated by the 90
o pulse at TE≈0.  
 
The T2 relaxation time can then be estimated from equation 2.11 by 
performing a least-square fit to a few sampled points (at least five) for the 
different echo times used in the experiment. The fit to the data usually takes 
the form of a monoexponential decay curve as shown in Figure 2.11. 
 
    
Figure 2.11: A typical T2 decay curve showing a plot of spin echo signal intensity, S versus 
echo time, TE 
        
       
In section 5.2.1.4, the T2 relaxation time of brain tissue was measured using a 
multi spin-echo pulse sequence commercially available on the GE MR scanner 
used for all the experiments of this thesis. The main advantage of the multi 
spin-echo acquisition is that several echoes can be measured within a 
reasonable experimental time. The technique could, however, measure T2 
inaccurately due to stimulated echoes arising from RF pulse imperfections [51-
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53]. Imperfect 180o pulses do not refocus all the magnetisation in the selected 
slice, thus converting part of the transverse magnetisation into longitudinal 
magnetisation, which is subject to T1 relaxation. The longitudinal components 
are later refocused by the subsequent 180o pulses, resulting in unwanted T1 
relaxation time-dependent echoes [54]. However, the pulse sequence used in 
the acquisitions applies crusher gradients in the slice direction during each 
echo acquisition to reduce the effects of T1 contamination in the image.  
 
The principles of NMR discussed in the preceding sections form the bases of MR 
imaging and spectroscopy. However, further discussion on MR imaging is 
beyond the scope of this thesis; Weishaupt et al [32] provides a good 
background to MR hardware and imaging. Subsequent sections of this chapter 
will discuss the principles of NMR applicable to MR spectroscopy.    
 
2.2 Principles of MR Spectroscopy 
 
 
MR Spectroscopy can also be performed with nuclei that are NMR-sensitive (due 
to their magnetic spin properties) and abundant in a given sample. Examples of 
these nuclei are mentioned in section 2.1.   
 
This section discusses the theory of MR Spectroscopy and its application in 
spectral generation and characterisation. The section concludes with a 
discussion on other factors that can affect the quality of the spectra and 
techniques of minimising them, some of which have been utilised in this thesis. 
   
2.2.1. Chemical Shift 
 
  
When a nucleus is placed in a magnetic field, B0, its electrons circulate in such 
a manner that there is an induced magnetic field, Bi, aligned opposite to the 
main field. This is known as the shielding effect. The effective field, Beff, 
experienced by the nucleus is then reduced by a fraction, δ of B0 given by: 
Beff = B0(1-δ), so that the Larmor frequency (equation 2.1) now becomes: 
 
 ω = γB0(1-δ)                                                                                   (Eq. 2.12) 
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A nucleus with a greater electron cloud density experiences a greater shielding 
effect and thus has a lower Larmor frequency at a given field. In a chemical 
bond, nuclei share their electron clouds and the more electronegative of the 
pair tends to ‘steal’ charge from around the other one. In this case, the 
nucleus whose charge density is reduced by the more electronegative one is 
said to be deshielded. The deshielded nucleus experiences a higher Beff value 
and so resonates at a higher frequency than its unbound state. Hence, the 
chemical environment of a given nucleus affects its resonance frequency. 
 
The shielding effect is expressed in terms of the chemical shift, δcs. This is the 
fractional difference, in parts per million (ppm), between the Larmor 
frequency, ωs of a nucleus in a particular chemical bond and the frequency, 
ωref of the same nucleus in a standard reference compound, expressed as: 
 
 
                                                                                                              (Eq. 2.13) 
 
 
The ppm scale is independent of B0. For in vitro 
1H-MRS, the reference 
compound is usually tetramethyl-silane, TMS [(CH3)4Si)], chosen because it 
contains almost a totally shielded nucleus. Its single peak is assigned a 
chemical shift of 0.0 ppm. TMS is toxic [31] and so in in vivo 1H brain MRS, the 
CH3 peak of N-acetyl aspartate (NAA) is usually the reference standard and δcs 
is expressed in this case as: 
 
 
                                                                                                     (Eq. 2.14) 
 
 
where ωs is the frequency of the sample, ωtransmitter is the frequency of the 
transmitter and offset is a constant that references the ppm scale to the in 
vivo standard (whose chemical shift value is 2.01 ppm). 
 
The chemical shift phenomenon makes it possible for metabolites and other 
resonances to be distinguishable in a spectrum.    
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2.2.2 Spin-Spin Coupling 
 
 
In the presence of a magnetic field, B0, a bond between two nuclei ‘A’ and ‘X’ 
where for instance ‘X’ has an equal chance of being aligned with or against B0, 
nucleus ‘A’ will be split into two equal spectral peaks. The spectral peak of 
nucleus ‘A’ that is coupled to ‘X’ aligned with B0 will have a higher frequency; 
the peak coupled to ‘X’ aligned against B0 will have a lower frequency. This 
frequency modification process by neighbouring nuclei is called spin-spin 
coupling. The J-coupling constant expresses the numerical difference (in hertz) 
between the two resulting frequencies from the same nucleus. It is a unique 
value for every molecule but unlike the chemical shift, it remains constant 
with B0.  
 
Generally, if nucleus ‘A’ is coupled to ‘n’ chemically equivalent ‘X’ nuclei, the 
spectral line of nucleus ‘A’ will be split into ‘n+1’ multiplet peaks. For 
instance, in the spectrum of ethanol, CH3-CH2-OH, the spectral line of the CH3 
group is split into a triplet by its interaction with the CH2 protons while there is 
a reciprocal splitting of the CH2 line into a quartet by its interaction with CH3 
protons. The OH line is split into a triplet by the CH2 protons and each 
component of the CH2 quartet is sub-split into a doublet by the OH proton. 
However, chemically equivalent nuclei (e.g. the three CH3 protons) do not 
produce an observable splitting with each other. The C-C bond here contributes 
to the covalent bond electrons through which these spin-spin interactions take 
place. 
 
 
2.2.3 Water Suppression and MRS Pulse Sequences 
 
 
In the simplest form, such as in analytical chemistry, the MR spectrum from an 
entire uniform sample is collected without any form of spatial information [1]. 
However, in in vivo MR spectroscopy, other techniques are required to isolate 
the spectroscopic signals of interest from those generated by surrounding 
tissues. Early in vivo spectroscopy used a surface coil to restrict the volume of 
tissue from which signal was effectively collected. Signal strength was related 
to distance from the coil but with a limited spatial range [1]. Surface coils 
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were later used with a single slice-select gradient in a sequence known as 
Depth-Resolved Surface-coil Spectroscopy or DRESS [55]. Signals were collected 
from a whole slice with DRESS and so volume selection was poorly defined due 
to the non-uniform RF field distribution of the surface coil. Another 
disadvantage of the use of surface coils for spatial localisation was that it was 
more difficult to localise signal originating from a given volume deep within an 
organ. The technique was therefore limited to signal localisation from 
superficial organs. 
 
Current methods rely on rapidly switched magnetic gradients to achieve spatial 
localisation. A voxel is defined by the intersection of three mutually orthogonal 
slabs, each slab being excited by a spatially selective pulse applied in the 
presence of a gradient (as in the case of slice selection in conventional MRI). 
The water, and sometimes fat, signals are several orders of magnitude larger 
than the signals of interest. The large spectral peak from the unwanted 
water/fat signal can cause distortion of nearby metabolite peaks and so it is 
necessary to suppress the solvent peak. The commonly used water suppression 
and spatial localisation techniques in 1H-MRS are discussed in the following 
subsections. CHESS water suppression and PRESS localisation have been used in 
this thesis. 
       
2.2.3.1 CHEmical Shift Selective (CHESS) Preparation 
  
 
CHESS (Figure 2.12) uses a highly frequency selective 90o pulse to excite only 
those spins present in free water or fat, and a high intensity ‘crusher’ gradient 
to dephase the spins; this process is known as “spoiling”. The RF pulse tips the 
spins through 90o so that at the start of the MRS sequence, the dephased water 
or fat magnetisation lies on the transverse plane and hence has no net z-
component (i.e. T1 recovery is absent).  
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Figure 2.12: The CHESS water/fat suppression module prior to MRS localisation 
 
 
2.2.3.2 Point-RESolved Spectroscopy (PRESS)  
 
 
PRESS uses a 90o slice selective excitation pulse together with two 180o slice 
selective refocusing pulses (Figure 2.13).  
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Figure 2.13: A schematic diagram of the PRESS localisation sequence. 
The large box represents a region of interest on an MR image. Gradient coils (Gx, Gy and Gz) 
generate magnetic fields that vary B0 experienced by spins linearly along the x, y and z 
directions. The RF pulses are applied in the presence of slice selection gradients. Crusher 
gradients (Gc1-Gc4) on each side of the 180
o refocusing pulses are used to ensure that only spins 
within the selected voxel (red box) contribute to the final spin echo while destroying those 
spins outside the voxel. The sequence is repeated at certain intervals, TR so that a number of 
signals can be averaged (NSA). A Fourier transform (FT) of the raw data in the time domain 
gives the spectra in the frequency domain. The actual number of spectral lines stored in the 
MRS data of the above PRESS acquisition is given by NSA/NEX. Thus in a given MRS acquisition, 
while NSA is the number of echoes sampled, NEX determines the number of spectral lines (from 
these echoes) that are stored over a given TR time. These stored spectral lines are those 
processed and quantified to represent the peak parameters (i.e. area, intensity and FWHM) 
using MRS processing software packages. 
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The initial 90o pulse is followed after a time period τ1 by a 180
o refocusing 
pulse. A spin-echo is generated at time 2τ1. A second 180
o pulse is applied to 
refocus this spin-echo at a time delay 2τ2. This produces the final spin-echo 
after time 2τ1 + 2τ2, referred to as the echo time (TE) of the sequence. The 
first spin-echo contains signal originating only from the column that is the 
intersection between the two orthogonal slices selected by the 90o and the 
first 180o pulses. The second spin-echo contains signal only from the 
intersection of the three planes selected by the three pulses. This results in 
the selection of the desired volume (red box). Spins outside of the voxel are 
dephased by large ‘crusher’ gradients (Gc1-Gc4) on each side of the 180
o 
refocusing pulses [31, 56], as shown in Figure 2.13. The block of three pulses 
(90o-180o-180o) is successively repeated to increase the SNR by averaging 
spectra. The number of acquisitions (NSA) is the number of times the sequence 
is repeated (typically 128). The repetition time (TR) is the time interval 
between repetitions of the entire pulse sequence (i.e. between the first 90o 
and the subsequent 90o). The echo time (TE) is the time between the 90o pulse 
and the appearance of the sampled echo signal.     
 
   2.2.3.3 STimulated Echo Acquisition Mode (STEAM)  
 
 
STEAM (Figure 2.14) uses three 90o pulses to generate the signal as a 
stimulated echo rather than a spin-echo. The times between the pulses are τ1, 
τ2 and τ3. The echo time (TE) is given by τ1 + τ3 and τ1 = τ2. The mixing time 
(TM) is the time, τ2 between the second and the third pulses.  
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Figure 2.14: A schematic diagram of the STEAM localisation sequence 
 
 
In the STEAM sequence, only half of the transverse magnetisation produced by 
the first 90o pulse is converted into longitudinal magnetisation by the second 
90o pulse; this reduces SNR by a factor of 2 [31]. Typically, the TE time in 
STEAM is shorter, and so during the TM period, longitudinal magnetisation 
decays with T1 rather than T2. The third RF pulse flips the longitudinal 
magnetisation stored by the second RF pulse back into the transverse plane to 
form the stimulated echo.  
 
Both PRESS and STEAM have advantages and disadvantages: In a PRESS 
sequence, the selective pulses are relatively long and time may also be 
required for eddy currents to die away after gradient switching. This could 
result in significant T2 decay accompanied by loss of SNR [1]. However, STEAM 
has a shorter minimum TE and so the stimulated echo has almost no T2 decay. 
The shorter acquisition time of the STEAM sequence allows more averages to be 
collected in a given time. STEAM also deposits less radiofrequency energy into 
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the subject as it does not use 180o pulses. PRESS depends on the scanner 
generating two accurate 180o pulses which may be difficult depending on local 
field homogeneities. The sequence timing of the 180o sinc pulses used in PRESS 
causes a fall off in flip angles and so the slice profile is not rectangular even 
for perfect homogeneity of the B0 field and uniformity of the RF coil sensitivity. 
Consequently, PRESS localisation causes spectral distortion near the edges of 
the voxel [57]. PRESS has the advantage that it is inherently a factor of two 
more sensitive than STEAM (section 3.3.1). This is because a stimulated echo is 
only half the amplitude of a conventional spin-echo. PRESS therefore is the 
sequence of choice for measuring signals with long T2 values. 
 
Improvements in selective pulses and gradient switching have now allowed for 
shorter TE times with PRESS, and so it is now more widely used as it does not 
have the intrinsic 50 % loss of STEAM [1]. For all the experiments reported in 
this thesis, the PRESS sequence was used because of its high SNR.       
 
 
2.2.4 Types of MRS Localisation 
   
 
Using PRESS or STEAM, MRS data can be collected by two main approaches: 
single-voxel spectroscopy (SVS) and multivoxel spectroscopy (also known as 
magnetic resonance spectroscopic imaging, MRSI). The most common form of 
MRSI is chemical shift imaging (CSI). In SVS, a region of interest is selected and 
one voxel is placed in this region. In CSI, a grid of voxels is placed over the 
region of interest. The CSI data can then be viewed as a matrix of spectra or as 
a colour map of the metabolite concentrations (or metabolite ratios).  
 
Practical disadvantages associated with CSI include adjacent voxel 
contamination and inefficiencies with shimming, water suppression and slice 
selection [31]. The advantage of CSI over SVS, however, is that it allows 
spectral acquisition from many locations simultaneously without prior 
knowledge of the location of any abnormality. Secondly, the CSI grid can be 
shifted to a precise location during post-processing [1, 31]. Nonetheless, 
consistently high quality short TE spectra in vivo are best acquired with SVS. All 
spectra in this thesis were collected using the SVS technique.     
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2.2.5 Echo Times  
 
 
The various metabolites (section 2.2.6) have different molecular structures and 
so their protons are said to reside in different chemical environments. MRS 
signals from the metabolites therefore have different recovery (or T1 
relaxation) and decay (or T2 relaxation) rates. Collecting MRS data at different 
echo times provides information from different number of metabolites. Figures 
2.15 and 2.16 show spectrum collected from an MRS brain phantom (Figure 
2.26) at the same repetition time (TR = 1500 ms), signal averages (NSA = 64) 
but different echo times (TE = 35 ms in Figure 2.15; TE = 144 ms in Figure 
2.16). 
 
A shorter echo time (TE) acquisition, typically 20-40 ms, will produce more 
information in the spectrum because less metabolite signals will have decayed. 
The spectrum will therefore contain more peaks (Figure 2.15). For in vivo 
acquisition, the problem with short TE spectra is that they overlap and contain 
contributions from lipids and macromolecules. A longer TE acquisition 
(typically TE ≥135ms) on the other hand will result in significant signal decay, 
resulting in fewer peaks in the spectrum (Figure 2.16). Lipids and 
macromolecules have short T2 relaxation times; their signals will therefore 
decay, eliminating their contribution in the spectrum. However, potentially 
interesting metabolite peaks are lost from the spectrum. These metabolites 
often have strongly J-coupled spins which undergo destructive interactions so 
that at the TE time, their signals have decayed.   
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Figure 2.15: MR spectrum collected at a short TE 
 
 
 
Figure 2.16: MR spectrum collected at a long TE 
The above spectra were collected using a TE of 144 ms; the lactate doublet is inverted at this 
TE time 
 
 
The choice of TE time in an acquisition therefore depends on the aim of the 
examination. In some cases, it may be beneficial to use both long and short TE 
times in the same examination. Both TE times have been used in this thesis.  
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2.2.6 Neurohistology, Brain Tissue Water and 
Metabolites 
  
 
Before describing the location and biological significance of each brain 
metabolite detected in vivo by 1H-MRS, it is appropriate to briefly discuss the 
cells that make up the central nervous system (CNS).  
 
The CNS is made up of neurons and glial cells. While the neurons transmit 
electrochemical signals through the CNS, glial cells provide support for the 
CNS.  
 
The neuron has three main parts: the cell body, the axons and the dendrites. 
The neuronal cell bodies constitute the grey matter in the brain and the axons 
are projections from each cell body. Signals from the cell body are transmitted 
through the axons. To enhance signal transmission, the axons are wrapped in 
layers of lipid called myelin. The tracts of myelinated axons constitute the 
white matter in the brain and spinal cord. The dendrites are nerve endings that 
receive signals from the axons through synapses.  
 
There are three types of CNS glial cells: astrocytes, oligodendrocytes and 
microglia. Astrocytes provide physical support to the neurons, nourish them, 
regulate the chemicals surrounding them and clean up dead neurons. There are 
more astrocytes in grey matter than there are in white matter. Oligodendrites 
make up the myelin sheath surrounding the axons and so provide physical 
support to the axons. The oligodendrites are therefore predominant in white 
matter. The microglia are the smallest of the CNS glial cells and they clean up 
debris from the CNS.    
 
The following subsections discuss the most 1H-MRS visible brain metabolites in 
vivo using a standard short echo MRS sequence, stating whether they are 
predominantly found in neurons or glia. They are discussed in order of their 
positions on the frequency axis (from left to right) as shown in Figure 2.15. 
There are many other chemicals but due to their low concentrations and 
substantial J-coupling, they contribute MR signals of low SNR and so it is 
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difficult to accurately measure them. Some of these chemicals include N-
Acetyl-aspartyl-glutamate (NAAG), γ-Aminobutyric acid (GABA), glucose and 
taurine. The unsuppressed or residual water peak is usually not shown in the 
spectral display window because its appearance dominates the metabolite 
peaks (Figure 1.10). However, since the focus of this thesis is on brain tissue 
water, it is necessary to mention it here as part of the MR spectrum. 
 
2.2.6.1 Water  
 
 
 
 
 
 
Figure 2.17: Chemical structure of water showing two polar ends: one end is slightly 
negative whereas the other end is slightly positive 
 
 
Water (Figure 2.17) provides the largest peak at 4.70 ppm in the 1H spectrum. 
It is present in all cells and its presence provides a medium for most 
biochemical reactions in the CNS. Brain water is uniformly distributed but 
slightly greater in grey matter than in white matter both in vivo [49, 58, 59] 
and in vitro [60]. Reported brain tissue water content is about 36 moles/kg 
[31, 61]. Due to its abundance and uniform distribution, brain water has been 
suggested to be a reference concentration in absolute metabolite 
quantification [62-64].  
 
Brain water content is increased in inflammation and tumours [1]. In healthy 
tissue, water content could decrease in severe dehydration but this is often 
less than 2 % because water loss above this estimate could be fatal [33-37]. 
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2.2.6.2 myo-Inositol 
 
 
 
 
 
 
 
 
 
Figure 2.18: Chemical structure of myo-inositol 
 
 
Among the nine isomers of inositol, myo-inositol, m-Ins (Figure 2.18) is the 
predominant form found in tissue. Often visible in a spectrum acquired at a 
shorter TE, its signal may contain smaller contributions from inositol 
monophosphate, inositol polyphosphates and glycine. Myo-inositol shows four 
resonances in the spectrum, two of which are prominent: a doublet-of-doublets 
at 3.52 ppm and a triplet at 3.61 ppm. The other two include a triplet at 3.27 
ppm usually obscured by choline, and another at 4.05 ppm which is usually not 
observed due to water suppression [65]. 
 
The function of m-Ins is unclear but it is believed to play a role in various 
neuronal signalling systems [66, 67], metabolism of membrane-bound inositol 
phospholipids [66], cell growth [31], an osmolite (particularly in the 
cerebellum)[66, 68], and a storage form of glucose [68]. It is not present in 
neurons and has been proposed as a glial cell marker [69]. 
 
Brain m-Ins varies regionally, being lowest in white matter, slightly higher in 
cortical grey matter and highest in the cerebellum [70, 71]. Normal brain m-Ins 
concentrations range from 3.8-8.1 mM [72, 73]. Increased levels have been 
associated with diffuse pontine gliomas, diabetes and Alzheimer’s disease, and 
decreased levels with malignant tumours [74] and stroke [1].  
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2.2.6.3 Choline-Containing Compounds  
 
 
 
 
 
 
 
 
Figure 2.19: Chemical structure of choline 
 
 
The choline-containing metabolites include glycerophosphorylcholine (GPC), 
phosphorylcholine (PCh) and free choline. They contribute to a prominent peak 
at 3.2 ppm and secondary peaks at 3.5 and 4.0 ppm. It is often not possible to 
separate their contributions with 1H spectroscopy but they are distinguishable 
with 31P spectroscopy [75]. The combined resonance of the choline-containing 
compounds is therefore often reported as total choline (tCho). However, GPC 
and PCh contribute more to the tCho signal than free choline as it is present in 
smaller amounts (< 0.03 mM) in the brain but could increase significantly in 
tumours [65]. Brain tCho concentration is about 0.9-2.5 mM [73], and is 
reported to vary significantly across the brain and increase with age [1, 65]. 
Because there is more Cho (Figure 2.19) in white matter than in grey matter, 
the level of Cho correlates with the degree of myelination [66, 70], and is 
considered to be a marker of membrane turnover and glial cell integrity.   
 
There are uncertainties associated with the metabolites contributing to the 
tCho signal. Interpretation of alterations in the tCho peak is thus difficult. 
Nonetheless, changes are commonly associated with alterations in membrane 
composition, with increased levels in tumours [74, 76-78], ischemia, head 
trauma, inflammation, multiple sclerosis, Alzheimer’s disease, and decreased 
levels in liver disease [1, 79].  
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2.2.6.4 Creatine 
 
 
 
 
 
       
 
Figure 2.20: Chemical structure of creatine 
 
 
The creatine signal arises from two chemicals: creatine (Cr) and 
phosphocreatine (PCr), both contributing overlapping signals to the resonances 
at 3.03 and 3.93 ppm. Cr (Figure 2.20) synthesis occurs in the kidney and liver. 
It plays a role in the anaerobic storage and production of energy in cells. 
During the energy production process, creatine kinase catalyses the reversible 
transfer of inorganic phosphate (Pi) from PCr and ADP to Cr and ATP. This 
Cr/PCr reaction sustains energy consumption in cells and facilitates ATP 
transfer from the mitochondria to sites where energy is needed. Total Cr is 
therefore thought to be a marker of the energetic status of cells. Regions with 
greater amounts of the creatine kinase enzymes also have high concentrations 
of Cr and PCr. Higher concentrations of these enzymes have been reported in 
cell preparations of astrocytes and oligodendrocytes than in neurons [80, 81]. 
Indeed, the total Cr signal has been reported to be higher in grey matter, at 
6.4-9.7 mM, than in white matter, at 5.2-5.7mM [66, 82]. The total Cr content 
of the human brain ranges from 5.1-10.6 mM [72, 73]. It is low in infants and 
increases with age [1].  
 
It is reported that the Cr peak is relatively stable with no age- [83] or disease- 
related changes. For this reason, it is commonly used as the concentration 
standard in quantifying the other metabolites. However, this assumption is not 
always true: decreased Cr levels have been observed in hypoxia, tumours [78, 
84] and stroke [21], and increased levels in trauma and myotonic dystrophy 
[85]. 
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2.2.6.5 Glutamate and Glutamine 
  
 
   (a)                                                          (b) 
  
 
 
 
 
Figure 2.21: Chemical structures of glutamine (a) and glutamate (b) 
 
 
The chemical structures of glutamine (Gln) and glutamate (Glu) are shown in 
Figures 2.21a and 2.21b respectively. At clinical field strengths (typically 1.5-
3.0 T), Glu and Gln signals overlap and are difficult to be distinguished and 
quantified in vivo due to strong J-coupling effects [1, 65]. They are usually 
observed as a complex overlapping resonance called Glx. The Glx signal also 
contains contributions from GABA, and is only observed at shorter TE 
acquisitions. The Glx complex can be separated by spectral editing or 
homonuclear decoupling techniques [86, 87]. It is also possible to separate the 
resonances at 4 T [88, 89] and when this is possible, the resonance of Glu 
occurs within 2.04-2.35 ppm and that of Gln within 2.12-2.46 ppm [65].    
 
Glu is present in all cells and is synthesised from the precursor α-ketoglutarate 
in the citric acid cycle in mitochondria. Glu acts as the major excitatory 
neurotransmitter in the CNS and so is found in higher concentrations in neurons 
than in glia. Its concentration in grey matter is thus reported to be higher than 
in white matter [66, 70], with brain concentration of 6.0-12.5 mM [70, 72, 73]. 
Gln on the other hand is an inhibitory neurotransmitter predominantly found in 
astrocytes which contain Gln ligase. Due to the larger population of CNS 
astrocytes, Gln concentration in grey matter is higher than in white matter [70] 
and ranges in concentration from 3.0-5.8 mM in the brain [72, 90]. 
 
The Glu/Gln pathway is essential for ammonia detoxification in the liver; they 
are therefore together regarded as amino acid neurotransmitters. If the liver is 
compromised, ammonia detoxification is carried out in the astrocytes by the 
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enzyme glutamine synthetase which combines ammonia and Glu to produce Gln 
[91]. Gln therefore is a storage form of Glu. When the Glu/Gln cycle is altered 
with hyperammonemia, Gln increases significantly. Gln thus acts as a 
biomarker of liver disease and its levels can be monitored in the brain [68, 92]. 
Increased Glu and Gln concentrations have been observed in severe ischaemia, 
hypoxia and hepatic encephalopathy [1, 93, 94], and could both possibly be 
decreased in Alzheimer’s disease [1].    
 
 
2.2.6.6 N-Acetyl Aspartate  
 
 
 
 
 
 
 
 
 
 
Figure 2.22: Chemical structure of N-Acetyl Aspartate 
 
 
N-Acetyl Aspartate or NAA (Figure 2.22) is a free amino acid relatively 
abundant in the human brain and contributes the most prominent peak in the 
1H spectrum at 2.01 ppm. NAA also has smaller resonances arising from the 
aspartate CH and CH2 groups contributing doublet-of-doublets at 2.49, 2.67 and 
4.38 ppm plus an amide temperature-dependent doublet at 7.82 ppm. Confined 
to the fluid portion of the cytoplasm [95, 96], it is primarily localised in the 
neurons and dendrites of the central and peripheral nervous system [65]. NAA 
concentration in grey matter is reported to be higher than in white matter 
[70]. Even though its exact function is unclear, brain NAA is believed to act as 
an osmolite in the nerve cell, a storage form of aspartate, a precursor of N-
acetyl-apartyl-glutamate (NAAG) and an acetyl donor for myelin synthesis [95, 
97]. Brain NAA concentration ranges from 7.9-16.6 mM [65, 72] but is low in 
infants and its increase coincides with myelination [95].  
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The NAA group contains at least two chemical moieties: NAA and NAAG. NAAG 
is predominant in the nerve cell but varies regionally within the brain with a 
concentration range of 0.6-2.7 mM [98]. It is suggested to be involved in 
excitatory neurotransmission and also acts as a source of glutamate [31, 65]. 
Its peak occurs at 2.10 ppm but mostly overlaps with the large NAA peak 
particularly at lower field strengths. The NAA peak thus contains contributions 
from NAAG, which can be separated at higher field strengths or by using 2-
dimensional MRS [65]. Unresolved NAA and NAAG are usually reported as the 
total NAA (tNAA).  
 
Because of its specificity to neurons, NAA is commonly considered to be a 
marker of healthy neuronal density [1]. NAA levels may also reflect reversible 
neuronal dysfunction rather than irreversible neuronal loss [31]. A decrease in 
the NAA peak intensity has been reported in a number of neurological disorders 
including multiple sclerosis [99], ischaemia [100], acute head injury [101], 
schizophrenia [102-104], inflammation [1] and tumours [74, 105]. Increased 
NAA has also been reported in Canavan’s disease [99, 106].     
 
2.2.6.7 Lactate 
 
 
 
 
 
 
 
Figure 2.23: Chemical structure of lactate 
 
  
Lactate (Figure 2.23) is an end product of anaerobic glycolysis, exhibiting a 
doublet at 1.31 ppm which becomes inverted at TE = 144 ms (Figure 2.16). In 
shorter TE acquisitions in vivo, it may be difficult to distinguish the lactate 
resonance from that of lipids and macromolecules [107] and so lactate is 
commonly studied at longer TE times. Brain tissue lactate content is low (about 
0.4 mM [73]) and only becomes MRS-visible in diseased tissue undergoing 
anaerobic respiration. It is thus suggested to be a marker of anaerobic 
metabolism.  Even though its presence can be highly variable, lactate 
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concentration increases rapidly following hypoxia and cases of blood flow 
impairment such as stroke, trauma, tumour, necrotic tissue and cystic masses 
[79, 108, 109]. Functional activation and hyperventilation have also been 
suggested to cause small increases of brain lactate content [110, 111].  
 
  
2.2.6.8 Lipids and Macromolecules  
 
 
In most cases, lipid and macromolecular resonances occur at various regions of 
the spectrum: around 0.9, 1.3-1.4 and 2.0-2.6 ppm. They could sometimes be 
more pronounced particularly at shorter TE times and in the presence of 
tumours. Their signals may also arise from a healthy brain if the voxel is placed 
close to the skull [45, 65]. Macromolecular/lipid spectra usually occur as broad 
singlet and/or multiplet peaks in the MR spectrum. These unwanted resonances 
could be reduced by planning acquisitions with longer TE times, placing the 
voxel away from the skull or using saturation bands to eliminate signals from 
outside the voxel [31].  
 
2.2.7 Challenges of in vivo MRS 
  
Apart from relaxation and partial volume effects (chapter 5), in practice, the 
quality of MRS data can be affected by a number of factors which could be 
subject, operator or equipment dependent. However, strategies are available 
to minimise the errors introduced into the data by these factors. These 
strategies have been used in this thesis. The most common factors that can 
possibly affect the spectral quality and how to minimise them are presented in 
the following subsections. 
    
 
2.2.7.1 Static Field Inhomogeneity  
 
 
This arises from limitations of the magnet design and from differences in 
magnetic susceptibility between tissues (especially at air-tissue boundaries). 
The width of a spectral peak is inversely proportional to the effective 
transverse relaxation time, T2* (defined in equation 2.8) [31] of its 
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corresponding metabolite. Local magnetic field inhomogeneities, ∆B0 widen 
and distort the spectral lines.  
 
Maximum homogeneity can be achieved by a technique known as shimming 
[31]. This involves adjustment of the DC currents in the gradient and shim coils 
so that the water signal attains a linewidth of about 30 Hz (equivalent to 
approximately 0.25 ppm). 
 
 
2.2.7.2 Detection Sensitivity 
  
 
Metabolites of interest in MRS are often in millimolar concentrations and so 
unwanted signals could easily corrupt the metabolite signals. Secondly, in a 
typical acquisition, the MR spectrum arises from more than one metabolite. 
Inherently, these metabolites differ in their T2 relaxation times due to 
differences in their chemical structures. The choice of echo time for an 
acquisition could therefore reduce the sensitivity of MRS to only those 
metabolites with longer T2 relaxation times, and at the same time help reduce 
the noise signals in the spectrum.  
 
In a typical acquisition, sensitivity can be increased by: i) using larger voxel 
sizes, ii) using more powerful magnets (typically B0 ≥1.5 T for human studies) to 
increase spectral resolution and SNR, iii) using a surface coil for superficial 
organs or phased-array coil, iv) accumulating many signal averages, NSA to 
increase SNR (SNR α √NSA) and v) collecting more complex data points (the 
raw data which when Fourier transformed, generates the spectra), so that the 
spectra in the frequency-domain will be of high resolution; this also enhances 
the SNR of the MR spectrum [31]. For all acquisitions in this thesis, 4096 
complex data points were collected.      
  
 
2.2.7.3 Solvent Signal   
 
 
The concentration of water protons is very high compared to that of protons 
contained in the metabolites of interest. At shorter TE acquisitions, the 
spectrum may also contain significant contributions from fat/lipid signals 
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coming from outside the skull due to non-ideal selective slice profiles [112], 
and also depending on the voxel position. The large spectral peaks from the 
unwanted water/fat signal can obscure and distort the metabolite peaks, 
making spectral quantification difficult. The water/fat contribution can be 
reduced by using a series of chemical-shift selective pulses, adjusted to the 
resonant frequency of water/fat (section 2.2.3.1). This ensures that the water 
magnetisation is destroyed just before the spectra are acquired. Other 
strategies include moving the voxel away from the skull, using outer volume 
saturation bands [112-115] and increasing the TE time of the acquisition 
(though this reduces the SNR of the spectrum [31]). However, none of these 
methods will reduce macromolecular contributions in the spectrum because 
macromolecules are a natural component of brain tissue and will always be 
present within the selected voxel [31].    
 
 
2.2.7.4 Eddy Currents 
 
 
Field gradient pulses induce eddy currents in the main magnetic field, which 
generate additional magnetic fields that add to the static field. There are two 
types of eddy currents: zero-order eddy current or time-varying B0 offset and 
time-varying first or higher order gradient [31]. Zero-order eddy currents cause 
a frequency-dependent phase shift during signal readout but no decrease in 
SNR from spin dephasing within the voxel. They can be corrected with a B0 coil. 
First-order eddy currents cause the spins within the voxel to dephase, 
decreasing SNR. Both types of eddy currents together with magnetic field 
inhomogeneities distort the peak shapes. Spectral distortion from eddy 
currents can be corrected by a technique known as QUAntification by 
converting to the LorentzIan TYpe (QUALITY) deconvolution [116]. This involves 
dividing the spectral time domain signal by the unsuppressed-water time 
domain signal (section 1.4.3) [45, 46, 116]. Another technique involves doing a 
point-by-point phase correction of the time domain signal, which also uses the 
unsuppressed-water signal. This is often known as Eddy Current Correction 
(ECC) [46, 117]. QUALITY corrects spectral distortion due to zero- and first- 
order eddy currents and B0 inhomogeneities, while ECC only corrects spectral 
distortion due to zero-order eddy currents [31]. The former technique was used 
in this thesis.  
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2.2.7.5 Phase Detection  
 
 
Differences in design between the two channels of an analogue quadrature 
receiver can introduce artefacts into the spectrum. If the amplifier gains 
between the channels are not equal, or if their phase difference is not 90o, 
there will be ghosting of the peaks mirrored about zero frequency. This is 
known as a quadrature ghost. A spike results if the DC offsets between the two 
channels is not zero. Phase cycling can be used to correct these artefacts. It is 
implemented by switching the transmitter phase between 0o and 180o during 
each repetition of the pulse sequence. The number of times the switching is 
done is known as number of excitations, denoted by NEX. The signal collected 
with the transmitter phase at 180o is subtracted from the signal collected with 
the transmitter phase at 0o. This adds the signal and subtracts the DC offsets, 
cancelling the DC artefact. Phase cycling also compensates for imperfect 180o 
flip angles during the acquisitions (especially in MR multi-echo imaging) [31]. 
Receiver designs with only one amplifier plus analogue-digital convertor do not 
have unequal DC offsets, unequal gains or non 90o quadrature detection. For all 
the acquisitions in this thesis (apart from some acquisitions in chapter 8), NEX 
was set to 8 phase cycles. A phased-array (and not the quadrature) head coil 
was used in all acquisitions in this thesis. 
   
 
2.2.7.6 Motion 
 
 
Increasing the number of signal averages in order to enhance spectral quality 
(section 2.2.7.2) prolongs the acquisition time. This could result in subject 
compliance issues. Subject movement and physiological motion of the 
examined organ during spatial localisation may affect the individual scans. This 
may cause motion-related signal loss and line-shape deterioration, resulting in 
considerable degradation of the averaged spectrum [118]. It is always better to 
use ‘reasonable’ signal averages that will offer tolerable scan times. It may be 
difficult to avoid motion artefacts in examination of organs in the trunk but for 
brain studies, a strap and head support can be used to minimise head 
movement. Post-processing techniques can also be used to restore the signal 
loss due to motion [119]. This is achieved by correcting each acquisition with 
the phase offset and frequency shift of its residual water signal before 
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averaging. By using NEX = 8 for the MRS acquisition, more spectral lines are 
averaged before data storage. This reduces the effects of motion that could 
otherwise lead to phase, frequency and signal shifts; the NEX does this by 
subtraction of these effects from the spectra using the phase cycling scheme 
described in section 2.2.7.5.    
 
2.3 Materials and Methods 
 
2.3.1 Overview of Spectral Analysis 
  
 
Metabolite quantification is performed by a spectral analysis procedure that 
quantifies the area under the peaks of interest within the spectrum. The 
estimated area is proportional to the absolute concentrations of the 
metabolites. 
 
Spectral analysis and/or quantification can be performed in either the time 
domain [120] or frequency domain [121]. In the time domain, the MRS signal is 
represented as a function of the recording time, whereas in the frequency 
domain, the signal is represented as a function of the resonance frequency. By 
Fourier transformation, the time-domain signal can be converted into its 
equivalent frequency-domain representation [45]. In theory, the two domains 
are the same [122]; however, the frequency domain representation of data is 
always preferable because it enables direct visual interpretation of the spectra 
[45]. For this reason, all MRS data shown in this thesis are represented in the 
frequency domain. 
 
Frequency domain spectral analysis can be performed in three ways: 
integration of peaks; peak fitting with Lorentzian or Gaussian lineshapes; and 
prior knowledge peak fitting.  
 
By the peak integration method, the user selects a frequency range containing 
only one peak and performs numeric integration. This procedure usually 
excludes signal contributions to the upper and lower limits of the peak and so 
the area will be underestimated, possibly by up to 40 % [45, 123]. Peak 
integration is suitable for spectra that are well separated and do not suffer 
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from baseline fluctuations. Unfortunately, this is not the case with in vivo 
spectra; they mostly suffer from significant spectral overlap and baseline 
fluctuations. The area cannot therefore be attributed to a single resonance; 
the baseline will also result in unknown contributions.  
 
By the peak fitting method, the user initially selects the peaks of interest and 
rough estimates of the resonance frequency, line width, and peak intensity are 
performed manually or by an algorithm. Subsequently, a fit is performed by 
using a least squares optimisation algorithm, which iteratively fits the selected 
peaks to a line shape model function, so that the fitted spectrum resembles 
the experimental spectrum as closely as possible [45, 124]. This method is 
generally robust for spectral overlap. The fit may however be inaccurate if the 
actual line shapes substantially deviate from Lorentzian or Gaussian model 
functions. A Lorentzian-Gaussian mixture or Voigt model function [31, 125] 
could be used in such cases but this can lead to ambiguous results because the 
fitting procedure introduces more degrees of freedom [45]. The two commonly 
fitted spectral lineshapes are shown in Figure 2.24. 
 
 
 
Figure 2.24: The two main spectral lineshapes used in spectral analysis 
The Gaussian lineshape is shown in solid line; the Lorentzian lineshape is shown in broken line. 
 
 
 
From Figure 2.24, two significant differences between these lineshapes are 
evident [126]: the Lorentzian is a sharper, narrower function toward the 
centre; the Gaussian falls off in the wings more rapidly than the Lorentzian. MR 
spectra are usually sharper, narrower and often overlap at their wings, which is 
why either of these two lineshapes could be used in spectral fitting. 
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The Gaussian and Lorentzian lineshapes can be described by equations 2.15 and 
2.16, respectively, as follows [126]: 
 
 
                                                                                                  (Eq. 2.15) 
 
 
                                                                                                  (Eq. 2.16) 
 
 
where f(υ – υo) is the amplitude of the function, δ is one-half of the width of 
the function at half-maximum intensity, and (υ – υo) is the value of the field 
measured from the centre frequency. 
 
Prior knowledge fitting incorporates prior knowledge about the metabolites 
that contribute to the 1H MR spectroscopic signal [45, 127]. Known signal 
parameters such as chemical shifts (relative frequencies), amplitude ratios, J-
coupling, splitting patterns, and phases of resonances specific to a given 
metabolite are used in an algorithm during the fitting routine. An advanced 
form of prior knowledge fitting also takes into account the type of MR scanner, 
B0, pulse sequence, TE, TR, as well as the pH, ion composition and 
temperature of the solution in which the individual metabolites are dissolved. 
This prior knowledge of each metabolite is used to create, by simulation or by 
phantom measurement, a basis set (template spectra) that matches the in vivo 
conditions. The in vivo MR spectra are then analysed as a linear combination of 
the separately recorded in vitro spectra of the individual metabolites. This 
fitting method introduces less degrees of freedom, takes a shorter time to 
complete and is mostly accurate [45, 48, 127].  
 
The main challenge of frequency domain spectral analysis is determining the 
shape of the baseline. When the baseline is underestimated, the peak areas 
could be overestimated. The baseline can be determined by three common 
approaches: a user manually selects reference frequency points in the 
spectrum and fits a straight line, cubic spline or polynomial function through 
· exp [- (υ – υo)2·ln2/δ2] f(υ – υo) =  √ ln2 
√ piδ 
 δ2 + (υ – υo)2 
f(υ – υo) =  
√ δ
√ pi 
1 
· 
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them [128]; an algorithm automatically selects reference points at predefined 
frequencies and fits a straight line through them [71]; an algorithm 
automatically fits a smooth curve to the baseline and fits the metabolite 
spectra, simultaneously [48]. 
 
2.3.1.1 Spectral Fitting in LC Model 
  
 
LCModel stands for Linear Combination Model. The LCModel software package 
is a user-independent fitting program that is commercially available [48]. It 
automatically performs eddy-current correction on the spectrum using the 
unsuppressed-water signal, phase-corrects the spectrum and fits the spectrum 
(in the frequency domain) with the linear combination of representative 
spectra (known as the basis set) of all the individual metabolites.  
 
LCModel estimates the metabolite concentrations by fitting the measured 
spectrum with a template spectrum of known concentrations. It further uses 
the transmitter and receiver gains to scale the measured areas to the template 
areas.  
 
Within the version of LCModel used for this project (version 6.2-4A), the 
chemicals used to simulate the templates were alanine (Ala), aspartate (Asp), 
creatine, Cr (CH2 and CH3 peaks), γ-aminobutyric acid (GABA), glucose (Glc), 
glutamine (Gln), glutamate (Glu), glycerophosphorylcholine (GPC), choline 
(Ch), myo-inositol (Ins), lactate (Lac), N-Acetyl-Aspartate (NAA), N-acetyl-
aspartyl-glutamate (NAAG), scyllo-inositol (Scyllo), taurine (Tau) and 
guanadinoacetate (Gua). The CH2 and CH3 peaks of creatine were fit as 
separate singlets. As long as the molecular structures of the various 
metabolites are accurately known, a simulated template does not suffer from 
systematic errors and offers a more robust fit compared to a phantom 
measured template [45]. This is because T1 and/or T2 relaxation times 
sometimes differ between the in vivo and in vitro situations (e.g. in 
pathology), and also different resonances in the same metabolite might have 
different relaxation times (e.g. the CH2 of Cr has shorter T1 and T2 relaxation 
times than its CH3 [129]). In such situations, the use of the in vitro created 
96 
 
template may require a separate relaxation measurement in order to enhance 
the fitting accuracy [45].   
 
Two templates of the highest SNR were provided (by the software vendor) in 
the molecular simulation library of LCModel: one template was simulated for 
TE = 35 ms, TR = 5000 ms, NSA = 128 and the other for TE = 144 ms, TR = 5000 
ms, NSA = 128. The templates were suitable for the data collected in this thesis 
at TE times of 35 ms and 144 ms because they (i.e. the acquired data) were 
influenced by the same J-coupling modulation and unknown scanner effects as 
the simulated spectra. Thus only a minimal fitting error could be achieved and 
the concentrations will be accurately measured. In this case, the need to 
modify the existing templates or to create a new template does not arise. 
  
LCModel calculates the Cramer Rao lower bounds (CRLB), otherwise known as 
the standard deviation (SD), for the concentration estimate of each 
metabolite. The CRLB or SD values are measures of the reliability of the 
concentration measurement, and values of SD less than 20 % are generally 
considered reliable [130, 131]; SD ≤ 50 % has also been considered reliable 
elsewhere [132]. Sample LCModel outputs are shown in Figures 2.15 and 2.16.  
  
2.3.1.2 Spectral Fitting in SAGE 
 
 
SAGE stands for Spectroscopy Analysis by General Electric. The SAGE software 
package is a semi-automated fitting program provided by the GE Company. It 
has peak integration, peak fitting and prior knowledge fitting capabilities. In 
this thesis, only the peak fitting capability of SAGE was utilised.   
 
The spectral quantification procedure involves two stages: preprocessing and 
analysis. In the preprocessing stage, the time domain signals from the eight 
channels of the head coil are eddy current corrected and combined [133] as 
illustrated in sections 1.4.3 and 1.4.4, respectively. The resulting FID is Fourier 
transformed into an MR spectrum in the frequency domain. The spectrum is 
then phase- and baseline- corrected. Temperature-dependent spectral offsets 
are corrected by selecting a reference peak (the NAA peak at 2.01 ppm in this 
case) and then moving it to its actual frequency position. In the analysis stage, 
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a table of the peaks to be analysed is created. This table contains the rough 
estimates of the peak amplitude, line width and frequency, as well as the noise 
standard deviation of the spectrum. These four variables are used by the peak 
fitting algorithm in SAGE to determine the area under each selected peak.  
  
To evaluate the peak areas, the spectra are fitted to a Lorentzian line shape 
using the Levenberg-Marquardt method for nonlinear least squares 
minimisation [134]. The Lorentzian model function was chosen over the 
Gaussian because it consistently showed minimal misfits between the model 
and experimental spectra (measured by the chi-square value). The reason for 
this could have been that the spectral peaks did not fall off rapidly in their 
wings where they overlapped. If that was the case, the wings of the Gaussian 
model fits would always fall within (and would not accurately fit) the 
experimental spectral peaks in a similar way to the representation of Figure 
2.24. The Lorentzian model fit would therefore perform better. The fitting 
algorithm converges when a minimal chi-square value, δ(α) is attained after ‘n’ 
iterations. In theory, for a given set of ‘n’ experimental datum pairs of 
independent and dependent variables, (xi, yi), the algorithm adjusts or 
optimises the parameters, α (i.e. amplitude, frequency and line width) of the 
model curve f(x, α) so that the sum of the squares of the deviations, δ(α) 
becomes minimal; where: 
    
 
                                                                                                   (Eq. 2.17) 
 
 
In SAGE, the fitting algorithm synthesises a signal, f(x, α) based on the rough 
estimates of the amplitude, line width and frequency of the Lorentzian peak. It 
then calculates the squared difference between the synthesised signal and the 
actual signal, y. The parameter variable, α may be adjusted to reduce the size 
of the difference, δ(α). The size of the adjustment varies dynamically 
depending on the success or failure of the previous adjustment attempt. If the 
adjustment reduces the difference, the current parameters in the peak table 
are updated. If, however, the adjustment fails to minimise the difference, the 
size of adjustment is reduced and a new difference is calculated. This process 
δ(α) = [yi — (xi, α)]
2
 ∑ 
i = 1 
n 
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continues until: a maximum number of iterations have been performed; the 
difference has decreased to an acceptable value; or the difference fails to 
fractionally decrease for a certain number of iterations. 
 
The maximum number of iterations is specified by the user at the start of the 
fitting routine (maximum number of iterations was set to 100 for all fits in this 
thesis so that any attained number of iterations could fall well within this 
chosen limit). The Marquardt fitting method in SAGE uses the SNR estimate 
from the peak table to determine an error value below which changes to the 
fitted parameters are statistically insignificant and at which value the chi-
square estimate (i.e. the acceptable difference in equation 2.17) is produced 
and the fit is generated. The final fit results contained in the peak table 
include the peak area, line width, frequency and amplitude.  
 
2.3.1.3 Quantification of Water-suppressed and 
Unsuppressed-water Spectra 
 
 
For any MRS data set to be analysed, the number of spectral lines stored in the 
raw data is a function of the number of spectral averages, NSA and number of 
phase cycles, NEX. Both NSA and NEX can be set on the MR scanner prior to the 
MRS acquisitions. At the beginning of the MRS sequence, the GE MR scanner, by 
default, acquires a minimum of 16 unsuppressed-water spectral lines. 
However, the actual number of unsuppressed-water spectral lines stored in the 
raw data also depends on the NEX value used for the acquisition. Thus, the 
total number of spectral lines, Nl in a typical MRS acquisition will be given by 
the sum of the unsuppressed-water lines, Nu and the suppressed-water lines, 
Ns: 
 
Nl = Nu + Ns                                                                                  (Eq. 2.18) 
 
So that: 
 
Nl = 16/NEX + NSA/NEX                                                                 (Eq. 2.19) 
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Suppose that two spectral acquisitions are performed with the same NSA value 
of 16 but with NEX values of 2 (Figure 2.25a) and 8 (Figure 2.25b). According to 
equation 2.19, Nu and Ns will be 8 each in the former (Figure 2.25a), but will be 
2 each in the latter (Figure 2.25b) acquisitions. Nl is therefore 16 and 4 in 
Figures 2.25a and 2.25b, respectively. NEX can therefore be said to control the 
number of spectral lines that are averaged by the scanner before data storage. 
It is this stored data that is then post-processed and analysed in the SAGE 
software (section 2.3.1.2) to yield the quantified unsuppressed-water and 
metabolite (i.e. suppressed-water) spectral peaks. This quantifiable water 
peak obtainable from the 16/NEX part of equation 2.19 can be used for a 
number of purposes. In fact, Brief et al [58] have used it as a reference 
unsuppressed-water signal area against which they quantified their cerebral 
metabolites. Similarly, this thesis corrected this signal area for all possible 
error sources and used it in absolute metabolite quantification (chapter 7). 
Specific reference will be made to this unsuppressed-water signal area where it 
has been used in this thesis. 
 
 
 
Figure 2.25: Number of stored data frames determined by NEX 
NSA = 16 in both acquisitions. In Figure 2.25a, NEX = 2, Nu = 8, Ns = 8; In Figure 2.25b, NEX = 8, 
Nu = 2, Ns = 2. Note the peak intensity difference between the Nu (taller peaks) and Ns (shorter 
peaks) lines. The figures are output images from the SAGE software package. 
 
 
 
 
 
(a) (b) 
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2.3.2 Spectral Fitting Software used in this Thesis 
   
 
Apart from aspects of the work presented in sections 3.2.2.1 and 3.2.2.2, all 
spectral analysis in this thesis were performed using the SAGE software 
package. The spectral peak areas were quantified by peak fitting to Lorentzian 
lineshapes with the manual baseline determination method using the SAGE 
software (as described in sections 2.3.1.2-3). In sections 3.2.2.1-2, the 
LCModel software package was used for spectral analysis (as described in 
section 2.3.1.1).  
 
LCModel uses prior knowledge peak fitting at the same time as fitting a smooth 
curve baseline to estimate metabolite concentrations. The fit is performed 
using a template created for only water-suppressed spectra. Even when the 
frequency range of the fit is extended to include the water resonance, 
accurate fitting to the water peak is not possible; and so an error message is 
returned. The residual water signal is however used by LCModel for phase and 
eddy current correction [48]. On the other hand, SAGE is able to fit the 
unsuppressed-water peak.  
 
Specific to the work presented in chapter 3, only the arbitrary estimates of 
water and metabolite quantities were required to study reproducibility. 
Therefore, for rapid and consistent spectral analysis, the metabolite and 
unsuppressed-water spectra for each acquisition were analysed using LCModel 
and SAGE, respectively. Apart from the use of the LCModel software package 
for the metabolite quantification work presented in that chapter (in sections 
3.2.2.1-2), the software was not used in any other work in this thesis.  
 
2.3.3 The MRI Scanner, Head Coil and MRS Phantom 
   
 
All experiments reported in this thesis were carried out on a 3 T GE Signa 
Excite HD (software version 12) MR whole-body scanner equipped with an 
eight-channel receive-only head coil (Figure 1.1). A GE MRS brain phantom 
(spherical and ~17 cm in diameter) shown in Figure 2.26 was used for the 
reproducibility and RF mapping experiments. The contents of the phantom (in 
millimolar concentration, mM) were NAA (12.5 mM), Cr (10.0 mM), Cho (3.0 
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mM), m-Ins (7.5 mM), Glu (12.5 mM) and lactate (5.0 mM) at a pH of 7.2. A 
temperature-sensitive colour strip is included in the body of the phantom for 
room temperature measurements. The phantom was kept in the scanner room 
to ensure thermal equilibrium with room temperature. Therefore, the 
temperature reading indicated on the temperature strip was taken to be the 
temperature of the phantom.  
 
 
 
 
        Figure 2.26: The GE MRS brain phantom 
The black temperature strip shows the temperature reading (in orange colour)  
 
2.3.4 Statistics in this Thesis 
 
 
All statistical tests in this thesis were performed using the Minitab software 
package (version 16, Minitab Inc.). Statistical tests were chosen depending on 
whether the data set to be analysed was normally distributed. If a given data 
set is normally distributed, then it can be subjected to parametric statistical 
tests; a non-normally distributed data set, on the other hand, can be subjected 
to non-parametric statistical tests. 
 
To test for normality of data, the Anderson-Darling (A-D) normality test was 
used. The A-D normality test generates a normal probability plot based on what 
a normally distributed data set of a given sample size should look like. It then 
tests the correlation between the predicted normal data with the actual data 
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(Figure 2.27). The null hypothesis of this correlation test is that there is no 
difference between the actual data and the generated normal data. The 
correlation coefficient gives a critical value, p which is usually defined such 
that this null hypothesis would be rejected if p < 0.05; the actual data set 
however would be considered normally distributed if p > 0.05. 
 
An example of the A-D normality test on age distribution of a group of healthy 
subjects is shown in Figure 2.27. The predicted normal distribution is the blue 
curve and the actual data is the histogram plot. 
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Figure 2.27: The Anderson-Darling normality test for normality of age distribution 
This is an output of the A-D normality test using the Minitab software  
  
The mean age of the subjects is 38.0 years (95 % confidence intervals of 32.1 
and 43.9). The standard deviation is 12.7 (95 % confidence intervals of 9.7 and 
18.5). Using a significance level of 0.05, the A-D normality test (A-squared = 
0.32, p-value = 0.512) indicates that the age distribution follows a normal 
distribution; it is therefore acceptable to assess the data using parametric 
statistical tests. 
 
The A-D normality test described above was performed on all data in this thesis 
before choosing a suitable parametric or non-parametric statistical test for 
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assessing such data set. Generally, data sets were tested for differences and 
associations. The various parametric and non-parametric statistical tests used 
for these assessments are summarised in Table 2.1. 
 
Type of analysis Parametric test Non-parametric test 
Comparison between two 
quantitative measurements 
taken from the same subject 
Paired t-test Wilcoxon (signed-rank) 
test 
Comparison between the   
means of the measurements 
from two independent groups 
Two-sample t-test Mann-Whitney (two-
sample Wilcoxon sum 
rank) test* 
Comparison of the means      
between three or more   
independent measurements 
One-way analysis of 
variance (ANOVA) 
Kruskal-Wallis test* 
Estimation of the degree of 
association between two 
quantitative variables 
Pearson coefficient     
of correlation, r 
Spearman’s rank 
correlation, ρ 
 
Table 2.1: Parametric and non-parametric statistical tests used in this thesis 
*Not used in any test in this thesis but included for the sake of completeness 
 
For all the above tests for differences, a p-value < 0.05 was considered 
significant, whereas for associations, a correlation coefficient greater than 0.5 
was considered strong. The means and standard deviations were mostly 
calculated over all volunteers. In some cases, the standard error was quoted in 
place of the standard deviation. The standard error is defined as the standard 
deviation divided by √ n, where n is the number of observations (or subjects). 
 
2.3.5 Ethical Approval of Human Studies 
   
 
The healthy volunteer studies reported in chapters 3, 5, 7, 8, and part of 
chapter 6 (the MT imaging study) were approved by the West of Scotland 
Research Ethics Committee 4 (WoSREC4); see Appendix 2.1. All subjects gave 
prior informed written consent after studying the full research protocol; time 
was also given for any concerns to be clarified to prospective volunteers.  
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The healthy volunteers were recruited from within Glasgow through direct 
(email and phone) contacts by the author. The exact procedures for 
participation were discussed and informed written consent was taken from 
each subject before study entry. After taking their consent, each volunteer was 
screened for any neurological and psychiatric conditions using the General 
Health Questionnaire (GHQ-12; Appendix 2.2). The MRI safety questionnaire 
(Appendix 2.3) was then used to screen them for any contraindications they 
may have going into the MRI scanner environment. All brain scans were 
reported by a consultant neuroradiologist while a standard clinical protocol was 
in place to deal with incidental findings.  
 
Two psoriatic arthritis patients were excluded from the TNF-α blockade study 
in chapter 7. One of them had an ear implant (information gathered during the 
MRI safety screening) while the other patient was found (after MR imaging and 
reporting) to have meningioma in the frontal brain region. Nothing was done 
about the first patient but the latter patient was then contacted for the 
necessary healthcare action to be taken according to the departmental 
standard protocol. 
  
Aspects of the human studies of chapters 6 and 7 received ethical approval 
through other studies. While part of the data in chapter 6 was retrospective, 
chapter 7 was a prospective study of psoriatic arthritis patients. This psoriatic 
arthritis study had an MRS component, and was approved by the WoSREC3 
(Appendix 2.4). The psoriatic arthritis patients were recruited from the 
Rheumatology departments of NHS Greater Glasgow & Clyde Hospitals. They 
also went through the same screening process as described above.   
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Chapter 3: Reproducibility Measurements of 
Water and Metabolites 
 
 
3.1 Introduction and Objectives 
 
  
MRS is capable of measuring changes in brain chemistry caused by disease. It is 
therefore necessary to evaluate the inherent uncertainty in concentration 
estimates from phantoms and healthy brains. Such a study would be useful in 
informing the extent of errors introduced by other factors apart from disease. 
The measure of uncertainty, also known as precision, can be obtained from a 
reproducibility study in healthy subjects or phantoms. Precision is an estimate 
of how consistent or repeatable a given measurement is, under similar 
conditions. The knowledge of precision therefore can be used in study design, 
MRS data interpretation and to assess the stability of the MR scanner over time.  
 
In study design, precision helps in the determination of the minimum sample 
size required to conduct a study in order to observe a specific change in 
metabolite concentration. The smallest detectable change in metabolite 
concentration (between successive scans in one subject or in a group of 
subjects) can also be determined from reproducibility studies. In MRS data 
interpretation, it can be used to establish a confidence interval for the 
difference (in a given metabolite concentration) observed between, say, the 
patient and healthy control groups. Variation in the performance of the MR 
scanner (arising from, say, fluctuations in temperature, CHESS water 
suppression efficiency, etc) can be assessed by estimation of the precision from 
various measurements carried out over time.  
    
Previous reproducibility studies have been conducted in vivo [135-140]. Most of 
these studies [135, 137, 139, 140] were conducted at long TE times where the 
spectra were reduced to only NAA, Cr and Cho (as they have longer T2 times 
compared to the other spectra). A few studies [136, 138] however measured 
the precision of m-Ins at a short TE time. Nonetheless, an in vivo 
reproducibility study (which compares with the clinical situation) is more likely 
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to provide a wider margin of error than an in vitro study. This is because inter-
subject variability (i.e. differences in subject characteristics) could increase 
the standard deviation of the mean of the measured metabolite 
concentrations, thus making precision poor. Other factors such as subject 
movement, reproducibility of voxel placement and health condition of a 
subject between scans are also likely to affect precision. The use of a phantom 
in a reproducibility study however appears not to be affected by these factors. 
A notable source of variation in the measurements using a phantom could come 
from room temperature changes; it is however generally difficult to interpret 
variations in phantom studies [1]. It may therefore sometimes be beneficial to 
conduct a reproducibility study both in vivo and in vitro. To the best of the 
author’s knowledge, no reproducibility study in the literature has investigated 
reproducibility of measuring the metabolite and water peaks with short TE 
both in vivo and in vitro at 3 T. 
 
The objectives of the work presented in this chapter were: 
 
1. To compare the signal-to-noise ratio (SNR) of the PRESS and STEAM 
localisation sequences as implemented on the MR scanner for this 
project. The measured SNRs would form the basis on which the sequence 
of choice was selected for the experiments in this thesis;   
2. To use short TE MRS acquisition to assess the within-session, between-
session and between-exam reproducibility of measuring the peak areas of 
NAA, Cr, Cho, Glu, m-Ins, Lac and water in a phantom (in vitro); 
3. To assess the impact of temperature on the in vitro reproducibility 
measurements and the stability of the MR scanner over a period of 18 
months (the period within which all the data for this thesis were 
collected); 
4.  To use short TE MRS to assess inter-subject and intra-subject 
reproducibility of measuring the peak areas of NAA, total NAA (tNAA), 
total Cr (tCr), total Cho (tCho), Glu, Gln, Glx, m-Ins and water in a 
healthy human brain (in vivo).  
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3.2 Methods 
 
 
The methods described in the following subsections are in respect of the 
above-stated aims. Section 3.2.1 describes the spectral acquisition and analysis 
aimed to compare the SNR between the PRESS and STEAM pulse sequences.  
Section 3.2.2 is the reproducibility study presented in two subsections 
describing the methods for the phantom (section 3.2.2.1) and human (section 
3.2.2.2) reproducibility studies. The spectral analysis for the reproducibility 
studies is presented in section 3.2.3, and the calculation of precision is 
presented in section 3.2.4.  
 
 
3.2.1 PRESS versus STEAM 
   
 
Single voxel spectra were acquired from the GE MRS phantom (Figure 2.26) 
using the PRESS and STEAM sequences on the same day; each experiment was 
performed once using the same receiver gain settings. The phantom remained 
in place while both experiments were performed. The same acquisition 
parameters were used in both sequences: TR = 2000 ms, voxel size = 2 x 2 x 2 = 
8 cm3, 4096 complex points and a bandwidth of 5000 Hz. Acquisitions were 
done using two echo times: TE = 35 and 144 ms. Metabolite and unsuppressed- 
water spectra were collected with 128 and 16 averages respectively. As the 
water signal is inherently large and of high SNR, the minimum number of 
averages (i.e. 16) on the scanner was used (section 2.3.1.3); this also made the 
acquisitions quicker. The temperature of the phantom during the experiments 
was 18 ±1 oC (~291 K). 
 
Spectral analysis was performed using the SAGE software package as described 
in sections 2.3.1.2-3. The signal-to-noise ratio (SNR) estimate for each 
sequence was obtained from their respective spectra in the frequency domain 
by defining SNR as [141, 142]:  
 
 
                                                                                                      (Eq. 3.1) 
 
 
SNR =
Highest metabolite peak amplitude 
SD of noise amplitude 
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The amplitude [142] of the NAA and water peaks were used to calculate the 
SNR of the water-suppressed and unsuppressed acquisitions, respectively. The 
standard deviation (SD) of the noise amplitude was automatically estimated by 
the SAGE software during spectral analysis. This is usually the amplitude of the 
highest spike in the region of the spectrum that does not include the 
metabolite peaks.  
 
3.2.2 Reproducibility Studies 
 
3.2.2.1 Phantom Studies 
 
 
CHESS water-suppressed spectra were acquired from the MRS phantom (Figure 
2.26) by placing an 8 cm3 voxel at its centre (Figure 3.1). The PRESS sequence 
parameters used were: TE = 35 ms, TR = 2000 ms and NSA = 16, 4096 complex 
points and a bandwidth of 5000 Hz. The temperature of the phantom was 
recorded before each experiment. 
 
 
 
Figure 3.1: Voxel position at the centre of the spherical phantom 
 
 
Prior to each spectral acquisition, the scanner performs a shimming routine. 
During shimming, the scanner automatically detects the water centre 
frequency (course adjustment), sets the transmitter gain, performs a localised 
shim on the voxel (to optimise B0 field homogeneity), detects the water centre 
frequency (fine adjustment), sets the receiver gains and determines the flip 
angles for the water suppression pulses. This shimming process is also known as 
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scanner tuning, and it returns the autoprescan results on the scanner console 
once tuning is completed.  
 
In the within-session study, the voxel was shimmed once and spectra were 
acquired. With the phantom in the same position, shimming and spectral 
acquisition (from the same voxel location) were repeated in four successive 
examinations.  
 
In the between-session study, the position of the phantom and coordinates of 
the voxel were recorded after the first acquisition. The phantom was removed 
and replaced (10 minutes later) on the padding in the head coil (Figure 1.1e) 
using the laser guide and position indicator on the scanner. The laser guide 
reflected a ray along the temperature strip of the phantom, and this was used 
to aid consistent positioning of the phantom. The same voxel size was 
prescribed in the same location as before using the voxel coordinates. Three 
more successive acquisitions were performed after the first one, with the 
phantom replaced between successive examinations. 
 
In the between-exam study, the phantom was scanned three times in one 
session (as in the within-session scans) every month over the course of 18 
months. Reproducibility of the phantom position was achieved by positioning 
the laser guides on its temperature strip and using the position indicator on the 
scanner. The voxel was consistently positioned at the centre of the phantom. 
During these scans, the temperature of the phantom was recorded to be used 
in the serial study of temperature effect on reproducibility. 
   
3.2.2.2 Human Studies 
   
 
Using a single voxel PRESS sequence with CHESS water suppression, TE = 35 ms, 
TR = 2000 ms, 128 signal averages, 4096 complex points and a bandwidth of 
5000 Hz, spectra were acquired from an 8 cm3 voxel positioned in the frontal 
grey matter region (Figure 3.2) in seven healthy volunteers. Compared to the 
phantom studies, more averages (at least 128) were required in the human 
studies to improve SNR; thus minimising noise contributions arising from lipids 
and macromolecules in the brain, which are absent in the phantom. Specific 
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anatomical landmarks were clearly identified to serve as guides so that voxel 
positioning would be reproducible. Three reproducibility studies were 
conducted in vivo: inter-subject, same day; inter-subject, same month; and 
intra-subject, same year. 
 
 
 
Figure 3.2: Voxel position in the frontal grey matter brain region 
 
 
For the inter-subject, same day study, three healthy volunteers were scanned 
approximately 1 hour apart. For the inter-subject, same month study, four 
healthy subjects were scanned approximately 1 week apart within the same 
month. For the intra-subject, same year study, one healthy volunteer was 
scanned three times over the course of one year.   
 
3.2.3 Spectral Analyses in Reproducibility Studies 
 
 
To quantify the unsuppressed-water spectral peak areas in both phantom and 
human reproducibility studies, spectral fitting was performed using the SAGE 
software package (sections 2.3.1.2-3). Both phantom and human metabolite 
spectra were fit using the LCModel software package (section 2.3.1.1). The 
reasons for using different spectral analysis software packages for the water 
and metabolite quantification were discussed in section 2.3.2. Briefly, the 
LCModel basis set does not include the unsuppressed-water resonance and so 
fitting to the water peak does not return any result. SAGE is however able to 
quantify this water peak but is semi-automated, unlike LCModel which is 
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automated. Due to the volume of data to be analysed, speed and consistency 
were critical. Moreover, only the arbitrary (and not the absolute) 
concentrations of water and metabolites would be required in the 
reproducibility studies.   
   
3.2.4 Assessment of Reproducibility 
 
 
Reproducibility was assessed using the estimate of the coefficient of variation 
(CoV), defined as: 
 
                                                                                                  
                                                                                                       (Eq. 3.2) 
 
CoV is an estimate of the uncertainty in the spectral peak area measurements. 
A smaller value of CoV means reproducibility is better. 
 
   3.3 Results and Discussion 
   
3.3.1 PRESS versus STEAM SNRs Compared 
 
 
This section presents the results for the first study aim: the comparison of the 
signal-to-noise ratios (SNRs) of the two commonly used MRS pulse sequences. 
The rationale for this was to make a choice (based on their SNRs) of pulse 
sequence to use for the experiments in this thesis. 
 
The SNR values of the PRESS and STEAM MRS localisation sequences are 
compared in Table 3.1. Both protocols were implemented on the MRS brain 
phantom as discussed in section 3.2.1. 
 
 
 
 
 
 
 
Standard deviation 
Mean 
 X 100 % CoV =  
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Table 3.1: Comparison of the SNR values of the PRESS and STEAM sequences at short (35 
ms) and long (144 ms) TE times. 
CHESS ON is the water-suppressed acquisition; CHESS OFF is the unsuppressed-water 
acquisition; a.u. means arbitrary units. All the above measurements were done on the MRS 
brain phantom (Figure 2.26).  
 
 
For the short TE CHESS ON scan (i.e. metabolite spectral acquisition), PRESS 
showed as much as twice the SNR of STEAM (3.56 vs. 1.39). This is because the 
spin echo signal produced by PRESS has two times the intensity of the 
stimulated echo produced by STEAM. For the long TE CHESS ON scan, the SNR 
of PRESS was about 1.5 times greater than that of STEAM (2.72 vs. 1.86). This 
reduced SNR of PRESS at the longer TE could be because at such longer TE 
times, the rise time of the selective pulses in PRESS is prolonged; this results in 
signal decay (due to T2 losses) and distortion (due to J-coupling), and 
consequently a drop in SNR [1]. The non-uniform flip angle profile with the 
180o pulses of PRESS causes spectral distortion at the voxel edges [57]. This 
could also be a factor in the reduced SNR of PRESS particularly at longer TE 
times. 
 
Using TE/TR = 288/1500 ms and 32 signal averages to acquire CHESS water-
suppressed and unsuppressed-water spectra from an 8 cm3 voxel, Drost et al 
[31] reported the SNR for PRESS and STEAM. The NAA peak was used to 
calculate the SNR of their water-suppressed acquisition. They observed that for 
the water-suppressed and unsuppressed acquisitions, the SNR of PRESS was 
about 1.78 and 2.31 times better than that of STEAM, respectively. These 
results are consistent with those reported in this thesis.  
 
Localisation sequence PRESS STEAM 
Echo time (ms) 35 144  35  144  
NAA peak amplitude x 105 (a.u.)  9.01 6.83 7.26 5.55 
Noise SD (CHESS ON) 252.98 250.82 523.86 298.48 
SNR (CHESS ON) x 103 3.56 2.72 1.39 1.86 
Water peak amplitude x 105 (a.u.)  1601.10 1057.20 1596.50 1095.50 
Noise SD (CHESS OFF) 316.78 257.74 358.49 287.56 
SNR (CHESS OFF) x 105 5.05 4.10 4.45 3.81 
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Ideally, for a CHESS OFF scan (i.e. unsuppressed, fully relaxed water signal 
acquisition), TE should be set to the minimum value on the scanner and TR to 
about 15 s (which is ~5 times the T1 of water). However, the respective TE and 
TR values of 35 and 2000 ms used in the CHESS OFF acquisitions in this study 
caused significant T1 and T2 losses to the water signal with the PRESS and 
STEAM sequences. However, PRESS still showed greater SNR than STEAM at both 
TE times. PRESS was therefore found to consistently show higher SNR than 
STEAM in agreement with theory, and so was the sequence of choice for the 
MRS measurements in this thesis. 
   
3.3.2 Reproducibility Results 
   
 
In this section, results for three studies are presented in respect of study aims 
2-4: firstly, results for the reproducibility studies measuring water and the 
metabolites in a phantom are discussed in section 3.3.2.1 (study aim 2); then 
investigation of the effect of temperature on the phantom reproducibility 
measurements/stability of the MR scanner is presented in section 3.3.2.2 
(study aim 3); lastly, results for the human reproducibility studies are discussed 
in section 3.3.23 (study aim 4).    
 
 
3.3.2.1 In vitro Measurements 
 
  
The in vitro reproducibility results are summarised in Table 3.2. The mean of 
the coefficient of variations (CoVs) and standard deviations (SDs) of the CoVs 
were calculated for all the metabolites (Table 3.3). 
 
The water peak was not acquired with CHESS OFF. However, the scanner 
always acquires some unsuppressed-water lines for eddy current and phase 
corrections, as well as combination of the phased-array coil data. With SAGE, it 
is possible to extract these water lines and process them into the water peak 
(section 2.3.1.3). This water peak was processed for both in vivo and in vitro 
reproducibility studies. 
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Peak Within-Session CoV (%) 
(n=5) 
Between-Session CoV (%)        
(n=5) 
Between-Exam CoV (%)           
(n=18, 3 scans per exam) 
m-Ins 3.62 6.35 4.47 
Cho 1.48 7.20 4.33 
Cr 1.83 6.80 4.49 
Glu 3.24 7.22 4.44 
NAA 1.90 5.28 3.95 
Lac 4.63 6.28 5.74 
Water 3.00 3.46 12.73 
 
       Table 3.2: Reproducibility of MRS measurements in the GE MRS phantom 
 
 
The within-session and between-session CoVs for the water peak were similar; 
between-exam reproducibility, however, was relatively less. This could be due 
to inconsistencies of the CHESS water suppression module or changes in the 
transmitter gains (which was observed to vary within ± 4 dB, representing a 
percentage change within ± 3.45 %).  
 
For all metabolites, both within-session and between-exam CoVs were better 
than between-session CoV; within-session was the most reproducible. The 
absence of possible phantom repositioning errors in the within-session 
experiments could have been a factor in its better reproducibility than those 
for the between-exam and between-session experiments. The large number of 
scans performed in the between-exam study could have contributed to its 
lower CoVs (as standard deviation is reduced) compared to those for the 
between-session study. 
 
The mean CoVs for all metabolites were closer to the LCModel percentage 
standard deviations (Table 3.3), a similar observation made by Hancu et al 
[136]; and has been reported to be the actual case [48]. This is in contrast to 
the trend observed in the in vivo study: the SDs of the mean CoVs were rather 
closer to the LCModel %SDs. For the in vivo study, the means of the CoVs were 
greater than the LCModel %SDs. The inherent variability in the subject group 
and the small sample size could have been the sources of the large discrepancy 
between the two parameters.  
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Metabolite Mean CoV SD of mean CoV LCModel %SD for between-
exam CoV 
m-Ins 4.64 1.49 8.0 
Cho 4.39 2.86 4.0 
Cr 4.32 2.48 3.0 
Glu 4.96 2.04 8.0 
NAA 3.88 1.77 2.0 
Lac 5.55 0.84 9.0 
 
Table 3.3: Mean CoVs and standard deviations of the measured metabolites in all the three 
studies (n = 64). 
The mean CoVs for NAA, Cr and Cho are comparable to their average %standard deviations from 
LCModel; for all metabolites, the SD of the means were however found to be smaller than the 
average % SDs from LCModel 
  
 
Simmons et al [135] performed a reproducibility study on a similar phantom as 
the one used in this thesis. They acquired spectra using PRESS with TE/TR = 
136/2000 ms and 256 averages. Using the SAGE software, the NAA, tCr and Cho 
peaks were fit to Lorentzian line shapes using the Levenberg-Marquardt fit, and 
normalised to the water peak. CoVs were calculated for three studies: five 
serial scans with single shim, while the phantom was unmoved (within-session), 
five serial scans with separate shims, while the phantom was repositioned each 
time (between-session), and one scan per week over 2 years (between-exam). 
The within-session CoVs (%) were: NAA = 0.5, tCr = 0.8, Cho = 1.2; between-
session CoVs (%) were: NAA = 0.8, tCr = 1.0, Cho = 1.0; and the between-exam 
CoVs (%) were: NAA = 1.5, tCr = 1.5, Cho = 2.4. Only the CoV for Cho in the 
within-session study by Simmons et al was comparable to the study here. All 
other CoVs were at least twice as good as those in this thesis.  
 
A number of factors could have accounted for this difference in the results: 
Simmons et al acquired 256 averages while only 16 averages were acquired in 
this thesis. SNR is proportional to √NSA [31], which means that the SNR of their 
signals were a factor of 4 more than those here. For the within-session scans in 
this thesis, shimming and water suppression were performed per scan (but 
Simmons et al performed shimming once in a similar exam). Variations in the 
efficiency of the scanner doing these two procedures (i.e. shimming and water 
suppression) could have propagated errors into the estimated CoVs, thus 
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making them larger. For the between-session scans, a time delay of ~10 
minutes was allowed between scans; Simmons et al, however, only retracted 
the couch of the scanner and replaced the phantom. Thus, there was a greater 
chance of equipment instabilities manifesting themselves in the CoV estimates 
of this thesis. Differences in the TE times (35 versus 135 ms), B0 (3T versus 
1.5T) and spectral quantification techniques (LCModel versus SAGE) could have 
also been the sources of the disagreements.   
 
Generally, the CoVs for all metabolites measured in vitro were better than the 
in vivo CoVs. The inherent sources of variability (e.g. voxel content, motion, 
etc) associated with the in vivo, that were absent in the in vitro, studies could 
have been the reason for this relationship between the two sets of CoVs. 
Temperature effects were also thought to have a role in this discrepancy, and 
so investigation of this in vivo became an interest. However, it is impossible to 
vary the temperature of the human body; only the temperature variations in a 
phantom could be measured in such studies. The effect of temperature 
variation on the in vitro reproducibility and/or stability of the MR scanner was 
therefore investigated (section 3.3.2.2).   
   
3.3.2.2 Temperature Effect on in vitro Measurements 
 
  
Temperature affects T1 more than T2; T1 relaxation time increases with 
temperature. In fact, both T1 and T2 (and hence magnetisation) have been 
reported to vary by about 2-3 % per oC [1]. Despite this argument from theory, 
the concentration estimates in this thesis were generally observed to remain 
fairly stable with room temperature over the period of the experiments. In 
fact, only the experiment in month ‘4’ corroborated the temperature-
concentration argument.  
 
Figure 3.3 shows a long term serial study assessing the stability of the 
metabolite concentration measurements. The graph indicates that even though 
the room temperature varied significantly, that did not introduce large 
variations in the concentration measurements. The CoVs for water, NAA, Cr, 
Cho, Glu, m-Ins, and Lac were respectively 12.73 %, 3.95 %, 4.49 %, 4.33 %, 
4.44 %, 4.47 % and 5.74 % (Table 3.2). The results thus indicate that 
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temperature variation did not cause substantial variations in the measured 
metabolite and water spectral peak areas. 
 
 
 
 
Figure 3.3: Reproducibility of phantom measured metabolite concentrations over a period 
of 18 months (October 2010 to March 2012). 
The topmost line (in light blue) is the variation of the temperature (in oC) of the phantom over 
the course of the reproducibility study period. Error bars are ±standard deviations of the 
LCModel concentrations 
  
  
3.3.2.3 In vivo Measurements 
 
 
The in vivo reproducibility results are summarised in table 3.4, and the spectra 
acquired from each reproducibility study are shown in Figures 3.4-6. The mean 
of the coefficient of variations (CoVs) and standard deviations (SDs) of the CoVs 
were calculated for all the metabolites (Table 3.5). 
 
For m-Ins, tCho and tNAA, the intra-subject, between-exam was the most 
reproducible, followed by inter-subject, same month and then inter-subject, 
same day. For Cr, tCr, NAA and water, intra-subject (between-exam) 
reproducibility was again the best, but this time, followed by inter-subject, 
same day and then inter-subject, same month reproducibility measurements. 
However, for Glu, Gln and Glx reproducibility, intra-subject, between-exam 
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was the worst, followed by inter-subject, same month; inter-subject, same day 
exam was the most reproducible. Intra-subject reproducibility of the water 
peak was the best, followed by inter-subject, same day; inter-subject, same 
month reproducibility was the worst. Using n = 3 for the inter-subject, same 
month measurements did not change the above comparisons. 
 
 
Peak Inter-Subject,         
same day CoV (%)     
(n=3) 
Inter-Subject,               
same month CoV (%)      
(n=4) 
Intra-Subject,              
same year CoV (%)       
(n=1, scanned 3 times) 
m-Ins 25.88 24.15 13.20 
tCho 15.12 14.59 3.87 
Cr 23.01 40.04 22.86 
tCr 11.22 17.95 10.51 
Gln 27.72 71.94 N.D.* 
Glu 4.58 9.95 26.05 
Glx 5.95 11.88 26.23 
NAA 11.93 16.70 3.13 
tNAA 14.50 11.99 5.98 
Water 11.99 13.63 7.63 
 
Table 3.4: Reproducibility of MRS measurements in healthy volunteers. 
*Gln was not detected (ND). tCho, tCr and tNAA mean total Cho, Cr and NAA, respectively. 
 
  
The standard deviations of the mean CoVs for the metabolites in all the studies 
were found to be comparable to the average LCModel standard deviations for 
the intra-subject, between-exam, same year study (Table 3.5). This was 
notable for m-Ins, Cr, tCr, Glu and Glx. It is therefore possible that the 
LCModel standard deviations could as well be used to assess reproducibility 
roughly. Estimating CoV in this manner might be useful in the clinical setting to 
save time having to conduct a rigorous reproducibility study as presented in 
this chapter.      
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Metabolite Mean CoV SD of mean CoV LCModel %SD for Intra-
subject, same year CoV 
m-Ins 21.07 6.88 7.67 
tCho 11.19 6.35 3.67 
Cr 28.64 9.87 10.00 
tCr 13.23 4.11 3.00 
Gln 33.22 36.28 ND 
Glu 13.53 11.17 9.33 
Glx 14.69 10.43 10.00 
NAA 10.58 6.88 3.67 
tNAA 10.83 4.38 2.33 
 
Table 3.5: Mean CoVs and standard deviations of the measured metabolites in all the three 
studies (n = 10). 
ND = not detected. The standard deviations of the mean CoVs are comparable to the average 
%standard deviations from LCModel 
  
 
In most cases, less variability will be expected from scanning the same healthy 
subject over a period of time. Possible sources of variation could come from 
motion, variability in the voxel placement, RF non-uniformity, shimming 
efficiency or change in hardware such as a head coil. However, for a number of 
subjects, variability in their own characteristics (e.g. age, gender, etc), 
biological variation, voxel placement, tolerance level in the scanner (e.g. 
motion), in addition to the above factors could worsen reproducibility. This 
might explain the better reproducibility in the intra-subject compared to inter-
subject studies.  
 
 
                             
                 
                     (a) 1st subject                                (b) 2nd subject                             (c) 3rd subject 
 
Figure 3.4: Inter-subject, same day reproducibility spectra 
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(a) 1st subject                   (b) 2nd subject              (c) 3rd subject                 (d) 4th subject 
 
Figure 3.5: Inter-subject, same month reproducibility spectra 
 
 
 
                                  
 
         (a) 1st scan                                     (b) 2nd scan                                   (c) 3rd scan 
 
Figure 3.6: Intra-subject, same year reproducibility spectra 
 
    
  
Hancu et al [136] compared the reproducibility of the conventional PRESS 
sequence with that of their TE-averaged PRESS sequence (PRESS-J). They 
acquired spectra from the posterior cingulate gyrus of two volunteers using 
TE/TR = 35/2000 ms and 256 averages for each sequence, except that the TE of 
PRESS-J was varied from 35 to 355 ms in steps of 2.5 ms. Volunteers were 
scanned three times a day on five different days over 6 months. The calculated 
CoVs (%), with their LCModel standard deviations in brackets, were: PRESS: NAA 
= 4.47 (3.97), Cr = 4.74 (3.94), Cho = 5.67 (5.88), Glu = 6.50 (7.76), m-Ins = 
7.51 (8.27); PRESS-J: NAA = 2.74 (2.18), Cr = 3.56 (3.55), Cho = 3.25 (4.15), Glu 
= 7.59 (10.36), and m-Ins = 13.57 (14.06). The standard deviations of all 
metabolites measured with both sequences were comparable to those reported 
in this study. The intra-subject CoVs for NAA, Cho and m-Ins of this study were 
comparable to those of Hancu et al [136]; while the inter-subject CoV between 
the two studies were also similar.  
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Simmons et al [135] performed a reproducibility study on 8 subjects using 
PRESS (TE/TR = 136/2000 ms), and placing their voxel in the left occipital lobe 
(comprising a grey-white matter mix). Five successive spectra were acquired 
within one session; all 8 subjects were again scanned five times over 3 months; 
and one volunteer was scanned 14 times over 2 years. The spectra were fitted 
to Lorentzian lineshapes with the Levenberg-Marquadart fitting algorithm, and 
normalised to the water peak. Calculated CoVs (%) for NAA, Cr and Cho were: 
within-session for all 8 subjects (NAA = 1.4, Cr = 2.7, Cho = 4.9); between-
exam for all 8 subjects (NAA = 2.5, Cr = 3.8, Cho = 6.4); 1 subject scanned 14 
times over 2 years (NAA = 3.6, Cr = 5.6, Cho = 6.9). Between-exam 
reproducibility for all 8 subjects by Simmons et al was better than those 
reported in this thesis. However, the results in this thesis were comparable to 
theirs for the between-exam, intra-subject reproducibility. 
  
Marshall et al [140] measured the CoVs for within-session and between-exam of 
the parietal white matter region of 12 volunteers using PRESS with TE/TR = 
135/1600 ms and 64 averages. Spectra were analysed using a custom software 
package (“Water Fit”, WFIT). The within-session CoVs (%) were; NAA = 4.4, Cr = 
17.2, Cho = 8.2, whereas the between-exam CoVs were; NAA = 8.1, Cr = 25.8, 
Cho = 11.4. The between-exam CoVs reported by Marshall et al were 
comparable to those reported in this work but no within-session study was 
conducted in vivo in this thesis. 
 
Using the PRESS sequence (TE/TR = 136/6000 ms), Duc et al [139] collected 
spectra from the frontal, parietal, occipital, cerebellum and hippocampal 
regions in “sequential” and “separate” scans of 28 volunteers. The reported 
percentage CoVs for NAA, Cr and Cho in the frontal region (for comparison with 
the work in this thesis) were: sequential (NAA = 7.4, Cr = 25.9, Cho = 20.5); 
separate (NAA = 6.5, Cr = 21.3, Cho = 15.0). Generally, the calculated 
reproducibility values in this thesis were better than those reported by Duc et 
al.    
 
Brooks et al [138] used STEAM with TE/TR = 30/2000 ms to acquire spectra 
from the occipitoparietal white matter region in 10 healthy subjects. Within 
one session, six successive acquisitions were done; this was repeated after one 
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hour, and again in a month’s time. Spectral analysis was performed in the java-
based Magnetic Resonance User Interface (MRUI) software by fitting Gaussian 
line shapes to the NAA, Cr, Cho and m-Ins peaks normalised to the water peak. 
The mean CoVs (%) for each individual in a session (similar to the intra-subject 
CoVs of Table 3.4) were calculated to be 3.30, 4.32, 5.30 and 8.10 for NAA, Cr, 
Cho and m-Ins respectively. Even though the sample size for this thesis was 
small, the reproducibility results were comparable to most of the literature 
values. 
 
 
            3.4 Summary and Conclusions 
 
 
In this chapter, the PRESS and STEAM pulse sequences were compared for their 
respective SNRs. For the same acquisition parameters, and using an MRS brain 
phantom, PRESS was found to produce spectra whose SNR was typically twice 
as much as that of spectra from STEAM. The PRESS sequence was therefore 
preferred over STEAM for subsequent experiments in this thesis.  
 
Using the PRESS sequence, reproducibility studies were conducted both in vivo 
and in vitro, measuring the water and metabolite signal areas. These studies 
also included serial measurements of the most common in vivo metabolites in 
order to assess the stability of the MR scanner and the impact of temperature 
variations on the measurements.  
 
The phantom studies showed that measurements performed while the phantom 
remained in place (i.e. within-session) were the most reproducible. For all 
metabolites, the standard deviations of the mean CoVs of their measurements 
were found to be better (i.e. lesser) than their corresponding LCModel 
estimated average % standard deviations. Generally, temperature variations 
during the phantom experiments did not introduce significant uncertainties in 
the measured metabolite and water spectral peak areas. To the best of the 
author’s knowledge, no other reproducibility study in the literature has studied 
the impact of temperature variation on reproducibility measurements at 3 T.  
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The human studies on the other hand indicated that apart from Glu and Glx, 
longitudinal measurements of all the other metabolites and water in the same 
volunteer were the most reproducible. Unlike the phantom studies, for all 
metabolites, the standard deviation of the mean CoVs of their measurements 
were comparable to their respective LCModel estimated average % standard 
deviations.   
 
It has been noted [1] that precision could be worse if measured from repeat 
scans over a long period of time, compared with short-term repeats. This is 
because over the prolonged measurement period, additional sources of 
variations are introduced into the measurements. The in vitro precision results 
(Table 3.2) of this thesis were consistent with this assertion. The in vivo results 
(Table 3.4) were however in contrast to this observation. In the same-day and 
same-month human studies, different subjects were scanned and so the 
contribution of subject-specific bias in the measurements cannot be ruled out. 
The year-long reproducibility human study on the other hand was conducted on 
the same subject, and so any error arising from the measurements could be 
considered to be the same in each experiment. This could have been the 
reason for the better precision in the year-long measurements. In case of the 
in vitro experiments, the same phantom was scanned in all sessions, and is 
most likely to be the ideal situation being referred to in the above principle; 
which could be the reason why the in vitro results agree with that assertion.    
 
Following the PRESS versus STEAM study, the rest of the studies in this thesis 
commenced and were then conducted concurrently with the longitudinal 
reproducibility studies. Since the scanner was found to be consistent in its 
measurements of the metabolite signals, as suggested by the work in this 
chapter, the subsequent MRS data may be considered not to be affected 
significantly by temperature and/or inconsistencies in the performance of the 
MR scanner.   
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Chapter 4: RF Field Mapping Using the 
Unsuppressed-Water Signal 
 
 
  4.1 Overview and Objectives 
 
 
In section 1.1.3, it was indicated that the non-uniform response of the phased-
array head coil could serve a good purpose in quantitative MRS. In this chapter, 
the sensitivity maps of the eight-channel RF coil (Figure 1.1b) will be deduced 
using the unsuppressed-water signal. The application of these sensitivity maps 
for referencing in absolute quantification of cerebral water formed the impetus 
for this chapter.  
 
The objective of this chapter was therefore to develop standard mathematical 
models from the RF sensitivity maps of the phased-array head coil. These 
standard models will be functions of voxel position, and will represent the 
spectral peak area of unsuppressed-water for any in vivo voxel position. Given 
any in vivo acquisition, the voxel coordinates should correspond to at least one 
of these mathematical functions. Substitution of these coordinates into the 
appropriate function would give a theoretical signal area at the same voxel 
position as the in vivo signal. This derived signal was suggested in this thesis as 
a reference in the absolute quantification of cerebral water, which itself has 
been used as a reference concentration in this thesis.  
 
The referencing method suggested in this chapter is novel and so it is necessary 
to discuss the commonly used referencing methods (section 4.1.2) in 
quantitative MRS (section 4.1.1) and the impact of phased-array coils on the 
accuracy of quantitative MRS (section 4.1.3). These background sections will 
then serve to clarify the differences between the methodology presented here 
and the existing methods. 
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4.1.1 Absolute versus Relative Quantitative MRS 
   
 
Metabolite levels are generally expressed as ratios or in absolute millimolar 
concentration units. Each one of these two quantification schemes has its 
practical advantages and disadvantages.  
 
The use of ratios commonly involves referencing each spectral peak area to 
that of Cr. The advantage of this technique is that it involves shorter 
acquisition times since there is no requirement for a separate acquisition of the 
reference signal. In acquisitions where the voxel includes some CSF (e.g. 
around the hippocampus), the use of ratios circumvents the need to perform 
partial volume correction (section 5.1.3)[1]. For such cases, both the reference 
and metabolite signals are affected by the same partial volume effect, which 
cancels out in the ratio. Reproducibility with ratios is therefore normally 
reported to be good [1]. However, metabolite ratios are vulnerable to 
pathological processes in which Cr changes, and also systematic variation of 
tissue Cr content with age [1]. The concentration of a reference has to be 
fairly constant, but grey matter (GM) changes with ageing have been associated 
with increased GM Cr in the elderly [1]. There has also been a reported 
significant increase in white matter Cr with age in young to middle-aged adults 
[143].  
 
Regional, tissue-specific and age-related [143, 144] variation in Cr 
concentration underscores the need for absolute metabolite concentrations. 
Moreover, changes in metabolite ratios observed between two examinations of 
the same individual or between two groups are ambiguous and have to be 
interpreted with caution. This is because the change may either be due to the 
numerator or the denominator. Therefore, ratios cannot withstand detailed 
comparison across different brain regions [1].  
 
Expressing metabolite concentrations in absolute units, on the other hand, 
requires a more rigorous technique [1] with careful consideration to the type of 
reference concentration, which is usually constant or fairly stable. In general, 
the accuracy and precision of absolute concentrations depend on the type of 
concentration standard chosen (section 4.1.2). Internal referencing is not 
126 
 
affected by effects due to coil loading and local B1 variation as with external 
referencing.  
 
The next consideration is the choice of TE and TR for the acquisition, which 
largely depends on the aim of the study. The challenge however is that the 
metabolites differ in T1 and T2 relaxation times. Therefore, the TE and TR 
values chosen will cause signal losses due to either T1 or T2 relaxation effects 
or both (section 2.1.2.1-2). Nonetheless, relaxation effects can be minimised 
by selecting a short TE and a long TR [132].  
 
When the B1 non-uniformity or coil loading and relaxation effects are 
corrected, the other sources of error (including partial volume effects) do not 
affect accuracy of absolute quantification by more than 5-10 %; and 
reproducibility stays well within 10 % [145]. Once all the necessary corrections 
are made, absolute metabolite concentrations provide direct means of 
interrogating tissue metabolite levels, and are not ambiguous. This is because 
the concentration of the reference does not change; therefore any observed 
change in concentration is purely due to change in the measured metabolite. 
For this reason, absolute concentrations improve the utility of MRS in the 
characterisation of pathological and developmental changes in metabolite 
levels. With absolute concentration estimates, MRS results from different sites 
can be compared in multicentre clinical trials, as long as the protocols are 
similar [30].  
   
 
4.1.2 Internal versus External Referencing 
 
 
The reference signal for absolute quantification may be acquired from a 
substance within the brain (internal) or outside of the brain (external). The 
concentration of the internal substance is usually assumed empirically [30, 62] 
or estimated at the same time as the metabolite concentrations [58]. Brain 
tissue water and Cr are widely used as concentration standards [62, 71, 146, 
147]. The concentration of the external reference on the other hand is always 
accurately known [30, 145]. Various chemicals have been used to prepare 
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solutions of known concentrations for external referencing; examples of these 
include Cr [145], cyclohexane and water [148].  
 
External referencing can be performed in two ways [1]: “same-place” and 
“same-time” external standards. A same-place external standard is scanned in 
place of the brain on a separate occasion, whereas a same-time external 
standard is placed next to the head in the RF coil, and is scanned at the same 
time as the brain; but with different voxel positions [1, 30].  
 
For an acquisition involving the same-time external standard, the brain and 
reference signals are affected by difference in flip angles of the RF pulse, and 
so a correction for B1 field non-uniformity is required [149]. The same-place 
external referencing technique may not require B1 non-uniformity correction on 
the assumption that the spatial sensitivity of the coil remains the same over 
the head. However, systematic errors in the quantification could arise from 
local B0 and B1 field inhomogeneities, loading effects, eddy currents and 
standing waves, all of which may depend on the properties of the human head 
and size, geometry, position and electrical properties of the filling substance in 
the phantom [30, 62, 144, 148]. The chemical composition of an external 
standard can be carefully controlled and its concentration is accurately known 
[62]. However, external referencing could complicate, prolong and introduce 
more errors into the quantification process [1].  
 
For internal referencing, a water-suppressed acquisition is performed first, and 
then from the same voxel, the signal from unsuppressed tissue water is 
acquired, which serves as the concentration reference [45]. Tissue water 
content could as well be derived from proton density weighted images [150, 
151]. This approach gives absolute concentration in units of molality (i.e. 
moles/kg of tissue water), which can be converted into molar concentration 
(i.e. moles/litre of tissue water) by using the density of brain tissue (section 
6.2.4.1) [71]. However, determination of brain density and brain water content 
can be challenging [45, 58], and so a value is usually applied from the 
literature [62].  
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The use of literature values require some caution since brain tissue water 
content is known to be affected by a number of pathologic conditions. For 
instance, it has been reported that hydrocephalus [152], brain tumours [152] 
and multiple sclerosis [153, 154] can cause brain water content to be as high as 
120 %, 50 % and 12 %, respectively, compared to the water content in healthy 
subjects. It might therefore be useful to measure the brain tissue water signal 
directly in such situations. Nonetheless, an internal standard is insensitive to 
the local variations in B0 and B1 fields suffered by an external standard, and so 
there is no requirement for non-uniformity correction [1, 62].  
 
Tissue water content as a concentration reference is uniformly distributed, in 
the absence of lesions and hydrocephalus, cerebral water content varies over a 
relatively small range (10-20 %) in most other pathologies [62]. The acquisition 
time for internal referencing is shorter (since acquisition is done in the same 
voxel using the same sequence), and only a few averages of the water signal 
need to be collected as it has a high SNR [1]; the technique is also less 
complicated (since it requires fewer corrections to be performed) and may 
have less compliance issues (since there is no object next to the subject’s head 
in the RF coil) compared to external referencing. 
   
  
4.1.3 Spatial Sensitivity of the RF Coil 
   
 
Receive-only surface coils and phased-array coils help increase the SNR of the 
MRS signal but significant standing wave effects due to the geometry of the 
human head (even at 1.5 T) cause inhomogeneous signal-receive characteristics 
of the RF coils [1, 144]. Signal losses due to T1 relaxation processes will also 
vary according to the flip angle at each location within the coil [1]. If 
uncorrected, the RF non-uniform response, which usually assumes a convex 
profile across the coil [30], could give rise to signal intensity variation of up to 
29 % in large water-filled phantoms [30], and up to 50 % in the human head 
[145]. These variations have been observed as signal intensity decreases from 
the centre of the coil to the edges. Thus voxel position in the brain could 
therefore determine the amount of signal acquired relative to noise [144, 155]: 
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metabolite concentrations will be overestimated and underestimated for voxel 
positions towards the centre and edge, respectively, of the coil.  
 
However, RF field non-uniformity cannot directly be measured by a uniform 
phantom [1, 144], because the coils are not used for transmission [144]. One 
way of correcting the received signal for RF field inhomogeneities is by 
recording the localised water signal using both the receive coil and the body 
coil. The recorded signal intensity may then be used to scale the low SNR 
metabolite signals to obey the receive characteristics of the transmit/receive 
body coil [47, 156]. However, with phased-array coils, the water and 
metabolite signals will have to be combined using consistent signal weights 
(section 1.4.4). This is because the low SNR of the metabolites is most likely 
influenced by noise, and the weights will account in part for the noise [144]. 
Since the normalisation of the signal is required for each voxel position, it will 
mean that this correction technique will have to be repeated for every single 
MRS acquisition. RF field mapping is thus the only rigorous means of correcting 
for the non-uniformity [1]. Even though this is time-consuming and may not be 
feasible in a clinical setting, it provides correction factors for all possible voxel 
positions within the field-of-view of the RF coil. RF mapping was performed in 
this thesis on a phantom, not to correct for the non-uniform response of the 
coil, but to deduce a reference signal for the absolute quantification of 
cerebral water content. 
 
 
4.2 Methods 
 
 
The head coil can be considered to have a 3-dimensional geometry described 
by three (anatomical) axes: right-left (RL), anterior-posterior (AP) and 
superior-inferior (SI). Therefore, the design allows for NMR signal reception 
from a 3-dimensional object such as the human head or the GE MRS phantom 
(Figure 2.26). To obtain the RF sensitivity maps, spectra were recorded from 
varying voxel positions, firstly along these three principal axes (sections 4.2.1-
3), and then within a 2-dimensional space (defined by the RL-AP axes) along 
the SI axis (section 4.2.4). For each acquisition, the unsuppressed-water 
spectral lines were processed (section 4.2.5) and plotted to give the sensitivity 
maps (section 4.2.6).  
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The process of switching OFF the CHESS water-suppression module on the MR 
scanner is not straightforward. Since many voxel positions were to be acquired 
in this study, it would have meant that the same process of turning OFF CHESS 
water-suppression be repeated prior to each acquisition. The water signal has a 
very good SNR and so only a few averages (at least one) of unsuppressed-water 
lines should be sufficient for the RF mapping study. Meanwhile, it is still 
possible to obtain at least two unsuppressed-water lines from a CHESS water-
suppressed acquisition (section 2.3.1.3). Therefore, acquisition of the CHESS 
water-suppressed spectra in this case made it possible to perform the 
experiments quicker, and then to obtain two unsuppressed-water lines (using 
NEX = 8) from the data set for this study. 
    
4.2.1 Sensitivity mapping along the RL axis 
   
                        
An axial T2-weighted FSE/propeller (TR/TE = 4050/110 ms) MRI of the phantom 
was acquired with 31 slices (3 mm thick per slice), and FOV of 20.0 x 20.0 cm2.  
 
 
The MRS protocol used was the PRESS localisation sequence with TE/TR = 
35/2000 ms, 64 signal averages, NEX = 8 and VOI = 10.0 x 10.0 x 10.0 mm3. All 
spectra were acquired with the CHESS water suppression module turned ON. 
 
The voxel was positioned at the origin along the RL axis of the MR image and 
spectra were acquired from this location. This was the isocentre of the 
receiver coil. Maintaining fixed coordinates for the AP and SI axes, the voxel 
was moved every 5.0 mm up to the right (R) edge of the image where the 
maximum possible coverage was -70.0 mm. The voxel was again moved by 5.0 
mm up to the left (L) edge of the image, a displacement of 70.0 mm from the 
isocentre. Twenty-eight voxel positions were covered; three acquisitions were 
made in each position, giving a total of eighty-four acquisitions.   
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Figure 4.1: A schematic of the voxel locations for the MRS acquisitions along the RL axis 
A few voxel positions along the RL plane of the phantom image are shown in (a) and a 
magnified representation of the RL axis is shown in (b). 
In figure 4.1(b), the isocentre is position 0; displacements to the right of the isocentre are 
indicated by the measure of the distance with an ‘R’; displacements to the left are marked 
with an ‘L’. The ‘R’ values are negatives, whereas the ‘L’ values are positives. All 
displacements were displayed with the aid of a position indicating cursor on the scanner 
console. The voxel was positioned such that its centre at one location was 5.0 mm away from 
its previous centre position. Since the length of the voxel was 10 mm, there was always an 
overlap of its length by 5.0 mm between neighbouring positions. Thus, spectra were collected 
effectively at each location along the RL axis. 
 
 
4.2.2 Sensitivity mapping along the AP axis 
  
 
For measurements along the AP axis, a sagittal T1-weighted FLAIR (TR/TI/TE = 
2500/920/9 ms) MRI of the phantom was acquired with 21 slices (3 mm thick 
per slice), and FOV of 20.0 x 20.0 cm2. The same MRS protocol described in 
section 4.2.1 was used for the spectral acquisitions but this time, after the 
acquisition at the isocentre along the AP axis, the voxel was moved to the 
anterior end of the image up to -70.0 mm; acquisitions were then made with 
voxel positions up to the posterior end of the image at 75.0 mm from the 
isocentre. Voxel displacements were in steps of 5.0 mm (as in Figure 4.1) and 
so with the voxel length of 10.0 mm, spectra were collected at every location 
along the AP axis. The coordinates along the RL and SI axes were kept constant 
throughout the measurements. Twenty-nine voxel positions were covered; 
three acquisitions were made in each position, giving a total of eighty-seven 
acquisitions.  
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4.2.3 Sensitivity mapping along the SI axis 
  
 
For measurements along the SI axis, a coronal T2-weighted FLAIR (TE/TR = 
158/9000 ms) MRI of the phantom was acquired with 21 slices (3 mm thick per 
slice), and FOV of 20.0 x 20.0 cm2. The same MRS protocol described in section 
4.2.1 was used in these measurements but in this case, the coordinates in the 
RL and AP axes were kept constant throughout the acquisitions.  
 
Spectra were collected at the isocentre along the SI axis; the voxel was 
subsequently moved in steps of 5.0 mm up the SI axis to a maximum 
displacement of 80.0 mm from the isocentre. In steps of 5.0 mm, spectra were 
collected from voxel positions down the SI axis to a maximum displacement of   
-65.0 mm from the isocentre. As the length of the voxel was 10 mm, spectra 
were collected from all points along the SI axis. With three acquisitions in all 
twenty-nine voxel positions, a total of eighty-seven acquisitions were made.  
 
4.2.4 Sensitivity mapping in the RL-AP plane along the 
SI axis 
 
For these measurements, an axial FSE/propeller (TE/TR = 110/4050 ms) MRI of 
the phantom was acquired with 34 slices (5 mm thick per slice), a matrix size 
of 160 x 160 pixels, and FOV of 20.0 x 20.0 cm2. The MRS protocol used in 
section 4.2.1 was maintained but this time, a voxel size of 20.0 x 20.0 x 20.0 
mm3 was used. 
 
Three positions were chosen above and below the isocentre along the SI axis. 
These selected points were each 20 mm apart; the length of the voxel used 
was also 20 mm. The centre of the voxel was placed on each of these selected 
points. Thus, one edge of the voxel at a particular position always coincided 
with the other edge in the next position. This made it possible to collect 
spectra at every point in a given row. The six selected points along the SI axis 
were accessed by scrolling in-plane through the slices of the axial image, using 
the position indicating cursor on the scanner console. 
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For a given axial slice (i.e. a selected point on the SI axis; Figure 4.2), spectral 
acquisitions were conducted in such a way that the voxel was moved along the 
RL axis until all points were covered. Acquisitions were subsequently made 
with this row of voxel positions along the AP axis of the same slice. When all 
points were covered on a particular slice, the next SI point was assessed by 
scrolling to the appropriate slice (in-plane or into the screen) on which 
acquisitions were made again until all voxel positions were covered. Due to the 
spherical geometry of the phantom, the number of voxel positions covered 
decreased towards the edges. For the six SI points, the numbers of voxel 
positions covered from the superior to inferior ends of the phantom were 19, 
27, 32, 31, 26 and 17. The measurements were not repeated at the voxel 
positions in this case due to the large number of voxel positions. Thus a total of 
152 acquisitions were made. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2: A schematic of the voxel positioning in the RL-AP plane 
The six SI positions are as shown. In this diagram, acquisitions are being made in slice 55S, the 
topmost part of the phantom image. When all positions are covered as shown by the matrix of 
voxel positions, the next slice, 35S is assessed and another matrix of positions are conducted. 
The other voxel positions in the subsequent slices in-plane are represented by the single voxels 
at their respective positions. The voxels were not spaced as shown here. In fact, their positions 
were such that the edge of each voxel coincided with the edge of the next one in the actual 
acquisitions, as shown in Figure 4.3  
Slice scroll into 
the screen 
R 
P 
I 
55I 
35I 
15I 
15S 
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Figure 4.3: SI positions through which the RL-AP plane acquisitions were made. 
Position O was covered during the acquisitions along the RL axis (section 4.2.1)  
 
 
4.2.5 Data Analysis 
   
 
As mentioned in section 4.2, water spectra extracted from the 16/NEX part of 
equation 2.19 was processed as described in section 2.3.1.2. Spectra from each 
one of the three acquisitions per voxel position were quantified in the same 
way to yield the unsuppressed-water peak area, Au. Each Au value was 
corrected for transmit gain, TG (a measure of coil loading), VOI size and 
relaxation effects to yield a corrected value, Aphan as follows: 
 
          
                                                                                                     (Eq. 4.1) 
 
 
where VOI is the voxel size used for the acquisition, KTG is the correction factor 
for transmit gain given by 10(TG/200) [149], TR and TE are respectively the 
repetition and echo times (for these acquisitions, TE = 35 ms, TR = 2000 ms), T1 
and T2 are respectively the longitudinal and transverse relaxation times of 
water at room temperature (where T1 = 3.3 s and T2 = 2.5 s [1]). The 
S I 
0 15I 35I 55I 15S 35S 55S 
20mm 20mm 20mm 20mm 20mm 20mm 
Aphan =  
Au x KTG  
VOI x [1-exp(-TR/T1)] x exp(-TE/T2)   
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transmitter gain value, TG in decibel units is provided on the scanner console 
during the acquisition, and is subsequently stored in the MRS header file.  
 
Aphan in equation 4.1 is the corrected water signal area acquired from the 
phantom. It was the mean of the three measurements of Aphan at each voxel 
position that was used for the RF field maps along the principal axes (section 
4.2.6). The mean for Aphan was however not calculated in the case of the data 
obtained in section 4.2.4 as the measurements were not repeated.   
 
4.2.6 Derivation of Sensitivity Maps 
    
 
To deduce the sensitivity maps along each one of the principal RL, AP and SI 
axes, a polynomial fit was performed on a plot of the mean water peak area, 
Aphan against the voxel positions in the respective axes. The equation of the 
best polynomial fit was then chosen as the model describing the sensitivity map 
of the receiver coil along that axis.  
 
To deduce the sensitivity map in the RL-AP plane along the SI axis, for each SI 
position (or slice), a 3-dimensional space was defined in MATLAB (version 
7.8.0.347, R2009a) and a surface plot of the water peak area, Aphan against the 
voxel positions in the RL-AP plane was obtained. Polynomial fits along the RL 
and AP axes were performed, and the equation of the best polynomial fit was 
chosen as the model describing the sensitivity map of the coil within that slice.    
 
 
4.3 Results and Discussion 
 
4.3.1 RF Field Maps along the Principal Axes of the RF 
Coil 
 
 
   
Figure 4.4 shows the sensitivity maps of the receiver coil along the RL, AP and 
SI axes using the unsuppressed-water signal. Water signal intensities recorded 
at voxel position –55 mm from the isocentre along each one of the RL and SI 
axes were far underestimated compared to the rest of the data; the reason for 
this observation was unclear. Their inclusion in the plots gave poor polynomial 
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fits to the data (Appendix 4.1). They were therefore regarded as outliers and 
subsequently removed from the plot to give better fits as shown in Figure 4.4. 
However, in both planes, this exclusion does not create any gap that was not 
covered by the voxel. This is because neighbouring voxel positions were already 
overlapping by 5 mm and so taking out one point between any two points will 
make the voxel edges at the remaining two points to coincide. 
 
 
 
 
               Figure 4.4: RF field maps in the RL, AP and SI planes                                                                 
Error bars are ±standard deviations of the mean of three measurements at each voxel position 
 
 
No such variations of over 180 % in signal intensity from the isocentre of the 
phased-array head coil (Figure 4.4) have been reported in the MRS literature. 
The sensitivity maps along the RL, AP and SI axes were best fit with polynomial 
functions of the following forms: 
 
 RL-70:70(y0, z0) = Ax
5 + Bx4 + Cx3 + Dx2 + Ex + F                                  (Eq. 4.2)    
                                                                                                                                     
 AP-70:75(x0, z0) = Ay
5 + By4 + Cy3 + Dy2 + Ey + F                                  (Eq. 4.3)  
                                                                                                                                                   
 SI-65:85(x0, y0) = Az
4 + Bz3 + Cz2 + Dz + E                                           (Eq. 4.4)   
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where SI-65:85(x0, y0) means signal intensities at voxel positions between -65 mm 
(or 65I) and 85 mm (or 85S) from the coil centre along the SI axis, while the 
voxel coordinates in the RL and AP were kept constant at 0 mm, represented 
respectively by x0 and y0, etc. The variables x, y and z in each equation are the 
voxel positions in the RL, AP and SI planes, respectively. The constants A, B, 
C,…, F are the coefficients of the polynomial fits given in Table 4.1. The RL 
and AP data were both best fit to fifth-degree, whereas the SI data was best fit 
to fourth-degree polynomials.   
 
 
 
      
 
 
 
 
 
Table 4.1: Values of the coefficients of the polynomial fits to the RF sensitivity maps along 
the principal axes of the receiver coil 
 
  
 
4.3.2 Inter-slice RF Field Maps along the SI Axis of the 
RF Coil 
  
The spatial variation of the sensitivity of the receiver coil is represented by the 
field maps shown in Figures 4.5-10. The 3D plots are presented in order: the 
topmost slice at the superior end (i.e. 55S) is shown first (Figure 4.5), followed 
by the intermediate slices down to the bottommost slice at the inferior end 
(i.e. 55I) shown in Figure 4.10. This order matches with in vivo anatomical 
slices taken from the top of the head down to the neck; thus covering the 
entire volume of the receiver coil. 
 
Due to the spherical shape of the phantom, fewer voxel positions were possible 
at the extreme ends (i.e. 55S and 55I). For this reason, the data collected in 
those slices were fewer compared to the data from the intermediate slices. 
Therefore, slices 55S and 55I were each best fit to fourth-degree whereas slices 
35S, 15S, 15I and 35I were best fit to fifth-degree polynomial functions. The 
 
Axis 
Coefficient of polynomial fit 
A B C D E F 
 
RL 
 
0.01 
 
1.11 
 
-43.45 
 
-14749 
 
-388472 
 
1.00e8 
 
AP 
 
-1.90e-3 
 
0.95 
 
27.06 
 
-12225 
 
-235667 
 
1.00e8 
 
SI 
 
1.72 
 
-70.74 
 
-17919 
 
850716 
 
1.00e8 
 
0 
 generic polynomial equation
form as given by equation
represented by A, B, C,…, U, the values of which are l
 
The lengths of the sides of the voxel used for these acquisitions were 20 x 20 x 
20 mm3. This means that if the centre of the voxel is placed at 55S, it will 
extend 10 mm above and 10 mm below this point. Therefore, 
deduce the RF 
appropriate to describe the signal sensitivity profile in terms of this possible 
range of voxel positions. Hence, the sensitivity map for slice 55S will be 
denoted by SI45:65(x, y). In this notation, 
extending 10 mm below and 
polynomial function, SI
coordinate lies anywhere 
corresponding voxel coordinates in the (RL, AP) plane at any SI position (i.e. 
within any slice). All the polynomial equations have therefore been expressed 
in the same notation as SI
 
 
 describing the RF maps of all the 
 4.5. The coefficients of the polynomial fits are 
isted in 
sensitivity maps using these standard
45:65 is the 
10 mm above 55S; this range means that the 
45:65(x, y) is appropriate for any in vivo
between 45 and 65 mm; 
45:65(x, y).  
 
 
Figure 4.5: RF Field map of slice 55S 
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Figure 4.6: RF Field map of slice 35S 
 
 
 
 
 
 
 
  
 
Figure 4.7: RF Field map of slice 15S 
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Figure 4.8: RF Field map of slice 15I 
 
 
  
 
Figure 4.9: RF Field map of slice 35I 
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Figure 4.10: RF Field map of slice 55I 
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Slice 
 
Coefficient of polynomial fit 
 
A 
 
B 
 
C 
 
D 
 
E 
 
F 
 
G 
 
H 
 
I 
 
J 
 
K 
 
L 
 
M 
 
N 
 
O 
 
P 
 
Q 
 
R 
 
S 
 
T 
 
U 
 
55S 
 
1.70e8 
 
-2.56e7 
 
-3.58e7 
 
2.85e5   
 
-2.26e6   
 
-1.03e6   
 
5475 
 
1.61e4   
 
-6.38e4   
 
-8980   
 
6.29   
 
154.90   
 
204 
 
-581.30   
 
3.53   
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
35S 
 
3.85e8   
 
2.00e6   
 
2.74e6   
 
3.82e5   
 
1.90e5   
 
2.81e5   
 
-1862   
 
-1769   
 
-333   
 
154.10   
 
-141   
 
-95.34   
 
-180.40   
 
-92.04   
 
-85.59   
 
0.10  
 
-1.14  
 
-1.83   
 
-1.11   
 
-0.71   
 
-0.65   
 
15S 
 
4.38e8   
 
4.44e6   
 
-4.88e6   
 
1.42e5   
 
1.27e5   
 
2.29e5   
 
-3552   
 
5595 
 
-2579   
 
8341 
 
-35.04   
 
-111.30   
 
-31.44   
 
-45.52   
 
81.44   
 
0.40   
 
-1.36  
 
-0.91   
 
-0.51   
 
-0.12   
 
0.25   
 
15I 
 
4.29e8   
 
1.07e6   
 
-1.39e7   
 
1.71e5   
 
2637 
 
-1.04e5   
 
-3161   
 
8353 
 
2611 
 
8594 
 
-60.11   
 
6.90   
 
139.60   
 
49.45   
 
170.10   
 
0.94   
 
-1.63   
 
-0.44   
 
1.24   
 
0.23   
 
0.87   
 
35I 
 
2.03e8   
 
1.55e6   
 
-8.06e6   
 
1.38e5   
 
-5660   
 
8.05e5 
 
-85.29   
 
7320 
 
-9696   
 
3.65e4   
 
0.66   
 
-101.70   
 
10.02   
 
-254.10   
 
503.80   
 
-0.87   
 
-1.17  
 
-1.35   
 
-0.54  
 
-1.73   
 
2.29   
 
55I 
 
9.53e7   
 
1.41e6   
 
-6.90e5   
 
8.11e5   
 
2.69e4   
 
9.55e5   
 
-6520   
 
4.66e4   
 
2025 
 
2.64e4   
 
37.21   
 
-109.90   
 
576 
 
30.68   
 
185.20   
 
0 
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0 
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Table 4.2: Values of the coefficients of the polynomial fits to the inter-slice spatial RF sensitivity maps of the receiver coil 
 
 
The general polynomial equation describing the RF map of any given slice is given by: 
 
SIa:b(x, y) = A +Bx +Cy +Dx
2 +Exy + Fy2 +Gx3 +Hx2y  +Ixy2 +Jy3 + Kx4 + Lx3y +Mx2y2 + Nxy3 +Oy4 + Px5 + Qx4y + Rx3y2+ Sx2y3 +Txy4 +Uy5     (Eqn 4.5) 
 
where SIa:b(x, y) is the calculated unsuppressed-water peak area, a:b is the range of possible voxel positions within an in vivo slice, x and y are 
respectively the  RL and AP coordinates of the in vivo voxel, A, B, …, U are the coefficients of the polynomial equation (Table 4.2). Each slice 
was 20 mm thick, and so the corresponding a:b values for slices 55S, 35S, 15S, 15I, 35I and 55I are 45:65, 25:45, 5:25, -5:-25, -25:-45, and       
-45:-65, respectively. The appropriate equation is chosen by checking to see which a:b range its SI coordinate falls within.   
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4.4 Use of RF Field Maps in Cerebral Water 
Quantification 
 
 
Polynomial equations describing a wide range of voxel positions within the 
eight-channel head coil have now been deduced (equations 4.2-5). Using 
equation 4.5 in particular, which is a function of voxel position in 3D, the 
coordinates of any in vivo spectral acquisition can be substituted in place of 
the variables x, y, and z which respectively represent the RL, AP and SI 
coordinates. For the human head, this substitution utilises the SI coordinate as 
a guide to select the appropriate slice coefficients (Table 4.2) that define the 
in vivo voxel position. The coefficients (representing the in vivo RL and AP 
coordinates) are then substituted into equation 4.5. When the substitution is 
done, the value of SIa:b(x, y) obtained becomes a theoretically deduced 
spectral peak area for the unsuppressed-water. Since this area is generated 
from the polynomial fits, it shall be represented by Afit in equation 6.1, where 
it will be used as a reference signal in the absolute quantification of cerebral 
water content. 
   
4.5 Summary and Conclusions 
  
   
 
In this chapter, the spatial non-uniform response of a typical receiver coil has 
been investigated using the unsuppressed-water signal as a reference. For the 
first time, generic signal sensitivity maps have been deduced for a wide range 
of voxel positions in 3-dimensional space within the phased-array head coil. 
Polynomial fits to the sensitivity maps were performed to derive standard 
mathematical equations that represented the signal response of the RF coil in 
3-dimensional space. Using these equations, which were functions of voxel 
position, a novel method was suggested to calculate a signal value from any of 
the fits that best described a given in vivo voxel position. It was concluded that 
this theoretically derived signal area could be used as a reference signal in the 
absolute quantification of cerebral water. Thus, this work also showed the NMR 
response of water with varying voxel positions within the head coil, in vitro. 
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Such a study has also been conducted in vivo in chapter 6, but with limited 
voxel positions as it is impractical to investigate a wide range of voxel positions 
in any single volunteer.   
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Chapter 5: Corrections for Relaxation and Partial 
Volume Effects  
 
 
 
5.1 Overview and Objectives 
 
 
In section 1.1.3, it was mentioned that in MRS, voxel with straight edges are 
used to acquire spectra from brain regions that are usually small and curved. 
The usual practice therefore is to use relatively large voxel sizes which would, 
in most cases, inevitably encompass some fraction of cerebrospinal fluid (CSF). 
A method of removing the CSF fraction from the MRS voxel is thus described 
and implemented in this chapter.  
 
Secondly, even when the voxel grey/white matter fraction has been obtained 
after CSF correction, the MRS signal still suffers from some losses due to 
relaxation effects. This usually arises due to the TE and TR times used for the 
spectral acquisition. Absolute quantification of cerebral water content would 
therefore require a correction factor accounting for relaxation effects in brain 
tissue. The absolute quantification of metabolite concentrations on the other 
hand would require correction factors for the relaxation effects in both brain 
tissue and the metabolites. These correction factors are normally obtained 
from equations involving the use of the T1 and T2 relaxation times of brain 
tissue water and the metabolites measured from the same brain regions from 
which the water and metabolite signals have been acquired. Thus, in order to 
correct for relaxation effects in the MRS signals in this thesis, the T1 and T2 
relaxation times of brain tissue water and the metabolites were measured in 
the specific brain regions in which the MRS voxels were placed in the various 
studies (chapters 6 and 7).  
 
Cerebral water content was quantified in chapter 6 in five brain regions: 
frontal white matter (WM), parietal WM, occipitoparietal white/grey matter 
and the hippocampus. In chapter 7, water content and metabolite 
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concentrations were quantified in the prefrontal grey matter and hippocampal 
brain regions. The T1 and T2 relaxation times of brain tissue were therefore 
measured for all these brain regions in this chapter; cerebral metabolite T1 and 
T2 relaxation times were also measured in the prefrontal grey matter and 
hippocampal brain regions. These measured relaxation times were then used in 
the calculation of the correction factors for the correction of relaxation effects 
in MRS measured water and metabolite signals from these regions.   
 
Before presenting the experiments for the above correction factors, it is 
necessary to provide some background to these relaxation and partial volume 
effects. These are discussed in subsections 5.1.1-2.    
   
  
5.1.1 NMR Relaxation Effects 
  
   
Signal attenuation occurs due to relaxation processes (section 2.1.2). For a 
given metabolite, relaxation effects can be kept to the minimum if TE ≈ 0 ms 
and TR ≈ 5 x the T1 of the signal of interest. Ideally, a short TE and a long TR 
(theoretically TE = 0, TR = ∞) should be used for minimal signal losses due to 
relaxation effects [31]. However, since gradients must be applied to define the 
voxel, TE can never be zero, and because the sequence has to be repeated 
many times, a TR of infinity is not practical. Instead, the MR spectrum from a 
typical acquisition consists of various metabolite signals collected together, 
and so the TE and TR are chosen depending on the main metabolites of 
interest, which still differ substantially in T1 and T2 relaxation times. The 
measured MRS signal is therefore always affected by saturation (T1) and 
relaxation (T2) effects. For instance, in normal tissue, a TR of 2000 ms will 
cause only a 50 % recovery (between repetitions) of the longitudinal 
magnetisation of the metabolites; a TR of 7000 ms will enable recovery of up 
to 99 % of the longitudinal magnetisation [1] but will increase acquisition time 
significantly. At 1.5 T, a TE of 30 ms will cause 7-14 % signal losses due to T2 
relaxation effects in metabolites with long T2 relaxation times (i.e. NAA, Cr 
and Cho with T2 range of 200-400 ms); metabolites with short T2 relaxation 
times will suffer more than 14 % signal losses.  
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Absolute quantification of metabolites without correction for T1 and/or T2 
relaxation effects may therefore significantly underestimate and/or 
overestimate some metabolites. For instance, in this thesis, metabolite and 
water spectra have been acquired with TE/TR = 144/1500 ms (chapter 6), 
TE/TR = 35/2000 ms and TE/TR = 144/2000 ms (chapter 7). These spectra 
would therefore have suffered at least 50 % and 14 % signal losses due to T1 and 
T2 relaxation effects, respectively. Absolute quantification of either cerebral 
water and/or metabolites will therefore require some corrections for these T1 
and T2 relaxation effects in their respective spectra. These relaxation effects 
can be corrected by performing separate measurements of the T1 and T2 
relaxation times of brain tissue and the metabolites of interest in the specific 
brain regions that correspond to the MRS voxel positions.  
 
   
5.1.2 Partial Recovery of Longitudinal Magnetisation of 
Water 
   
 
In the measurement of cerebral water content, particularly, in this thesis, the 
fully recovered water signal was not acquired; the CHESS water-suppression 
module was not also turned OFF. However, spectral acquisition with CHESS 
turned ON was not a major issue regarding its effect on the amount of 
unsuppressed-water signal collected. This is because the scanner still acquired 
some quantifiable unsuppressed-water lines prior to the PRESS localisation 
sequence (section 2.3.1.3). In fact, the only issue that could affect the amount 
of unsuppressed-water signal collected was the TE/TR for the acquisitions. 
 
In order to acquire the maximum water signal, it is not possible to use the 
expected TE = 0 ms and TR = 5 xT1 of water (section 5.1.1) for the acquisitions. 
If the T1 of water is approximately 3000 ms, then that will mean that the ideal 
TR should be 15000 ms. Since these theoretical conditions cannot be met for 
reasons mentioned in section 5.1.1, TE values of 35 and 144 ms, and TR values 
of 1500 ms and 2000 ms were used in this thesis to acquire the water signal 
that was quantified to yield cerebral water content.  
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It should be emphasised that the water signal area was quantified from a 
water-suppressed acquisition (i.e. originally metabolite data). For this reason, 
using the shortest possible TE on the scanner should not cause significant T2 
relaxation effects in both the water and metabolite peaks. However, using the 
longest TR possible in consideration for the collection of a greater amount of 
the water signal would lead to significant decay of the metabolite signals. In 
order to have a fair balance in the amounts of water and metabolite signals, 
therefore, the above TE/TR values were used. However, that still required 
correction of the metabolite signals for T1 and T2 relaxation effects. The water 
signal on the other hand would have suffered more losses due to T1 than it 
would have due to T2 relaxation effects. With TR = 1500 ms and 2000 ms, only 
about 39.3 % and 48.7 %, respectively, of the longitudinal magnetisation, Mz of 
water would have recovered. Meanwhile, it is the amount of Mz tipped into the 
xy-plane that determines the amount of NMR signal recorded. This therefore 
means that only a fraction of the water signal would have been used to derive 
the unsuppressed-water peak area for the quantification of cerebral water 
content. Therefore, whereas the T1 correction involved an extra consideration 
for this partial recovery, T2 correction of the water peak area was done in the 
same way as was done for the metabolite spectra. 
 
This additional consideration in correcting the water signal for T1 relaxation 
effects involved the calculation of a partial recovery constant, kpr. This 
constant is defined as a ratio of the unsuppressed-water signal area obtained 
from the optimum TE/TR to the suppressed-water signal area obtained from a 
standard TE/TR. In theory, the optimum TE/TR for acquiring the water signal 
should be 0/15000 ms, respectively. However, the minimum TE on the MR 
scanner used for acquisitions in this thesis was 23 ms. Thus, kpr was defined as: 
 
 
                                                                                                      (Eq. 5.1) 
 
 
where ATE23_TR15000 is the water peak area obtained from a CHESS OFF 
acquisition with the optimum TE/TR of 23/15000 ms, and ATE acq_TR acq is the 
kpr = 
ATE23_TR15000 
ATE acq_TR acq 
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water peak area obtained from a standard CHESS ON acquisition (i.e. those of 
this thesis for water quantification). 
 
The constant, kpr represents the lost water signal fraction and so when 
multiplied by the quantified water signal area (acquired using the above TR 
values), a corrected signal area is obtained. This corrected peak area can be 
considered to be approximately equal to the total water signal acquired with 
TR = 5 x T1 of water. The kpr constant also accounts for T1 relaxation effects, 
and so there is no need to correct the water signal for T1 relaxation effects as 
long as the kpr correction factor is used. However, since TE was not equal to 0 
ms, the kpr-corrected signal area will then be corrected for the minimal T2 
relaxation effects left.   
 
   
5.1.3 Partial Volume Effect 
 
   
The voxel may contain CSF, and it may contain both grey and white matter. 
CSF contains no metabolites (except lactate and glucose); thus any metabolite 
peaks that are observed in the spectrum must be located in the brain 
parenchyma (i.e. either grey or white matter) [1, 144]. It is the mean 
concentration in the parenchyma that is required and not the mean in the 
whole voxel. If the voxel CSF fraction is not corrected for, the metabolite 
spectrum will be contaminated by signal originating from CSF; and the final 
metabolite concentrations will be underestimated [144]. For instance, for the 
same voxel size, metabolite signal intensities from a voxel containing 50 % 
tissue and 50 % CSF would be half of that acquired from a voxel containing   
100 % tissue [78].  
 
Three approaches of correcting for partial volume effects are reported in the 
literature: correction with grey matter fraction, bi-exponential fitting using 
multiecho dataset, and segmentation of a structural MR image. 
 
In the grey matter fraction technique [157-159], signals are acquired using a 
series of voxels with known, differing grey matter fractions. In a plot of signal 
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intensity against grey matter fraction, the y-axis intercepts at grey matter 
fractions of 0 and 1 give the amounts of signal arising from white and grey 
matter respectively. The disadvantage of this technique is that it prolongs the 
acquisition time, and also the estimation of the fraction of grey matter in the 
voxel is likely to be subjective. Reproducibility of the measurements may 
therefore not be good. 
 
The bi-exponential fitting technique distinguishes between signal from CSF and 
that from tissue water [144, 160]. In its implementation, a multiecho spectral 
acquisition is performed and a bi-exponential fit of the T2-decay can reveal 
long-T2 and short-T2 components. The long-T2 decay is attributable to CSF and 
thus gives a measure of the amount of CSF in the voxel; the short-T2 
component is attributable to water trapped between myelin sheaths in brain 
tissue [58, 160]. However, the T2-decay in healthy brain is reported to exhibit 
three distinct pools of water: CSF with T2 > 1000 ms, intra/extra-cellular water 
with 80 ms < T2 < 200 ms, and myelin water with 10 ms < T2 < 50 ms [59]. The 
number of water pools could even be increased in pathology [161, 162]. To 
correctly measure the T2-decay of water, considerations to these ‘pool effects’ 
will have to be taken into account; a full water T2-decay will also have to be 
acquired and fit accurately. The fitting routine usually employs a non-negative 
least squares fitting method [59, 154, 163], the accuracy of which depends on 
the number of plotted points. At least twelve time points yield reasonable 
goodness of fits [54]; this therefore means more acquisitions. Consequently, 
the measurement time may be clinically unacceptable [58], and could be 
affected by motion artefacts.     
 
For the imaging-based CSF correction technique, a high resolution structural 3D 
MR image (usually T1-weighted) is used to determine the proportions of CSF, 
grey and white matter in the voxel. The T1-weighting gives CSF a low pixel 
intensity value relative to brain tissue. An image segmentation routine is then 
performed on the 3D image to segment it into CSF, grey and white matter 
fractions, and also return the corresponding mean probabilities over all pixels 
for each segment within the voxel. The average probability for CSF serves as 
151 
 
the estimate for the CSF fraction in the voxel [144]. This technique practically 
adds about 8-10 minutes to the main MRS acquisition, but the time could be 
reduced down to 3-5 minutes by using an SPGR sequence, which does not use 
the inversion pulse (IR). Resolution obtained with this non-IR sequence is 
however about 35 % lower compared to that obtained with the IR sequence.  
 
In any case, the acquisition time with the imaging-based partial volume 
correction is not as long as the times for the other two techniques. Moreover, 
subject displacements between the MRS and 3D MRI acquisitions can be 
corrected for by co-registration of the 3D MRI to the 2D MRI used for planning 
the MRS voxel [164]. The technique has fewer potential error sources and is 
therefore more reproducible and reliable. It was therefore the method of 
choice for correction of partial volume effects in this thesis (in chapters 6 and 
7). 
 
5.1.4 Objectives 
 
Since the MRS data would always be affected by the above sources of error, the 
work presented in this chapter was aimed to: 
 
1. Measure the T1 and T2 relaxation times of brain tissue in the frontal, 
parietal, occipital and hippocampal regions (the reason for these regions 
was discussed in section 5.1); 
2. Measure the T1 and T2 relaxation times of the cerebral metabolites and 
water in the frontal and hippocampal brain regions (section 5.1 explains the 
reason for these regions); 
3. Develop a method for correcting the partially recovered in vivo 
unsuppressed-water signal for fractional signal losses; 
4. Develop and demonstrate a method for correcting the MRS voxel for partial 
volume effects.  
 
From these experiments, correction factors could then be obtained to correct 
the acquired MR spectra for the respective errors.  
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5.2 Methods 
 
 
In the order of the study objectives (section 5.1.4), this section describes the 
methods for measuring the relaxation times of brain tissue (section 5.2.1) and 
the MR spectra (section 5.2.2); the procedures for obtaining kpr and correcting 
for partial volume effects are also presented in sections 5.2.3 and 5.2.4, 
respectively. 
 
 
5.2.1 Measurement of NMR Relaxation Times in the 
Brain 
 
  
Five subsections are presented in this section: section 5.2.1.1 describes the 
characteristics of the study volunteers, section 5.2.1.2 describes the MRI 
protocol for the acquisition of structural MR images, sections 5.2.1.3 and 
5.2.1.4 present the imaging methods for recording the various signals to be 
used in the estimation of T1 and T2 of brain tissue, and section 5.2.1.5 explains 
the selection of the various brain regions of interest, and estimation of the T1 
and T2 relaxation times for these brain regions. 
 
   
5.2.1.1 Subjects 
   
 
Four subjects (2 males, 2 females) were studied for T1 measurements; another 
group of four subjects (3 males, 1 female) was studied for T2 measurements. 
The mean ages of subjects in the T1 and T2 studies were 32.0 and 32.5 years, 
with ranges from 23 to 51 and 29 to 38 years, respectively.  
 
5.2.1.2 MR Imaging 
 
   
All images were acquired using the spin echo (SE) pulse sequence (section 
2.1.3.2). Axial slices covering the whole brain were planned along the 
hippocampal angle. Each slice was 3 mm thick without slice gaps; and a matrix 
of 256 x 128 pixels was used to give a reasonable compromise between image 
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resolution and total experimental time. A field of view (FOV) of 25.6 x 25.6 
cm2 was selected to cover the entire axial image, including the hippocampi. 
For each subject, a high resolution T1-weighted 3D image of the whole brain 
was also acquired using an axial slab along the hippocampus. This high 
resolution axial 3D image gave a better grey/white matter tissue contrast than 
the SE axial images. These high-resolution 3D MR images served as references 
during ROI selection in the SE images by co-registration of each SE image to the 
3D image. Thus the SE images were all corrected for rotational errors, and 
were now in the same orientation after co-registration to the corresponding 3D 
image. The advantage of using axial slices for this study is that in all 
acquisitions, they provide access to consecutive slices that contain sufficient 
grey and white matter for the placement of regions of interest (ROIs). 
Measurements of the T1 and T2 relaxation times were performed in separate 
examination sessions.   
 
5.2.1.3 Imaging for the Estimation of T1 Relaxation Times 
   
T1 measurements were carried out using a saturation recovery method with a 
variable TR spin-echo imaging sequence. A constant echo time (TE) of 11.0 ms 
was maintained, while axial images were acquired at eight successive TR times 
of 200, 350, 550, 750, 1000, 1500, 2000 and 4000 ms.  
   
5.2.1.4 Imaging for the Estimation of T2 Relaxation Times 
  
For the T2 measurements, a multi spin-echo pulse sequence was used. A 
constant TR value of 3000 ms was maintained and twelve T2-weighted images 
were acquired using the following TE values: 16, 25, 30, 32, 48, 50, 60, 64, 75, 
90, 100 and 120 ms. The multi spin-echo pulse sequence on the GE MR scanner 
used for the measurements produces images at four echo times for each user-
selected TE value. The TE values of these generated images are multiples of 
the user-selected TE value set. For these T2 measurements, three TE values 
were selected: 16, 25 and 30 ms. Thus TE = 16 ms produced images at TE times 
154 
 
of 16, 32, 48 and 64 ms. The TE values of 25 and 30 ms also produced four 
images each, resulting in twelve image sets at the above TE times.   
   
 
5.2.1.5 ROI Selection and Estimation of Relaxation 
Times 
 
In the T1 and T2 images acquired in sections 5.2.1.3 and 5.2.1.4 respectively, 
four anatomical sites were chosen in each hemisphere, plus one frontal region 
of the brain. This resulted in a total of nine ROIs per subject, as shown in 
Figures 5.1a and 5.1b. Care was taken in selecting the ROIs, which did not 
include the ventricles or extra-axial CSF. The shapes of the ROIs were either 
circular, rectangular or freehand-drawn (in the Image-J software, version 
1.46r) depending on what best fit the target area. In selecting the ROIs in a 
given image, reference was made to its corresponding high resolution 3D axial 
image in the same slice in order to verify that each ROI selection contained the 
required brain tissue.   
  
 
                     
  
 
Figure 5.1: T2-weighted MRI scan of an axial slice through the prefrontal brain region (a) 
and the bilateral hippocampi (b) in a healthy volunteer. 
The 3 mm thick slices shown in figures (a) and (b) are typical of those chosen for analysis in all 
subjects. The ROIs are indicated by a circle, squares, ovals, rectangles and freehand-drawn 
selections, all in yellow. Numbers correspond to brain structures listed in Table 5.1 and voxel 
positions in chapters 6 and 7 
9 8 
1 
2 3 
4 5 
6 7 
(a) (b) 
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Estimates of the brain tissue T1 relaxation times were obtained from a 
nonlinear least square monoexponential fit of the signal intensities measured 
(from ROIs 1 to 9 in Figures 5.1a-b) at their respective TR values. The fitting 
method solved equation 2.10 for T1. 
 
Estimates of the brain tissue T2 relaxation times were obtained from a 
nonlinear least square monoexponential fit of the mean pixel intensity values 
(measured from ROIs 1 to 9 in Figures 5.1a-b) at their corresponding TE times. 
The fitting method solved equation 2.11 for T2.  
 
Curve fitting for the estimation of both T1 and T2 relaxation times were 
performed using the curve fitting toolbox in MATLAB (version 7.8.0.347, 
R2009a).  
   
5.2.2 Measurement of the NMR Relaxation Times of 
Cerebral Metabolites and Water 
 
5.2.2.1 Subjects 
  
   
A total of eighteen subjects (10 males, 8 females) were studied for T1 and T2 
relaxation times of the metabolites and water. Volunteers were randomly 
assigned to four relaxation measurement experiments denoted by labels 5A-D 
as follows:  
 
(5A) T1 of the ventromedial prefrontal cortex (ROI number 1 in Figure 5.1a), 
involving three (1 M/2 F) volunteers aged 27-55 years (mean age = 34.3 years); 
(5B) T2 of the ventromedial prefrontal cortex, involving seven (3 M/ 4 F) 
volunteers aged 27-60 years (mean age = 33.4 years); 
(5C) T1 of the bilateral hippocampi (ROI numbers 8 and 9 in Figure 5.1b), 
involving three (2 M/1 F) volunteers aged 25-33 years (mean age = 22.3 years); 
and   
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(5D) T2 of the bilateral hippocampi, involving five (4 M/1 F) volunteers aged 27-
53 years (mean age = 34.6 years).  
 
The sample sizes in the various experiments varied because volunteers were 
randomly assigned to the groups as they were being recruited. Three 
volunteers were studied initially in the following order of experiments: 5B, 5D, 
5A, and 5C. Time was not sufficient for another batch of volunteers to be 
recruited and assigned to all the experiments (except for 5B and 5D) following 
the above order. 
 
5.2.2.2 MR Imaging 
 
   
To plan the MRS voxels, two structural scans of the brain were conducted on 
each subject: sagittal T1-weighted FLAIR (TE/TR/TI = 9/2685/920 ms) and axial 
T2-weighted FSE/propeller (TE/TR = 110/5000 ms) MRI. For the sagittal scan, 
21 slices (each of thickness 4 mm) were planned along the long axes of the 
hippocampi. For the axial scan, 22 oblique slices (each of thickness 5 mm) 
parallel to, and covering, the hippocampi were planned. In both structural 
scans, a field of view of 24.0 x 24.0 cm2 was chosen, with an in-plane image 
matrix of 512 x 512 pixels to give good image resolution. The T2-weighted 
FSE/propeller also meant that images were acquired with good grey/white 
matter contrast. 
  
 
5.2.2.3 MRS Protocol  
 
  
The following MRS protocol was used for both spectral acquisitions described in 
sections 5.2.2.4 and 5.2.2.5. The protocol involved the acquisition of 128 
averages of CHESS water-suppressed spectra from the ventromedial prefrontal 
grey matter (region 1 in Figure 5.1a) and the bilateral hippocampi (regions 8 
and 9 in Figure 5.1b). The average voxel size on region 1 was 2.0 x 3.0 x 2.0 
cm3 while that on regions 8 and 9 was 3.5 x 1.2 x 1.0 cm3 in the AP x LR x SI 
directions, respectively. For the acquisitions in regions 8 and 9, the same voxel 
was moved from region 8 to region 9 after recording spectra from the former. 
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In all acquisitions, NEX = 8 was maintained in order to make data averaging 
faster; so two (or 16/NEX) unsuppressed-water lines were stored.  
 
Since these unsuppressed-water lines are acquired from the same voxel as the 
metabolite lines, they (i.e. both the water and metabolite signals) should be 
affected by the same factors such as effects of eddy currents, motion and 
relaxation [46-48]. Therefore, when processing the metabolite spectra from 
the relaxation experiments, the unsuppressed-water lines within each data set 
could be quantified as well. Using the same analysis procedure, it should be 
possible to estimate the T1 and T2 relaxation times for cerebral water and 
metabolites from the same data set.      
 
5.2.2.4 Estimation of Metabolite and Water T1 Relaxation 
Times 
  
T1 measurements were carried out using the saturation recovery method with a 
variable TR PRESS localisation sequence. A constant TE value of 23.0 ms was 
maintained, while single voxel spectra were acquired at six TR times: 1070, 
1200, 1500, 2500, 3000 and 3500 ms.  
 
For each TR acquisition, the two unsuppressed-water lines and metabolite 
spectra were quantified separately in the SAGE software package as described 
in sections 2.3.1.2-3. This yielded the metabolite and water spectral peak 
areas. 
  
Estimates of the metabolite and water T1 relaxation times were obtained from 
a nonlinear least square monoexponential fit of the measured peak areas at 
their respective TR values using equation 2.10. The solution to the fitting 
routine yielded the T1 of either water or the given metabolite. 
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5.2.2.5 Estimation of Metabolite and Water T2 Relaxation 
Times 
   
For T2 measurements, the PRESS localisation pulse sequence was used with a 
fixed TR value of 2000 ms. Spectra were acquired with a variable TE spin-echo 
method: 35, 85, 128, 164, 262, 326, 400 and 600 ms. 
 
The metabolite and water signals were quantified in the same way as described 
in sections 2.3.1.2-3. Metabolite and water T2 relaxation times were estimated 
from a nonlinear least square monoexponential fit of the measured peak area 
at each TE value. The fitting routine solved equation 2.11 for T2 of either water 
or the given metabolite. 
  
The curve fitting routines for the estimation of both T1 and T2 relaxation times 
of the MR spectra were performed using the curve fitting toolbox in MATLAB 
(version 7.8.0.347, R2009a).  
   
5.2.3 Compensation for the Lost Fraction of Water 
Signal 
  
In one healthy male volunteer, aged 29 years, 16 averages of CHESS water-
suppressed spectra were recorded from an 8 cm3 voxel positioned in the 
prefrontal grey matter brain region. The following TE/TR pairs were used in 
turn: 35/2000 ms, 144/2000 ms, and 144/1500 ms. NEX = 8 was used in all 
acquisitions. 
 
Maintaining the same voxel position and NEX value, the CHESS water-
suppression module was turned OFF and 16 averages of the fully recovered 
water signal was acquired using TE/TR = 23/15000 ms.  
 
Only the two unsuppressed-water lines were quantified in both the CHESS ON 
and OFF acquisitions to yield the two signal areas ATE acq_TR acq and ATE23_TR15000, 
respectively (as described in sections 2.3.1.2-3). The ratio of these signal areas 
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produced the correction factor, kpr (equation 5.1) which will be used to 
compensate for the lost fraction of the water signal acquired from the standard 
CHESS ON spectral acquisitions (section 5.1.2) of chapters 6 and 7.   
 
 
5.2.4 Estimation of MRS Voxel CSF Content  
 
 
In this thesis correction of MRS voxels for CSF content (otherwise known as 
partial volume correction) involved the use of high resolution T1-weighted 3D 
MR brain images of the study subjects. These images were acquired within the 
same exam session as the MRS acquisitions, being performed either before or 
after the MRS. 
 
In this section the partial volume correction (PVC) procedure will be described 
and implemented. The illustration will be presented using analysis of example 
data from one healthy volunteer. The same correction procedure was applied 
for the rest of the volunteer data presented in chapters 6 and 7. The PVC 
method developed in this thesis can be described in six steps as follows: 
 
1. Calculation of Starting Values from VOI coordinates 
  
The MRS voxel is a region of interest defined in three-dimensional space. Thus, 
a three-coordinate space can be used to represent the three sides, LR x AP x SI 
of the voxel, where these sides correspond to the x, y and z axes, respectively 
(Figure 5.2). A voxel is normally specified in three (xyz) dimensions by three 
quantities: “starting values”, “centre coordinates” and “dimensions”. The 
starting values represent the coordinates of each corner of the voxel and the 
dimensions are the lengths of each side of the voxel; the centre coordinates 
define the centre of the voxel. These three quantities are related such that 
when any two of them is known, the third can be calculated.  
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Figure 5.2: A three-dimensional representation of the MRS voxel 
The small blue square represents the starting point for the RL side (along the x-axis) of the 
voxel; the small red circle is the centre, C of the voxel with coordinates Xo, Yo, Zo; the 
dimensions of the three sides, RL, AP and SI of the voxel are respectively represented by |X|, 
|Y| and |Z|.    
 
 
The dimensions of the voxel and their corresponding centre coordinates are 
usually stored in the SAGE header file after every spectral acquisition. 
Therefore, the starting values for each side of the voxel can be calculated 
using the following equations for each side of the voxel: 
 
Xstart = Xo – (|X|/2);    Ystart = Yo – (|Y|/2);    Zstart = Zo – (|Z|/2)           (Eq. 5.2)   
 
These calculated starting values are usually predefined by SAGE in scanner 
anatomical space (SAS). By this convention, a voxel side lies along, say, the R 
or L axis but not along the RL axis. Therefore, the voxel dimensions will 
normally be presented in SAGE, for example, as 20R x 20A x 20I and not as 
20RL x 20AP x 20SI. It should be noted, however, that certain sign conventions 
apply to the relationships stated in equation 5.2: Xstart and Yo should be 
negated when the SAS labels are L and P, respectively. In this case, the 
negation of Yo should be done before calculating Ystart. This is necessary due to 
the change in image orientation (and hence the voxel) when loading the MR 
C (Xo, Yo, Zo) 
|Y| 
|Z| 
|X| 
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image/voxel in the FSL (FMRIB's Software Library, www.fmrib.ox.ac.uk/fsl) 
program. The Z-axis serves as the mirror line for the reorientation and so its 
values are not negated.  
 
2. Generation of Coordinate Space Starting Values 
 
In order to localise the MRS voxel in its corresponding 3D MR image, the FSL 
program requires the starting values in the coordinate space (CS). The CS 
starting values are generated automatically by FSL when the calculated SAS 
starting values are entered. Note should however be taken of the above sign 
conventions when entering the SAS starting values.    
 
3. Segmentation of the 3D MRI  
The brain tissue is extracted from the skull (Figures 5.3a-b) using the brain 
extraction tool (BET) in FSL (Figure 5.3c). The brain is then segmented into 
three tissue classes using the FMRIB’s Automated Segmentation Tool (FAST) of 
FSL (Figures 5.3d-f) [165]. The segmentation routine also corrects the image 
for spatial intensity variations, also known as bias field or RF inhomogeneities. 
For a three-tissue class segmentation, the FAST algorithm assigns intensity 
values (between 0 and 1) to all voxels of the image and then classifies these 
intensities as high, intermediate and low. Tissue classes 0, 1 and 2 have low, 
intermediate and high intensities, and are thus assigned to CSF (Figure 5.3d), 
grey matter (Figure 5.3e) and white matter (Figure 5.3f), respectively. The 
output images of the tissue classes are known as partial volume maps, whose 
intensity values represent the proportion of each tissue class in the voxels of 
the 3D MRI [165].   
 
4. Localisation of the voxel in brain segments 
 
The voxel is localised in, and ‘cut out’ from, the 3D MR image (Figure 5.3j) by 
running the following command on the image of each tissue class in the 
command line: 
 
‘fslroi <Input tissue class> <Output voxel image> Xstart  |X|  Ystart  |Y|  Zstart  |Z|’ 
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where Xstart, Ystart and Zstart are the coordinates of one of the vertices, and |X|, 
|Y| and |Z| are respectively the dimensions in the RL, AP and SI axes of the 
voxel as stated in procedure 1. Output voxel images are produced and saved 
for each one of the CSF (Fgure 5.3g), grey matter (Figure 5.3h) and white 
matter (Figure 5.3i) fractions.  
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Figure 5.3: A schematic of the voxel localisation procedure in the 3D MR image. 
A large voxel (AP x RL x SI = 92.0 x 103.7 x 20.0 mm3) was planned in one healthy volunteer to 
validate the accuracy of the localisation technique. Figures (d), (e) and (f) are the partial 
volume maps of CSF, GM and WM. Figures (g), (h) and (i) are the amounts of CSF, GM and WM 
within the localised VOI in the corresponding partial volume maps.  
 
 
 
 
 
 
(a) (b) (c) 
(d) (e) (f) 
(g) (h) (i) 
(j) 
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5. Estimation of brain tissue and CSF contents of the voxel 
  
The volume of CSF, grey matter and white matter of each voxel image (in voxel 
units) is calculated as the product of the mean pixel intensity value of the 
voxel image and the volume of that tissue class in the voxel image. Estimation 
of the voxel content in this way is known as partial volume estimation, 
executed in the command line by the following lines of code on each one of the 
CSF, grey matter and white matter voxel images [165]:  
 
vol=`$FSLDIR/bin/fslstats voxel image -V | awk '{print $1}'` 
mean=`$FSLDIR/bin/fslstats voxel image -M` 
tissuevol=`echo "$mean * $vol" | bc -l` 
echo $tissuevol 
 
This returns the tissue volume in voxel units, stored in the variable ‘tissuevol’. 
To get the volume in mm3, {print $1} is replaced with {print $2} in the first 
line. 
   
  
6. Estimation of voxel fraction of GM/WM tissue 
 
If υCSF, υGM and υMW are the FSL estimated voxel volumes of CSF, grey and white 
matter, respectively, then the tissue content of the voxel will be (υGM + υWM) 
and the  fractions of grey (fGM) and white (fWM) matter will be  υGM/(υGM + υWM) 
and 1 - fGM, respectively. This calculation excludes υCSF leaving behind only 
solid brain tissue (i.e. grey and white matter fractions). 
                   
 
5.3 Results and Discussion 
 
  
 
Results for four groups of experiments are presented in this section in relation 
to the four aims of this chapter: relaxation times of brain tissue (section 
5.3.1), metabolites and water (section 5.3.2), the partial recovery (section 
5.3.3) and volume (section 5.3.4) correction factors. At the end of the 
discussion of each results subsection, the applications of those measurements 
in correcting the MRS data in this thesis are restated. However, correction for 
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relaxation effects (using the relaxation time results) is mentioned only in 
subsection 5.3.2 so that the same discussion is not repeated twice in that 
section and in section 5.3.1, as the correction procedure involving their use is 
the same.   
   
5.3.1 Brain Tissue NMR Relaxation Times 
 
   
Table 5.1 summarises the relaxation times measured in each of the ROIs 
defined in Figures 5.1a and 5.1b. The tabulated results are averages of 
measurements in the ROIs on the left and right cerebral hemispheres. The 
uncertainties of all measurements are given in terms of the standard error (SE), 
calculated as a ratio of the standard deviations of the measurements to the 
square root of the sample size measured. The goodness of the relaxation curves 
were assessed in terms of their R2 values generated by the non-linear least 
square curve fitting program (i.e. MATLAB). 
 
  
 
 
 
 
 
 
 
 
 
 
    Table 5.1: Average Regional Relaxation Times in the Brain 
 
 
 
Both T1 and T2 relaxation times varied significantly among all ROIs by one-way 
ANOVA (p < 0.05). For those measurements in bilateral grey (GM) and white 
(WM) matter regions, there were no significant (p > 0.05) differences in T1 and 
T2 relaxation times between the left and right hemispheres: T1 estimates in the 
left hemisphere were generally observed to be greater than those in the right 
hemisphere, but this difference was not significant (p > 0.05).  
 
Label Brain Region T1 (ms, ±SE) 
n = 4 
T2 (ms, ±SE)  
n = 4 
1 Ventromedial  prefrontal grey matter  1942 (29) 147 (9) 
2 Left frontal white matter 1235 (52) 122 (5) 
3 Right frontal white matter 1170 (64) 120 (4) 
4 Left parietal white matter 1238 (21) 128 (4) 
5 Right parietal white matter 1196 (36) 134 (8) 
6 Left occipitoparietal white/grey matter 1441 (40) 127 (1) 
7 Right occipitoparietal white/grey matter 1410 (47) 127 (2) 
8 Left hippocampus 1439 (96) 134 (15) 
9 Right hippocampus 1432 (94) 150 (5) 
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At 4 T, Kim et al [166] also observed that the average T1 of GM was greater in 
the left than in the right hemisphere, even without performing any significance 
test on their results. Similarly, Wansapura et al [54] also observed at 3 T that 
out of nine ROIs in each hemisphere, eight ROIs in the left had greater T1 
estimates than the same regions in the right hemisphere. They only found this 
difference to reach statistical significance in GM insular. Garber et al [167] also 
reported higher T1 values in the left than right hemispheres in GM and WM 
regions at 1.5 T.  
 
Hemispheric T2 differences were not significant in most regions. However, right 
parietal WM and hippocampal T2 values were observed to be greater than the 
T2 values for the same regions in the left hemisphere. Even though they did not 
study the same regions as has been studied in the thesis, Wansapura et al [54] 
did not find any difference in T2 between the two hemispheres for all their 
nine ROIs. They reported that they could not cite any literature reporting 
hemispheric T2 differences. They attributed the T1 differences they observed 
between the two hemispheres to non-uniformity of the B1 field caused by the 
non-uniform characteristics of brain tissue. Tissue-type differences give rise to 
standing waves in the head which cause variation in the flip angles across the 
brain with the application of the RF pulse [1, 144]. The extent of the standing 
waves effect depends on the tissue water proton density of the region of 
interest. Thus, Wansapura et al [54] did not find differences in T1 and T2 
between left and right ROIs selected on the image of a uniform MnCl2-doped 
water phantom. 
 
T1 values in GM regions were observed to be greater than those in WM regions. 
Even though a similar observation has been made previously [54], this 
difference was not significant. This is because due to the dependence of T1 on 
B0 field strength [168, 169], at high fields (≥ 3T), tissue relaxation rates 
approach that of water, resulting in low GM/WM T1 contrast [54]. The 
hippocampi, which are GM structures, showed the highest T2 values compared 
to the other structures, while the frontal WM regions had the lowest T2 values. 
This observation compares with the finding of Wansapura et al [54]; they found 
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the highest and lowest T2 estimates in the occipital GM and frontal WM, 
respectively. The lower T2 relaxation rates in WM tissue could be attributable 
to its high ferric iron content [170], which is reported to reduce T2 relaxation 
times [170-173].   
 
Generally, studies of hemispheric and regional differences in quantitative T1 
and T2 measurements in the brain are not based on a consistent selection of 
ROIs or subjected to tests of statistical significance [54]. It is therefore difficult 
to do a more rigorous comparison between the results reported in this thesis 
and those in the literature. Nonetheless, the results in this thesis are 
consistent with those reported in the literature for the selected brain regions 
at high fields. 
  
  
5.3.2 Cerebral Metabolite and Water Relaxation Times 
 
  
Tables 5.2 and 5.3 summarise the mean relaxation times of the metabolites 
and water measured, respectively, in the ventromedial prefrontal GM brain 
region (region 1 in Figure 5.1a) and bilateral hippocampi (regions 8 and 9 in 
Figure 5.1b). The uncertainties of all measurements are given in terms of the 
standard error (SE). In all measurements, if less than five points (i.e. signal 
intensity versus TE or TR) for a particular metabolite were available for the 
least square fit, the data was removed from the analysis. This was necessary 
because those fits generated negative R2 values and so were regarded as 
unreliable.   
 
The two regions studied were both predominantly GM regions. For the 
prefrontal region, the voxel was placed centrally across the two hemispheres 
and so the relaxation time estimates were averages from both hemispheres. 
Water and all the metabolites exhibited similar T1 and T2 relaxation times in 
the three regions studied (Tables 5.2 and 5.3). Both T1 and T2 relaxations times 
for the regions studied were in agreement with published results.   
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Metabolite T1 (ms, ±SE) 
n = 3 
T2 (ms, ±SE) 
n = 7 
NAA 1199 (363)a 212 (28) 
Glu 1193 (265)a 62 (7) 
Gln 1436 (131) 56 (10) 
Cr 1266 (167) 148 (23) 
Cho 1527 (286) 208 (24) 
mI 1368 (262) 125 (21) 
Water 1574 (61) 147 (6) 
 
 
Table 5.2: Relaxation times of the metabolites and water in the ventromedial prefrontal 
grey matter. 
aAverages from 2 subjects; NAA and Glu data for one subject were removed from the analysis 
due to unreliable least square fitting  
  
  
 
With a similar measurement technique to the one reported in this thesis, T2 
relaxation times of NAA, Cr and Cho in the cingulate gyrus GM were found to be 
254 (15), 161 (10) and 242 (37) ms respectively in six healthy subjects at 3 T 
[129]; where the values in parenthesis are standard deviations. However, in 
reporting their T1 values, averages from the occipital WM, motor cortex and 
fronto-lateral WM/GM were provided [129]: NAA, Cr, Cho and mI exhibited 1.34 
(0.08), 1.11 (0.11), 1.14 (0.07) and 0.98 (0.16) s, respectively; where values in 
parenthesis are standard deviations. Pure GM (in the occipital region) T1 values 
have also been reported elsewhere [174]: NAA, Glu, Cr, Cho and mI had 1.47 
(0.12), 1.27 (0.10), 1.46 (0.07), 1.30 (0.06) and 1.23 (0.09) s, respectively; 
where values in parenthesis are standard errors. However, relaxation times for 
Gln and water in the ventromedial prefrontal GM have not been reported in the 
literature to the best of the author’s knowledge. 
 
 
 
 
 
 
 
 
 
 
Table 5.3: Relaxation times of the metabolites and water in the bilateral hippocampi. 
Due to unreliable least square fitting, some data were removed from the analyses: bright 
hippocampal Cho and mI data for one subject; cleft hippocampal NAA and mI for one subject; 
and *the whole MRS T2 data for one subject out of the 5 subjects studied. 
 
 
Metabolite T1 (ms, ±SE); n = 3 T2 (ms, ±SE); n = 4* 
Right Left Right Left 
NAA 1283 (472) 1547 (119)c 114 (32) 153 (43) 
Cr 1131 (337) 1144 (232) 113 (28) 105 (16) 
Cho 1414 (206)b 1365 (207) 251 (70) 338 (101) 
mI 1462 (442)b 1772 (797)c - - 
Water 1389 (58) 1475 (68) 273 (98) 178 (83) 
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With the STEAM sequence at 2 T, the relaxation times of NAA, Cr, Cho and mI 
were measured and averaged in the bilateral hippocampi of eight healthy 
subjects [175]. The average hippocampal T1 relaxation times were: NAA = 1408 
(253), Cr = 1554 (317), Cho = 1438 (365), mI = 1726 (512) ms; whereas the T2 
values were: NAA = 283 (62), Cr = 191 (43), Cho = 334 (106), mI = 138 (14) ms, 
where the values in parenthesis are standard deviations. Thus, these estimates 
are comparable with those reported in this thesis. Unlike the T1 of brain tissue, 
T1 of the metabolites do not seem to depend on the field strength [174], which 
could be why the results in this thesis at 3 T are comparable to those of Choi 
and Frahm at 2 T. The reason for this non-dependence of metabolite T1 on B0 
could be that the major metabolite peaks in the spectrum arise from non-
exchangeable protons, and unlike water protons, they have reduced 
interactions with less mobile macromolecular protons [174].  
 
No study was found in the literature reporting the relaxation times of water in 
the hippocampus. 
 
For the MRS acquisitions of chapters 6 and 7, the spectra are affected by 
relaxation effects according to the TE and TR values chosen for the 
acquisitions. Using the PRESS localisation sequence, the spectra are corrected 
for T1 and T2 relaxation effects according to the following equations [31]: 
 
 
                                                                                                      (Eq. 5.3) 
 
 
                                                                                                      (Eq. 5.4) 
 
 
where Ameasured is the measured spectral peak area, A(T1)corrected and A(T2)corrected 
are the spectral peak areas after T1 and T2 corrections, respectively.  
 
Correction of the data for total relaxation effects to yield AT_corrected would thus 
take the form [31]: 
A(T1)corrected = 
Ameasured 
[1 – exp(-TR/T1)] 
A(T2)corrected = 
Ameasured 
exp(-TE/T2) 
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                                                                                                       (Eq. 5.5) 
 
 
The MRI measured relaxation times (section 5.3.1) were used to correct tissue-
specific relaxation effects, whereas the MRS measured relaxation times were 
used to correct the metabolite signals for relaxation effects in the brain 
regions corresponding to the respective voxel positions in chapters 6 and 7. In 
those equations in chapters 6 and 7, the relaxation correction factors (i.e. the 
denominators of equations 5.3-5) for T1, T2 and total relaxation effects will be 
represented by R1, R2 and RT, respectively. 
   
5.3.3 Partial Recovery Correction Factors 
 
   
The CHESS OFF unsuppressed-water peak area, ATE23_TR15000 acquired with the 
optimum TE/TR pair was found to be 4.99e8 a.u. The CHESS ON unsuppressed-
water peak areas (in a.u.) from the standard acquisitions were as follows: 
 
ATE35_TR2000, = 3.97e8, ATE144_TR2000 = 3.81e8 and ATE144_1500 = 3.78e8.  
 
Dividing the value of ATE23_TR15000 by each one of the above water signal areas 
(equation 5.1), the partial recovery correction factors, kpr for each standard 
acquisition was obtained; thus: 
 
kpr for acquisition TE=35/TR=2000, TE=144/TR=2000 and TE=144/TR=1500 were 
1.26, 1.31 and 1.32, respectively. The first two kpr values were multiplied by 
the unsuppressed-water peak areas acquired with the respective TE/TR values 
in chapter 7; whereas the last kpr value was multiplied by the unsuppressed-
water peak area acquired at the same TE/TR pair in chapter 6. Thus, the 
fractional signal losses from these partially recovered water signals (as TR was 
not equal to 15000 ms in each case) were accounted for by these kpr values.  
 
AT_corrected  = 
Ameasured 
exp(-TE/T2) x [1 – exp(-TR/T1)] 
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As TE was not also equal to 0 ms in each case, it meant that the water signals 
still suffered some losses due to T2 relaxation effects. Therefore, correction for 
these T2 relaxation effects was done for each kpr-corrected water peak area. It 
is important to mention that this kpr correction applied to only the water peak 
area, and not to the metabolites. This is because the metabolites have shorter 
T1 relaxation times than water, and so at the TR times of the measurements, 
their longitudinal magnetisations would have recovered far more than that of 
water. The partial recovery effect would thus not be applicable in the case of 
the metabolites. Therefore, T1 (and not kpr) and T2 relaxation corrections were 
done for the metabolite peak areas (chapter 7). 
 
In order to quantify the total water signal area measured by MRS, Brief et al 
[58] used TE/TR = 30/2500 ms for their spectral acquisitions. Their 
unsuppressed-water lines were quantified from the 16/NEX part of equation 
2.19 (section 2.3.1.3), as has been done in this thesis. Thus, their water peak 
area also required correction, kpr for the partial recovery effect. In their case, 
they obtained kpr using MRI (compared to the use of MRS in this thesis). They 
used a modified multi-echo imaging pulse sequence to measure 32 echoes from 
the human brain with TE values ranging from 10 ms to 320 ms (in steps of 10 
ms). They then fit a mono-exponential curve to their measured MRI water 
signal intensities and extrapolated this curve to TE = 0 ms, where they 
theoretically obtained the total MRI estimated water signal area, AMRI_TE0. 
Another MRI of the same subject was acquired at TE = 30 ms, which was the 
same TE of their MRS acquisition; the MRI water signal area, AMRI_TE30 was 
obtained from this acquisition. The ratio AMRI_TE0/AMRI_TE30 yielded kpr, which was 
then multiplied by their MRS measured water peak area to correct it for the 
partial recovery effect. 
 
However, the difference in the use of kpr between the study by Brief et al [58] 
and this thesis is that while this thesis considers it to correct for T1 relaxation 
effects, Brief et al considered it as a correction for T2 relaxation effects. This 
is because in the MRI acquisitions by Brief et al, both AMRI_TE0 and AMRI_TE30 were 
acquired using the same TR (of 3000 ms) and so had the same T1 relaxation 
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effects which cancelled out on division. Measurements of the two peak areas 
however differed in TE, where AMRI_TE0 was considered to be corrected for T2 
relaxation effects; so dividing it by AMRI_TE30, which was not T2 corrected, would 
yield a result, kpr equal to the fraction by which AMRI_TE30 would have decayed 
by T2 relaxation relative to AMRI_TE0. Thus, kpr in this case should be a T2 
relaxation correction factor for the water peak, while T1 correction is done for 
the water and metabolite spectral peaks in the same way.  
 
This thesis, on the other hand, did not perform a multi-echo signal acquisition 
to determine kpr; only the total water signal area, A TE23_TR15000 was measured 
using   TR = 5 x T1 of water. The total signal area was therefore considered to 
be T1 corrected. This thesis measured ATE23_TR15000 and ATEacq_TRacq using different 
TR values, and so kpr should equate a factor by which ATEacq_TRacq would have 
lost some signal by T1 relaxation relative to ATE23_TR15000. Hence, kpr should be a 
T1 relaxation correction factor for water in this case. T2 correction was then 
done for the water and metabolite spectral areas in the similar manner.     
   
5.3.4 Partial Volume Correction Factor 
 
  
For the large voxel prescribed in the single volunteer shown in Figure 5.3, the 
partial volume estimates in voxel units of CSF (Figure 5.3g), GM (Figure 5.3h) 
and WM (Figure 5.3i) were 16744, 90986 and 127662 mm3, respectively. These 
represented 7 %, 39 % and   54 % of CSF, GM and WM, respectively, in the voxel.  
 
Excluding the CSF content of the voxel to correct for partial volume effects, 
the voxel tissue content then had a total partial volume estimate of 218648 
mm3, representing 93 % (or a fraction of 0.93) of the voxel. This tissue fraction 
of the voxel was then made up of 42 % (or 0.42) and 58 % (or 0.58) of GM and 
WM, respectively (section 5.2.4).    
 
The voxel localisation technique presented in this thesis is accurate for non-
oblique voxel placements, which was the case with most of the acquisitions 
reported in this thesis. For oblique voxel placements, the orientation angle will 
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have to be taken into account. In this case, a rotation matrix involving the 
voxel starting values and rotation angle would have to be used. However, 
unlike the Siemens scanner used elsewhere [176], the GE scanner used for the 
experiments in this thesis does not generate information on the orientation 
angle of the voxel in the MRS header files; and there is no straightforward way 
of obtaining such information.  
 
The need for oblique voxel placement arises when MRS acquisitions are 
required in brain structures such as the hippocampus which lies obliquely 
within the brain (Figure 5.4a). Since the hippocampus was one of the regions of 
interest in this thesis, in all the MRI acquisitions for voxel placement, the slices 
were planned along the hippocampal axis. By doing this, the hippocampi in 
both hemispheres were now reasonably horizontal (Figure 5.4b) so that there 
was no need to tilt the MRS voxel to cover most of the length of the 
hippocampus.  
 
The slice planning for the structural MRI, voxel placement and partial volume 
correction techniques described in this section were applied to the MRS data 
presented in chapters 6 and 7. Correcting the measured MRS signal area, 
Ameasured for partial volume effects usually takes the form [1]:  
 
Acorrected = Ameasured/(fGM + fWM)                                                       (Eq. 5.6) 
 
where fGM and fGM are the fractions of grey and white matter tissues in the 
voxel (i.e. excluding CSF) and Acorrected is the corrected spectral peak area after 
excluding CSF from the voxel. Thus, even though CSF actually contributes some 
amount of signal to Ameasured, the partial volume correction technique assumes 
otherwise.  
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Figure 5.4: Sagittal MRI scans showing voxel placements on the hippocampus in (a) its 
normal oblique orientation and (b) a horizontal orientation 
 
   
5.4 Summary and Conclusions 
 
   
The work in this chapter was primarily aimed at measuring and developing 
techniques to deal with the main factors that introduce large errors in spectral 
quantification (sections 5.1.1-3) by the internal referencing method. The 
cerebral water signal has been chosen as the internal reference in this thesis. 
Thus the two main factors that could impact on the accuracy of quantitative 
MRS using this reference were dealt with. These factors were: signal relaxation 
and partial volume effects. 
  
Relaxation times in the brain and of metabolites and water were therefore 
measured. The T1 and T2 values obtained compared with values in the 
literature. For most regions of the brain, T1 was observed to be slightly higher 
in the left hemisphere but T2 did not vary widely regionally. Unlike brain tissue 
T1, metabolite T1 estimates tend not to depend on B0 field, and so metabolite 
T1 values were comparable at different field strengths. Measurement of the 
relaxation times of water in the hippocampus using MRS has been done for the 
first time in this chapter. 
 
The reference unsuppressed-water signal in this thesis is affected more by T1 
than by T2 relaxation effects. This is because at the TR of the acquisitions, only 
a fraction of the water signal has recovered its longitudinal magnetisation. A 
(a) (b) 
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method of estimating the unrecovered or lost signal fraction was suggested. 
This signal compensation method was also suggested to include correction for 
T1 relaxation effects.   
 
A method for partial volume correction using MR image segmentation of the 
MRS voxel was also presented. Though the voxel localisation technique 
described is not suitable for cases where oblique voxels are used, a method of 
dealing with this was suggested. It was recommended that for brain structures 
like the hippocampus that are in oblique orientation, the MRI of the brain 
should be acquired with slices tilted to the region of interest so that the voxel 
can be prescribed on that region in a non-oblique orientation. 
 
The results presented in this chapter will be used to estimate the correction 
factors for relaxation and partial volume effects in the spectral quantification 
of chapters 6 and 7.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
176 
 
Chapter 6: Quantification and Assessment of 
Regional Brain Water Content 
 
 
 
6.1 Introduction and Objectives 
 
 
The advantages of using brain tissue water content as an endogenous reference 
concentration in quantitative MRS were discussed in section 4.1.2. However, 
the direct measurement of brain tissue water content with MRS remains a 
challenge. To date, all non-invasive MRS measurements of this endogenous 
tissue water concentration involve the use of another external reference 
concentration [58, 59, 61]. This defeats the full benefit of internal referencing 
to tissue water content and potentially introduces more errors into the 
estimate, depending on the type of external reference used and where it is 
positioned in the receiver coil [1]. When metabolite quantification is needed in 
the same study, the examination is prolonged because the metabolite signals 
will have to be recorded separately [58]. Even when the water concentration 
estimate is taken from the literature, a separate unsuppressed-water signal 
acquisition is usually conducted [30, 45, 61, 62]. Using a mathematical model 
that relates the peak area of this unsuppressed reference signal, the literature 
or measured value of tissue water content and the metabolite peak area, the 
concentrations of the metabolites of interest are obtained (this is further 
explored in chapter 7).  
 
Ideally, the reference water and metabolite signals should be recorded from 
the same voxel, and simultaneously. The intensity of this acquired water signal 
should also be enough to give an estimate of tissue water concentration within 
the region of interest (i.e. where the voxel is placed). If such an estimate of 
water concentration is used as an endogenous reference specific to the region 
of interest, then it will be possible to have a reference concentration that will 
always correspond to each voxel position. Such a quantification scheme will be 
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implementable within clinical examination times, and will be less susceptible 
to the errors inherent in the previous quantification methods. 
 
The MRS measured water signal could also be probed by magnetisation transfer 
(MT) imaging. This is because MT imaging measures signal intensities related to 
the amount of tissue-bound water; MRS on the other hand is capable of 
measuring the total water signal from tissue, and if CSF contribution to this 
signal is excluded, then what is left is the tissue-bound component. The 
amount of tissue-bound water as measured by MT imaging is indicated by the 
MT ratio (MTR). The MT effect is greater in regions of high macromolecular 
content but less bulk water (e.g. in myelin sheaths). In a healthy or developing 
brain, the relative amounts of MTR in different brain regions mainly point to 
the relative amounts of white/grey matter or degrees of myelination [1]. It is 
therefore possible that in the same healthy subject, MRS measured tissue 
water content could be related to MTR obtained from MT imaging of the same 
regions of interest. This potential relationship (between MRS and MT imaging) 
and its practical implication for future studies were investigated and are 
presented in section 6.3.5. 
 
The dependence of cerebral water content on age [177]and brain region [61] 
has been reported previously. There are also indications of MTR variation with 
age [178, 179] and brain region [180, 181]. However, no single study in the 
literature has, at the same time, investigated both cerebral water content and 
MTR variations with age, gender, brain region and/or tissue type. Such a study 
would help rule out these factors as possible sources of variance (or otherwise) 
in cerebral water content. Findings involving these factors may have 
implications for studies that utilise published estimates of cerebral water 
content (from healthy volunteers) for referencing in quantitative MRS. The 
agreement (or otherwise) of the findings between the MTR and water content 
studies would also indicate whether or not any one of the two measurements 
could be used to validate the other.   
     
The studies presented in this chapter were therefore aimed to: 
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1. Develop an MRS technique to accurately quantify brain tissue water content 
without the need for extra unsuppressed-water signal acquisition;  
2. Assess the variation of quantified tissue water content across the brain 
including brain tissue water variation by gender and the possible associations of 
brain water content with voxel tissue content and age;  
3. Compare (for the same regions of interest) the brain tissue water contents 
and MT ratios as measured by MRS and MT imaging, respectively. 
   
 
6.2 Methods 
 
   
Data from three different studies were used for the work presented in this 
chapter. Two studies were retrospective MRS studies whereas one was a 
prospective MT imaging study conducted during this PhD project. The brain 
tissue water quantification technique was developed and implemented using 
the retrospective MRS data; the MT imaging results for the same regions 
investigated in the MRS studies were then compared to the MRS results. The 
three studies are specified as follows: 
 
Study 6A: A retrospective single-voxel MRS study measuring metabolite signals 
from three voxel positions in the left hemisphere of healthy subjects 
 
Study 6B: A retrospective single-voxel MRS study measuring metabolite signals 
from the left and right hippocampi of healthy subjects 
 
Study 6C: A prospective MT imaging study assessing the MT effects in the voxel 
positions of studies 6A and 6B in healthy volunteers.  
 
The tissue water quantification technique involved a novel spectral processing 
method that quantified the unsuppressed-water signal from a CHESS water-
suppressed acquisition (sections 2.3.1.2-3). The method was successfully 
implemented in studies 6A and 6B where both MRS data were CHESS water-
suppressed. The details of the methods for this chapter are discussed in 
subsections 6.2.1-4.  
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     6.2.1 Subjects 
  
   
Table 6.1 summarises the age-sex distribution of the subjects in the three 
studies. 
 
Study Sample Size                           
(Males/Females) 
Mean age ± SD (range) in years 
Total Sample Males Females 
6A 11/11 38 ± 13 (20-64) 37 ± 10 (20-52) 39 ± 15 (23-64) 
6B 37, all males 51 ± 9 (38-66) 51 ± 9 (38-66) - 
6C 4/4 32 ± 9 (23-51) 37 ± 10 (29-51) 26 ± 4 (23-32) 
 
 
Table 6.1: Age-sex distribution of the healthy volunteers for the three studies. 
In a two-sample t-test, the mean ages of males and females were not significantly different in 
studies 6A (p = 0.840) and 6C (p = 0.101) 
  
6.2.2 MRI, MRS and Voxel Placement 
 
 
 
In both studies 6A and 6B, high resolution T1-weighted axial 3D MR images of 
the brain of each subject were acquired to be used for partial volume 
correction by image segmentation (section 5.2.4). In each study, structural 2D 
MRI scans of the brain were also performed (Table 6.2) for planning the MRS 
voxel positions (Figures 6.1 and 6.2).  
 
 
MRI parameters Study A Study B 
Sequence                                                                                                    
(image orientation)
T2-w FSE
(sagittal)               
T1-w FLAIR
(sagittal) 
T2-w FSE/propeller          
(axial) 
T2-w FSE  
(coronal) 
TR/TE/TI (ms) 4040/91.8/0 2557/8.9/920 5000/109/0 4060/127/0 
FOV (cm2) 20 x 20 24 x 24 24 x 24 20 x 20 
Matrix size 256 x 256 320 x 224 512 x 512 512 x 512 
Number of slices 20 18 21 11 
Slice thickness/gap 5.0/1.0 5.0/2.0 5.0/1.5 4.0/1.0 
 
   
Table 6.2: Structural MRI parameters for voxel planning in the two retrospective studies 
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In both studies, the PRESS localisation sequence was used to acquire CHESS 
water-suppressed spectra, with TR/TE = 1500/144 ms, NEX = 8, 4096 complex 
points and a spectral width of 5000 Hz. Spectral averages of 128 and 256 were 
acquired in studies 6A and 6B, respectively. In study 6A, spectra were recorded 
from a voxel of   20 x 20 x 20 mm3 placed in the frontal, parietal and occipital 
regions of the left brain hemisphere (Figures 6.1a-f). In study 6B, spectra were 
recorded from a voxel of 10 x 20 x 15 mm3 (in the LR x AP x SI directions, 
respectively) positioned in the right (Figures 6.2a-c) and left hippocampi. 
 
 
 
a 
b 
c 
d 
e 
f 
 
Figure 6.1: Voxel placement in study 6A in the frontal (a and b), parietal (c and d) and 
occipital (e and f) regions of the left brain hemisphere of the same subject. 
The top row (a, c and e) shows the voxel positions in the sagittal view; the bottom row (b, d 
and f) shows the voxel positions in the axial 3D MRI 
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a b c 
 
 
Figure 6.2: Representative sagittal (a), axial (b) and coronal (c) MR images showing the 
voxel placement in the right hippocampus of the same subject in study 6B. 
The yellow lines are saturation bands prescribed by the scanner around the voxel edges; these 
help prevent signal contamination from adjacent tissue. They are applied in all the MRS 
acquisitions in this thesis but have only been shown in this example. 
 
 
6.2.3 MT Imaging 
  
  
Without turning the MT pulse ON, an axial MRI of the brain was acquired using a 
gradient echo pulse sequence with the following parameters: TR/TE = 3000/35 
ms, 15 slices (4 mm thick per slice without gaps) planned along the 
hippocampal angle, FOV = 25 x 25 cm2 and a matrix size of 256 x 128. Following 
this acquisition, the MT saturation pulse (frequency offset = 1000 Hz, flip angle 
= 5o) was then switched ON and the same MRI parameters were used to acquire 
an MT image. 
 
   
6.2.4 Data Analysis 
 
   
The MRS and MT imaging data were analysed using the SAGE (version 7) and 
Image-J (version 1.46r) software packages, respectively. The SAGE spectral 
fitting method was discussed in section 2.3.1.2. For the work in this chapter, 
only the water resonance at 4.7 ppm was analysed. Therefore, only the use of 
the SAGE results (i.e. spectral peak areas) for the calculation of tissue water 
content will be presented in this chapter (section 6.2.4.1). The Image-J 
software package gives image intensities from selected ROIs, the intensities 
being associated with the presence and absence of the MT effect in the 
corresponding images (details in section 6.2.4.2).    
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6.2.4.1 Calculation of Tissue Water Content 
 
    
In this thesis, the brain tissue water content, WC refers to the tissue-bound 
water component (i.e. excluding cerebrospinal fluid, CSF). The complete 
equation describing the total tissue water contents, WC in grey matter, GM and 
white matter, WM tissues was given by: 
 
 
 
                                                                                                           (Eq. 6.1)       
 
 
 
 
Abrain is the spectral peak area of the in vivo unsuppressed-water signal derived 
from the spectral analysis of the 16/NEX lines (sections 2.3.1.2-3); Afit is the 
peak area obtained by substitution of the in vivo VOI coordinates of Abrain into 
the appropriate position-dependent polynomial equation from the phantom 
experiments (section 4.4); ktemp is the temperature correction factor that 
accounts for the larger proton population difference between water in the 
phantom (which is at lower temperature) and brain tissue water [1]; kpr is the 
compensation factor for the fractional water signal loss due to partial recovery 
and T1 relaxation effects together (section 5.3.3); kTG is the transmitter gain 
factor (section 4.2.5) accounting for differences in coil loading effects between 
the phantom and the head; VOI is the voxel size in the respective spectral 
acquisitions; fGM and fWM are the voxel fractions of grey and white matter 
tissues respectively, after CSF exclusion (section 5.2.4); R2_GM and R2_WM are the 
compensation factors for T2 relaxation effects in grey and white matter tissues, 
respectively (equation 5.4). 
 
Afit in equation 6.1 is already corrected for T1, T2, VOI and transmitter gains 
according to equation 4.1 (section 4.2.5), and since it is obtained primarily 
from phantom experiments, using it for referencing here would require 
corrections for temperature, coil loading and VOI differences between the MRS 
phantom and the human brain as in equation 6.1.   
 
The temperature correction factor, ktemp was calculated from [1]: 
WC =  
Abrain  
 Afit 
Kpr 
ktemp  
kTG_brain  
x x x
VOIbrain  
fGM  
R2_GM  
fWM  
R2_WM  
+
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ktemp = (273.2 + Tphantom)/310.2                                                         (Eq. 6.2)                              
 
Tphantom is the temperature of the phantom in degree Celsius; which was 18 
oC 
during the phantom experiments, giving a ktemp value of 0.94. 
 
In section 5.3.3, kpr was found to be 1.32. Thus, the kpr/ktemp factor in equation 
6.1 becomes 1.32/0.94 = 1.40. 
 
Tissue-specific absolute WC was obtained from equation 6.1 as follows: 
                                                                                                    
 
                                                                                                       (Eq. 6.3) 
  
 
where ftissue and R2_tissue are the GM or WM tissue fraction in the voxel and T2 
relaxation correction factor, respectively; the fraction kpr/ktemp is replaced by 
the constant value of 1.40. Thus the WC for GM and WM were calculated 
separately as WCtissue. 
 
The WC calculated in either one of equations 6.1 and 6.3 is in percentage 
units. To express WC in units of g/mL, it was multiplied by the density of water 
at 37 oC (0.9934 g/mL [58]); this yielded tissue water density, WCρ. WC was 
also expressed in concentration units per kilogram of wet tissue weight. This 
was done by multiplying WC by the concentration of water (55.51 mol/L); WC 
in mol/L was then divided by the density of water at 37 oC (0.9934 g/mL), 
resulting in units of mol/kg wet weight for WC, denoted by WCkg
-1. It was 
necessary to express WC in both units in order to allow for direct comparison 
with literature values that are expressed in either unit.   
 
The technique for the measurement and quantification of brain tissue water 
content presented in this section is unique compared to the previous methods 
in the following ways: from a normal water-suppressed acquisition, the 
WCtissue  =  
Abrain 
Afit 
KTG_brain 
VOIbrain 
x x 
ftissue  
R2_tissue  
x 1.40 
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unsuppressed-water signal area can be derived. To obtain the reference signal 
area (in equation 6.3), the in vivo voxel coordinates are used in the 
appropriate polynomial equation to calculate the required signal area. There is 
therefore no need for prolonged or any extra acquisitions in the estimation of 
brain tissue water content. The technique is thus less time consuming and less 
stressful for patients.   
 
  
6.2.4.2 Calculation of MT Ratios 
 
   
ROIs were drawn in the ventromedial prefrontal GM, and bilateral frontal, 
parietal, occipital and hippocampal brain regions (regions 2-9 as shown in 
Figures 5.1a and 5.1b) of the MR images acquired with and without the MT 
saturation pulse. These ROI selections included all the brain regions in which 
the water content has been estimated in studies 6A and 6B. To ensure the 
same ROI was selected in the MT ON and OFF images of the same subject, the 
ROI Manager tool in the Image-J software package (version 1.46r; National 
Institutes of Health, USA) was used to store the coordinates of the selected ROI 
in the image that was loaded first. When the next image was loaded, the 
stored ROI coordinates were superimposed on it at exactly the same location as 
in the first image. This method yielded the same results as co-registration of 
the two images and selecting the ROIs. Therefore, any difference in voxel 
intensity value between the two images was only as a result of the MT 
saturation difference and not due to inconsistent ROI selection. The fraction of 
the magnetisation transfer (MT) effect was estimated from the MT ratio (MTR) 
expressed as a percentage in the following equation [22]: 
 
MTR = (1 – Ms/Mo) x 100 %                                                                (Eq. 6.4) 
 
Ms and Mo are the pixel intensity values of the ROI selections in the MR images 
with and without MT saturation, respectively. Example images acquired 
without and with MT saturation are shown in Figures 1.4a and 1.4b, 
respectively. 
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6.3 Results and Discussion 
 
  
The details of the technique developed for the calculation of brain tissue water 
content, WC has been discussed in section 6.2.4.1 (see objective 1). The 
results obtained by implementing the technique will be presented and 
discussed in the following subsections in relation to WC values in the literature, 
variation across the brain, by gender, age, and voxel tissue content (sections 
6.3.1-3) - see objective 2. Results for the regional variation in MTR are also 
presented (section 6.3.4) and then compared to variation in WC for the same 
brain regions (section 6.3.5) - see objective 3. 
 
6.3.1 Hemispheric Tissue Water Content 
 
  
Subsections 6.3.1.1-5 discuss the results for study 6A recording MRS data from 
the left hemisphere, along the frontal, parietal and occipital brain regions. The 
results presented in the subsections include comparison between GM and WM 
water contents, WC for the three brain regions (section 6.3.1.1), assessment of 
regional mean WC (section 6.3.1.2), comparison of the regional mean and 
GM/WM water contents between males and females (section 6.3.1.3), 
assessment of the association between voxel tissue and water contents (section 
6.3.1.4), and the investigation of WC variation with age (section 6.3.1.5).     
  
 
6.3.1.1 GM versus WM Tissue Water Contents 
 
  
 
Before presenting the results for tissue water content, it is necessary to assess 
the relative amounts of grey (GM) and white (WM) matter in the three 
hemispheric voxel positions. These are summarised in Table 6.3. 
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Region Mean GM fraction ± SD (range) Mean WM fraction ± SD (range) p-value 
Frontal 0.54 ± 0.04 (0.50-0.68) 0.46 ± 0.04 (0.32-0.50) < 0.01 
Parietal 0.53 ± 0.04 (0.37-0.58) 0.47 ± 0.04 (0.42-0.63) 0.010 
Occipital 0.48 ± 0.09 (0.37-0.76) 0.52 ± 0.09 (0.24-0.63) 0.346 
 
 
Table 6.3: Voxel tissue compositions in the left hemisphere of all subjects. 
Comparisons were done by paired t-tests for the parietal and occipital regions; the Wilcoxon 
signed rank test was used for comparisons in the frontal region as the data did not follow a 
normal distribution 
 
 
The frontal (p < 0.01) and parietal (p = 0.01) voxel positions had significantly 
greater amount of GM than WM; only the occipital voxel did not contain 
significant amount of either tissue type than the other (p = 0.35). A one-way 
ANOVA indicated a significant variation of voxel GM content among the three 
regions (p < 0.01), with frontal > parietal > occipital. Voxel WM content also 
varied significantly among the three regions (p < 0.01), with frontal < parietal < 
occipital. The impact of the tissue content of the voxels on water content is 
discussed in subsection 6.3.1.4. 
 
 
The mean GM and WM water contents in the three voxel positions are shown in 
Table 6.4. Estimates for the water content are provided in concentration  
(WCkg
-1) and density (WCρ) units. Since both quantities have been derived from 
the same base equation (equation 6.3), it was expected that their variation by 
tissue type and sex should be the same. However, a correlation analysis was 
still performed between WCkg
-1 and WCρ for all voxel positions in studies 6A and 
6B. As was expected, each correlation analysis resulted in a Pearson 
correlation coefficient of 1, which meant that both quantities were accurately 
and directly proportional; thus, inferences drawn from statistical tests on 
either one of the two quantities could be applied to the other. As shown in 
Table 6.4, the paired t-tests between GM and WM for WCkg
-1 and WCρ gave the 
same p-values for all three brain regions. Therefore from this point, tissue 
water content will be provided in concentration units, WCkg
-1; and conclusions 
drawn with WCkg
-1 will also apply directly to tissue water density, WCρ. 
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Brain  
region 
Mean WCkg
-1 ± SE (range)       
in mol/kg wet weight 
 
 
 
p-value 
Mean WCρ ± SE (range)      
in g/mL 
 
 
 
p-value 
GM WM GM WM 
Frontal 46.37 ± 2.58 
(26.70-48.25)  
42.86 ± 2.46 
(25.44-46.77)
0.016 0.82 ± 0.05 
(0.57-0.94) 
0.75 ± 0.04 
(0.53-0.88) 
0.016 
Parietal 37.23 ± 1.70 
(30.59-48.12)
34.14 ± 2.02 
(29.82-42.72)
0.031 0.66 ± 0.03 
(0.54-0.86) 
0.61 ± 0.04 
(0.53-0.83) 
0.031 
Occipital 34.92 ± 2.34 
(31.00-49.56)
37.45 ± 2.35 
(29.70-48.99)
0.435 0.62 ± 0.04 
(0.53-0.88) 
0.67 ± 0.04 
(0.50-0.87) 
0.435 
 
 
Table 6.4: Mean regional brain tissue water content by tissue type within the left 
hemisphere. 
Comparisons were done by paired t-tests 
 
 
Generally, the relative amounts of GM/WM water contents appear to follow the 
same pattern as their amounts in the three voxel positions (more in section 
6.3.1.4). GM water content was found to be significantly higher than WM water 
content of the frontal (p = 0.02) and parietal (p = 0.03) brain regions. WM 
water content was higher (but not significantly) than GM water content in the 
occipital region. Water content of GM is known to be slightly higher than that 
of WM [49, 58, 59]. This observed relative water contents of the two tissue 
types, and the relative amounts of GM and WM in the frontal and parietal 
voxels may explain the significantly higher GM water content than that of WM 
in the frontal and parietal brain regions.  
 
The occipital voxels contained more or less equal amounts of GM and WM 
tissues. The mean water contents of GM and WM were therefore not 
significantly different (p = 0.44). GM tissue water content varied significantly 
among the three voxel positions (p = 0.007), with frontal WC > parietal WC > 
occipital WC. WM tissue water contents of the three voxels also varied 
significantly (p = 0.012), with frontal WC > occipital WC > parietal WC. The 
significant variation in the water contents of GM and WM in the three voxel 
positions originated from higher WC values for the frontal GM and WM. The 
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parietal and occipital regions did not vary significantly in WC of either GM (p = 
0.105) or WM (p = 0.241).  
 
The following discussion compares the results of this thesis with those of 
previous studies. 
   
   
With a voxel size of 7.84 mL (compared to 8.0 mL in this study; section 6.2.2) 
containing an average (standard error) of 86 (1) % (compared to 47 (0.9) % in 
this study; Table 6.3) white matter in parietal voxels and 73 (3) % (compared to 
49 (1.9) % in this study; Table 6.3) of grey matter in occipital voxels, Brief et al 
[58] measured the water contents in GM and WM tissues to be 0.73 ± 0.01 and 
0.77 ± 0.01 g/mL (mean ± standard error). They measured the total water 
signal by a multi-echo (32 echoes) MR imaging technique and fit a 
monoexponential curve to the points to obtain Abrain at TE ≈ 0 ms. The water 
signal was then referenced to a signal acquired from an external water 
phantom. They reported that due to the voxel tissue mixture used in their 
measurements, their GM and WM tissue water contents were slightly under and 
over estimated, respectively, compared to literature estimates. Compared to 
the study by Brief et al, the average voxel contents of WM and GM in this study 
were lower and so were their water contents: 0.61 ± 0.04 in parietal WM and 
0.62 ± 0.04 g/mL in occipital GM (Table 6.4). 
 
 
Whittal et al [59] used a similar method to that of Brief et al and measured the 
water content of pure WM and GM brain regions to be 0.71 ± 0.01 and 0.83 ± 
0.03 g/mL, comparable to post mortem water content estimates of 71.6 % and    
81.9 % for pure WM and GM, respectively [60]. In concentration units, pure WM 
and GM water estimates have been reported to be 39.2 and 46.8 mol/kg wet 
weight [62]. Even though these estimates are well within the range of the WM 
and GM water contents measured in this study (Table 6.4), the average 
estimates in this study were found to be lower for the parietal and occipital 
voxels. Only the means of the water contents for both GM and WM in the 
frontal voxels were directly comparable to those in the literature: 0.82 ± 0.05 
for GM and 0.75 ± 0.04 g/mL for WM in density units, and 46.37 ± 2.58 for GM 
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and 42.86 ± 2.46 mol/kg wet weight for WM in concentration units. The 
relative amounts of CSF in the three voxel positions and the voxel tissue mix 
(i.e. no “pure” GM or WM in the voxels) could have accounted for the 
discrepancies between the reported mean WC and those measured in the 
parietal and occipital voxels in this study. In fact, most of the WC values 
measured in those two voxels were relatively lower (see the ranges in Table 
6.4).  
 
 
 
Elsewhere [160], the T2 contribution of myelin water to the total water signal 
has been subtracted from the decay curve. This yields a signal attributable to 
only “solid brain” tissue which is then referenced to an identical volume of 
pure water in an external standard. With this technique, Ernst et al [160] 
estimated the water content of pure WM and GM to be 0.646 ± 0.015 and 0.780 
± 0.015 g/mL, respectively. They however reported average relative signal 
losses of 35.4 % and 20.2 % in WM and GM, respectively.  An observation by 
Whittall et al [59] suggests an explanation to these signal losses in that the fast 
relaxing myelin water component accounts for about 11 % and 3 % of the signal 
in normal WM and GM, respectively. It is therefore likely that in neglecting the 
T2 contribution from myelin water, the fully-relaxed water signal is 
underestimated, leading to the brain tissue water content being 
underestimated. This means that in order to accurately measure the total 
tissue water signal, multi-echo techniques will have to acquire as many echo 
points as possible, and these should include points close to TE = 0 ms.  
  
 
The technique of measuring the total tissue water signal presented in this 
thesis is not relatively complicated and includes contributions from all possible 
“water pools” in the brain. As long as Kpr is accounted for in the model for WC, 
the total water signal obtained yields estimates for tissue water content 
comparable to the literature estimates. No voxel contained as much of GM or 
WM as those amounts in the above studies, and yet all the mean literature 
estimates for both GM and WM water contents fall within the range of WC 
values for the two tissue classes in this thesis.    
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6.3.1.2 Regional Hemispheric Mean Water Contents  
   
 
For each brain region, the mean of the GM and WM water contents were 
calculated. This was to allow for further comparison of the results from the 
technique of this thesis to the results of other studies that reported average 
brain tissue water contents. As shown in Figure 6.3, the mean ± SD of the 
water contents in the frontal, parietal and occipital brain regions were 40.06 ± 
7.84, 35.69 ± 5.73 and 36.18 ± 7.71 mol/kg wet weights, respectively. The 
mean water contents in the three regions did not vary significantly (p = 0.064), 
even though the mean water content in the frontal region was slightly higher. 
 
 
 
 
Figure 6.3: Mean water content in the left hemispheric frontal, parietal and occipital 
voxels 
Error bars represent ±standard deviations 
 
  
 
These estimates compare with the average brain tissue water content of 36 
moles reported elsewhere [31]. In a study of the water contents in four brain 
regions among four age groups, Christiansen et al [61] measured the 
unsuppressed-water signal and referenced it to an external water-filled bag. 
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Among adolescents (aged 10-15 years), adults (aged 22-28 years) and the aged 
(60-74 years), they estimated water contents in the frontal, temporal, occipital 
and basal ganglia to be between 35.8 and 39.6 mol/kg wet weight (mean = 36.9 
mol/kg wet weight). The water content was not significantly different among 
the four brain regions. The average water content (of 51.5 mol/kg wet weight) 
in a group of newborns (aged 0-23 days) was however found to be significantly 
higher than that in the other three groups (p < 0.01). This thesis did not 
include newborns; however, the ages of the subjects studied fell between the 
adult and aged groups of Christiansen et al. The estimates of the water 
contents for the adult population were comparable between the two studies. 
Similarly, this thesis did not also find significant difference in water content in 
the three regions of interest. 
        
6.3.1.3 Tissue Water Content by Sex 
  
   
The voxel tissue contents are compared between males and females in Table 
6.5. The mean voxel GM and WM tissue contents were not significantly 
different between the two sexes in all three brain regions (p > 0.05). However, 
most voxels in the frontal region of the females had more GM tissue compared 
to those in the males; nonetheless the mean voxel GM tissue content 
difference between them was not, but close to being, significant (p = 0.061). 
  
 
 
Brain  
region 
Mean GM fraction ± SD (range) Mean WM fraction ± SD (range) 
Males Females p-value Males Females p-value 
Frontal 0.52 ± 0.01 
(0.50-0.55) 
0.56 ± 0.05 
(0.51-0.68) 
0.061 0.48 ± 0.11 
(0.45-0.50) 
0.44 ± 0.13 
(0.32-0.49) 
0.783 
Parietal 0.52 ± 0.06 
(0.37-0.58) 
0.51 ± 0.02 
(0.47-0.55) 
0.397 0.48 ± 0.06 
(0.42-0.63) 
0.49 ± 0.02 
(0.45-0.53) 
0.357 
Occipital 0.47 ± 0.07 
(0.37-0.55) 
0.49 ± 0.10 
(0.40-0.76) 
0.684 0.53 ± 0.07 
(0.45-0.63) 
0.51 ± 0.10 
(0.24-0.06) 
0.519 
 
 
  Table 6.5: Voxel tissue compositions in the left hemisphere of subjects by sex. 
    Comparisons were done by two-sample t-tests 
 
 
Water contents of GM and WM did not vary significantly between males and 
females in the frontal, parietal and occipital brain regions (Table 6.6). The 
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mean water contents ± SD in mol/kg wet weight for males/females in the 
frontal (43.2 ± 11.5/47.4 ± 11.9; p = 0.412), parietal (33.63 ± 5.15/37.6 ± 10.0; 
p = 0.271) and occipital (33.8 ± 3.39/38.6 ± 10.1; p = 0.183) regions were also 
not significantly different. Females however showed slightly higher mean water 
content than males in all the three brain regions (Figure 6.4).  
 
 
Brain  
region 
GM Water content ± SD (mol/kg)  WM Water content ± SD (mol/kg) 
Males Females p-value Males Females p-value 
Frontal  42.8 ± 11.4 47.0 ± 11.8 0.406 47.1 ± 11.7 45.6 ± 13.0 0.783 
Parietal 36.4 ± 5.7 38.0 ± 9.6 0.656 30.8 ± 6.2 37.1 ± 10.8 0.116 
Occipital 31.9 ± 5.0 37.9 ± 13.6 0.213 35.7 ± 6.7 39.2 ± 13.5 0.476 
 
                
  Table 6.6: Mean GM and WM water contents compared between males and females 
 
 
Among the males, GM water content varied significantly (p = 0.016) across the 
brain such that frontal WC > parietal WC > occipital. WM water content also 
varied significantly (p = 0.001) such that frontal WC > occipital WC > parietal 
WC. However, the mean water contents in the three regions were not 
significantly different (p = 0.199). The variation in water contents of both GM 
and WM followed the same pattern in females but they did not vary 
significantly in the three regions (p = 0.136 for GM, p = 0.265 for WM). Mean 
water content did not also vary significantly in the three regions (p = 0.128) in 
the female group.   
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Figure 6.4: Mean water contents in the three voxel positions compared between males and 
females. 
Error bars represent ±standard deviations 
 
 
To the best of the author’s knowledge, no study in the literature has compared 
brain tissue water contents of the above brain regions as measured by MRS 
between males and females. 
 
 
6.3.1.4 Association between Voxel Tissue and Water 
Contents 
  
The tissue-specific and mean WC values depend on a number of parameters 
(equation 6.3), each contributing in a different way to the estimate. However, 
since the thesis focuses on tissue-bound water content, it was necessary to 
assess the extent to which the amount of voxel tissue contributed to its 
corresponding water content. It can be deduced from equation 6.3 that voxel 
tissue and water contents are directly related. It is thus the strength of this 
relationship that is investigated in this section. 
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The contributions of the voxel contents of GM (Table 6.7) and WM (Table 6.8) 
to the estimated water contents in the two tissue classes, and to the mean 
water content, for the three regions of interest were investigated by Pearson’s 
correlation analysis. 
 
Association; 
Significance 
Frontal voxel Parietal voxel Occipital voxel 
GM WC Mean WC GM WC Mean WC GM WC Mean WC 
r; 
 
p-value 
0.678;  
 
0.001 
0.070;  
 
0.768 
0.939;    
 
< 0.01 
0.206;   
 
0.399 
0.361;    
 
0.118 
0.113;    
 
0.636 
 
 
Table 6.7: Pearson’s correlation analysis of the association between voxel GM tissue 
content, GM WC and mean WC. 
The mean water content is the average of the GM and WM water contents of the region of 
interest; r is the Pearson’s correlation coefficient; and p-value is the strength of the 
association   
 
 
 
Association; 
Significance 
Frontal voxel Parietal voxel Occipital voxel 
WM WC Mean WC WM WC Mean WC WM WC Mean WC 
r; 
 
p-value 
0.566; 
 
0.009 
0.070;   
 
0.768 
0.945;    
 
< 0.01 
0.798;   
 
< 0.01 
0.638;    
 
0.002 
0.113;    
 
0.636 
 
 
Table 6.8: Pearson’s correlation analysis of the association between voxel WM tissue 
content, WM WC and mean WC 
 
 
   
In the frontal voxels, both GM and WM contributed significantly to their 
respective water contents. For the GM water content, the voxel content of GM 
tissue contribution alone was significant at 45 % (i.e. 0.6782; p = 0.001); 
whereas the contribution to WM water content of WM tissue alone was about 
32 % (p = 0.009). Both tissue types contributed equally, but not significantly (p 
= 0.768), to the mean frontal water content.   
 
In the parietal voxels, both tissue types again contributed significantly (p < 
0.01) to their respective water contents. However, WM alone still contributed 
(about   64 %; p < 0.01) significantly to the mean GM/WM water content. The 
parietal brain region is predominantly WM tissue, and so even though the mean 
parietal GM was higher than the mean parietal WM (Table 6.3), most voxels 
were positioned in the deep WM brain region (see the range of voxel WM tissue 
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contents in Table 6.3). This might explain why WM tissue contributed more, 
and significantly, to the mean water content in the parietal voxels but GM 
tissue did not.   
 
The occipital brain region is predominantly GM. However, most occipital voxels 
were placed deeper in the brain, containing more WM tissue (Table 6.3). 
Therefore, WM alone contributed significantly to its water content but GM did 
not; both tissue types then contributed equally, but not significantly, to the 
mean GM/WM occipital water content. 
 
 
6.3.1.5 Variation in Brain Tissue Water Content with Age 
  
In all the three brain regions, neither tissue-specific nor mean water content 
variation was found to be associated with age in both sexes, and in the whole 
study sample put together. An example regression plot of mean frontal water 
content versus age is shown in Figure 6.5. The plot shows an average water 
content of 37.38 mol/kg wet weight whose change over time is indicated by 
the gradient of the straight line. The gradient, which measures the change in 
water content with age, is only 0.0704; this is not a significant change (p = 
0.655). In fact, Christiansen et al [61] did not also find a significant difference 
in water content in their groups of adolescents, adults and the aged (ages 
between 10 and 74 years). Brain tissue water content variation has also been 
reported elsewhere [177] to remain insignificant with age in a group of healthy 
subjects, aged 20 to 70 years. Similarly, brain tissue water content appears to 
be fairly stable with age within the studied age group (between 20 and 64 
years) of adults in this thesis. 
 
 
196 
 
       
706050403020
60
55
50
45
40
35
30
Age (years)
M
e
a
n
 F
ro
n
ta
l 
W
C
 (
m
o
l/
k
g
 w
e
t 
w
e
ig
h
t)
S 8.05359
R-Sq 1.5%
R-Sq(adj) 0.0%
Fitted Line Plot for Frontal Water Content vs. Age
Mean WC =  37.38 + 0.0704 Age
 
 
Figure 6.5: Variation in brain tissue water content with age. 
No significant change with respect to age was observed: p = 0.655; r = 0.121 (this is only 
a 1.4 % increase in tissue water content with age) 
 
 
 
6.3.2 Hippocampal Tissue Water Content 
 
  
Subsections 6.3.2.1-2 discuss the results for study 6B recording MRS data from 
the left and right hippocampi of male subjects. The results for this study are 
presented in two subsections: the first (section 6.3.2.1) compares the mean 
water contents between the left and right hippocampi, and the second (section 
6.3.2.2) investigates variation in hippocampal water content with age. All the 
subjects in this study were males, and so it was not possible to do the water 
content analysis by gender in this case.  
   
6.3.2.1 Left versus Right Hippocampal Water Contents 
  
  
The mean ± SD percentage of hippocampal tissue fraction covered by the voxel 
in the left (82 ± 6 %) and right (82 ± 8 %) hemispheres did not differ (p = 0.706). 
The mean ± SD of the left hippocampal water content (37.34 ± 8.02 mol/kg wet 
weight) was not significantly different (p = 0.648) from that of the right 
hippocampus (36.24 ± 13.93 mol/kg wet weight) as shown in Figure 6.6. In both 
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hippocampi, the voxel tissue contents were found to contribute significantly (p 
< 0.05) to their respective mean water contents. 
 
 
 
 
 
 
Figure 6.6: Mean water contents in the left and right hippocampi compared. 
Error bars represent ±standard deviations 
 
   
  6.3.2.2 Variation in Hippocampal Water Content with Age 
   
Variation in hippocampal water content with age was assessed by correlation 
tests. The regression plots representing the variation in water contents with 
age of the left and right hippocampi are shown in Figures 6.7 and 6.8, 
respectively. In both hippocampi, tissue water content did not vary 
significantly with age (p > 0.05). The small, but not significant, decreases in 
hippocampal water content over time may be suggesting hippocampal tissue 
atrophy associated with normal ageing. This could result in a small increase in 
CSF within the hippocampal regions over time; the increase in CSF fraction of 
the MRS voxel over time has been reported elsewhere [177].   
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Figure 6.7: Variation in left hippocampal water content with age. 
No significant change with respect to age was observed: p = 0.493; r = -0.138 (this is only 
a 1.9 % decrease in tissue water content with age) 
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Figure 6.8: Variation in right hippocampal water content with age. 
No significant change with respect to age was observed: p = 0.926; r = -0.019 (this is only 
a 0.04 % decrease in tissue water content with age) 
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  6.3.3 Distribution Profile of Brain Tissue Water Content 
 
 
An exploratory one-way ANOVA test was performed on the hemispheric and 
hippocampal water contents in order to assess whether whole brain tissue 
water content varied across the voxel positions in the two studies (i.e. studies 
6A and 6B). This analysis was based on the assumption that the water contents 
were estimated for each subject in the frontal, parietal, occipital, left and 
right hippocampal voxels. It became necessary to make this assumption 
because no single subject in this thesis was scanned in all these voxel positions. 
The consequence of the assumption, however, could be that some amount of 
inter-subject variability could influence the result of the statistical test.  
 
Figure 6.9 shows the variation of brain tissue water content in the frontal, 
parietal, occipital, left and right hippocampi. The exact water content values 
for all these brain regions are provided in Table 6.10. The ANOVA test 
indicated that the mean water contents did not vary significantly (p = 0.599) 
among the five voxel positions. The results thus suggest that brain tissue water 
content might be uniformly distributed across the brain (considering the five 
regions investigated).  
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Figure 6.9: Brain tissue water distribution profile. 
Error bars represent ±standard deviations 
 
 
The limitation of this study is that only the left hemisphere was investigated 
for the frontal, parietal and occipital water contents. However, bilateral MT 
studies (which also probed tissue water content) indicated that water content 
does not vary significantly between the two hemispheres (Table 6.9). In fact, 
the left and right hippocampal study also corroborates this argument (section 
6.3.2.1). Another limitation is the lack of data for same-brain measurements of 
tissue water content in all the five voxel positions. Both gender (section 
6.3.1.3) and age (sections 6.3.1.5 and 6.3.2.2) do not appear to influence 
tissue water content significantly. Therefore, the expected inter-subject 
variability due to the age and gender difference between the two studies 
should not substantially affect the results of the ANOVA test combining the 
datasets. Nonetheless, it is recommended that future studies measuring 
regional brain tissue water content should do so for all voxel positions within 
the same brain. Only then can the possibility of the inter-subject variability 
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(due to separate voxel positions in different subject groups) be avoided 
completely.   
   
   
6.3.4 Regional Brain Tissue MT Effects 
 
  
This section presents the results, in three subsections (sections 6.3.4.1-3), of 
the MT imaging study (study 6C): section 6.3.4.1 compares the MT ratios 
between the left and right hemispheres, section 6.3.4.2 compares the MT 
ratios between males and females, and section 6.3.4.3 investigates the 
variation of the MT effect with age. 
  
 
            6.3.4.1 Left versus Right Hemispheric MT Ratios 
  
 
Table 6.9 summarises the comparison of the percentage MT ratios between the 
left and right hemispheres, specifically within the same brain structures 
investigated for water content (i.e. frontal, parietal, occipital, left and right 
hippocampi).  
 
 
Brain region Mean percentage MT ratio ± SD (range) p-value 
Left hemisphere Right hemisphere 
Frontal 29 ± 8 (20-41) 29 ± 9 (18-41) 0.640 
Parietal 29 ± 7 (23-40) 29 ± 6 (22-37) 0.135 
Occipital 30 ± 9 (19-41) 29 ± 8 (18-40) 0.904 
Hippocampus 21 ± 6 (10-27) 22 ± 6 (11-27) 0.264 
 
    Table 6.9: Percentage MT ratios in the left and right hemispheres compared 
 
 
Apart from the hippocampus, none of the other three regions was investigated 
bilaterally for water content. The paired t-test indicates laterality of 
percentage MT ratio in all regions. This may as well be the case for water 
content in the frontal, parietal and occipital regions but data was not available 
to confirm this. A one-way ANOVA also did not find significant variation in 
percentage MT ratio among all the regions (p = 0.081). Thus, the uniform 
distribution of percentage MT ratio in these regions corroborates the validity of 
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the deduction made about the uniform distribution of tissue water content as 
observed in section 6.3.3. 
 
6.3.4.2 Percentage MT Ratio by Sex 
 
 
For all ROIs, MT ratios did not vary significantly among both males (p = 0.136) 
and females (p = 0.310). Mean percentage MT ratios were also not significantly 
different between males and females (M/F ± SD) in the frontal (23.72 ± 6.42 
%/33.94 ± 7.36 %; p = 0.091), parietal (25.56 ± 5.17 %/32.46 ± 6.33 %; p = 
0.152) and occipital (26.96 ± 6.49 %/32.03 ± 9.25 %; p = 0.410) ROIs. Only the 
mean hippocampal percentage MT ratios between males (17.03 ± 5.28 %) and 
females (25.14 ± 2.24 %) was found to be significantly different (p = 0.047) as 
shown in Figure 6.10.  
 
 
 
 
Figure 6.10: Mean MT ratios compared between males and females. 
For both groups, the means of the MT ratios for all ROIs in the two hemispheres was averaged; 
the error bars represent ±standard deviations. *The difference in hippocampal MT ratio 
between males and females was significantly different (p = 0.047). 
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Hippocampal water content was estimated only in males in this thesis and it is 
unclear if males and females in a normal population will show a significant 
difference in mean hippocampal water content (as with the mean hippocampal 
MT ratio observed here). To the best of the author’s knowledge, no study was 
cited in the literature investigating gender-related hippocampal water content 
or MT effects.  
 
 
The difference in the age range between males (29-51 years) and females (23-
32 years) was rather too wide, even though the statistical analysis did not show 
a significant mean age difference between the two groups (p = 0.101; Table 
6.1). Brain tissue atrophy occurs with normal ageing [1, 182]. Atrophy 
decreases the amount of water bound in brain tissue which MT imaging 
measures. MT ratio has therefore been observed to decrease with atrophy [183-
185]. Hence, it is likely that the lower mean percentage MT ratio in the male 
population could be due to age-related atrophy in some of the elderly subjects. 
It may also be that the hippocampus is more susceptible to age-related brain 
tissue atrophy than the other brain regions. It may however be misleading to 
make a conclusion on this significant difference in hippocampal MT ratio with 
only 4 subjects in each sex group. This therefore warrants further investigation 
of the MT effects in these ROIs in a larger population of males and females 
within the same age group. Only then can a conclusion be made on whether the 
significance observed in this study is accurate or otherwise.      
 
 
6.3.4.3 Age-MT Ratio Association 
  
  
Pearson’s correlation analysis was performed between age and the mean 
percentage MT ratios in the frontal, parietal, occipital and hippocampal ROIs.  
 
Age accounted for 12.3 % (p = 0.395), 7.3 % (p = 0.516), 3.0 % (p = 0.681) and 
only 0.7 % (p = 0.848) of the variances in mean percentage MT ratios in the 
frontal, parietal, occipital and hippocampal ROIs, respectively. The 
contribution of age (23-51 years) to the measured MT effects within this 
population was not found to be significant as indicated by the p-values (p > 
0.05). Age does not therefore appear to explain the significant difference in 
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the mean percentage hippocampal MT ratios between males and females as 
was thought initially by the author (see discussion in section 6.3.4.2). This 
thesis did not however investigate this further due to time limitation.  
 
  
6.3.5 Comparison between Water Content and MT Ratio 
Profiles  
 
The mean MT ratio and water content estimates for all the brain regions 
investigated in this chapter are summarised in Table 6.10. 
 
 
Brain region MT ratio ± SD (%) Water content ± SD (mol/kg)
Frontal 28.83 ± 8.16 40.06 ± 7.84 
Parietal 29.01 ± 6.33 35.69 ± 5.73 
Occipital 29.50 ± 7.91 36.18 ± 7.71 
Left hippocampus 20.61 ± 5.98 37.34 ± 8.02 
Right hippocampus 21.55 ± 5.69 36.24 ± 13.93 
 
Table 6.10: Comparison between MT ratio and water content estimates by region of 
interest 
 
 
 
WM is high in myelin sheaths [186] which promote the MT effect [178, 186] and 
so the MT ratios were observed to decrease with decreasing amount of WM 
tissue within the selected ROI. Thus in decreasing order of WM tissue 
content/MT ratios, Table 6.10 shows that: occipital > parietal > frontal > right 
hippocampus > left hippocampus. The predominantly GM brain regions (i.e. 
frontal and hippocampal regions) have comparatively less MT effects.   
 
GM water content is reported to be slightly higher than that of WM [49, 58, 
59]. Therefore, the predominantly GM brain regions will have more tissue-
bound water than the WM regions. Table 6.10 thus indicates decreasing amount 
of tissue water contents from the GM to WM structures; i.e. frontal WC > left 
hippocampal WC > right hippocampal WC > occipital WC > parietal WC. 
 
The variations of both MT ratios and water contents were not significant (p > 
0.05) across the brain regions studied. Estimation of MT ratio does not require 
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any correction (but its reproducibility is affected by flip angle settings and 
variation in the B0 field [1]) as compared to estimation of tissue water content. 
It is therefore easier and less time consuming to conduct an MT imaging study. 
The comparison of the two datasets in this section indicates that if both 
techniques are done on the same subjects, the MT ratio variation could be used 
to validate the tissue water distribution profile across the same brain regions. 
 
6.4 Summary and Conclusions 
   
 
The first objective of the work presented in this chapter was to develop an MRS 
technique for the accurate quantification of brain tissue water content. The 
technique employs similar corrections (to those in the literature) to the 
unsuppressed-water signal using a comprehensive mathematical model that 
yields the water content value. The novelty of the technique lies in the use of 
the in vivo voxel coordinates to deduce a reference signal. In addition to this, 
the unsuppressed-water signal is also obtained from a water-suppressed 
acquisition, and a straightforward correction factor is included in the model to 
account for T1 and partial recovery losses, simultaneously. Therefore, the 
developed method is applicable to any water-suppressed acquisition from any 
voxel position within the eight-channel head coil. The limitation of its use in 
this thesis was the use of measured T2 relaxation times in a different sample to 
correct the water signal for T2 relaxation effects. Most studies in the literature 
have corrected for relaxation times in the same way; the study by Brief et al 
[58] is an example. This is a common practice since it is inherently impractical 
to perform both relaxation and water content measurements in any single 
volunteer, simultaneously. In this thesis, the CoVs in the T1 and T2 estimates 
did not exceed 10 % among the subjects; therefore an error of not more than 
this could have been introduced into the water content estimates.  
 
Following the development of the tissue water quantification technique, the 
second objective in this chapter was to assess the variation in the quantified 
tissue water content across the brain. The brain regions (from two separate 
studies) assessed included the frontal, parietal, occipital, left and right 
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hippocampi. Aside from the hippocampi, all other regions were studied only in 
the left brain hemisphere due to lack of data for the right hemisphere. 
Generally, grey matter (GM) water content was found to be higher (though not 
significantly) than white matter (WM) water content, in agreement with the 
findings of previous studies. Water content (WC) was found to vary significantly 
in both tissue types across the brain, with frontal GM WC > parietal GM WC > 
occipital GM WC and frontal WM WC > occipital WM WC > parietal WM WC. The 
left and right hippocampal water contents were not significantly different. The 
mean water contents did not vary significantly among all the brain regions. 
Water contents in the frontal, parietal and occipital regions also did not vary 
significantly between males and females; there was no data for hippocampal 
water content in females. Water content by tissue type (and mean WC) in all 
the brain regions did not vary with age in both males and females; but was 
influenced by the amount of each tissue type in the voxel. 
 
Assessment of the variation in regional brain tissue water content was 
conducted using the one-way ANOVA test. This was done by putting together 
the water content results from two studies: frontal, parietal and occipital WC 
from one study, and left and right hippocampal WC from another. Combining 
two different datasets from two separate studies investigating different brain 
regions could introduce some degree of uncertainty arising from inter-subject 
variability in the ANOVA results. With the developed technique in this thesis, it 
is possible for future studies to measure water content in all the brain regions 
in the same subject within tolerable scan times.  
 
The last objective in this chapter was to use MT imaging to assess the variation 
in the MT effect arising from tissue-bound water. This was to enable the 
comparison of the variations in brain tissue water content and the MT effect in 
the same brain regions. In the MT imaging study, it was possible to study all the 
brain regions that should have ideally been studied in the MRS studies. Thus, 
bilateral MT effects, expressed as MT ratios (MTR), were measured in the 
frontal, parietal, occipital, left and right hippocampi. Even though there is 
evidence of regional/anatomical variation of MT ratios in the normal adult 
brain [180, 181], and physiological age-related variation in MT ratios [178, 
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179], this thesis did not find variation in the MTRs among the brain regions, and 
between the left and right brain hemispheres in those regions. MTR did not also 
vary significantly with age and among males and females separately. MTR did 
not also vary in those brain regions between males and females except for 
mean hippocampal MTR which was significantly higher (p = 0.047) in females. 
This however could not be confirmed for the water content in the hippocampus 
as no female was studied for hippocampal water content. The female group 
comprised of a relatively young population compared to the male group. There 
is evidence for high myelin content in the younger brain [178], and myelin has 
high amounts of galactocerebrosides which enhance the MT effect, as reflected 
by high MT ratios. The sample size for the MT study was however small and the 
influence of random errors (arising from subject-specific bias) on this 
significant finding cannot be ruled out. Future studies would have to study a 
larger sample size of males and females of comparable age groups. This will 
minimise any possible age and sample size related effects on the findings.  
  
Comparison of the MTRs and tissue water contents indicated the same pattern 
of variation across the brain, and the same associations with age. Both 
quantities were fairly uniformly distributed across the brain regions 
investigated, and did not vary with age. However, they were not measured in 
any one volunteer at the same time and this could be a limitation in the 
comparison as the regions of interest did not necessarily contain the same 
relative amounts of GM/WM. At best, the ROIs for the MT imaging study were 
carefully selected using the structural scans from the MRS studies as a guide. 
This minimised substantial mismatch between each MT image ROI and its 
corresponding MRS voxel position. 
 
Finally, the findings of the work presented in this chapter are particularly in 
support of the suitability of tissue water as a concentration reference for 
quantifying cerebral metabolites. The results in this chapter suggest that 
cerebral water content does not appear to vary substantially with age, gender 
and brain region. However, there could be significant variations in the water 
contents between grey and white matter tissues. The water content 
208 
 
quantification technique presented will make it more convenient and rapid to 
quantify the metabolites relative to endogenous tissue water content.       
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Chapter 7: Brain Tissue Water and Metabolite 
Concentrations in Psoriasis 
 
 
 
7.1 Introduction 
 
Inflammation is a defensive mechanism of the human body against harmful 
agents. The inflammatory process could however sometimes lead to a harmful 
condition known as auto-immune disease. Common auto-immune diseases 
include multiple sclerosis and arthritis. Two forms of arthritis are mostly 
studied by MRS in the literature: rheumatoid (in the joints, affecting synovial 
fluid) and psoriatic (mostly on the skin, causing plaques) arthritis. Whereas 
multiple sclerosis directly affects the brain, arthritis affects peripheral organs 
of the human body.  
 
It has been reported that cerebral water content could increase by at least 12% 
[154] with associated changes in the levels of cerebral metabolites [187-189] in 
multiple sclerosis compared to the normal brain. There is also evidence of the 
involvement of the human brain even in peripheral inflammation, where the 
brain is not directly involved. MRS studies of rheumatoid arthritis [190, 191], 
and at least one study of psoriatic arthritis [191], have also reported changes in 
the levels of cerebral metabolites (reported in ratio units). No MRS or any brain 
imaging study has reported changes in the levels of water either in the brain or 
any part of the body in either forms of arthritis.  
 
In the healthy population, significant changes in the levels of water in body 
tissue has been reported to be associated with behavioural/mood and 
performance changes [34, 37]. Similarly, the inflammatory condition is also 
believed to be associated with behavioural/mood changes in the affected 
persons [192-194]. MRS brain studies investigating the relationship between 
mood and cerebral metabolite changes in multiple sclerosis, psoriatic and 
rheumatoid arthritis have previously been conducted. The most commonly 
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studied metabolites in these studies of inflammation (i.e. multiple sclerosis, 
psoriatic and rheumatoid arthritis) were NAA, Cho, Cr, Glu and mI. Mood 
changes have been found to be associated with changes in mI and Glu, 
particularly [195]. However, no previous MRS brain study has studied the 
relationship between mood and cerebral water changes in any one of these 
inflammatory conditions.  
 
In this chapter, the impact of the peripheral inflammatory condition, psoriatic 
arthritis on the absolute concentrations of cerebral water and the metabolites 
(i.e. the notable ones above: NAA, Cr, Cho, mI and Glu) will be investigated, 
simultaneously. Secondly, the effects of the possible changes in brain 
metabolism (i.e. changes in water and metabolites) on mood will also be 
explored. Compared to the previous studies, the above investigations are novel 
since they involved the simultaneous measurements of the absolute 
concentrations (rather than ratios) of cerebral water and the metabolites in 
psoriatic arthritis for the first time. Investigation of the mood-water content 
relationship in psoriatic arthritis has also not been done previously.   
 
Specific brain regions are believed to be primarily adapted to mood control 
(e.g. the prefrontal and hippocampal regions). Therefore, the MRS voxel 
positions were prescribed in the prefrontal grey matter (GM) and bilateral 
hippocampi. The prefrontal voxel contained predominantly grey matter (mean 
± SD = 86 % ± 7), and so the estimated metabolite and water concentrations 
were considered to be for grey matter (excluding white matter and CSF). The 
hippocampus is a predominantly grey matter brain structure, and so localising 
the MRS voxel in the predominantly grey region would make it appropriate to 
conduct an exploratory analysis of the regional (i.e. in the prefrontal GM and 
hippocampi) variation in the concentrations of the cerebral metabolites and 
water. Inclusion of the small amount of white matter tissue in the estimates of 
the prefrontal concentrations would rather yield an average for the two tissue 
types, and it would then not be appropriate to conduct the required 
exploratory analysis. It is important to mention that, the voxel tissue contents 
of the previous studies of the above inflammatory conditions were 
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predominantly white matter; thus, the work presented here is unique regarding 
the brain tissue type studied. 
 
Cerebral water and creatine (Cr) have been used as endogenous references in 
absolute quantitative MRS. Variation in cerebral water content with age, 
gender and brain region was investigated in chapter 6 in order to test whether 
its concentration remains the same with these variables. The work in this 
chapter thus also tests the variations in the cerebral concentrations of Cr and 
water with age, gender and brain region in order to compare the two for their 
stability with these variables. In fact, NAA [196] and Cho [197] are also 
sometimes used as denominators for expressing metabolite ratios. For this 
reason, NAA and Cho were also included in the above exploratory analysis.  
 
Before describing the work in this chapter in detail, it would be helpful to 
provide some background to the cause and progression of inflammation 
(section 7.1.1.1), and how the brain is implicated in the inflammatory process 
(section 7.1.1.2). One of the treatment options of the condition is the use of 
anti-inflammatory medication, which tries to reverse the inflammatory 
process. Thus, a discussion of the role of anti-inflammatory therapy on brain 
chemistry and the consequence of this effect on mood is also presented 
(section 7.1.1.3). Finally, this background section concludes with a brief 
discussion on what MRS can offer in the studies of inflammation, and the 
objectives of this chapter (7.1.2). 
 
     
7.1.1 Brain involvement in Psoriasis 
  
7.1.1.1 Pathogenesis of Inflammatory Disease 
    
 
The immune system (through vascular tissues) of the body offers complex 
biological mechanisms to protect it from various disease causing agents known 
as pathogens, as well as other potential harmful substances such as damaged 
cells or irritants. This immune response mechanism of the body is known as 
inflammation. The primary purpose of the inflammatory mechanism is to 
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remove the injurious agent and initiate a healing process for the tissue. 
Inflammation is not necessarily an infection but can be caused by an infectious 
pathogen [198, 199].  
 
In some cases, the immune system of the body inappropriately triggers the 
inflammatory response in the absence of the harmful agent. This is known as 
auto-immune response, and it results in the release of white blood cell 
chemicals that otherwise become harmful to the tissues of the body. The initial 
inflammatory response increases the movement of plasma and leukocytes from 
the blood into the injured tissues; this is known as acute inflammation. A 
cascade of biochemical events may occur and translate the acute response into 
chronic inflammation which progressively changes the type of cells within the 
site of the inflammation [200]. Chronic inflammation is characterised by the 
simultaneous destruction and healing of tissues, which can result in a host of 
diseases including rheumatoid (RA) and psoriatic (PsA) arthritis [199-201]. The 
chronic inflammatory, non-contagious autoimmune disease of focus in this 
thesis is psoriatic arthritis (PsA).  
 
Psoriasis commonly causes red, scaly patches to appear on the skin and joints. 
The scaly patches, called psoriatic plaques, are areas of inflammation and 
excessive skin production (which results in the rapid accumulation of skin, 
silvery-white in appearance, at these sites). Common occurrences of plaques 
are on the (extensor) skin of the elbows and knees, but can affect any part of 
the body including the scalp, fingernails and genitals. Psoriatic inflammation 
(or plaques) of the joint is what is known as psoriatic arthritis. The symptoms 
vary among different patients, and may also go through various cycles in a 
patient. The cause of PsA is not clear but it is believed to have a genetic 
component; and is likely to be aggravated in affected individuals by stress, 
smoking, excessive alcoholism and withdrawal of systemic corticosteroid [192, 
202]. Due to its chronic recurrent nature, PsA is difficult to treat despite the 
availability of a number of treatment options [191]. 
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7.1.1.2 Involvement of the Central Nervous System in 
Inflammatory Disease 
   
Apart from immune cells, non-immune cells such as epithelial cells, endothelial 
cells and fibroblasts also contribute to inflammatory processes [199]. 
Inflammatory pathways and their target tissues vary widely depending on the 
nature of stimulants. In the presence of bacterial infection, the immune cells 
through specific receptors immediately sense pathogens. Activation of 
pathogen-specific receptors induces the production of inflammatory mediators 
such as inflammatory cytokines [e.g. tumor necrosis factor (TNF), interleukin-1 
(IL-1) and interleukin-6 (IL-6)] and chemokines. These mediators rapidly 
accelerate the progression of inflammation by modifying the permeability of 
vascular endothelial tissues; they also direct neutrophils and excess plasma 
into the site of infection. At the same time, the invading pathogens are 
targeted and destroyed by the immune cells [192, 199].  
 
In most cases, inflammatory responses extend toward systemic effects through 
the excessive production of pro-inflammatory cytokines, which mediate the 
secretion of acute phase proteins by the liver cells [199]. These proteins, in 
turn, induce brain endothelium and facilitate the production of prostaglandins, 
which are primarily responsible for the onset of symptoms (e.g. psoriatic 
arthritis) through their effects on the central nervous system. 
   
 
7.1.1.3 Effect of Anti-inflammatory Therapy on Brain 
Chemistry and Mood 
     
In peripheral disease, such as PsA, animal studies [203, 204] have shown that 
peripheral immune cells access the brain through humoral and/or neural 
routes, resulting in central neural changes and associated behavioural 
alterations. TNF-α (a pro-inflammatory cytokine) signalling was implicated as 
the prerequisite for this peripheral-CNS communication process to occur [199, 
203, 204]. This peripheral cytokine (TNF-α) stimulates microglia to produce the 
harmful protein molecules that access the brain through a number of ways 
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including crossing the blood brain barrier [192, 193]. There is also an indication 
[189, 205] that during the inflammatory process, the CNS might attempt to 
reduce neuroinflammation by conducting some water-soluble proteins out of 
the brain to the site of inflammation; thus increasing the levels of cerebral 
water, which could possibly result in edema [205]. Chronic inflammation may 
arise where this defensive function of the brain has been compromised.  
Therefore, any form of anti-TNF-α therapy targeted at inhibiting microglial 
activation or blocking the receptors of microglia could reverse the 
communication pathway between the CNS and the periphery, and reduce the 
physiological and behavioural impacts of peripheral inflammation [192-194]. 
 
The inflammatory-related physiological changes in the CNS have been reported 
by brain imaging studies (including fMRI [206], PET [207] and SPECT [208]) to 
be associated with under-activation of the forebrain structures (notably the 
dorsolateral prefrontal and anterior cingulate cortices) and over-activation of 
the limbic structures (notably the hippocampus, amygdala, insula and 
thalamus). This activation pattern has been shown by various 1H-MRS studies to 
correlate with changes in brain chemistry in these brain regions [209-213].The 
consequence of these physiological alterations in these brain regions might 
explain the associated behavioural changes over time.  
    
   
7.1.2 The Role of MRS in Studies of Inflammation and 
Objectives 
   
In section 7.1.1, it can be inferred that inflammation has a molecular basis 
which involves initial biochemical processes at the cell level. Even though 
inflammation may affect peripheral organs, the involvement of the brain in the 
disease process could have implications for normal cerebral metabolism. Thus, 
subtle biochemical changes may occur in the brain, but may not be visible on a 
normal MRI of the affected individual. MRS is relatively sensitive [1] at 
recording the minute inflammation-related biochemical changes before the 
effects of the disease are manifested on a macroscopic scale on MRI.    
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The previous section has also indicated that as a chronic inflammatory 
condition, psoriatic arthritis can be treated by an anti-TNF-α medication that 
acts to reverse the communication pattern between the mood-regulating brain 
regions and the peripheral inflammation sites, and possibly impact on mood as 
a result. In this thesis, therefore, psoriatic arthritis patients received an 
intravenous injection of anti-inflammatory/anti-TNF-α medication, and MRS of 
their prefrontal and hippocampal brain regions were studied to observe 
changes in their neurochemistry (i.e. cerebral water and metabolites), and 
associated mood changes.       
 
The objectives of this chapter were to: 
 
1. Develop a method to quantify cerebral metabolites using an optimised 
endogenous water signal from the same MRS acquisition; 
2. Quantify changes (from normal and with anti-inflammatory medication) in 
prefrontal and hippocampal metabolite and water concentrations in 
psoriatic arthritis (PsA) patients; 
3. Investigate possible associations between metabolite concentrations as 
measured by MRS and mood assessment outcomes in medicated PsA 
patients; 
4. Assess the variation in regional water and metabolite concentrations in 
the brains of PsA patients and healthy controls.  
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7.2 Methods 
   
7.2.1 Subjects, Mood Assessment, MRI/MRS and Voxel 
Placement 
 
7.2.1.1 Recruitment of study volunteers and their 
characteristics 
 
The patient group in this study were recruited in the context of another study 
that was not part of this thesis. This patient group comprised of subjects 
diagnosed with psoriatic arthritis (PsA) and were attending the Rheumatology 
departments of NHS Greater Glasgow and Clyde Hospitals. Prior to study entry, 
no patient was receiving the Etanercept medication as a treatment for 
psoriatic arthritis. On study entry, they received the medication only after 
their first (or baseline) MRS scans. Etanercept is a TNF-α blockade medication 
for inflammatory conditions, including PsA. The study and the exact procedure 
participants went through were described to prospective PsA volunteers and 
only those who gave prior written consent participated in the study. The 
control group was recruited for the study in this thesis, specifically. Ethical 
issues about the study and eligibility screening of the study volunteers were 
discussed in section 2.3.5. 
 
Each group of the controls and patients comprised of 8 males and 8 females. 
The controls/patients did not vary significantly in mean age (SD): 38.9 
(11.9)/45.9 (9.9) years, p = 0.068. There were no significant mean age (SD) 
differences between males/females in the patient (46.3 (10.3)/45.0 (10.8) 
years, p = 0.816) and control (37.1 (12.9)/36.1 (11.2) years, p = 0.871) groups. 
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7.2.1.2 Medication and Mood Assessment of the 
Psoriasis Patients 
 
The patients had an MRS scan prior to taking the Etanercept medication (given 
intravenously), followed by 6-8 weeks of the medication, and another MRS scan 
post-medication. The Beck’s Depression Inventory (BDI), a self-assessment 
mood questionnaire, was answered by each patient before each one of the MRS 
scan sessions (i.e. at pre- and post-medications).  
 
The BDI (Appendix 7.1) is a 21-item questionnaire, each item comprising of four 
questions arranged in worsening order of mood condition that are scored from 
0 to 3. For all 21 questions, the volunteer marks the score corresponding to 
their present mood condition and then sums up all the scores for each one of 
the 21 questions by counting the marked scores. If the participant scores 3 on 
all twenty-one questions, then the highest total for the entire test will be 63; 
and the lowest possible score will be 0 if they scored 0 on each one of the 
twenty-one questions. When the total depression score is evaluated, the level 
of depression in the individual can be interpreted according to Table 7.1.    
 
 
Total BDI score Level of depression 
1-10                                              These ups and downs are considered normal 
11-16                  Mild mood disturbance 
17-20                  Borderline clinical depression 
21-30                  Moderate depression 
31-40                  Severe depression 
Over 40                  Extreme depression 
 
 
   Table 7.1: Interpretation of the Beck’s Depression Inventory 
 
 
A persistent score of 17 or above indicates that the patient requires some 
medical attention. 
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7.2.1.3 MRI/MRS Protocol and Voxel Placements 
 
The MRI protocol consisted of T1-weighted FLAIR sagittal and T2-weighted FSE 
propeller axial scans, each with the following acquisition parameters: TR = 
25000 ms, FOV = 24 x 24 cm2, 21 oblique slices parallel to the hippocampus, 
each of slice thickness 4 mm with no slice gaps. A high resolution T1-weighted 
IR-FSPGR 3D axial MRI (TR/TE/TI = 6.9/1.6/920 ms, matrix size = 320 x 160 x 4) 
was also acquired for the purpose of partial volume correction (section 5.2.4).   
 
All MRS acquisitions were performed using the PRESS localisation sequence with 
CHESS water suppression, NSA = 128, and NEX = 8. 
 
Spectra were acquired from the prefrontal brain region (Figure 7.1) using 
TE/TR = 35/2000 ms. The VOI was adjusted for the brain size of each subject, 
and positioned in the dorso-ventral region of the anterior cingulate cortex, 
covering sections of both halves of the prefrontal brain, just next to the frontal 
region of the corpus callosum. The VOI sizes therefore ranged between 8.0 and 
14.5 mL, and covered predominantly grey matter tissue. The voxel position in 
the prefrontal brain region is also known as the anterior cingulate cortex 
(ACC).  
 
 
 
                                         
     Figure 7.1: Voxel placement in the prefrontal brain (ACC). 
     The images are shown in the sagittal (a) and axial (b) views 
 
 
Spectra from the right (Figure 7.2a) and left (Figure 7.2b) hippocampi were 
acquired using TE/TR = 144/2000 ms. Rectangular voxels were adjusted for the 
(a) (b) 
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brain size of each subject, and planned with the longest dimension along the 
axis of the hippocampus, starting just posterior to the amygdala. The VOI sizes 
ranged between 5.3 and 13.2 mL.  
 
 
 
 
Figure 7.2: Voxel placement in the right (a) and left (b) hippocampi of the same volunteer 
 
 
 
Voxels were carefully positioned to avoid artifacts in the spectra arising from 
the nasal cavity and CSF around the hippocampi. The voxels were varied for 
the ACC and hippocampal brain regions due to differences in brain sizes of the 
volunteers. The use of varying voxel sizes in the same MRS study is not new as 
it has been done previously [214]. However, correction for the varying voxel 
sizes were performed in the calculation of the concentrations of water and 
metabolites using the VOIbrain (equation 6.1) and ftissue (equation 7.2) correction 
terms, respectively. 
 
The long TE of 144 ms was used for the MRS of the hippocampi in order to 
eliminate potential signal contributions from CSF and lipids surrounding the 
hippocampi, a situation which is relatively minimal in the prefrontal region. 
Therefore, it was possible to measure all the metabolites of interest (i.e. NAA, 
Cr, Cho, mI and Glu; section 7.1) in the prefrontal region, whereas only NAA, 
Cr and Cho were those measured from the hippocampal regions. In fact, these 
were the main metabolites of interest in the hippocampal region; they were 
required for the regional variation exploratory analysis (section 7.1). 
Therefore, the TE values of 35 ms and 144 ms were appropriate for the studies 
reported in this chapter.   
(a) (b) 
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7.2.2 Data Analysis 
  
7.2.2.1 Calculation and Interpretation of Changes in BDI 
Scores 
  
For the patient group, the percentage changes in the BDI scores (%∆ BDI) 
between baseline (BDIpre) and post-medication (BDIpost) mood scores were 
calculated according to: 
 
 
%∆ BDI = [(BDIpost – BDIpre)/BDIpre] x 100 %                                          (Eq. 7.1) 
 
 
From equation 7.1, a negative value of %∆ BDI corresponds to a reduction in 
the BDI score post-medication, indicating an improved mood condition; a 
positive %∆ BDI value on the other hand means a worsened mood condition 
post-medication.                
 
 
7.2.2.2 Calculation of Tissue Water and Metabolite 
Concentrations 
  
MR spectra were analysed as described in sections 2.3.1.2-3: spectral peak 
areas of water (Abrain) and metabolites (AMet) were derived from the 16/NEX and 
NSA/NEX lines, respectively (equation 2.19). Both prefrontal and hippocampal 
MRS acquisitions were performed using NEX = 8 and NSA = 128; therefore Abrain 
and AMet resulted from 2 and 16 spectral lines, respectively.  
 
Tissue water content was calculated according to equation 6.3, and expressed 
in the units of mol/kg wet weight. Brain metabolite concentrations were 
calculated according to the following equation: 
 
 
 
                                                                                                   (Eq. 7.2) 
 
 
 
[Met]  = 
AMet 
Abrain x kpr 
R2_brain 
RT_Met 
2 
NMet 
1 
ftissue 
55 510 mM/L x x x x 
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In equation 7.2, for a given metabolite, [Met] is the metabolite concentration 
in mM/L, AMet is the spectral peak area of the metabolite, NMet is the number of 
protons contributing to the spectral peak of the metabolite (NAA: 3, Cr: 3, 
Cho: 9, mI: 4, Glu: 2 [31]), the constant value of 2 is the number of protons 
contributing to the water peak area, and RT_Met is the correction factor 
accounting for both T1 and T2 relaxation effects in the metabolite signal from 
the ACC and hippocampal regions (section 5.3.2). Abrain is the spectral peak 
area of the in vivo unsuppressed-water signal from the acquisition of AMet, kpr is 
the compensation factor for the fractional water signal loss due to partial 
recovery and T1 relaxation effects together (section 5.3.3) in Abrain, R2_brain is 
the correction factor for T2 relaxation effects in Abrain (section 5.3.2), ftissue is 
the voxel tissue fraction (section 5.2.4), and 55 510 mM/L is the concentration 
of pure water. 
 
Note that the actual total voxel tissue contents should contain both GM and 
WM, so that 1/ftissue would be replaced by (1/fGM + 1/fWM), and [Met] would be 
concentration attributable to the two tissue types, [Met]GM + [Met]WM. 
However, this thesis ignores the small fraction of WM in the voxel (mean ±SD = 
7 % ±3), leaving only the metabolite (and water) concentrations in the required 
GM tissue, [Met]GM (section 7.1). This was done for the prefrontal voxels; for 
the hippocampal voxels, 1/ftissue was the whole hippocampal tissue within the 
voxel (since the hippocampus is a GM structure). By ignoring the prefrontal 
WM, this thesis does not assume that the prefrontal voxel contained only GM 
tissue but only did so for a purpose (see section 7.1). Due to the GM/WM tissue 
mix in the brain, it is inherently impractical that the voxel can contain 
exclusively one tissue type. Most MRS studies [22, 58, 190, 215], including the 
work in this chapter, typically prescribe the voxel in a region where one of the 
tissue types is predominant, so that concentrations would be reported as 
though they were from one tissue type.  
     
According to equation 7.2, the concentration of the metabolite, [Met] is 
expressed in mM/L. However, this was further converted to mM/kg wet weight 
by dividing the result in equation 7.2 by the density of pure water at 37 oC 
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(which is 0.9934 g/mL). This unit conversion was done in order to express both 
water and metabolite concentrations in similar units, referenced to tissue 
water density. 
 
 
7.2.2.3 Estimation of Changes in Water and Metabolite 
Concentrations in the Patients 
 
In the patient group, percentage changes in water and metabolite 
concentrations (%∆ C) between baseline (Cpre) and post-medication (Cpost) 
concentrations were calculated from: 
 
 
%∆ C = [(Cpost – Cpre)/Cpre] x 100 %                                                        (Eq. 7.3) 
 
 
According to equation 7.3, if there is a concentration increase post-
medication, %∆ C will have a positive value; a concentration decrease post-
medication will yield a negative %∆ C value. 
 
 
 
7.3 Results and Discussion 
    
  
The results discussed in this section are presented in four subsections: 
assessment of the mood changes in the psoriasis patients between baseline and 
follow up (section 7.3.1), comparison of the concentrations of cerebral water 
and metabolites between PsA patients and controls in the prefrontal (section 
7.3.2) and hippocampal (section 7.3.3) brain regions, and assessment of the 
regional variation in cerebral water and metabolite concentrations in PsA 
patients and controls (section 7.3.4).     
    
 
7.3.1 Mood Assessment Outcomes in Psoriatic Patients 
   
 
The BDI mood assessment (BDIpre) of the 16 psoriatic arthritis patients prior to 
the Etanercept medication indicated that 7 were normal, 5 had mild mood 
disturbances, 3 were moderately depressed and only 1 patient was on the 
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borderline of clinical depression (only those 4 patients in the last two groups 
could be considered depressed). After medication, percentage changes in BDI 
scores (%∆ BDI) showed that the mood conditions of 10 patients improved. Of 
these 10 patients, 6 were initially normal, 2 had mild mood disturbances, 1 
each was on borderline depression and moderately depressed. Only one patient 
(who was initially moderately depressed) was on borderline depression post-
medication; the other nine patients were all normal post-medication.  
 
The BDI scores of four patients rather increased post-medication, indicating 
worsened mood conditions. Of these four, 2 each had mild mood disturbances 
and moderate depression pre-medication. Following medication, the two 
patients who were moderately depressed were still moderately depressed, 
while the other two patients who were mildly depressed were now moderately 
depressed (representing a worsened mood condition). 
 
One patient had mild mood disturbances initially, and still maintained the same 
mood condition (with the same BDI score at pre- and post-medication). Another 
patient who was normal at pre-medication could not be followed up for post-
medication BDI assessment – this patient dropped out of the study.  
 
Putting together all those patients who took the BDI assessment at baseline and 
follow up, there was an average mood improvement (i.e. BDI decrease) of 
about 9.92 ± 0.34 % (BDIpre = 12.8 ± 1.8; BDIpost = 11.5 ± 2.5); values are means 
± SE. This average percentage change in BDI was however not significant (p = 
0.864).  
 
 
7.3.1.1 Gender differences in BDI scores 
 
Table 7.2 shows the sex-age distribution of the psoriatic arthritis patients, with 
their respective BDI scores at baseline (BDIpre), post-medication (BDIpost) and 
percentage changes in BDI scores (%∆ BDI). Only identifiers (e.g. p01, p02, etc) 
are used to represent the patients’ names, consistent with the ethical 
provisions of the study.   
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Prior to the anti-inflammatory medication, the mood conditions of the 8 males 
(M) and 8 females (F) by gender were (BDI scores are given as M/F): normal = 
5/2, mild mood disturbances = 2/3, borderline clinical depression = 0/1, and 
moderate depression = 1/2. At post-medication, one male dropped out leaving 
a male/female distribution of M/F = 7/8 with the following mood scores (given 
as M/F): normal = 5/4, mild mood disturbances = 0/1, borderline clinical 
depression = 0/1, and moderate depression = 1/2 (diagnosis were done 
according to Table 7.1). Overall, more females showed worse mood conditions 
than males. This is consistent with observations made previously that 
depression is more common among women compared to men [190, 216, 217], 
and so some authors have identified the female gender as a co-morbid 
diagnosis of depression [218]. However, post-medication, the percentage 
change (SD) in the BDI scores between males (-16.3 (12) %) and females (-20.8 
(21) %) were not significantly different (p = 0.857). Both sexes showed 
improved mood conditions but females responded better to mood improvement 
than did males (but the mean response, %∆ BDI did not reach statistical 
significance). Indeed, this finding is in agreement with the observation made 
elsewhere [217] that the antidepressant effect of some antidepressants is 
faster in women. This implies that the anti-inflammatory medication may as 
well have this antidepressant effect that is manifested more among the 
females in this study.   
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Table 7.2: Patients age-sex distribution and mood scores at baseline and post-medication. 
Negative values are reductions in BDI, positive values are increases in BDI, ∆BDI is the 
percentage change in BDI between pre-medication mood scores (BDIpre) and post-medication 
mood scores (BDIpost); *patient dropped out of study 
 
  
Those patients who were identified to be depressed according to the BDI 
questionnaire were not further assessed for clinical depression (i.e. major 
depressive disorder) using either one of the Structured Clinical Interview for 
DSM-III-R-patient version (SCID-P) [219] or the 17-item Hamilton Rating Scale 
for Depression (HRSD) [220] criteria. This was because the current study was 
not aimed at looking at clinical depression specifically but was aimed at 
assessing mood changes associated with the pathogenesis and treatment of 
peripheral inflammation (psoriatic arthritis in this case). The BDI assessment 
was therefore thought to be sufficient for this purpose, and which happens to 
identify clinical depression as well. Moreover, all 21 BDI items have been 
reported to be relatively sensitive at picking up depressive symptoms [221]. 
Patient Sex Age (years) BDIpre BDIpost ∆BDI (%) 
p01* M 38 2 - - 
p02 F 49 17 3 -82.4 
p03 M 36 16 22 37.5 
p04 F 33 2 1 -50.0 
p05 F 34 11 4 -63.6 
p06 M 56 5 2 -60.0 
p07 M 34 22 23 4.6 
p08 F 62 16 16 0 
p09 M 49 9 6 -33.3 
p10 F 49 7 5 -28.6 
p11 M 42 14 10 -28.6 
p12 M 53 5 4 -20.0 
p13 F 47 25 29 16.0 
p14 M 31 7 6 -14.3 
p15 F 56 23 18 -21.7 
p16 F 32 13 24 84.6 
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7.3.1.2 Association between age and BDI Scores 
 
The mood scores were positively, but not strongly, correlated with age at 
baseline (r = 0.107, p = 0.692) and follow up (r = 0.177, p = 0.529). Age 
contributed to only about 15.8 % of the variance in the change in BDI scores, 
and so the correlation (Figure 7.3) between age and %∆ BDI was weak and not 
significant (ρ = 0.397, p = 0.160).     
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Figure 7.3: Correlation between change in mood scores and age in the patient group 
 
 
 
7.3.2 MRS of the Prefrontal Brain 
 
 
7.3.2.1 Assessment of prefrontal voxel GM/WM tissue 
contents 
 
The mean (SE) ACC voxel tissue contents were not significantly different 
between controls and patients at baseline (0.75 (0.07) vs. 0.82 (0.07); p = 
0.479), controls and patients post-medication (0.75 (0.06) vs.0.85 (0.07); p = 
227 
 
0.283), and patients at pre- and post-medication (0.80 (0.08) vs. 0.85 (0.07); p 
= 0.658).  
 
Mean (SE) ACC voxel tissue contents also did not vary significantly between 
males/females in the control (0.74 (0.10)/0.75 (0.11); p = 0.923) and patient 
groups at baseline (0.90 (0.08)/0.72 (0.12); p = 0.234) and post-medication 
(0.89 (0.10)/0.82 (0.10); p = 0.628). There was neither significant difference 
between males in the control vs. patient groups nor females in the two groups 
compared, both at baseline and follow up (p > 0.05). Since there were no 
significant differences in the voxel tissue contents, any group differences or 
changes between baseline and follow up in the tissue water and metabolite 
concentrations could not have been due to substantial variations in the voxel 
tissue contents.  
   
 
7.3.2.2 Tissue Water Content in Psoriatic versus Healthy 
Subjects 
   
One patient dropped out and two MRS acquisitions post-medication were of 
poor quality. Therefore, data for 13 subjects could be analysed at follow up. In 
order to have equal sample sizes (to that in the post-medication group) at 
baseline and in the control group, data for 13 subjects (7M/6F) were used in 
the final analysis. The individual value plots (red dots) comparing the tissue 
water values of all subjects in the control, pre-medication and post-medication 
groups are shown in Figure 7.4. The mean tissue water content in each group is 
shown by the blue dots. 
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Figure 7.4: Individual value plots comparing the tissue water contents in the prefrontal 
brains of healthy subjects and psoriatic patients before and after anti-inflammatory 
medication. 
The red dots represent water contents of individual subjects (n = 13 in each group), the blue 
dots are the mean water contents for each group, and the blue bars are the 95 % confidence 
intervals of the mean values 
 
 
The mean tissue water content (SE) in the: controls was 37.0 (2.8), patients at 
pre-medication was 39.0 (3.0) and post-medication was 42.72 (2.5) mol/kg wet 
weight. The difference in mean tissue water contents was not significant 
between controls and patients pre-medication (p = 0.629), between controls 
and patients post-medication (p = 0.141). Pre- and post-medication mean 
water contents were not also significantly different (p = 0.352). Indeed, all the 
95 % confidence intervals of the mean tissue water values for the three groups 
shown in Figure 7.4 are overlapping. There is thus no significant difference in 
the three means.   
 
 
7.3.2.2.1 Gender differences in prefrontal water content in controls and 
patients 
 
In the control group, the mean tissue water content (SE) in males (39.0 (3.8) 
mol/kg wet weight) and females (38.5 (5.4) mol/kg wet weight) were not 
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different (p = 0.941). Male/female patients did not also show significant 
differences in mean tissue water contents (SE) in mol/kg wet weight at 
baseline (45.3 (3.1)/36.8 (6.1); p = 0.245) and follow up (46.0 (4.4)/42.2 (4.7); 
p = 0.564). 
 
Among male PsA patients alone, baseline (45.3 (3.1) mol/kg wet weight) and 
follow up (46.0 (4.4) mol/kg wet weight) mean tissue water contents (SE) did 
not vary significantly (p = 0.961). Females also did not show significant 
difference (p = 0.430) in mean water content (SE) between baseline (36.8 (6.1) 
mol/kg wet weight) and follow up (42.2 (4.7) mol/kg wet weight).  
 
Mean water contents (SE) in mol/kg wet weight between controls/patients at 
baseline were not significantly different in males (39.0 (3.8)/45.3 (3.1); p = 
0.222) and females (38.5 (5.4)/36.8 (6.1); p = 0.837). Following medication, 
the differences in the mean water contents (SE) in mol/kg wet weight between 
controls/post-medicated patients were still not significant in males (39.0 
(3.8)/46.0 (4.4); p = 0.251) and females (38.5 (5.4)/42.2 (4.7); p = 0.618). 
Thus, the percentage changes in tissue water content were not found to be 
significant in both male and female patients considered separately (p > 0.05 in 
each case), and also in the two sexes compared (p = 0.315). 
 
 
7.3.2.2.2 Association between age and prefrontal tissue water content in 
controls and patients 
 
There was no strong correlation between ACC tissue water content and age in 
the control (r = 0.119, p = 0.648) and patient groups at baseline (r = 0.025, p = 
0.933) and post-medication (r = 0.056, p = 0.850). Similarly, the association 
between age and change (between pre- and post-medication) in ACC tissue 
water content was weak   (ρ = 0.281, p = 0.659). Age was therefore not 
expected to be a mediator of any group differences in water content, as well 
as water content changes following medication. The positive, but weak, 
correlation of age with water content however indicates that prefrontal brain 
tissue water content increases slightly with healthy ageing.  
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7.3.2.2.3 Link between changes in prefrontal tissue water content and mood 
in psoriasis 
 
Figure 7.5 shows the fitted line plot for percentage changes in mood and tissue 
water content in the patient group. Along the %∆ BDI axis, most of the plotted 
points (red dots) fall below the zero mark, indicating that most patients 
improved in mood post-medication. Most (8/14) points along the %∆ water 
content on the other hand fall almost along the zero mark, indicating that 
tissue water content did not change much with medication in most patients. 
Both parameters however did not change significantly, and the small increase 
in water content was not necessarily linked to significant improvement in 
mood.  
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Figure 7.5: Correlation between percentage changes in mood scores and tissue water 
contents in the PsA patients 
 
   
The mood scores of patients at baseline (r = -0.031, p = 0.916) and follow up    
(r = -0.326, p = 0.287) were both inversely correlated with the tissue water 
contents at the respective stages. The inverse correlations meant that a higher 
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tissue water content is associated with a lower BDI score (i.e. better mood or 
lesser depression). The percentage changes in BDI scores and tissue water 
content were positively correlated (ρ = 0.321, p = 0.482). Thus, a greater 
change in water content was associated with a greater change in mood scores, 
in the same direction (i.e. either both are increasing or decreasing, 
simultaneously). From the spearman’s correlation coefficient (ρ = 0.321), 
change in tissue water content contributes about 10.3 % to the change in mood 
scores. However, all the correlations deduced in these cases were weak (as 
shown by the r and ρ values) and not significant (p > 0.05 in each case).  
 
 
7.3.2.3 Metabolite Concentrations in Psoriatic versus 
Healthy Subjects 
  
 
The mean concentrations of the five quantified metabolites are compared 
between controls and patients (at baseline and follow up) in Table 7.3. The 
mean concentrations are for males and females combined in each group. 
Separate comparisons of the mean concentrations between males and females 
in each group are shown in Table 7.4. A sample size of 13 (7M/6F) was used in 
all those comparisons for the same reason as discussed in the first paragraph of 
section 7.3.2.2.    
 
  
 
 
 
Metabolite 
Mean concentration (SE) in mM/kg P-values for group comparisons 
Controls      
(C) 
Pre-
medication 
(Pr)                        
Post-
medication 
(Po)
C vs. Pr C vs. Po Pr vs. Po 
NAA 10.42 (0.49) 9.45 (0.35) 9.51 (0.46) 0.121 0.187 0.882 
Cr 7.78 (0.38) 6.34 (0.38) 6.69 (0.25) 0.014 0.027 0.274 
Cho 1.83 (0.11) 2.03 (0.10) 1.94 (0.05) 0.170 0.371 0.110 
Glu 9.38 (0.32) 8.93 (0.45) 9.05 (0.71) 0.432 0.681 0.800 
mI 7.66 (0.55) 6.05 (0.62) 5.87 (0.78) 0.063 0.078 0.322 
 
Table 7.3: Comparison of the quantified metabolite concentrations between controls and 
patients at baseline and post-medication 
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Metabolite 
Mean Concentration (SE)/mMkg-1 in Males/Females; p-value 
Controls Pre-medication Post-medication 
NAA 9.65 (0.72)/11.19 (0.59)   
p = 0.121 
9.27 (0.35)/9.66 (0.66)     
p = 0.619 
9.93(0.82)/9.01 (0.27)    
p = 0.327 
Cr 7.64 (0.75)/7.90 (0.35)    
p = 0.763              
6.03 (0.56)/6.66 (0.53)  
p = 0.433 
6.45 (0.29)/6.97 (0.42)  
p = 0.335 
Cho 1.73 (0.14)/1.96 (0.17)    
p = 0.311 
2.17 (0.11)/1.89 (0.15)  
p = 0.166 
2.02 (0.04)/1.85 (0.10)  
p = 0.156 
Glu 8.71 (0.37)/9.65 (0.36)    
p = 0.330 
9.18 (0.55)/8.64 (0.79)  
p = 0.596 
8.32 (0.47)/9.78 (1.3)    
p = 0.348 
mI 7.46 (0.70)/7.94 (0.96)    
p = 0.693 
6.54 (0.95)/5.63 (0.84)  
p = 0.487 
6.33 (1.10)/5.32 (1.20)  
p = 0.548 
 
Table 7.4: Comparison of the mean metabolite concentrations between males and females in 
the control and patient groups at baseline and post-medication 
 
 
 
In Table 7.3, concentrations of all the metabolites were lower in patients 
compared to the controls, both at baseline and post-medication; only choline 
(Cho) was slightly higher in patients than in controls at baseline and post-
medication. However, none of these differences reached statistical significance 
(p > 0.05) except for creatine, Cr (see below). The decrease in myo-inositol 
(mI) concentration in the patients (relative to controls) almost reached 
significance at baseline (p = 0.063) and follow up (p = 0.078). Only the 
concentration of Cr was significantly lower in the patients compared to the 
controls at baseline (p = 0.014) and post-medication (p = 0.027). Following 
medication, the concentrations of all the metabolites increased slightly except 
those of mI and Cho which were slightly decreased. No metabolite 
concentration was significantly different between pre- and post medication (p 
> 0.05). 
 
 
 
7.3.2.3.1 Gender differences in prefrontal metabolite concentrations in 
controls and patients 
 
There were no gender differences in all the metabolite concentrations among 
controls, patients at baseline and post-medication (Table 7.4). This meant that 
the patterns of metabolite changes in the ACC region resulting from PsA were 
similar in both males and females. In the control group, all the metabolites 
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were slightly higher in females than in males; but none of the differences was 
statistically significant (p > 0.05). However, there was no specific trend in 
metabolite level differences between males and females in the patient group, 
both at baseline and post-medication. 
  
 
7.3.2.3.2 Association between age and prefrontal metabolite concentrations 
in controls and patients 
 
In the control group, age and each one of the NAA (r = -0.130, p = 0.631), Cr (r 
= -0.143, p = 0.611), Glu (r = -0.354, p = 0.259), and mI (r = -0.142, p = 0.628) 
concentrations were inversely correlated. Only the concentration of Cho was 
positively correlated with age (r = 0.240, p = 0.430) in the controls. However, 
none of these correlations was significant (p > 0.05 in each case). Nonetheless, 
the results indicate that in the control group, to some extent, healthy ageing is 
associated with decreased levels of NAA, Cr, Glu and mI; but increased levels 
of Cho in the prefrontal brain.  
 
In the PsA patient group, age was inversely correlated with changes in the 
concentrations of NAA (r = -0.258, p = 0.443), Cr (r = -0.297, p = 0.348), and 
Cho (r = -0.036, p = 0.911); but was positively correlated with changes in the 
concentrations of Glu (r = 0.377, p = 0.317) and mI (r = 0.465, p = 0.207). None 
of the correlations was however found to be significant (p > 0.05 in each case) 
but indicated that given the Etanercept medication, older PsA patients are 
more likely to show smaller changes in the concentrations of NAA, Cr and Cho 
compared to younger patients; whereas the reverse is true for changes in Glu 
and mI concentrations.   
 
 
 
7.3.2.3.3 Link between changes in prefrontal metabolite concentrations and 
mood in psoriasis 
 
Percentage changes in the concentrations of NAA (r = -0.538, p = 0.088) and Cr 
(r = -0.436, p = 0.156) were inversely correlated with percentage changes in 
BDI scores. The percentage changes in the concentrations of Cho (r = 0.381, p = 
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0.222), Glu (r = 0.203, p = 0.601) and mI (r = 0.516, p = 0.155) were positively 
correlated with percentage changes in patient BDI scores.  
 
Even though none of the associations appeared significant, the association with 
change in NAA concentration was rather strong and almost reached statistical 
significance. NAA is a neuronal marker and the percentage change observed in 
this study might not necessarily mean neuronal death but rather neuronal 
dysfunction. Thus, the correlation analysis may be suggesting that a substantial 
change in the way neurones function (manifested in %∆ NAA) due to PsA could 
be linked to very small changes in mood following anti-inflammatory 
medication. However, further studies on a larger sample size of PsA patients 
may be required to ascertain this observation.  
   
 
7.3.3 MRS of the Hippocampus 
 
7.3.3.1 Assessment of the left and right hippocampal 
voxel tissue contents 
 
For the left hippocampus, the mean voxel tissue fractions (SE) were not 
significantly different in the following comparisons: patients at pre-
medication/post-medication (0.71 (0.01)/0.72 (0.02); p = 0.765), 
controls/patients at baseline (0.74 (0.02)/0.71 (0.01); p = 0.250), and 
controls/patients post-medication (0.74 (0.02)/0.72 (0.02); p = 0.497). Left 
hippocampal voxel tissue fractions (SE) did not also vary significantly between 
males/females in the pre-medicated (0.71 (0.02)/0.75 (0.02); p = 0.205), post-
medicated (0.72 (0.03)/0.73 (0.03); p = 0.869), and control (0.72 (0.02)/0.75 
(0.02); p = 0.326) groups. Comparison of the males in the control vs. patient 
groups at baseline and follow up did not also show significant differences (p > 
0.05 in each case) in the left hippocampal voxel tissue fractions; the same was 
also true among females.  
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For the right hippocampus, the mean voxel tissue fractions (SE) were not 
significantly different in the following comparisons: patients at pre-
medication/post-medication (0.71 (0.01)/0.73 (0.02); p = 0.515), 
controls/patients at baseline (0.74 (0.02)/0.71 (0.01); p = 0.264), and 
controls/patients post-medication (0.74 (0.02)/0.73 (0.02); p = 0.675). Right 
hippocampal voxel tissue fractions (SE) did not also vary significantly between 
males/females in the pre-medicated (0.71 (0.02)/0.75 (0.02); p = 0.252), post-
medicated (0.72 (0.02)/0.74 (0.02); p = 0.591), and control (0.72 (0.02)/0.75 
(0.02); p = 0.409) groups. Comparison of the males in the control vs. patient 
groups at baseline and follow up did not also show significant differences (p > 
0.05 in each case) in the right hippocampal voxel tissue fractions; the same 
was also true among females.  
 
There was no voxel tissue difference between the left and right hippocampi in 
both groups, and among males and females, separately, in both groups. Thus, 
there was no possibility of significant contributions to any concentration 
differences between groups that could arise from differences in hippocampal 
voxel tissue fractions. 
   
7.3.3.2 Hippocampal Water Content in Psoriatic versus 
Healthy Subjects 
  
For a sample size of 13 subjects in each group (7M/6F), left and right 
hippocampal water contents (Figure 7.6) were not significantly different in the 
control (p = 0.572) and patient groups at baseline (p = 0.102) and post-
medication (p = 0.884).  
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Figure 7.6: Comparison of the mean left and right hippocampal water contents in controls 
and patients at baseline and follow up. 
The error bars represent ±standard deviations of the mean values 
 
 
For the left hippocampus, mean (SE) water contents in mol/kg wet weight did 
not vary significantly between: controls/patients at baseline (35.45 
(1.80)/36.14 (1.60); p = 0.777), controls/patients post-medication (35.45 
(1.80)/37.03 (1.70); p = 0.526), and baseline/post-medication (36.14 
(1.63)/37.03 (1.70); p = 0.747). There were also no significant gender 
differences in left hippocampal water contents in both groups. Water content 
in males was not significantly different between the two groups; this was true 
for females too (p > 0.05). 
 
For the right hippocampus, mean (SE) water contents in mol/kg wet weight 
were not significantly different between: controls/patients at baseline (34.31 
(2.20)/34.06 (1.20); p = 0.921), controls/patients post-medication (34.31 
(2.20)/35.41 (1.60); p = 0.693), and baseline/post-medication (34.06 
(1.21)/35.41 (1.60); p = 0.590). There were no significant variation in right 
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hippocampal water contents between males and females in either group, and 
among males (and females too) compared between the two groups (p > 0.05). 
 
 
 
7.3.3.2.1 Association between age and hippocampal water content in 
controls and patients 
 
Hippocampal water content did not vary with age in either group, and among 
males or females in each group. Changes in both left (r = 0.159, p = 0.621) and 
right (r = 0.188, p = 0.580) hippocampal water contents were not associated 
with age in the patient group. Controls did not also show an association 
between age and hippocampal water contents in both left (r = 0.131, p = 
0.654) and right (r = 0.169, p = 0.547) hippocampi. The correlation analyses 
however indicated a tendency of small increments and more changes in 
hippocampal tissue water content with age in both groups and with 
medication, respectively. 
 
 
7.3.3.2.2 Link between changes in hippocampal water content and mood in 
psoriasis 
 
Percentage changes in the left (r = 0.370, p = 0.193) and right (r = 0.508, p = 
0.134) hippocampal water contents were positively but not significantly 
correlated with percentage changes in BDI scores. These correlations were not 
different between males and females. The correlation for the right 
hippocampus was rather stronger even with the fewer data points of n = 13 
(which could have possibly contributed to the non-significance of the 
correlation analysis). The results thus suggest that compared to the left, 
changes in the right hippocampal water content might be more associated with 
mood changes. 
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7.3.3.3 Hippocampal Metabolite Concentrations in 
Psoriatic versus Healthy Subjects 
 
At the echo time (TE) of the MRS acquisition in the hippocampi, only three 
metabolites (NAA, Cr and Cho) were reliably detected and quantified. This 
section thus compares the concentrations of these metabolites in the left 
(Tables 7.5 and 7.6) and right (Tables 7.7 and 7.8) hippocampi between 
patients and controls, and between baseline and post-medication in the patient 
group. 
 
 
 
 
 
Metabolite 
Mean concentration (SE) in mM/kg P-values for group comparisons 
Controls      
(C) 
Pre-
medication 
(Pr)                        
Post-
medication 
(Po)
C vs. Pr C vs. Po Pr vs. Po 
NAA 7.61 (0.45) 7.98 (0.47) 8.01 (0.56) 0.578 0.588 0.631 
Cr 6.54 (0.42) 6.24 (0.43) 6.32 (0.43) 0.622 0.724 0.826 
Cho 1.71 (0.10) 1.71 (0.14) 1.41 (0.13) 0.993 0.099 0.086 
 
Table 7.5: Comparison of the left hippocampal metabolite concentrations between controls 
and patients at baseline and post-medication 
 
 
 
 
Metabolite 
Mean Concentration (SE)/mMkg-1 in Males/Females; p-value 
Controls Pre-medication Post-medication 
NAA 7.72 (0.57)/7.46 (0.78)  
p = 0.798 
7.84 (0.52)/8.07 (0.74)  
p = 0.807 
8.22 (0.97)/7.74 (0.51)  
p = 0.675 
Cr 6.65 (0.52)/6.37 (0.77)    
p = 0.770 
6.09 (0.54)/6.44 (0.76)  
p = 0.722 
6.27 (0.58)/6.41 (0.78)  
p = 0.893 
Cho 1.77 (0.12)/1.62 (0.19)    
p = 0.499 
1.75 (0.23)/1.66 (0.18)  
p = 0.754 
1.45 (0.10)/1.74 (0.16)  
p = 0.065 
 
Table 7.6: Comparison of the left hippocampal metabolite concentrations between males 
and females in the control and patient groups at baseline and post-medication 
 
 
Concentrations of all the three metabolites in the left hippocampus did not 
vary significantly between patients at baseline and controls, and between post-
medication and controls (Table 7.5). Whereas both NAA and Cho were slightly 
higher, Cr was slightly lower in patients at baseline. At post-medication, while 
Cr and Cho were slightly lower, NAA was slightly higher in patients. Only Cho 
reduced considerably with medication but this change did not reach statistical 
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significance (p = 0.086). Gender-specific analyses (Table 7.6) showed that this 
considerable reduction in Cho concentration post-medication occurred in males 
(from 1.75 to 1.45 mM/kg); females on the other hand showed slight increase 
in Cho (from 1.66 to 1.74 mM/kg) with medication. This might therefore 
explain the almost significant difference (p = 0.065) in Cho concentration 
between males and females post-medication (Table 7.6). 
 
However, none of the three metabolite concentrations varied significantly 
between controls and patients, both at baseline and post-medication in the 
right hippocampus (Table 7.7). Pre- and post-medication concentrations were 
not also significantly different for any metabolite. Gender-specific analyses did 
not also show significant difference in any metabolite concentration between 
males and females in either group (Table 7.8). 
 
 
 
 
 
 
Metabolite 
Mean concentration (SE) in mM/kg P-values for group comparisons 
Controls      
(C) 
Pre-
medication 
(Pr)                        
Post-
medication 
(Po)
C vs. Pr C vs. Po Pr vs. Po 
NAA 8.08 (0.64) 8.23 (0.25) 8.45 (0.45) 0.833 0.640 0.547 
Cr 6.59 (0.25) 6.81 (0.19) 6.18 (0.35) 0.502 0.366 0.421 
Cho 1.55 (0.13) 1.58 (0.24) 1.48 (0.13) 0.922 0.674 0.610 
 
Table 7.7: Comparison of the right hippocampal metabolite concentrations between controls 
and patients at baseline and post-medication 
 
 
 
Metabolite 
Mean Concentration (SE)/mMkg-1 in Males/Females; p-value 
Controls Pre-medication Post-medication 
NAA 8.06 (0.82)/8.10 (1.20)    
p = 0.981 
8.65 (0.88)/8.09 (0.23)  
p = 0.649 
9.09 (1.20)/8.07 (0.17)  
p = 0.488 
Cr 6.89 (0.33)/6.10 (0.29)    
p = 0.103 
6.60 (0.19)/6.91 (0.28)  
p = 0.431 
5.78 (0.39)/6.43 (0.51)  
p = 0.356 
Cho 1.53 (0.19)/1.59 (0.20)    
p = 0.854 
1.73 (0.49)/1.52 (0.30)  
p = 0.781 
1.53 (0.20)/1.44 (0.18)  
p = 0.750 
 
Table 7.8: Comparison of the right hippocampal metabolite concentrations between males 
and females in the control and patient groups at baseline and post-medication 
 
 
 
In controls, NAA (p = 0.875), Cr (p = 0.966) and Cho (p = 0.255) concentrations 
in the left and right hippocampi were not significantly different. At baseline, 
patients did not also show significant differences in NAA (p = 0.167), Cr (p = 
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0.298) and Cho (p = 0.466) concentrations in the two hippocampi.  Post-
medication concentrations of NAA (0.731), Cr (0.714) and Cho (0.642) did not 
also differ between the two hippocampi. Percentage changes in NAA (p = 
0.923), Cr (p = 0.625) and Cho (p = 0.777) concentrations were also not 
different between the left and right hippocampi. The bilaterality of the 
concentrations of the metabolites (and their percentage changes) in the two 
hippocampi was the same in males and females, considered separately, in each 
group.  
 
 
7.3.3.3.1 Association between age and hippocampal metabolite 
concentrations in controls and patients 
 
In the controls, age was positively correlated with the concentrations of NAA (r 
= 0.326, p = 0.236), Cr (r = 0.629, p = 0.028) and Cho (r = 0.401, p = 0.155) in 
the left hippocampus; but was inversely correlated with NAA (r = -0.202, p = 
0.576) and Cr (r = -0.112, p = 0.717) concentrations in the right hippocampus; 
only Cho was positively correlated with age (r = 0.011, p = 0.969) in the right 
hippocampus. However, only the age-Cr concentration direct relationship in 
the left hippocampus was both strong (r = 0.629) and significant (p = 0.028). 
This suggests that the concentration of Cr increases gradually with normal 
ageing, in some brain regions (the left hippocampus in this case). In fact, this 
finding agrees with previous reports that cerebral Cr increases with age [1, 65].   
 
In the PsA patients, age was found to be inversely related to percentage 
changes in NAA (left: r = -0.444, p = 0.318; right: r = -0.250, p = 0.633), Cr 
(left: r = -0.010, p = 0.981; right: r = -0.214, p = 0.729) and Cho (left: r =          
-0.005, p = 0.993; right: r = -0.021, p = 0.973) concentrations in both left and 
right hippocampi.  
 
 
7.3.3.3.2 Link between changes in hippocampal metabolite concentrations 
and mood in psoriasis 
 
Percentage change in BDI scores was positively correlated with percentage 
changes in the concentrations of Cr (r = 0.219, p = 0.603) and Cho (r = 0.256, p 
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= 0.624) in the left (only %∆ NAA concentration was inversely correlated with 
%∆ BDI (r = -0.812, p = 0.027) in the left hippocampus); but was inversely 
correlated with percentage changes in the concentrations of NAA (r = -0.115, p 
= 0.828) and Cr (r = -0.062, p = 0.921) in the right hippocampus (only %∆ Cho 
was positively correlated with %∆ BDI (r = 0.331, p = 0.586) in the right 
hippocampus). However, only the %∆ BDI-%∆ NAA concentration inverse 
association in the left hippocampus was both strong (r = -0.812) and significant 
(p = 0.027).  
  
 
7.3.4 Variation in Cerebral Water and Metabolite 
Concentrations 
 
Four spectra were quantifiable in the ACC and hippocampal voxel positions, at 
the same time; these were the water, NAA, Cr and Cho spectra. To assess their 
variation across the three voxel positions, one-way ANOVA tests were 
performed for each one of the water and metabolite concentrations (in the 
ACC, left and right hippocampi) in the controls and patients (both at baseline 
and post-medication). Particularly for the tissue water content in the control 
group, the results will show whether or not prefrontal and hippocampal water 
contents vary significantly; thus corroborating or otherwise the accuracy of the 
deductions made in chapter 6 when the hippocampal and hemispheric water 
contents were combined in a similar ANOVA test. Data for an equal number of 
males and females totalling a sample size of 12 (6M/6F) was used in the ANOVA 
tests in the following subsections. 
 
 
7.3.4.1 Regional variation in cerebral water contents in 
controls and patients 
 
Table 7.9 shows the variation of water content among the three regions (i.e. 
prefrontal GM, left and right hippocampi). The comparisons are done for the 
control and patient groups using the one-way ANOVA test.  
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Subjects 
Mean water content ± SD (mol/kg wet weight)  
p-value Prefrontal GM Left hippocampus Right hippocampus 
Controls 35.87 ± 9.65 35.90 ± 4.90 34.31 ± 6.99 0.863 
PsA-1 36.64 ± 11.07 37.20 ± 6.52 34.06 ± 3.84 0.631 
PsA-2 41.92 ± 10.10 35.83 ± 6.08 35.41 ± 5.05 0.107 
 
Table 7.9: Regional water contents in the three voxel positions compared in controls and 
patients. 
PsA-1 and PsA-2 represent the psoriatic arthritis patients at baseline and post-medication, 
respectively; SD is the standard deviation of the mean. Note that these abbreviations have also 
been used Tables 7.10-12  
 
 
The p-values shown in Table 7.9 indicated that water content did not vary 
significantly among the three brain regions in both controls and patients (at 
baseline and post-medication).  
 
 
7.3.4.2 Regional variation in cerebral NAA 
concentrations in controls and patients 
 
The assessment of regional NAA concentrations (Table 7.10) showed that 
regional concentration of NAA varied significantly in the patients at baseline (p 
= 0.012); post-medication concentrations however did not vary significantly in 
the three regions (p = 0.164). Controls did not show significant variation in the 
three regions (p = 0.089). Prefrontal GM NAA concentration however was 
consistently higher in both groups, and almost reached statistical significance 
in the controls while being significantly higher in the patients at baseline.   
 
 
 
Subjects 
Mean NAA concentration ± SD (mM/kg wet weight)  
p-value Prefrontal GM Left hippocampus Right hippocampus 
Controls 9.75 ± 1.76 7.93 ± 2.08 8.08 ± 2.04 0.089 
PsA-1 10.10 ± 1.49 8.29 ± 1.48 8.23 ± 0.71 0.012 
PsA-2 9.58 ± 1.54 8.14 ± 1.74 8.45 ± 1.27 0.164 
 
Table 7.10: Regional NAA concentrations in the three voxel positions compared in controls 
and patients 
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7.3.4.3 Regional variation in cerebral Cr concentrations 
in controls and patients 
 
Regional Cr concentration was not found to vary significantly in both controls 
and patients (at baseline and post-medication), as shown in Table 7.11. 
  
 
Subjects 
Mean Cr concentration ± SD (mM/kg wet weight)  
p-value Prefrontal GM Left hippocampus Right hippocampus 
Controls 7.38 ± 1.25 6.65 ± 1.58 6.62 ± 0.90 0.337 
PsA-1 6.06 ± 1.09 6.57 ± 1.63 6.81 ± 0.48 0.538 
PsA-2 6.71 ± 0.82 6.10 ± 1.14 6.35 ± 0.95 0.520 
 
Table 7.11: Regional Cr concentrations in the three voxel positions compared in controls 
and patients 
 
 
 
7.3.4.4 Regional variation in cerebral Cho 
concentrations in controls and patients 
 
The results in Table 7.12 show that regional Cho concentration did not vary 
significantly in controls (p = 0.315) and patients at baseline (p = 0.218); post-
medication Cho concentrations however were found to vary significantly (p = 
0.009). Prefrontal Cho concentration was consistently higher in all cases. 
  
 
Subjects 
Mean Cho concentration ± SD (mM/kg wet weight)  
p-value Prefrontal GM Left hippocampus Right hippocampus 
Controls 1.87 ± 0.29 1.67 ± 0.42 1.59 ± 0.51 0.315 
PsA-1 2.00 ± 0.22 1.54 ± 0.43 1.71 ± 0.58 0.218 
PsA-2 2.02 ± 0.20 1.55 ± 0.43 1.47 ± 0.36 0.009 
 
Table 7.12: Regional Cho concentrations in the three voxel positions compared in controls 
and patients 
 
 
 
 
244 
 
7.4 Comparison with the existing peer reviewed 
literature 
  
This section discusses the key findings presented in section 7.3 in relation to 
published results. Three main themes are discussed: results for cerebral water 
(section 7.4.1) and metabolites (7.4.2), and the assessment of their 
distributions (section 7.4.3) in the three voxel positions in this chapter. 
Discussion of the mood assessment outcomes in the patient group in relation to 
the literature was dealt with in section 7.3.1.   
   
   
7.4.1 Cerebral Water Content 
   
 
The tissue water quantification technique developed in this thesis references 
the unsuppressed-water signal to an estimated in vitro signal obtained from 
the same voxel position (details in chapter 6). The technique offers a unique 
opportunity of obtaining both the unsuppressed-water and metabolite spectra, 
simultaneously, within clinical scan times compared to a previous technique 
[222]. In their method, Dreher and Leibfritz [222] implemented a two-scan 
method without water suppression involving a short echo time (TE = 18 ms) 
PRESS localisation sequence. Prior to the standard single-voxel PRESS 
localisation sequence, two scans are implanted: the first is a chemical shift 
inversion pulse being turned off, and the next is another inversion pulse being 
turned on, both yielding the time domain (TD) datasets SA and SB, respectively. 
The 180o inversion pulses, followed by spoiler gradient pulses, invert 
magnetisation within the spectral range where metabolite signals are expected 
either upfield or downfield relative to water. The water signal remains 
unaffected by both inversion pulses and so, together with its associated 
gradient-induced sidebands, it appears in the same way in both TD signals and 
the corresponding frequency domain spectra. Thus, the signal difference SA-SB 
yields the metabolite signals (while the water signal and the gradient-induced 
artifact signals are significantly reduced); and the signal sum SA+SB yields the 
water signal, which may be used for referencing in absolute metabolite 
quantification.  
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The method by Dreher and Leibfritz [222] and that in this thesis both do not 
require extra adjustments in spectral acquisition or sophisticated data post-
processing, and scale favourably with increasing B0 field. However, compared 
to the method in this thesis, the disadvantage of the two-step method 
implemented by Dreher and Leibfritz [222] is that it doubles the minimum total 
measurement time. The study by Dreher and Leibfritz [222] however did not 
quantify cerebral water content. 
 
Christiansen et al [61] quantified brain tissue water content by acquiring the 
unsuppressed-water signal and referencing it to a signal acquired from an 
external water bag. In a group of healthy subjects aged 10-70 years, they 
estimated cerebral water content in the range of 35.8-39.6 (mean 36.9) mol/kg 
wet weight for four brain regions: frontal, temporal, occipital and basal 
ganglia, selecting predominantly GM and WM tissues in separate cases. They 
did not find significant variation in water content among the four regions, 
tissue types or with age, similar to the findings in this thesis (the same 
observation was true even in the psoriasis group, and when compared to 
controls). By relating signal intensities from selected ROIs in MR images and 
relating them to fractional brain water content (βMR), Brooks et al [177] did not 
also find a significant association between age and βMR in the frontal brain. No 
other study reported gender differences in brain tissue water content. 
 
Compared to controls, cerebral water content in the psoriasis patients was 
higher in the prefrontal (by 5.41 ± 0.71 %) and left hippocampal (by 1.95 ± 0.11 
%) regions, but lower in the right hippocampal (by 0.73 ± 0.45 %) region. After 
receiving the Etanercept medication, the psoriasis patients showed percentage 
increases in cerebral water contents by 7.54 ± 2.16 % (males: 4.55 ± 1.30 %; 
females: 8.67 ± 3.43 %) in the prefrontal, 2.46 ± 0.63 % (males: 1.83 ± 0.17 %; 
females: 1.97 ± 0.18 %) in the left, and 3.96 ± 0.52 % (males: 1.89 ± 0.22 %; 
females: 2.04 ± 0.21 %) in the right hippocampal regions. After medication, 
water content increased more in females than in males for all regions. These 
increases were observed to be associated (but not significantly) with small 
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improvement in mood for all three regions but the association in the right 
hippocampus was the strongest (r = 0.508, p = 0.134).   
 
The increase in cerebral water content post-medication could imply that 
psoriasis, even though being peripheral, may be associated with dehydration of 
brain tissue. Chronic dehydration even as little as 2.2-3.0 % of body mass, as a 
consequence of psoriasis, could affect brain structure on a macroscopic level 
(e.g. expansion of the ventricular system [37, 223]). This study however did not 
incorporate measurement of intracranial volumes with the MRS measurements 
as has been done by Wilkinson et al [197] or the volumes of the regions 
studied. Structural brain changes due to dehydration may have various 
implications depending on the degree of water deficit [224]. However, notable 
consequences are that water loss slows down visual-motor tracking, 
psychomotor processing speed and reduces attention/memory performance 
[34, 37]; and dehydration of up to 10 % could be life threatening [225]. 
However, not all studies (including this thesis) have found behavioural/mood 
effects in the reported range of 2-3 % dehydration [37]. On average, the 
psoriasis patients in this thesis had cerebral water contents well within the 
normal range. This might explain why most of them did not have low mood 
according to their BDI scores. 
    
       
7.4.2 Cerebral Metabolite Concentrations 
 
  
Metabolite concentrations in this thesis were calculated by referencing their 
signals to the in vivo unsuppressed-water signal obtained within the same 
acquisition and voxel position. The estimated absolute concentrations for the 
healthy controls were comparable with those (matched for age) in the 
literature for the prefrontal [62, 210, 226, 227] and hippocampal [175, 226, 
227] regions. All the metabolite concentrations in the investigated voxel 
regions for both patients and controls were also within the published normal 
ranges [65]. In the prefrontal region, healthy females were found to have 
higher concentrations of all the quantified metabolites (NAA: 15.95 %, Cr: 3.40 
%, Cho: 13.29 %, Glu: 10.79 %, and mI: 6.43 %) than their male counterparts. In 
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the left hippocampus, female controls had lower NAA (by 3.38 %), Cr (by 4.21 
%) and Cho (by 8.47 %). In the right hippocampus, female controls had higher 
NAA (by 0.50 %) and Cho (by 2.56 %) but lower Cr (by 11.47 %). None of these 
metabolite concentration differences was found to be statistically significant 
between the two sexes. The pattern of gender differences on the other hand 
was not consistent among patients pre- and post-medication, probably due to 
the presence of psoriasis. 
 
Sex-dependent cerebral metabolite concentrations however appears to be 
contradictory. While Wilkinson et al [197] observed significantly higher and 
lower NAA/Cho and Cho/Cr ratios respectively in females than in males in the 
parieto-occipital WM, Komoroski et al [228] did not find significant difference 
in Cho/Cr and mI/Cr ratios in any one of the basal ganglia, frontal, temporal, 
thalamus and hippocampus. However both studies did not find significant 
difference between both sexes in NAA/Cr ratio whereas this thesis did not find 
significant difference in the absolute concentrations of all the metabolites.     
 
In the control group, none of the metabolites was found to vary significantly 
with age in the prefrontal region. These weak associations however showed 
tendencies towards increase in only Cho but decrease in all other metabolites; 
in particular, age-dependent decrease in frontal lobe NAA is reported 
elsewhere [177]. However, in the left hippocampus, only Cr concentration was 
found to increase significantly with age (r = 0.629, p = 0.028). Variations in 
metabolite concentrations were not associated with age in the right 
hippocampus. Apart from the significant increase in left hippocampal Cr with 
age, all other age-metabolite concentration associations in this thesis were 
comparable to those reported by Saunders et al [229]. There is however an 
indication that these associations may vary by brain region [230].  
 
In the PsA patients, neither age nor gender had additional effect on response 
to the treatment. However, metabolite changes were inversely (but not 
strongly or significantly) correlated with age in both left and right hippocampi; 
associations in the prefrontal region were not consistent. Changes in NAA and 
mI were strongly (but not significantly) negatively and positively, respectively, 
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associated with mood in the prefrontal region. Only change in NAA in the left 
hippocampus was negatively and significantly correlated with mood (r = -0.81, 
p = 0.03). There were no strong or significant associations between metabolite 
and mood changes in the right hippocampus. The significant association in the 
left hippocampus appears to agree with previous reports that the left 
hemisphere of the brain may play a role in the pathogenesis of mood-related 
conditions [209, 231].      
 
In the prefrontal region, compared to controls, the psoriasis patients had lower 
mean percentage ± SE NAA (by 9.31 ± 0.29 %), Cr (by 18.51 ± 1.19%), Glu (by 
4.8 ± 0.41 %) and mI (by 21.02 ± 1.27 %); only Cho was higher (10.93 ± 1.50 %). 
Following the anti-inflammatory medication, NAA, Cr and Glu were increased 
by 0.63 (0.31) %, 5.52 (0.34) % and 1.34 (0.58) %, respectively; Cho and mI 
were decreased by 4.43 (0.50) % and 2.98 (0.26) %, respectively. In the left 
hippocampus of the psoriasis patients, compared to controls, NAA and Cho 
were higher (by 4.86 ± 0.04 % and 8.19 ± 0.40 %, respectively) while Cr was 
lower (by 4.59 ± 0.02 %). With medication, NAA and Cr levels were increased by 
0.38 ± 0.19 % and 1.28 ± 0.10 %, while Cho was decreased by 17.54 ± 0.77 %. In 
the right hippocampus, patients showed a relatively higher NAA (by 1.86 ± 0.61 
%), Cr (by 3.34 ± 0.32 %) and Cho (by 1.90 ± 0.46 %) levels. Post-medication, Cr 
and Cho levels were reduced (by 9.25 ± 0.84 % and 6.76 ± 0.46, respectively) 
while NAA was increased (by 2.67 ± 0.8 %). Neither the percentage differences 
from normal nor changes post-medication was statistically significant in all 
three regions.  
 
The consistently lower levels of Cr and Glu in this study were directly opposite 
of the three-fold increases of Cr/glycine and Glu/serine ratios in psoriatic 
plaque extracts collected from the skin of PsA patients [232]. Ratios can be 
difficult to interpret regarding which metabolite changed precisely, 
particularly when it is unclear how a particular disease affects the individual 
metabolites. In this case, putting the two results together, it appears that the 
decrease in cerebral Cr and Glu are associated with the increase of the two 
249 
 
metabolites in peripheral tissue, thus suggesting involvement of the brain in 
peripheral inflammation such as psoriasis.   
 
In a previous study [191] of 5 rheumatoid (RA) and 2 psoriatic (PsA) arthritis 
patients on various TNF-α blocking medications including Etanercept (3 
patients were on this), medication was given after the first scan and repeated 
3 days later (24 hours after the time of maximal plasma concentration of 
Etanercept in those patients who took it). MRI examinations focusing on the 
left centrum semiovale included MT imaging, diffusion weighted imaging (DWI) 
and MRS. Neuropsychological tests included global cognitive and executive 
functioning, memory, and attention. The study did not find difference in the 
neuropsychological assessment outcome or visual abnormalities on the MR 
images before and after medication. Apparent Diffusion Coefficient for WM and 
GM and metabolite ratios of NAA/Cho, NAA/Cr and Cho/Cr did not change 
significantly with medication. However, significant decreases of the MTR 
histogram peak heights (MTR-Pht) of WM and GM post-medication were 
observed. The study thus concluded that the observed decrease of MTR-Pht 
post-medication suggested loss of parenchyma integrity; nonetheless, those 
changes were not attributable to inflammation or demyelination according to 
the DWI and MRS results. The decrease of the MTR-Pht was not observed to 
result in decreased cognitive function. 
 
In a separate study of 35 RA patients alone also focusing on the centrum 
semiovale region [190], the patients were on various medications excluding 
Etanercept. The study reported significantly higher and lower Cho/Cr and 
NAA/Cho ratios, respectively in active RA patients (who also had elevated 
erythrocyte sedimentation rates (ESR)) compared to their counterparts who 
had inactive RA and normal ESR. The NAA/Cho and Cho/Cr ratios were 
significantly correlated with ESR but medication use had no additional effect 
on those associations. 
 
It thus appears that even though both RA and PsA are peripheral inflammatory 
diseases, they may have different ways in which they impact neurochemistry: 
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while RA seems to show significant metabolite changes [190], PsA does not 
appear to show significant metabolite changes (based on the findings of this 
thesis and those of Bijl et al [191]). However, unlike multiple sclerosis [233-
235], which involves demyelination of the CNS, both RA and PsA do not appear 
to be associated with significant mood/neuropsychological symptoms.  
 
However, given that only four PsA patients in this study were depressed, a 
separate statistical analysis of the spectral changes for these subjects (not 
shown) indicated that the spectral changes (though not significant) were 
observed to be comparable with some significant findings in previous studies of 
depression [209, 211, 236, 237]. Results from the remainder of the data set did 
not differ significantly from those of the depressed PsA patients. Combining the 
two types of PsA patients (i.e. depressed and non-depressed) still did not yield 
significant results in the spectral changes, even though the average changes in 
some of the metabolite concentrations were comparable with those for 
depression in the literature. For instance, this thesis found elevated Cho 
concentrations in all three voxel positions; significantly higher cerebral Cho 
concentrations in depression have been reported elsewhere [236]. The lower 
prefrontal mI and Cr concentrations found in this thesis can be compared to a 
decreased mI/Cr ratio in depression reported previously [211]. Finally, the 
reduced prefrontal Glu in this study compares with previously [237] observed 
lower concentrations of Glx and GABA in the same brain region. It is therefore 
possible that, depending on the sub-type, depressed PsA patients could show 
similar neurometabolite changes (to specific sub-types of clinically depressed 
patients) with associated neuropsychological/mood symptoms. The non-
depressed state in PsA, on the other hand, may be suggestive that some 
patients could adapt to cope with the body image and self-esteem issues 
associated with the skin disorder [238, 239]. Interestingly, this study found an 
inversely significant association between change in left hippocampal NAA 
concentration and mood in the PsA patients after the anti-TNF-α therapy, in 
agreement with reports that the left brain hemisphere may play a role in mood 
regulation [209].     
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7.4.3 Regional Distribution of Cerebral water and 
Metabolites  
   
The regional assessment results (though for only three brain regions) shown in 
Tables 7.9-12 suggest that water, NAA, Cr and Cho are all uniformly distributed 
between the prefrontal and hippocampal brain regions (predominantly GM 
regions) in healthy subjects. However, prefrontal NAA was slightly higher than 
the hippocampal concentrations; there were no differences in the water and 
metabolite concentrations between the two hippocampi in both groups. In the 
psoriasis patients, prefrontal NAA was significantly higher before medication, 
but normalised post-medication. Prefrontal (compared to hippocampal) Cho 
increased significantly post-medication. Only water and Cr remained uniformly 
distributed in the three voxel positions in both controls and patients at 
baseline and post-medication. From these three predominantly GM regions, 
cerebral water and metabolites (i.e. NAA, Cr and Cho) therefore appear to be 
uniformly distributed (at least for this tissue type) as has been reported 
previously [61, 229].  
 
Water, NAA, Cr and Cho have been used widely to express metabolite ratios in 
studies of several disease conditions such as brain tumors [240, 241], AIDS [29, 
242] and tuberous sclerosis complex [243]. Assessment of regional variation in 
these will have implications for the choice of reference standard in future 
studies. It is however important to mention that the findings from this 
assessment cannot be true in all disease conditions since the metabolite profile 
varies widely among different diseases. At least, it will be informative in 
absolute quantitative MRS studies of peripheral inflammation and similar 
conditions that do not directly affect the brain.   
  
  
7.5 Summary and Conclusions 
 
  
 
The work presented in this chapter was aimed primarily at developing a novel 
technique to absolutely quantify cerebral metabolites by using an optimised 
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unsuppressed-water signal acquired simultaneously with the metabolite signals. 
This was achieved by processing, separately, the unsuppressed-water lines 
from a normal water-suppressed acquisition to yield the water and metabolite 
peaks for absolute quantification involving all the necessary corrections. While 
the cerebral tissue water quantification technique was developed in chapter 6, 
the metabolite quantification technique was developed in this chapter. 
 
The two techniques were then applied in the prefrontal and hippocampal brain 
regions in a group of psoriatic arthritis patients and healthy controls with the 
aims of: quantifying observed changes in the cerebral metabolite and water 
concentrations associated with psoriasis; assessing the association between the 
MRS results and mood outcomes in the psoriasis patients; and examining the 
regional variations in the metabolite and water concentrations in normal brain 
and in psoriasis. Thus, for the first time, absolute quantification of cerebral 
water content in peripheral inflammation, assessment of cerebral water 
content changes with anti-inflammatory medication, and its effect on mood 
have been carried out in this thesis. 
 
The psoriasis patients did not show significant metabolite and water 
concentration differences from the healthy controls. The patients did not also 
show visible abnormalities on their MR images as assessed by a consultant 
neuroradiologist. Variations in all concentrations either in controls or with 
medication were neither age nor gender dependent. The psoriasis-related 
metabolite concentration changes were not associated with mood changes for 
all brain regions studied, in agreement with previous studies. Most of the other 
findings reported in this chapter were comparable with those in the literature. 
However, the only significant and new findings in this chapter were the 
significant association between: higher Cr levels and old age in the left 
hippocampus; and lower BDI scores and higher changes in NAA levels, also in 
the left hippocampus.   
 
 
Despite the success in the implementation of the techniques, the work 
presented in this chapter was not without some limitations.  
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Glu is strongly coupled to Gln and GABA. If not well resolved, then it is possible 
that any attempt to measure any of those metabolites (e.g. measurement of 
prefrontal Glu in this study) will result in contributions from the other two 
metabolites as well. These are best decoupled by post-processing techniques 
involving spectral editing. Spectral editing was not done in this thesis but at 
the TE and TR of the acquisitions, which were performed at 3 T, at least Glu 
and Gln were well resolved. The contribution from GABA alone was therefore 
not expected to be significant. 
 
 
The normal controls were not assessed on the BDI questionnaire and so the 
absence of normal mood scores did not allow for a clear distinction to be made 
between the PsA patients and the controls on the mood scale. Such information 
could also have been useful in identifying the threshold BDI score at which PsA 
could be associated with a significant mood change. Nonetheless, since most of 
the PsA patients did not experience significant mood disturbances, the 
presence of their BDI scores alone was sufficient for the analysis in this 
chapter. Future studies should improve on the quality of the data by including 
the mood scores of controls as well.  
 
Detailed patient clinical information was lacking; these included time since the 
psoriasis symptoms appeared, severity of the condition, blood pressure/heart 
rate, demographics, present medication, smoking/alcoholism frequencies (if 
any), blood markers of inflammation such as erythrocyte sedimentation rate 
(ESR) and/or blood cytokine levels. The presence of these clinical variables 
could have improved the outcomes of the analyses such that even if the MRS 
results did not significantly correlate with any one of the available data (e.g. 
BDI scores, age and gender), there could have been some interesting findings 
with any one of these missing variables. Moreover, any one of these missing 
variables could be a possible confound in the final outcome, which should have 
otherwise been corrected for in the statistical analyses. To increase the 
specificity of the MRS results and make them more meaningful, future studies 
should therefore include these missing variables.  
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Chapter 8: Functional MRS of Brain Tissue Water 
and Metabolites 
 
 
 
 
8.1 Introduction and Objectives 
  
 
In section 1.3.4, the blood oxygen level dependent (BOLD) contrast mechanism 
was discussed. The BOLD signal is generated when an external stimulus causes 
neural activity to increase above baseline physiological state. The new 
physiological state is associated with changes in cerebral blood flow, cerebral 
blood volume and the cerebral metabolic rate of oxygen consumption [244]. 
Consequently, there is an increased flow of oxygenated blood to the region of 
activity, resulting in susceptibility gradients spreading around and away from 
this activation site [245]. With MRI, this susceptibility gradient, associated with 
changes in T2*, can be detected in vessels (intravascular compartment) and 
tissue near the vessels (extravascular compartment). In general, the 
extravascular BOLD effect is desirable for mapping locations of functional 
activation [246], where the effect appears as increased intensity in the pixels 
that coincide with the site of the neural activity. This is known as BOLD 
contrast and the technique is called functional MRI. In the same way, MRS is 
also sensitive to this neural activity. Usually, the BOLD effect in MRS is 
observed as increases in the spectral peak intensities (or height) accompanied 
by decreases in spectral linewidth [246, 247]. This application of MRS is called 
functional MRS (fMRS).   
 
In this chapter, the BOLD effects on the water and metabolite resonances were 
studied by sustained stimulation of the primary visual cortex (V1) of the normal 
human brain. The primary objective was to assess the relative degrees of 
change in the peak areas of water and the metabolites while they responded to 
the stimulus. The water peak has been chosen as the concentration standard in 
this thesis. Therefore, this assessment of relative peak area changes was aimed 
to evaluate the relative consistency (i.e. not changing significantly) or 
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otherwise of the water peak area during the BOLD response. Furthermore, the 
study would provide an understanding of the dynamics of the MRS signal during 
neuroactivation, and hence the implication of this dynamics for cerebral water 
as a reference standard. 
 
For a given duration of stimulation, the time interval between successive lines 
of recorded spectra (defined by the NEX value) determines how many lines will 
be averaged for that acquisition; this is known as the temporal resolution of 
the data in the frequency domain. The only two NEX values available on the MR 
scanner (section 8.1.2.3) were used in two separate acquisitions on three 
healthy volunteers. Thus, the secondary objective of this chapter was to 
compare the BOLD changes observed (in the water and metabolite resonances) 
using these NEX values for any significant difference. The findings of this study 
would explain whether or not NEX could be another source of discrepancy in 
the results of fMRS studies.      
     
 
8.1.1 The Theory of fMRS 
   
  
A localised spin-echo 1H MR Spectroscopy sequence can be used to detect the 
BOLD effect in fMRS [248]. Compared to fMRI, the fMRS technique has a much 
higher SNR because its signal is acquired from a relatively large voxel [246]. It 
is therefore sensitive to subtle BOLD changes in the human brain during sensory 
stimulation [248, 249]. The NMR signal sources of the gradient-echo based fMRI 
and spin-echo based fMRS techniques differ remarkably. In order to make these 
differences clear, it will be useful to initially, and briefly, discuss the relations 
between the FID and spectrum (Fourier transform of the FID). The associations 
between the spectrum parameters and the BOLD origins can then be deduced 
from these FID-spectrum relations.  
 
A spin-echo FID can be defined by three parameters [246]. The first parameter 
is the FID amplitude (AFID) of the first sampling point at the centre of the echo. 
AFID is mainly determined by the transverse relaxation time, T2 and the initial 
magnetisation, Mo as follows [246]:  
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AFID = Mo x exp (-TE/T2)                                                                   (Eq. 8.1) 
 
and assuming there is no contribution from spin exchange, 
 
1/T2 = 1/T2,int + 1/T2,D                                                                      (Eq. 8.2) 
 
where TE is the echo time, T2,int is the intrinsic T2, and T2,D is the component of 
T2 accounting for the contribution of diffusion. Mo is proportional to the proton 
density (ρ) and the NMR signal intensity. 
 
The second parameter of the spin-echo FID is the FID decay rate (1/T2*), 
defined as [246]: 
 
1/T2* = 1/T2 + 1/T2,SS                                                                        (Eq. 8.3) 
 
where T2,SS is the transverse relaxation time related to local static 
susceptibility. However, these effects of field inhomogeneities cancel out in 
the spin-echo experiment; but they occur in gradient-echo fMRI experiments. 
 
The third parameter of the spin-echo FID is the FID integral (IFID), which can be 
determined by both AFID and T2*. In the frequency domain, IFID, AFID and T2* are 
quantitatively correlated to three other NMR parameters: peak height (H), 
linewidth at half peak height (∆υ1/2), and spectral peak area (AS). These 
correlations can be deduced from the following relations [246]: 
 
AS α AFID                                                                                          (Eq. 8.4) 
 
∆υ1/2 = 1/piT2*                                                                                  (Eq. 8.5) 
 
H α IFID                                                                                            (Eq. 8.6) 
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Thus, from a typical MR spectrum that is acquired with the spin-echo pulse 
sequence, information about the following relationships can be deduced: AS 
correlates with changes in T2 and Mo, ∆υ1/2 correlates with changes in T2 and 
T2,SS, and H correlates with all changes in T2, T2,SS, and Mo. With this 
information, the BOLD contributions from various origins can be studied by 
fMRS: neuronal activation increases oxygenated blood supply to neurones; thus, 
Mo increases and manifests as increase in spectral peak height, H and area, As. 
T2* also increases and causes a decrease in ∆υ1/2 [250].   
 
The gradient-echo based fMRI technique on the other hand mainly provides 
information related to the changes in T2 and Mo. This difference in detection 
sensitivity between fMRI and fMRS mainly arises from the fact that the 
susceptibility gradient caused by neural activation produces only a much 
smaller linewidth change (~10 Hz) in fMRS than the frequency width of a single 
pixel  (about several kHz) in fMRI [246].  
 
The contribution of T2,SS to the BOLD signal detected by the gradient-echo 
based fMRI technique is negligible. Thus, the main difference between the fMRI 
and fMRS techniques is that the contributions of both T2 and T2,SS to the BOLD 
effect can be detected simultaneously by fMRS.  
 
To observe the BOLD effects on the water resonance, the CHESS water 
suppression module was switched OFF during the fMRS studies. The BOLD effect 
on the metabolite spectra was recorded by switching ON the CHESS water-
suppression module. Cerebral water is present in the intracellular and 
extracellular spaces, CSF and blood. For this reason, the BOLD effects on both 
intra- and extravascular compartments will contribute to the water signal 
change during the sensory stimulation. On the other hand, the BOLD effects on 
the cerebral metabolites only manifest the susceptibility changes in the 
extravascular tissue compartment [246].   
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8.1.2 Recording the BOLD Effect in MRS 
   
8.1.2.1 The Main Acquisition Parameters 
  
  
The accuracy of the functional MRS measurements largely depends on how 
successful the stimulation period is synchronised with the data acquisition time 
on the MR scanner. This will then make it possible to capture the maximum 
BOLD effect available in the MRS data. In order to achieve this, it is necessary 
to understand the data acquisition schemes implemented on the scanner 
regarding sequence timing. This section therefore discusses the acquisition 
timing parameters of the spectroscopy pulse sequence implemented on the 
scanner, and how this was synchronised to the stimulation period in the fMRS 
experiments. 
 
For a standard MRS acquisition on the GE MR scanner, the total spectral 
acquisition time, Tacq is a function of the repetition time, TR, and number of 
signal averages, NSA. However, before acquisition of the actual MRS data, 
some dummy scans (Ndummy) are collected during which time the scanner starts 
running but no data is stored. This allows some time for the scanner to be 
tuned and the voxel to be shimmed (section 3.2.2.1) prior to data collection. 
The unsuppressed, reference water lines (Nref) and the suppressed, metabolite 
data (NSA) are then collected at the TR set for the acquisition. The total MRS 
acquisition time, Tacq, is thus given by:  
 
Tacq = TR x (Ndummy + Nref + NSA)                                                        (Eq. 8.7) 
 
In all acquisitions on the scanner, Ndummy = 8 and Nref = 16, so (Ndummy + Nref) = 
24. All the fMRS experiments presented in this chapter were performed using 
TR = 3 sec; thus, equation 8.7 can be simplified as: 
 
Tacq = 3 x (24 + NSA)                                                                         (Eq. 8.8) 
 
In order to record the BOLD effect in the MRS data, the stimulus was applied 
for only the duration within which the actual MRS data was being collected, 
259 
 
which is the 3 x NSA part of equation 8.8. Therefore, the duration of visual 
stimulation (Tsti) was given by: 
   
Tsti = Tacq – 72 sec                                                                            (Eq. 8.9) 
 
Equation 8.9 indicates that visual stimulation should be commenced 72 seconds 
after the MRS sequence starts running. However, with consideration for a 9 sec 
deadtime (see section 8.1.2.2), stimulation rather began 63 sec from when the 
MRS sequence started running. 
 
8.1.2.2 The fMRS Paradigm and Duration of Stimulation  
  
In order to detect signal changes, it was necessary to perform MRS acquisitions 
both with and without the visual stimulus; i.e. alternating the stimulus periods 
with equal rest periods. Therefore, two paradigms were designed for the fMRS 
experiments: one with a rest period followed by a stimulation period of equal 
duration in separate scans; and another with interleaved three rest and three 
stimulation periods of equal durations within a single scan. Throughout this 
chapter, the former paradigm will be called the “Off-On” paradigm, whereas 
the latter will be called the “block” paradigm. 
 
In the “Off-On” paradigm, NSA = 64 was used, giving Tacq = 264 sec and Tsti = 
192 sec or 3 min, 12 sec; the rest period was also 192 sec. In the “block” 
paradigm, each block had NSA = 32 (and of duration 32 x TR or 96 sec) and so 
the total NSA for the six blocks was 192 (i.e. 6 x 32), giving Tacq = 648 sec and 
Tsti = 576 sec or 9 min, 36 sec; this included the three rest periods interleaved 
with three stimulus periods. The total length of time for one rest and one 
stimulus period is known as the cycle duration [251]. Thus, the cycle durations 
for the “Off-On” and “block” paradigms were 384 sec and 576 sec, 
respectively.  
 
In addition to the estimated Tsti periods, a period of 9 sec deadtime was added 
between the stimulus being turned on or off and when the scanner began 
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acquisition of the 3 x NSA part of equation 8.8 (i.e. the actual MRS data; see 
section 8.1.2.3). The reason for the deadtime was to serve two purposes [251]: 
firstly, it reduced the possibility of a movement artefact which will arise due 
to the subject flinching when the lighting level changed suddenly between 
stimulus and resting conditions. Secondly, within the deadtime period, the 
changing blood flow stabilises as it alternates between the stimulus and rest 
periods. This transient response time is about 6.5-8 sec risetime, with falltime 
duration within 7-9 sec [251, 252]. With the additional 9 sec deadtime, the Tsti 
period in the “Off-On” paradigm was 201 sec and so the cycle duration was 402 
sec. However, in the “block” paradigm, Tsti was the same as the cycle 
duration, which was now 585 sec (when the deadtime was added).    
 
 
8.1.2.3 Accessing the Recorded BOLD Effect in MRS 
Data 
  
Since the Ndummy lines are not stored in an acquisition, only the reference water 
lines (Nref) and the suppressed spectral lines or actual MRS data (Ndata) are left. 
The total number of spectral lines (Nl) in the spectral domain is determined by 
the number of phase cycles (NEX) as in equation 2.19 (section 2.3.1.3), where 
16/NEX and NSA/NEX are the number of spectral lines or data frames stored in 
Nref and Ndata, respectively.  
 
The duration of stimulation, Tsti was set to match with the time required to 
acquire Ndata (section 8.1.2.1), and so the BOLD effect was recorded in those 
spectral lines. Note that stimulation had not begun during the period in which 
the Nref lines were collected. Thus, equation 2.19 can now be written in terms 
of the number of “BOLD effect spectral lines” (NBOLD) as follows: 
 
NBOLD = NSA/NEX                                                                            (Eq. 8.10) 
 
With NSA = 64 in the “Off-On” paradigm, NBOLD will be 64/NEX; the “block” 
paradigm with NSA = 192 will have an NBOLD value of 192/NEX. Only two NEX 
values are available on the scanner used for this project: 2 and 8. Therefore, 
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setting NEX = 8 will produce 8 (Figure 8.1a) and 24 spectral lines (4 per block) 
in the “Off-On” and “block” paradigms, respectively. On the other hand, if NEX 
= 2, 32 (Figure 8.1b) and 96 spectral lines (16 per block) will be stored for the 
“Off-On” and “block” paradigms, respectively. These stored data frames were 
those ones processed to estimate the BOLD effects (see section 8.2.4.2) in the 
fMRS data presented in this thesis. 
 
           
 
 
Figure 8.1: Representative data frames from a typical fMRS experiment during the rest 
period in the “Off-On” (a) and “block” (b) paradigms. 
The raw data had already been Fourier transformed and shows the SAGE output of the water 
peak at 4.7 ppm in both examples 
 
 
 
8.2 Methods 
 
8.2.1 Subjects 
   
 
A total of 6 healthy volunteers (2 females/4 males, aged 29-36 years, mean ± 
SD = 31.5 ± 2.6 years) participated in all the studies reported in this chapter. 
Five of these volunteers were scanned on the NEX = 2 protocol; 3 of these 5 
volunteers plus one more volunteer (making a sample size of 4) were scanned 
on the NEX = 8 protocol. Thus, 3 (2males/1 female) volunteers were scanned 
on both the NEX = 2 and NEX = 8 protocols. 
 
 
 
(a) (b) 
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              8.2.2 The Visual Stimulus and its Presentation 
 
 
A previous positron emission tomography (PET) study [253] has shown that a 
rate of pattern presentation of about 7.8 reversals per second (or 7.8 Hz) 
induces the maximum blood flow response in the visual cortex. Based on this 
observation and other fMRS studies [246, 254-256], an in-house 8 Hz 
black/white pattern-reversal checkerboard was designed by the author (Figure 
8.2b) and used for the visual stimulation. During the rest period, a black 
background was displayed (Figure 8.2a). In both displays, a small fixation cross 
was centrally placed in order to keep the subject awake and attentive during 
the scans. There was no background illumination within the scanner room 
throughout the experiments.  
 
                  
 
 
 
Figure 8.2: The black background with a white centrally placed fixation cross displayed 
during the rest period (a) and the 8 Hz pattern-reversal checkerboard used for visual 
stimulation (b). 
The checkerboard comprised of a 12 x 10 matrix of black/white squares, each of size 50 x 10 
(length x breadth) ‘Excel’ units 
 
 
The rest and stimulus displays were each presented using a Windows Media 
Player (Microsoft Corporation, USA, 2006) installed on a DELL laptop computer. 
Each display was projected from a screen panel that has image transmission 
cables passing through an observation window into the magnet room, where 
the projected image is displayed on bifocal lenses. The lens ensemble (Nordic 
Neurolabs, NNL; http://www.nordicneurolab.com) was attached to the head 
coil and positioned vertically above, but close to, the eyes of the subject. For 
(a) (b) 
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each subject, the foci of the lenses were adjusted until they could see a single 
projected and sharp image through both lenses, simultaneously.  
  
  
            8.2.3 Functional MRI and MRS Studies 
 
    
Following a structural MRI scan, an fMRI examination was performed for each 
subject prior to the fMRS experiments. The purpose of this preceding fMRI scan 
was to determine the location and size of the activated V1 area. Using this 
information, the localised voxel for acquiring the fMRS data was prescribed 
(Figures 8.3a-b).  
 
   
            
 
Figure 8.3: Axial (a) and sagittal (b) views of the localised fMRS voxel within the activation 
map generated in the V1 brain region during the fMRI examination. 
The functional activation maps were created by thresholding: z-values ranged from 3 to 12, 
with a cluster significance value, p = 0.05 
 
 
 
 
 
 
Figure 8.4: Time course analysis plot for the fMRI examination shown in figures 8.3a-b. 
This is the on-screen output of the analysis performed by the MR scanner software: the grey 
bars indicate the stimulus periods; the white bars indicate the rest periods.   
 
 
 
(a) (b) 
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8.2.3.1 The fMRI Protocol 
   
 
Following a 3-plane localiser scan, 40 axial slices were planned parallel to both 
the anterior commissure-posterior commissure (AC-PC) line and the primary 
visual cortex, and covering the whole brain. MRI of the head was then acquired 
using the single-shot gradient echo-planar imaging (GRE-EPI) sequence (64 x 64 
image matrix size, 24 x 24 cm2 FOV, 4.5 mm slice thickness, TE = 30 ms, and TR 
= 3000 ms).  
 
Three rest periods and three stimulus periods (each of duration 30 sec, 
resulting in a 3-minute cycle duration) were designed in an interleaved 
manner; this paradigm was different from the fMRS block paradigm described 
in section 8.1.2.2. The fMRI acquisition began with four dummy scans (see 
section 8.1.2.1); then ten image volumes were acquired in each of the six 
consecutive periods, resulting in a total of 60 image volumes.  
 
For each subject, the functional activation maps were generated and overlaid 
on the occipital brain region (Figures 8.3a-b) in real time by the proprietary 
scanner software (Brainwave RT); the corresponding on-screen time course 
analysis output (Figure 8.4) was also provided in real time. This information 
then served as guide during localisation of the fMRS voxel.  
 
 
8.2.3.2 The fMRS Protocol 
 
   
A single-voxel (20 S/I x 20 A/P x 30 R/L mm3) PRESS localisation sequence was 
used in the fMRS experiments. Outer-volume and CHESS water suppression 
techniques were incorporated in the PRESS sequence. The PRESS acquisition 
parameters were: TE = 23 ms, TR = 3000 ms, spectral width = 5000 Hz; 64 and 
192 scan averages (NSA) were used for the “Off-On” and “block” paradigms, 
respectively; for one set of “Off-On”/”block” experiments, NEX was set to 2, 
and then to 8 for another set. The “Off-On” paradigm was of the form OFF-ON, 
whereas the “block” paradigm was OFF-ON-OFF-ON-OFF-ON; where OFF and ON 
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mean the rest and stimulus periods, respectively. Figure 8.4 is representative 
of the switching periods between ON and OFF.  
 
The metabolite spectra were recorded first with the CHESS water suppression 
module turned on. The acquisition protocol was then repeated but with CHESS 
water suppression turned off to acquire the water spectra. Thus, the water and 
metabolite spectra were acquired using the same spectral acquisition 
parameters.       
 
 
8.2.4 Data Analysis 
 
8.2.4.1 Generation of Activation Maps for fMRI 
Acquisitions 
 
For each subject, thresholded activation mapping was carried out to visualise 
the pattern of activation in the V1 brain region; the corresponding time course 
plot for each experiment was also produced. A representative activation map is 
shown in Figures 8.3a-b. This example image (just like all the other activation 
images for each subject) was post-processed and overlaid on a high resolution 
3D T1-weighted brain scan of the same subject (acquired after the fMRI scan). 
The activation images (colour maps) were generated using FEAT (FMRI Expert 
Analysis Tool [257]) Version 5.98, part of FSL (FMRIB's Software Library, 
www.fmrib.ox.ac.uk/fsl). The pre-statistics processing steps involved: motion 
correction using MCFLIRT [258]; non-brain removal using BET [259]; spatial 
smoothing using a Gaussian kernel of FWHM 5 mm; mean-based intensity 
normalisation of all volumes by the same multiplicative factor; highpass 
temporal filtering (Gaussian-weighted least-squares straight line fitting, with 
sigma = 37.5 sec). For the post-statistical analysis, Z (Gaussianised T/F) 
statistic images were thresholded using clusters determined by Z > 3.0 and a 
(corrected) cluster significance threshold of P = 0.05 [260]. Co-registration of 
the GRE-EPI image to the high resolution 3D MR image was carried out using 
FLIRT [258, 261]. The corresponding time-series statistical analysis was carried 
out using FILM (FMRIB's Improved Linear Model) with local autocorrelation 
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correction [262]. The output of this analysis was similar to the time course plot 
shown in Figure 8.4; an example FSL output is not therefore shown in this 
thesis. 
 
   
8.2.4.2 Spectral Analysis and Estimation of the BOLD 
Effect 
 
Spectra were analysed as described in sections 2.3.1.2-3. However, specific to 
this chapter, spectral quantification was performed in two ways: firstly, each 
line in the spectral domain (Figures 8.1a-b) was quantified by invoking a 
“local” quantification algorithm that utilises the Levenberg-Marquardt method 
(section 2.3.1.2). The “local” Levenberg-Marquardt method ensures that the 
same processing and quantification steps are applied to each spectral line. 
Secondly, all the spectral lines were averaged by invoking a “global” 
Levenberg-Marquardt method. Both quantification schemes yielded the peak 
height (H), linewidth at half peak height (∆υ1/2), and spectral peak area (AS). 
The “locally” quantified spectral parameters (i.e. H, ∆υ1/2 and As) were used to 
plot the respective time courses of their changes over the cycle duration. The 
“globally” quantified spectral parameters on the other hand were used to 
quantify their respective BOLD effects (i.e. percentage changes in H, ∆υ1/2 and 
As).  
 
The BOLD effect is associated with increase in H following stimulation (Figure 
8.5), with a corresponding decrease in ∆υ1/2 and increase in As (section 8.1.1). 
In fMRI, the BOLD effect is associated with increase in pixel intensities. In 
fMRS, the BOLD effect is most discernible on the spectral peak height (H), and 
so the term “BOLD change or response” is often used to mean “change in 
spectral peak height” [246, 247]. Hence, the BOLD change in the tissue water 
and metabolite resonances was quantified as a percentage change in H as 
follows:  
 
Percentage BOLD change = [(Hstimulation – Hrest)/Hrest] x 100 %                (Eq. 8.11) 
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where Hstimulation and Hrest are the spectral peak heights (or intensities) 
associated with the stimulus and rest periods. The corresponding percentage 
changes in ∆υ1/2 and As were calculated in the same way as in equation 8.11. 
However, the calculated percentage changes in the peak linewidth (% ∆υ1/2) 
were negative values but have been reported as positive values in the summary 
tables (see Tables 8.1-8.6).  
 
In this thesis, the term “BOLD effect” will refer to % ∆H, % ∆υ1/2 and % ∆AS 
together, whereas the term “BOLD change” or “BOLD response” will refer to    
% ∆H alone.  
 
      
 
 
Figure 8.5: Estimation of the BOLD effect on the water resonance peak. 
The intensity increase is associated with decrease in linewidth and increase in the area under 
the peak. The small difference is expressed as a percentage of the intensity at rest. The BOLD 
effects on the metabolite peaks were estimated in the same manner. This example is the fMRS 
on subject D8; see Table 8.3 for the percentage changes in the peak parameters. 
 
 
 
Both the rest and stimulation spectral peaks of Figure 8.5 were produced by 
averaging their individual spectral lines, such as the representation shown in 
Figure 8.1a. Signal changes due to neuroactivation are usually small [251] and 
within the noise level [255]. Therefore, spectral averaging over the 
rest/stimulus cycles in this sense will allow for a clearer discrimination of the 
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signal changes from background noise [251]. This means that the higher the 
number of rest/stimulus cycles, the clearer the signal difference will be, since 
the background noise will be averaged.  
 
 
8.3 Results and Discussion 
  
 
This section is divided into three main subsections: the first subsection (section 
8.3.1) presents the results of the fMRS study using NEX = 2; this comprises the 
BOLD effect on the tissue water (section 8.3.1.1) and metabolite (section 
8.3.1.2) resonances. The second subsection (section 8.3.2) presents the results 
of the fMRS study using NEX = 8; this also comprises results for tissue water 
(section 8.3.2.1) and the metabolites (section 8.3.2.2). The third/last 
subsection (section 8.3.3) compares the calculated BOLD changes between NEX 
= 2 and NEX = 8 for three healthy volunteers scanned on both NEX values; this 
comprises results for the “Off-On” (section 8.3.3.1) and “block” (section 
8.3.3.2) paradigms. Sections 8.3.1 and 8.3.2 also show the results for these two 
paradigms, but they are summarised in tables together.  
 
The 6 volunteers studied in this chapter were each labelled with a unique 
identifier: A, B, C, D, E and F. Subscripts ‘2’ and ‘8’ were included in the 
identifiers to distinguish between those scanned on the NEX = 2 and NEX = 8 
protocols, respectively. Subjects C, D and E were scanned on both protocols, 
and are thus identified as C2, D2 and E2 for NEX = 2 (Table 8.1); and C8, D8 and 
E8 for NEX = 8 (Table 8.3).    
  
   
8.3.1 Functional MRS Study with NEX = 2 
 
   
For both tissue water and the metabolite resonances, 64 spectral peaks were 
quantified for the entire cycle duration (acquisition time window = 6-384 sec, 
step 6 sec) in the “Off-On” paradigm. On the other hand, 96 spectral peaks (16 
peaks per block) were quantified for the cycle duration of the acquisition (time 
window = 6-576 sec, step 6 sec) in the “block” paradigm. The time activity 
plots for water shown in Figures 8.6-811 were therefore obtained by plotting 
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the values of H, υ1/2 and AS for 64 and 96 spectral peaks versus the respective 
acquisition time windows for the two paradigms. For the metabolites (section 
8.3.1.2), only the time course plots for the stimulus periods in the “Off-On” 
paradigm have been shown (Figures 8.12-8.14). The percentage changes in H, 
υ1/2 and AS for water and the metabolites were then calculated from 64 and 96 
averages of their respective values for the “Off-On” and “block” paradigms. 
 
 
8.3.1.1 BOLD Effect on the Water Resonance when     
NEX = 2 
  
Table 8.1 shows the percentage BOLD changes (∆H %), and the associated 
linewidth (∆υ1/2 %) and area (∆As %) changes in water for each one of the five 
volunteers; the changes are shown for the two paradigms. For both paradigms, 
the average percentage change (± standard error, SE) for the five subjects in 
all three peak parameters were calculated. The significance values of the 
changes are indicated by the P-value (from paired t-tests).  
   
  
Subject ∆H (%) ∆υ1/2 (%) ∆AS (%) 
Off-On Block Off-On Block Off-On Block 
A2 5.05 0.20 4.24 0.25 1.34 0.05 
B2 6.58 1.97 3.42 1.99 1.12 0.08 
C2 8.31 1.58 3.50 2.72 0.96 0.12 
D2 9.53 0.42 5.37 1.62 1.19 0.10 
E2 2.91 0.99 6.90 1.96 1.01 0.01 
Mean ± 
SE 
6.48 ± 
1.17 
1.03 ± 
0.34 
4.69 ± 
0.65 
1.71 ± 
0.41 
1.12 ± 
0.07 
0.07 ± 
0.02 
P-value < 0.01 < 0.01 < 0.01 < 0.01 < 0.01 0.91 
 
Table 8.1: Spectral peak height (∆H), linewidth (∆υ1/2) and area (∆As) changes in water 
during visual stimulation when NEX = 2. 
Note that the percentage ∆υ1/2 values are all negative 
 
 
For each subject, the percentage changes in the three quantitative parameters 
of the water peak were significantly greater in the “Off-On” than in the 
“block” paradigms (% ∆H: P = 0.01; % ∆υ1/2: P = 0.02; % ∆AS: P < 0.01). The 
resulting difference between the two paradigms could have been due to two 
reasons: firstly, the longer stimulation period in the “block” paradigm may 
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have resulted in volunteer fatigue and loss of attention [251], the effect being 
a decrease in response to the stimulus after repeated presentations (this is 
known as the habituation effect). Secondly, 32 (compared to 64 in the “Off-
On” paradigm) averages were collected in each one of the rest and stimulus 
periods of the “block” paradigm. Theoretically, this will mean that the BOLD 
change that will be recorded in each cycle period of the “block” paradigm will 
be half of that which will be recorded in the “Off-On” paradigm. Consequently, 
two cycle periods should have given approximately the same BOLD effect; 
however, this did not happen even with three cycle periods. Higher spectral 
noise amplitudes due to the fewer averages collected in each cycle period, in 
addition to the habituation effect and possibly motion artefacts, could have 
accounted for the lower BOLD change in the “block” paradigm.   
 
However, the BOLD changes (∆H) and their associated decrease in spectral 
linewidth (∆υ1/2) were small but significant in both paradigms (P < 0.01). The 
effect on the water peak area (∆AS) was significant in the “Off-On” (P < 0.01) 
but not in the “block” paradigm (P = 0.91). Generally, the changes in H and 
υ1/2 cause only a small change in AS. Therefore, if the changes in H and υ1/2 
become considerably smaller with the “block” paradigm, then the change in AS 
will not be significant.  
 
The inter-subject variability (in this case, the CoV) in BOLD response varied 
widely among the volunteers in both paradigms, and was even poorer in the 
“block” paradigm. The CoVs ([SD/mean] x 100 %) for the “Off-On” paradigm 
were: ∆H = 40.45 %, ∆υ1/2 = 31.25 % and ∆AS = 13.41 %; those for the “block” 
paradigm were: H = 72.65 %, ∆υ1/2 = 53.18 % and ∆AS = 60.06 %. The generally 
significant inter-subject variability could arise from differences in vascular 
architectures and cerebral blood volume changes induced by neural activity 
[263, 264]. The increased variability with the “block” paradigm may be due to 
the afore-mentioned factors, plus differences in the tolerance levels (motion 
and habituation) of the individual subjects to the prolonged and repeated 
stimulation.  
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Only two studies, so far, in the literature [246, 247] have measured the BOLD 
effect on the water resonance. Whereas Zhu and Chen [246] conducted their 
study at 4 T and used only the “block” paradigm with an 8 Hz visual stimulus, 
Shih et al [247] performed their experiments at 3 T using the two paradigms 
with a 6 Hz visual stimulus. Zhu and Chen [246] collected 20 averages in each 
of their five consecutive periods (designed as three OFF periods interleaved 
with two ON periods), resulting in a total of 100 spectra. For six volunteers, 
they reported a mean (SE) percentage BOLD change of 3.0 (0.4) % and 
associated linewidth percentage decrease of 2.3 (0.3) %. No change in the 
water peak area was reported. Shih et al [247] on the other hand, collected 
128 averages in each of the rest and stimulus periods of their “Off-On” 
paradigm; and 32 averages for each of their eight consecutive periods 
(designed as four ONs and four OFFs), resulting in 256 spectra. For five 
volunteers, they reported a mean (SE) percentage BOLD change of 3.0 (0.5) % 
and associated linewidth decrease of 0.6 (0.1) Hz; the peak area increased by 
0.8 (0.3) %. The estimated BOLD and linewidth changes were said to be the 
same for both paradigms but it was not clear which paradigm gave the 
reported area change, which was comparable to the estimate from the “Off-
On” paradigm of this thesis (i.e. 1.12 (0.07) %).    
 
Compared to the above paradigm designs, the “block” paradigm presented in 
this thesis consisted of 32 averages collected for each of the six consecutive 
periods (three OFFs interleaved with three ONs), resulting in a total of 192 
spectra. The “Off-On” paradigm consisted of 64 averages in each one of the 
rest and stimulus periods. The experiments were conducted with the same TR 
value and with the PRESS sequence as in the above studies (Shih et al used a 
variant of PRESS that collected the water and metabolite spectra, 
simultaneously). The TE value on the other hand of this thesis differed from 
that of Shih et al (23 ms vs. 30 ms), but was the same as that of Zhu and Chen. 
The discrepancies in some of the results reported in this thesis and those in the 
literature [246, 247] cannot be explained by the differences in the TE values or 
the order of the rest and stimulus periods in the paradigms [265]. There are, 
however, possible contributions of field strength [246] and the inherent inter-
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subject variability observed in this thesis to the discrepancies. At a higher field 
strength, the susceptibility gradient that is associated with changes in T2* 
increases; and so does the BOLD effect, which varied at the field strength in 
this study and those in the literature. 
 
The higher field strength used by Zhu and Chen [246] could have accounted for 
the slightly higher BOLD change they reported; their linewidth change was 
however comparable to that reported in this thesis (for the block paradigm). In 
particular, significant habituation effects could have also contributed to the 
slightly lower BOLD responses in this thesis due to the prolonged examination 
period. Compared to the study by Shih et al [247], their 6 Hz visual stimulation 
could have caused a slightly lower BOLD change, even though they reported a 
similar BOLD change to Zhu and Chen [246]. With only half the number of 
averages used by Shih et al [247], the BOLD change observed in this thesis was 
twice what they recorded with the “Off-On” paradigm; the area changes were 
however comparable between the two studies. The higher BOLD change in this 
thesis could be due to the stronger stimulus used. The similarity in the BOLD 
changes between their (Shih et al) two paradigms was rather surprising, 
particularly when their “block” paradigm was considerably longer. With only 
one cycle duration difference in the “block” paradigms (same averages per 
block in both studies) used in the two studies, the BOLD and area changes 
reported in this thesis were significantly lower compared to those of Shih et al 
[247]. The large variation in the BOLD responses even among subjects in the 
“block” paradigm in this thesis could be the main source of this discrepancy.      
  
Figures 8.6-8.8 and 8.9-8.11 show the fMRS time courses for water in the “Off-
On” and “block” paradigms, respectively. Each plotted point is the average 
from five healthy volunteers, and the error bars represent standard deviations. 
The coloured rectangular blocks on the time axes indicate the task period of 
visual stimulation.   
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      Figure 8.6: Time course (“Off-On”) of the fMRS BOLD changes (∆H %) in tissue water 
 
 
 
 
      
 
 
       Figure 8.7: Time course (“Off-On”) of the fMRS linewidth changes (∆υ %) in tissue water 
 
 
 
             
 
 
 
   Figure 8.8: Time course (“Off-On”) of the fMRS peak area changes (∆AS %) in tissue water 
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      Figure 8.9: Time course (“block”) of the fMRS BOLD changes (∆H %) in tissue water 
 
 
 
     
 
 
 
Figure 8.10: Time course (“block”) of the fMRS linewidth changes (∆υ %) in tissue water. 
Note that the linewidth decreases during the stimulus periods and increases during the rest 
periods  
 
 
 
 
 
  Figure 8.11: Time course (“block”) of the fMRS peak area changes (∆AS %) in tissue water 
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8.3.1.2 BOLD Effect on the Metabolite Resonances when 
NEX = 2 
 
Table 8.2 shows the percentage BOLD changes (∆H %), and the associated 
linewidth (∆υ1/2 %) and area (As %) changes in the metabolite resonances. For 
both paradigms, the average percentage changes (± standard error, SE) are 
shown. These were calculated from the five subjects in section 8.3.1.1. The 
significance values of the changes are indicated by the P-value (from paired t-
tests).    
 
 
Peak % ∆H ± SE (P-value) % ∆υ1/2 ± SE (P-value) % ∆AS ± SE (P-value) 
Off-On Block Off-On Block Off-On Block 
NAA 10.20 ± 1.74 
(< 0.01) 
0.38 ± 0.12 
(0.56) 
6.12 ± 1.03 
(< 0.01) 
0.38 ± 0.11 
(0.76) 
4.09 ± 0.89 
(< 0.01) 
0.79 ± 0.18 
(0.53) 
Glu 6.21 ± 1.42 
(< 0.01) 
1.93 ± 0.27 
(0.14) 
0.98 ± 0.10 
(0.87) 
1.23 ± 0.53 
(0.81) 
9.19 ± 1.78 
(0.11) 
1.39 ± 0.40 
(0.74) 
Gln 5.21 ± 2.36 
(< 0.01) 
0.28 ± 0.13 
(0.80) 
12.12 ± 2.34 
(0.04) 
2.05 ± 0.54 
(0.66) 
15.73 ± 1.44 
(< 0.01) 
2.59 ± 0.90 
(0.47) 
Cr 10.27 ± 2.46 
(< 0.01) 
0.30 ± 0.12 
(0.80) 
6.55 ± 1.34 
(< 0.01) 
1.10 ± 0.35 
(0.49) 
3.45 ± 0.82 
(0.03) 
1.65 ± 0.42 
(0.25) 
Cho 11.06 ± 2.69 
(< 0.01) 
2.31 ± 0.82 
(< 0.01) 
12.94 ± 1.49 
(0.01) 
1.76 ± 0.57 
(0.46) 
17.54 ± 2.02 
(< 0.01) 
3.61 ± 0.92 
(0.11) 
mI 5.20 ± 1.16 
(< 0.01) 
0.11 ± 0.04 
(0.92) 
0.88 ± 0.17 
(0.84) 
2.05 ± 0.86 
(0.49) 
3.63 ± 1.52 
(0.38) 
1.64 ± 0.47 
(0.52) 
 
Table 8.2: Average spectral peak height (∆H), linewidth (∆υ1/2) and area (∆As) changes in the 
metabolites during visual stimulation when NEX = 2 
 
 
The BOLD effect alters the T2* of both water and metabolite signals [246]. This 
phenomenon causes a small narrowing (0.2-0.3 Hz) of the spectral linewidth at 
4 T of all signals in the spectrum during neural stimulation, which is mostly 
discernible on the strongest singlets of the methyl group of NAA and total Cr 
[256] particularly with the single (“Off-On”) activation paradigm (see Table 
8.2). In fact, all the metabolite peaks in Table 8.2 showed significant BOLD 
changes (∆H %) with the “Off-On” paradigm (P < 0.01), which were each also 
significantly greater than their corresponding changes with the “block” 
paradigm. Only Cho showed a significant ∆H % with the “block” paradigm but 
this was lower than its corresponding change with the “Off-On” paradigm. For 
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the associated ∆AS %, each metabolite peak changed significantly more with 
the “Off-On” than with the “block” paradigm. Apart from Glu and mI, ∆υ1/2 % 
in all metabolite peaks was greater with the “Off-On” than with the “block” 
paradigm. For Glu and mI, the higher ∆υ1/2 % for the “block” paradigm could 
have resulted from random line broadening effects during prolonged 
stimulation as shown by the larger error values. Otherwise, the higher ∆υ1/2 % 
in the Glu and mI peaks for the “block” compared to that for the “Off-On” 
paradigm was not expected. Shih et al [247] also did not find any correlation 
between mI change and stimulation. 
 
For their “block” paradigm, Shih et al [247] reported average changes in the 
concentrations of Cho, NAA and Cr (in decreasing order) from five volunteers as 
6.0, 2.7 and 2.3 %. This study did not calculate the metabolite concentrations 
but that should not cause any difference in the percentage BOLD changes 
between the two studies [265]. The BOLD changes (% ∆H) in this study were 
relatively lower but followed the same decreasing order of changes (Cho: 2.31 
%, NAA: 0.38 %, Cr: 0.30 %). The corresponding area changes were however of 
the form Cho > Cr > NAA.      
 
To record the BOLD effects in their spectra, Zhu and Chen [246] performed the 
following interleaved acquisition: rest-visual stimulation-rest; eight and sixteen 
spectra were acquired in the rest and stimulation periods, respectively. They 
estimated the mean (SE) % ∆H and % ∆υ1/2 for NAA and Cr from six volunteers 
as: % ∆H; NAA = 2.5 (0.6), Cr = 3.1 (0.7); and % ∆υ1/2; NAA = 1.7 (0.5), Cr = 1.8 
(0.5). The estimated % ∆H of this study for both metabolites were 
comparatively lower but % ∆υ1/2 for Cr was similar in both studies.    
 
Mangia et al [256] reported a 3.0 (1) % increase in Glu concentration (from 
twelve healthy volunteers) at 7 T during the “Off-On” paradigm. The scanner 
was equipped with a quadrature transmit/receive half-volume RF coil with 
increased local sensitivity in the visual cortex. Their rest and stimulus periods 
lasted for 2.7 and 5.3 minutes, respectively. This study used equal rest and 
stimulus periods of 3.2 minutes and recorded a BOLD change of 6.2 (1.4) % in 
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Glu. In their study, Mangia et al observed that Glu exhibited a delayed 
response to the stimulus and manifested a general tendency of decreasing over 
time. If this is the case, then their lower percentage concentration change 
(which is comparable to the BOLD change in this thesis) could have been due to 
the longer activation period of their paradigm; the percentage change could 
have been lower with the same activation period at 3 T. Secondly, they 
minimised the effects of linewidth changes by applying line-broadening filters 
to their stimulation spectra to match with their rest spectra before the 
subtraction. This may proportionally decrease the area under the smaller peaks 
in particular (which includes Glu). Consequently, the percentage change in 
concentration will be lower since concentration is estimated from the peak 
area. About 2 % to 11 % stimulation induced increases in lactate, glutathione 
and Glu during the “Off-On” and “block” paradigms at 7 T have been reported 
elsewhere [266]. Thus, even though there are some discrepancies in the 
results, they appear to be within some general range.    
 
In another study at 7 T by Mangia et al [255], they simulated the BOLD effect 
on spectral line narrowing by applying line-broadening filters that increased 
spectral linewidth to 0.3-0.4 Hz (the same order of line narrowing due to the 
BOLD effect at 7 T). For most of the seventeen metabolite spectra they 
quantified in vivo (in two healthy subjects), they reported that the estimated 
concentrations systematically decreased by almost 1 %. Thus their simulated 
BOLD changes (in those metabolites of interest in this study) were:  NAA = 1.2 
%, Glu = 1.1 %, Gln = 0.1 %, Cr = 0.8 %, Cho = 1.4 % and mI = 1.0 %. However, 
the non-simulated, in vivo linewidth changes in this study were at least 1.2 Hz 
(~ 3 times those simulated by Mangia et al). Therefore, if the stimulated BOLD 
effects by Mangia et al were adjusted by the respective multiplicative factors 
(i.e. when the linewidth changes in the two studies are compared) for the 
metabolites, the results may be directly comparable. It is also likely that the 
relatively high change in spectral linewidth reported in this study could be due 
to poor spectral resolution issues at 3 T since the actual T2* change due to the 
BOLD effect is usually small as reported by Mangia et al. However, since the 8 
Hz stimulation periods in both paradigms were prolonged, the BOLD effects 
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became more prominent (evident in the comparisons with previous studies) and 
discernible in the presence of the poor resolution.  
 
Baslow et al [254] used an 8 Hz stimulus in a 10 minute rest-10 minute 
stimulation-10 minute rest paradigm at 3 T to study six subjects (aged 31-73 
years). Their main metabolite of interest was NAA, which was quantified by the 
integral of its peak; the BOLD change was therefore defined as the percentage 
change in peak area. They found a 13.1 % decrease in the NAA peak area during 
stimulation, which increased gradually to the baseline level during the 
recovery period (i.e. the last rest period). This negative BOLD effect was 
attributed to increase in neuronal NAA metabolism, hydrolysis and efflux during 
stimulation; while its synthesis was decreased. They therefore concluded that 
NAA possibly acts as a molecular water pump during sustained neuronal 
activity. However, large variations (standard deviation of up to 12.8 %, and 
26.4 % decrease in NAA) in some of their trials were pointed out by Mangia and 
Tkac [265] as possible factors that could have affected their overall estimates 
since they (Mangia and Tkac) observed only ~2 % increase in the height of the 
NAA peak at 7 T in their study [256].  
 
However, a similar negative BOLD effect has also been observed elsewhere 
[267]. In this study, migraine patients without (MwoA) and with aura (MwA) 
were compared to control subjects (C) by photic stimulation at 8 Hz. Scans 
were performed at 1.5 T using a paradigm of the form 3.7 minutes of rest, 25.7 
minutes of stimulation and 7.4 minutes of recovery periods. They estimated 
their BOLD changes in the NAA and Cr peaks as percentage change in their 
areas. For the three groups (C/MwoA/MwA), the percentage mean BOLD 
changes (SD) in NAA were 7.42 (1.32)/5.79 (0.25)/14.05 (2.0) and those in Cr 
were 11.66 (1.87)/11.71 (3.41)/12.50 (0.31). Note that these averages are 
negatives, indicating decreases in the areas of the two metabolite peaks. 
Compared to the result of Baslow et al (who studied healthy subjects only), the 
negative BOLD change in NAA for the controls was much lower (7.4 % vs. 13.1 
%); and the positive BOLD effects on the NAA and Cr peak areas were relatively 
small (if considered as decreases) in this thesis. The signals however were 
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reported to gradually recover during the rest period, similar to the observation 
made by Baslow et al. They conceded it was difficult to explain this reversible 
decrease of the metabolite signals, particularly of NAA. This was because the 
decrease and recovery did not mean neuronal loss and resynthesis of NAA, 
respectively. At best, they thought the reason could be due to redistribution of 
NAA from intra- to extracellular space. It is suggested that [268] this variation 
in the chemical environment of NAA (and for that matter all the metabolites 
and water) could result in its NMR visibility, resulting in the rapid signal 
changes.  
 
The origin of the negative BOLD effect in the visual cortex during visual 
stimulation has been attributed to a reduction in neural activity, such as 
attention or higher-order cognitive functions [269]. In an fMRI study at 4.7 T, 
Harel et al [270] observed a prolonged negative BOLD signal change in the high-
order visual cortex region in anaesthetised cats. This region of interest they 
studied was suggested to experience increased spike activities during the task 
period. They attributed the negative BOLD change to a decrease in cerebral 
blood flow (CBF), which they thought was likely induced by a reallocation of 
blood flow from the less demanding areas to the most CBF demanding regions. 
They therefore concluded that a negative BOLD change does not necessarily 
reflect a decrease in spike activity. In the case of fMRS, a reduction in the 
spike [270] or neural [269] activity during visual stimulation will mean that 
those lines of data collected during the reduction may have approximately the 
same peak height, linewidth and area. The average of these stimulation 
spectral lines may not be too different from the average of the rest spectra; a 
negative difference could result from the subtraction, which does not 
necessarily, in this case, represent a BOLD change. The exact origin, nature 
and approximate absolute value of the negative BOLD change is unclear in fMRS 
since no other study in the literature (including this thesis), apart from the two 
discussed, has so far reported such findings.       
 
Summary plots of the time courses for all the metabolites studied in this thesis 
are shown below: their peak height changes are shown in Figure 8.12, linewidth 
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changes in Figure 8.13, and area changes in Figure 8.14. Note that the 
paradigm blocks are not shown in these figures as all the plotted points (or 
time courses) are related to only the stimulation periods; points for the rest 
periods are not plotted so that the activation time courses appear clearer.  
 
     
 
 
 
Figure 8.12: Time course of the fMRS BOLD changes (∆H %) in the metabolites during the 
stimulation period of the “Off-On” paradigm when NEX = 2 
   
 
 
  
 
 
 
Figure 8.13: Time course of the fMRS linewidth changes (∆υ1/2 %) in the metabolites during 
the stimulation period of the “Off-On” paradigm when NEX = 2 
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Figure 8.14: Time course of the fMRS area changes (∆AS %) in the metabolites during the 
stimulation period of the “Off-On” paradigm when NEX = 2 
 
 
8.3.2 Functional MRS Study with NEX = 8 
 
 
Compared to NEX = 2, when NEX = 8 is used for the fMRS acquisitions, four lines 
of spectra are collected and averaged to represent a single spectral line (Figure 
8.1) with a temporal resolution of 24 sec. This causes the data space to be 
filled with fewer spectral lines, with the advantage that motion artefacts are 
reduced [31]. Since a number of lines are averaged per NSA (4 lines/24 seconds 
in this case), any motion artefact will not be affecting a larger number of 
individual lines but an average, which is less affected by motion-related noise. 
Such averaging is usually suitable in the case of normal MRS acquisitions but 
may impact on how much of the BOLD effect could be recorded in fMRS. It is 
possible that during spectral averaging, some neural activity may not be 
captured or that some lines within the rest and stimulus periods could be 
averaged together. This could then possibly lead to significant losses in the 
amount of BOLD effect recorded or that if the absolute BOLD change (∆H) is 
not affected, then the estimated percentage change (∆H %) will be 
underestimated. Thus, the results presented in this section were aimed to 
investigate the impact of NEX = 8 on the amount of BOLD effect to be recorded 
during fMRS. 
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The same acquisition protocol as in section 8.3.1 was used except for the NEX 
value being switched to 8 for the results presented in this section. The first 
subsection (section 8.3.2.1) presents the BOLD effects on water and the last 
subsection (section 8.3.2.2) are the results for the metabolites. 
 
   
8.3.2.1 BOLD Effect on the Water Resonance when     
NEX = 8 
 
Table 8.3 shows the BOLD effects on the water resonance peak amplitude (∆H), 
linewidth (∆υ1/2) and area (∆AS). The percentage changes are shown for each of 
three subjects in section 8.3.1, plus one more subject (F8). The mean 
percentage changes (± standard error, SE) from all four subjects for the two 
paradigms are also shown, with the P-values indicating the significance of the 
change. 
 
Subject ∆H (%) ∆υ1/2 (%) ∆AS (%) 
Off-On Block Off-On Block Off-On Block 
C8 20.52 0.27 7.20 0.01 0.10 0.01 
D8 14.77 0.05 4.87 0.04 0.31 0.08 
E8 9.93 0.13 1.28 0.02 0.07 0.05 
F8 28.25 0.10 0.45 0.02 0.89 0.31 
Mean ± 
SE 
18.37 ± 
3.94 
0.14 ± 
0.05 
3.45 ± 
1.58 
0.02 ± 
0.01 
0.34 ± 
0.19 
0.11 ± 
0.07 
p-value < 0.01 0.82 < 0.01 1.00 0.24 0.49 
 
Table 8.3: Spectral peak height (∆H), linewidth (∆υ1/2) and area (∆As) changes in water 
during visual stimulation when NEX = 8 
 
 
 
In a similar pattern to that observed in section 8.3.1.1, the BOLD changes, ∆H 
with the “Off-On” were significantly  greater than those with the “block” 
paradigm (P = 0.02). However, the corresponding changes in linewidth, ∆υ1/2 (P 
= 0.12) and peak area, ∆AS (P = 0.16) were not significantly different between 
the two paradigms, even though the changes were greater in the “Off-On” 
paradigm.  There was also a significant variability in the BOLD responses among 
the subjects, indicated by the CoVs for both paradigms (“Off-On”: ∆H = 42.92 
%, ∆υ1/2 = 91.34 %, ∆AS = 111.04 %; “block”: ∆H = 68.58 %, ∆υ1/2 = 55.92 %, ∆AS = 
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119.78 %). Unlike the case for NEX = 2, the CoV of the linewidth changes was 
better in the “block” than in the “Off-On” paradigm. This is because NEX = 8, 
with more signal averages as in the “block” paradigm, helps to reduce spectral 
linewidth broadening due to motion artefacts [31]. Therefore, the reduced 
contribution of motion to the linewidth changes could have left changes mainly 
due to stimulation, resulting in a better variability which is then due to the 
factors mentioned in section 8.3.1.1.  
 
As was expected, the BOLD effects on the three peak parameters were 
generally lower compared to the BOLD effects with NEX = 2. Incidentally, the 
mean BOLD change (∆H) in the “Off-On” paradigm was significantly higher. 
Even though this appears to be the observed trend between the two NEX 
values, it is best to make these comparisons for the same subjects scanned 
with the two NEX values (this was done in section 8.3.3) due to the inherent 
variability factor introduced into these estimated mean changes by subject F8. 
 
Indeed, compared to the results of Shih et al [247] and Zhu and Chen [246], the 
BOLD changes recorded with NEX = 8 were all significantly lower. Only ∆H % for 
the “Off-On” paradigm with NEX = 8 in this thesis was significantly higher than 
those of the above studies. The NEX value does not particularly affect the 
amount of neural activity; it only affects the way (and how much of) the 
resulting BOLD effect is recorded by the scanner. Therefore, this exceptionally 
high BOLD change was unexpected; and so it was unclear what might have 
caused such a change. Acquisitions in the rest and stimulus periods of the “Off-
On” paradigm were performed separately and not in a continuous way (as in 
the case of the six consecutive acquisitions of the “block” paradigm). After the 
rest scan, the scanner was re-shimmed and the stimulus period acquisition was 
done. This could have offered two advantages: firstly, the subject had some 
rest between the “Off” and “On” acquisitions, and so could tolerate the next 
acquisition with less movement. Secondly, there is no possibility that the 
scanner will average the “Off” and “On” lines together. This then gives two 
spectral line sets containing the pure “Off” and “On” effects, where the 
averaged spectral lines with the “On” effect have less contribution from 
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motion (so peak height and linewidth changes will be mainly due to the BOLD 
effect). Therefore, a higher difference in peak heights between the two data 
sets could result. However, since this is the first study that has investigated 
this NEX = 8 effect, future studies may be required to further investigate the 
findings presented.  
 
The time courses of the fMRS BOLD effects on the water resonance are shown 
in Figure 8.15 for the “Off-On” and Figures 8.16-18 for the “block” paradigms. 
The plotted points are averages from the four subjects in Table 8.3; the error 
bars represent standard deviations. The coloured rectangular blocks on the 
time axes indicate the task period of visual stimulation. 
 
 
  
 
 
 
 
Figure 8.15: Time courses of the fMRS BOLD, ∆H (top left), linewidth, ∆υ1/2 (top right) and 
area, ∆AS (bottom) changes in water during the visual stimulation when NEX = 8 
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Figure 8.16: Time course of the fMRS BOLD changes (∆H %) in water during the stimulation 
period when NEX = 8 
 
 
 
 
 
Figure 8.17: Time course of the fMRS linewidth changes (∆υ1/2 %) in water during the 
stimulation period when NEX = 8 
 
 
 
 
 
 
Figure 8.18: Time course of the fMRS area changes (∆AS %) in water during the stimulation 
period when NEX = 8 
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8.3.2.2 BOLD Effect on the Metabolite Resonances when 
NEX = 8 
 
Table 8.4 summarises the mean BOLD effects on each of the cerebral 
metabolite peaks from the four volunteers in Table 8.3. The significance of 
each average change is denoted by a P-value in parenthesis and under the 
average value.  
 
 
Peak % ∆H ± SE (P-value) % ∆υ1/2 ± SE (P-value) % ∆AS ± SE (P-value) 
Off-On Block Off-On Block Off-On Block 
NAA 0.49 ± 0.18 
(0.72) 
1.09 ± 0.41 
(0.14) 
5.59 ± 1.94 
(0.07) 
1.09 ± 0.35 
(0.45) 
11.17 ± 1.94 
(0.01) 
0.85 ± 0.47 
(0.68) 
Glu 0.24 ± 0.14 
(0.90) 
0.05 ± 0.02 
(0.98) 
4.52 ± 0.78 
(0.69) 
5.26 ± 1.28 
(0.61) 
0.57 ± 0.24 
(0.95) 
4.76 ± 0.57 
(0.56) 
Gln 1.61 ± 0.46 
(0.29) 
0.16 ± 0.07 
(0.91) 
2.06 ± 0.79 
(0.72) 
7.19 ± 1.24 
(0.22) 
14.59 ± 1.88 
(0.05) 
2.42 ± 0.68 
(0.11) 
Cr 0.78 ± 0.24 
(0.53) 
0.18 ± 0.09 
(0.90) 
0.85 ± 0.28 
(0.79) 
3.05 ± 0.97 
(0.04) 
7.35 ± 0.94 
(0.02) 
0.86 ± 0.35 
(0.71) 
Cho 2.24 ± 0.47 
(0.01) 
1.41 ± 0.65 
(0.25) 
2.10 ± 0.95 
(0.73) 
2.62 ± 0.93 
(0.12) 
7.59 ± 0.84 
(0.11) 
2.09 ± 0.63 
(0.54) 
mI 1.75 ± 0.38 
(0.35) 
1.23 ± 0.46 
(0.35) 
1.82 ± 0.47 
(0.69) 
1.03 ± 0.65 
(0.74) 
0.86 ± 0.39 
(0.85) 
2.92 ± 0.74 
(0.32) 
 
Table 8.4: Average spectral peak height (∆H), linewidth (∆υ1/2) and area (∆As) changes in 
the metabolites during visual stimulation when NEX = 8 
 
 
The results in Table 8.4 show that only the BOLD change in Cho during the 
“Off-On” paradigm was significant (P = 0.01); all other metabolites did not 
respond significantly (P > 0.05) to the BOLD effect. No metabolite showed a 
significant BOLD response with the “block” paradigm. The linewidth narrowing 
effect was not significant in all metabolites with the “Off-On” paradigm; and 
only Cr showed significant linewidth narrowing with the “block” paradigm (P = 
0.04). Change in spectral peak area was significant in only NAA (P = 0.01) and 
Cr (P = 0.02) with the “Off-On” paradigm; Gln (P = 0.05) was on the minimum 
P-value to showing significance in peak area change. No spectral peak area 
change was significant with the “block” paradigm. 
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Compared to the fMRS results with NEX = 2 in Table 8.2, % ∆H in all metabolites 
were significantly lower with the “Off-On” paradigm; and only changes in NAA 
and mI were slightly higher with the “block” paradigm. The % ∆υ1/2 in all 
metabolites were lower with NEX = 8, except for Glu and mI, in the “Off-On” 
paradigm. However, in the “block” paradigm, % ∆υ1/2 in all peaks were greater 
with NEX = 8; except for mI. For % ∆AS, apart from NAA and Cr, all other 
metabolites showed less changes with NEX = 8 in the “Off-On” paradigm. 
Finally, only NAA, Glu and mI showed greater % ∆AS in the “block” paradigm 
(with NEX = 8).    
 
The NEX = 8 BOLD effects shown in Table 8.4 were found to compare 
favourably with the BOLD simulation results at 7 T by Mangia et al [255]. The 
percentage changes in their concentrations compared with the “Off-On” results 
for Cr (0.8 % vs. 0.78 %); and with the “block” results for NAA (1.2 % vs. 1.09 
%), Gln (0.1 % vs. 0.16 %), Cho (1.4 % vs. 1.41 %) and mI (1.0 % vs. 1.23 %); only 
the BOLD change in Glu was found to be comparatively lower in this study (1.1 
% vs. 0.24 %). However, with the “block” paradigm, its peak area change due 
to the BOLD effect compared with the percentage concentration change in Glu 
elsewhere, also at 7 T [256] (3.0 ± 1.0 vs. 4.76 ± 0.57). 
 
Specifically for NAA, with the “block” paradigm, % ∆H and % ∆υ1/2 were found 
to be comparable to the “block” paradigm results of Zhu and Chen at 4 T [246]: 
2.5 ± 0.6 vs. 1.09 ± 0.41 for % ∆H, and 1.7 ± 0.5 vs. 1.09 ± 0.35 for % ∆υ1/2.  
 
These findings suggest that even though NEX = 8 appears to ‘worsen’ the 
temporal resolution of the data, it tends to average the spectral lines in such a 
way that the estimated BOLD effects at 3 T now have less uncertainties, which 
otherwise would have made % ∆H, % ∆υ1/2 and % ∆AS considerably different 
from the expected results at higher fields. These similarities of the estimated 
BOLD effects when NEX = 8 (which gives a temporal resolution of 24 sec) at 3 T 
with those estimated at higher fields (4 T and 7 T), where better temporal 
resolutions have been used, imply that using a lower temporal resolution may 
offer some benefits at lower fields when studying the BOLD effects with fMRS. 
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However, such a resolution often gives fewer points to plot the time courses of 
the spectra for the cycle durations. The time courses for the BOLD changes, 
linewidth and peak area changes for each metabolite are shown in the 
summary plots of Figures 8.19, 8.20 and 8.21, respectively. The paradigm 
blocks are not shown in these figures as all the plotted points relate to only the 
stimulation periods; points for the rest periods are not plotted so that the 
activation pattern can be more visible in the graphs.     
 
 
 
 
Figure 8.19: Time course of the fMRS BOLD changes (∆H %) in the metabolites during the 
stimulation period of the “Off-On” paradigm when NEX = 8 
 
 
 
 
   
 
Figure 8.20: Time course of the fMRS linewidth changes (∆υ1/2 %) in the metabolites during 
the stimulation period of the “Off-On” paradigm when NEX = 8 
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Figure 8.21: Time course of the fMRS area changes (∆AS %) in the metabolites during the 
stimulation period of the “Off-On” paradigm when NEX = 8 
 
 
8.3.3 NEX = 2 versus NEX = 8 BOLD Effects on the 
Spectra 
 
The reproducibility of measuring the in vivo metabolite and water signals by 
the MR scanner used for this project was assessed in chapter 3. It was shown 
that over a course of a year, the CoVs of measuring water, NAA, and Cho were 
less than 10 %; those for Glu, tCr and mI were about 26 %, 10 % and 13 %, 
respectively; and Gln was not reliably detected (see Table 3.4). In this section, 
results are presented for the BOLD effects on water and the metabolites 
measured in three volunteers with NEX = 2, and again, over the course of about 
3-4 months, with NEX = 8. From the CoVs measured previously, the difference 
in the BOLD effects observed between the two NEX values should also be 
interpreted in light of the contributions from the respective uncertainties in 
the spectra arising from the time interval between the experiments. Even 
though these uncertainties (from the reproducibility results) may appear not to 
contribute significantly to the changes in the prominent spectral peaks of 
water, NAA and Cho, they could contribute to significant changes in Gln, Cr and 
mI. 
 
It was not appropriate to estimate the intra-subject CoV for each peak in the 
current study because the measurements were not done with the same 
protocol (i.e. NEX was not the same). Hence, the reproducibility study of 
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chapter 3 provided the level of uncertainty that should be considered when 
interpreting the results in this section (see the paragraph above).    
 
 
8.3.3.1 NEX = 2 vs. NEX = 8 BOLD Effects in the “Off-On” 
Paradigm 
 
  
Table 8.5 compares the effects of the two NEX values on the mean % ∆H, % 
∆υ1/2 and % ∆AS in the water and metabolite peaks from three healthy subjects 
during the “Off-On” paradigm. The P-value next to each comparison is the 
significance of the difference between the two percentage values. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 8.5: Average spectral peak height (∆H), linewidth (∆υ1/2) and area (∆As) changes in 
water and the metabolites during visual stimulation: comparison between NEX = 2 and NEX 
= 8 estimated changes in the “Off-On” paradigm 
 
 
The results indicate that with this paradigm, NEX = 8 reduced the BOLD signal 
(% ∆H) recorded from all the metabolites except that from water. The BOLD 
effects on linewidth were also decreased in all resonances except those on Glu 
and mI. Apart from NAA and Cr, all other resonance peaks also showed lesser 
changes in their peak areas when NEX = 8 compared to when NEX = 2. However, 
only NAA showed a significant reduction (P = 0.03) in % ∆H with NEX = 8, only 
 
 
Peak 
% ∆H ± SE  
p-
value 
% ∆υ1/2 ± SE  
p-
value 
% ∆AS ± SE  
p-
value 
 
NEX =2 
 
NEX = 8 
 
NEX = 2 
 
NEX =8 
 
NEX = 2 
 
NEX = 8 
H2O 6.92 ± 
2.03 
15.07 ± 
3.06 
0.06 5.26 ± 
0.98 
4.45 ± 
1.72 
0.79 1.05 ± 
0.07 
0.16 ± 
0.08 
< 0.01 
NAA 7.94 ± 
1.23 
0.46 ± 
0.25 
0.03 5.35 ± 
1.13 
4.34 ± 
2.10 
0.70 4.19 ± 
1.53 
12.63 ± 
1.81 
0.03 
Glu 4.55 ± 
1.78 
0.29 ± 
0.18 
0.15 0.92 ± 
0.16 
4.29 ± 
1.06 
0.11 10.60 ± 
1.58 
0.70 ± 
0.28 
0.02 
Gln 3.05 ± 
1.22 
1.26 ± 
0.41 
0.24 10.13 ± 
3.05 
1.75 ± 
1.02 
0.06 14.14 ± 
1.92 
12.85 ± 
0.98 
0.30 
Cr 8.99 ± 
2.41 
0.73 ± 
0.33 
0.09 6.45 ± 
1.33 
0.85 ± 
0.39 
0.04 2.93 ± 
1.38 
7.75 ± 
1.20 
0.20 
Cho 9.32 ± 
2.99 
2.14 ± 
0.65 
0.17 11.74 ± 
1.67 
2.55 ± 
1.19 
0.02 14.82 ± 
1.04 
7.50 ± 
1.18 
0.06 
mI 4.62 ± 
1.39 
1.41 ± 
0.26 
0.18 0.84 ± 
0.30 
1.97 ± 
0.62 
0.30 4.09 ± 
2.34 
1.08 ± 
0.45 
0.26 
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Cr (P = 0.04) and Cho (P = 0.02) in % ∆υ1/2, and water (P < 0.01), NAA (P = 0.03) 
and Glu (P = 0.02) in % ∆AS.  
 
Even though the reduction in the BOLD effects with NEX = 8 appeared quite 
large, the paired t-test analysis did not show a significant outcome (i.e. P < 
0.05) in most cases. This could have been due to a power issue as the sample 
size (n = 3) was small. A small sample size may reduce the sensitivity of the 
statistical test to picking significant differences. A confidence interval (CI) of 
90 % could have been used, so that the minimum P-value for significance 
becomes 0.10; hence making the statistical test more sensitive. However, this 
lowers the chances of eliminating significant outcomes arising from large 
random errors in the measurements. Moreover, changing the significance level 
at this stage is inconsistent with the P-value of 0.05 set for all significant 
results in this thesis. In a separate exploratory analysis (not shown) assuming 
the data was non-parametric, even though it was shown to be parametric, and 
so using the Wilcoxon (signed-rank) test, the same significance outcomes were 
obtained. In any case, the limitation of the paired t-test used here is that it 
assumes that the measurements were carried out at equal time intervals in all 
subjects and experimental sessions [254], which is practically not the case with 
the experiments discussed in this thesis.        
 
8.3.3.2 NEX = 2 vs. NEX = 8 BOLD Effects in the “Block” 
Paradigm 
  
Table 8.6 compares the effects of the two NEX values on the mean % ∆H, % 
∆υ1/2 and % ∆AS in the water and metabolite peaks from three healthy subjects 
(in Table 8.5) during the “block” paradigm. The P-value next to each 
comparison is the significance of the difference between the two percentage 
values. 
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Table 8.6: Average spectral peak height (∆H), linewidth (∆υ1/2) and area (∆As) changes in 
water and the metabolites during visual stimulation: comparison between NEX = 2 and NEX 
= 8 estimated changes in the “block” paradigm 
 
 
 
Table 8.6 shows that with the “block” paradigm, NEX = 8 reduced the BOLD 
changes (% ∆H) in all spectral peaks except those in NAA and mI. The BOLD 
effects on linewidth were also decreased in most resonances except those on 
NAA, Glu, Gln and Cr. Apart from NAA, Glu and mI, all other resonance peaks 
also showed lesser changes in their peak areas when NEX = 8 compared to when 
NEX = 2. However, only Glu showed a significant reduction (P = 0.02) in % ∆H 
with NEX = 8, only water (P = 0.03) and Gln (P = 0.03) in % ∆υ1/2, and no 
spectral peak showed a significant change in % ∆AS. For both NEX values 
however, the BOLD effects with the “On-Off” paradigm were generally greater 
than those with the “block” paradigm.  
 
NEX = 8 is the default value on most clinical MR scanners and so the user does 
not have to change it before an acquisition, which is an advantage. Therefore, 
if NEX = 8 appears not to significantly cause a change in the water peak area in 
fMRS while providing BOLD changes comparable to literature estimates, then 
two deductions could be drawn: water has proven to be consistent in its peak 
area while responding significantly to the BOLD effect; and that for fMRS at 3T, 
 
 
Peak 
%∆H ± SE  
p-
value 
%∆υ1/2 ± SE  
p-
value 
%∆A ± SE  
p-
value 
 
NEX = 2 
 
NEX = 8 
 
NEX = 2 
 
NEX = 8 
 
NEX = 2 
 
NEX = 8 
H2O 0.99 ± 
0.34 
0.15 ± 
0.06 
0.09 2.10 ± 
0.33 
0.02 ± 
0.01 
0.03 0.08 ± 
0.03 
0.05 ± 
0.02 
0.55 
NAA 0.43 ± 
0.15 
1.38 ± 
0.42 
0.24 0.42 ± 
0.19 
0.76 ± 
0.18 
0.40 0.73 ± 
0.31 
0.81 ± 
0.67 
0.93 
Glu 2.23 ± 
0.33 
0.05 ± 
0.03 
0.02 0.84 ± 
0.50 
4.91 ± 
1.74 
0.20 1.76 ± 
0.55 
4.94 ± 
0.76 
0.13 
Gln 0.43 ± 
0.17 
0.18 ± 
0.10 
0.37 2.36 ± 
0.88 
6.60 ± 
1.55 
0.03 3.52 ± 
1.26 
2.30 ± 
0.95 
0.53 
Cr 0.36 ± 
0.19 
0.21 ± 
0.11 
0.19 0.69 ± 
0.09 
2.97 ± 
1.37 
0.24 2.02 ± 
0.63 
1.01 ± 
0.45 
0.11 
Cho 3.29 ± 
1.00 
1.36 ± 
0.91 
0.37 1.82 ± 
0.92 
1.77 ± 
0.51 
0.96 3.91 ± 
1.62 
1.66 ± 
0.67 
0.16 
mI 0.14 ± 
0.07 
1.20 ± 
0.66 
0.21 2.51 ± 
1.43 
1.36 ± 
0.78 
0.59 2.01 ± 
0.73 
3.15 ± 
0.99 
0.56 
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NEX = 8 may be the suitable choice of temporal resolution as it provides better 
results (compared to NEX = 2). 
 
  
8.4 Summary and Conclusions  
 
 
In this chapter, the BOLD effects on the spectral peaks of water and the 
metabolites have been investigated with the single-voxel MRS technique called 
fMRS. The BOLD effect caused increases in spectral peak height with associated 
narrowing of linewidth, and small increases in peak area. The magnitude of 
these changes were influenced by local susceptibility changes during elevated 
neural activity, the changes arising from variations in deoxyhaemoglobin 
content in blood that create a susceptibility gradient (as well as changes in 
water diffusion gradient) across the intravascular and extravascular tissue 
compartments. This phenomenon affects the NMR visibility of both water and 
the metabolites, and so their rapid changes as observed by fMRS.  
   
Absolute concentrations were not calculated for water and metabolites in this 
chapter because reliable quantification of the concentrations during functional 
experiments is demanding. Moreover, estimation of the BOLD effects in 
percentage units using the peak intensity, linewidth and area do not require 
any rigorous quantification, which could even introduce more errors in the 
estimated percentage BOLD changes.  
 
Two objectives were investigated in the chapter: firstly, the consistency of the 
water peak area during neural stimulation and secondly, the relative effects on 
the amount of BOLD effects observed in water and the metabolites when the 
temporal resolution of the data is varied. 
 
The temporal resolution of the spectral lines in fMRS is defined by the NEX 
value. Only two NEX values were available on the MR scanner used for this 
project: ‘2’ and ‘8’. Two fMRS experimental paradigms were designed to 
investigate the above objectives: ‘single’ and ‘repeated’ activation paradigms.  
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The water peak area was found to be relatively stable with both paradigms, 
regardless of temporal resolution. Only the peak area change with NEX = 2 in 
the single paradigm was significant. This significant change during the 
sustained, single activation paradigm (which was not the case with the 
metabolites) was possibly due to significant BOLD signal contribution from 
water within the intra- and extravascular compartments, simultaneously when 
stimulation persisted; the metabolites are mainly confined to the brain 
parenchyma and so their BOLD signals are said to originate from only the 
extravascular cellular compartment. Indeed, the water peak area changes 
between NEX = 2 and NEX = 8 were found to be significantly different with the 
single, but not the repeated, activation paradigm. 
    
The investigation of the effect of the temporal resolution, NEX on the 
quantified BOLD changes at 3 T has been done for the first time in this thesis. 
For the effects of temporal resolution, the results showed that the single 
activation paradigm generally gave higher BOLD effects than the repeated 
activation paradigm (this possibly also contributed to the significant change in 
the water peak area). For both paradigms, the BOLD effects with NEX = 2 were 
generally higher than those with NEX = 8. The NEX = 8 BOLD changes however 
showed better comparison with literature values than the changes with NEX = 
2. The estimates of BOLD changes were in good agreement with results at 
higher fields, specifically at 4 and 7 T, where detection sensitivity is even 
higher. The study thus shows that temporal resolution of at least 24 seconds 
(when NEX = 8) at 3 T offers benefits of reduction of motion-related artefacts 
in the data, quicker signal averaging and better estimation accuracy of the 
BOLD changes in cerebral water and the metabolites in fMRS experiments. 
However, the sensitivity to detecting accurate BOLD changes in these 
experiments can be increased by using field strengths above 3 T.  
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Chapter 9: Final Conclusions 
 
 
 
 
9.1 Novel Contributions and Main Findings of this 
Thesis 
  
 
This thesis embodies a series of studies that have been put together to form a 
comprehensive and cohesive description of the NMR response of cerebral water 
under different experimental conditions. The main investigations were: 
relaxation properties of regional cerebral water content in a healthy brain 
(chapter 5); effect of varying voxel positions on cerebral water content in a 
healthy brain (chapter 6); cerebral water content in medicated and 
unmedicated peripheral inflammation (chapter 7); and cerebral water BOLD 
signal characteristics in a healthy brain (chapter 8). The investigations in 
chapters 6 and 7 primarily involved the quantification of cerebral water 
content, which would not have been possible without partial saturation, T1 and 
T2 corrections (chapter 5), which, in turn, were aided in establishing their 
reliability by the reproducibility study in chapter 3. It was suggested that the 
BOLD changes of the functional MRS study in chapter 8 should also be 
interpreted in relation to the reliability of the measurements, which were 
established by the reproducibility study (chapter 3). Thus, cohesion was 
established among all the chapters presented in this thesis. This thesis did not, 
however, exclude the measurement of cerebral metabolites; chapters 3, 5, 7 
and 8 included the metabolites in the respective investigations as well. 
 
In the process of quantifying cerebral water content and investigating its NMR 
response characteristics, new techniques were developed and novel results 
were discovered. 
 
Sensitivity maps of the eight-channel RF coil for all possible voxel positions in 
vivo have been established for the first time in this thesis. The maps were 
obtained by plotting the unsuppressed-water signal areas against their 
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respective voxel positions in phantom experiments. Polynomial fits to these 
plots in 3-dimensional space yielded standard polynomial equations. To 
quantify in vivo cerebral water content, the SI-coordinate value of the 
respective in vivo voxel position was used to choose the appropriate polynomial 
function from the fits. Substitution of the AP and LR coordinates of that voxel 
position into this polynomial function yielded a signal area that was from the 
same voxel position as the in vivo water signal. The in vivo measured water 
signal was then referenced to the deduced (same-voxel-position) signal using a 
standard mathematical model that accounted for all necessary corrections; the 
result was an absolute measure of cerebral water content. This one-time-only 
external reference calibration method has been developed and applied for the 
first time in this thesis. This new technique for quantifying tissue water 
content does not require extra or prolonged signal acquisitions for purposes of 
referencing; the quantification procedure does not also require correction for 
spatial variation in coil sensitivity since both the in vivo water and deduced 
reference signals are measured from the same voxel position. In addition to 
these, the unsuppressed-water signal can be acquired at the same time as the 
metabolite signals.  
 
Further to the use of the unsuppressed-water signal for quantification of 
cerebral water content, the same signal area was optimised (by the necessary 
correction factors) and used as an endogenous reference in the estimation of 
cerebral metabolite concentrations. Both the water and metabolite 
quantification techniques yielded estimates that were comparable with 
published values for the same brain regions and tissue types. Thus, both 
techniques were validated and could be used in future MRS studies. 
 
In agreement with previous studies [61, 177], cerebral water content was found 
in this thesis to be uniformly distributed across various brain regions, and was 
not observed to vary with age or gender. The results also corroborated previous 
findings [58-60, 62]that water content of grey matter tissue is higher compared 
to that of white matter tissue. 
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For the first time, this thesis also compared regional water content and MT 
ratio variation across the brain. For the same brain regions, the pattern of 
cerebral water distribution as measured by MRS was found to be comparable to 
the regional MT ratio estimates derived from MT imaging. MT imaging was thus 
suggested in this thesis as a possible way of validating regional variation in 
cerebral water content as measured by MRS. In any case, such comparative 
deductions have not been done previously, and so the comparison in itself adds 
to the novel contributions of this thesis.  
 
The voxel contents for the estimation of the cerebral water values in previous 
MRS studies [58, 59] were either almost grey or white matter tissues. However, 
the voxel contents of grey and white matter tissues in this thesis did not vary 
significantly in most cases; yet the tissue water estimates were comparable to 
those of the previous studies. This was possible due to the inclusion of partial 
volume correction in the quantification method that ensured the right amount 
of voxel tissue fraction was used in the estimate. Thus, the water value was 
scaled to the amount of tissue fraction from which it was quantified. The use 
of this voxel grey matter/white matter tissue mix in the accurate estimation of 
tissue-specific cerebral water content is also original.     
 
To date, the few peripheral inflammation (and even fewer psoriatic arthritis 
particularly) studies [190, 191] have only measured NAA, Cho and Cr, and 
expressed them in relative units. Using the techniques developed in this thesis, 
absolute quantification of cerebral water and metabolite concentrations were 
done for the first time in a group of volunteers diagnosed with, and treated 
for, psoriatic arthritis. In addition to the three generally measured metabolites 
(expressed as ratios), this thesis further measured Glu and mI (expressed in 
absolute units) in the prefrontal brain. Voxel positions in the psoriatic arthritis 
(PsA) study were the prefrontal, left and right hippocampal regions. 
 
Female PsA patients were found to improve in mood more than their male 
counterparts; but this did not necessarily mean improvement in their PsA 
condition as a disability assessment was not done in this study. Even though 
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cerebral water content in the PsA patients were well within the normal range, 
they were generally found to have higher tissue water content compared to 
healthy controls, matched for age and gender. The results of this thesis suggest 
that in psoriatic arthritis, higher cerebral water content may be associated 
with improvement in mood. This does not therefore support the suggestion that 
in peripheral inflammation, brain water content is likely to increase when the 
normal brain function of recruiting water-soluble proteins to the affected site 
is compromised (section 7.1.1). In fact, the insignificant changes in the 
cerebral metabolite concentrations in the PsA patients also indicated that the 
condition of PsA does not appear to affect cerebral metabolism significantly. 
Further to this, the patients did not differ significantly from normal in their 
mood scores. The mood scores did not also vary with cerebral water and 
metabolite changes following anti-inflammatory therapy. 
 
A significant and new finding from the PsA study was that higher absolute 
concentrations of left hippocampal NAA may be associated with lower BDI 
scores (i.e. better mood). This thesis therefore further supports previous 
studies that have implicated the left brain hemisphere (and structures therein) 
to play a role in the regulation of mood/behaviour.    
 
In terms of regional variation within the three voxel positions studied in both 
patients and controls (at baseline and post-medication), only Cr and water 
were found to be fairly constant. However, in terms of which was stable in PsA, 
cerebral water was relatively constant. Both were however neither age nor 
gender dependent in all voxel positions studied.   
 
The stability of cerebral water peak area during sustained neural activation 
was investigated using two temporal resolution values in the same volunteers, 
for the first time, in this thesis.   Generally, the cerebral water peak area was 
found to remain fairly constant even though it responded to the activation (the 
response was manifested as increases in its peak height). Only the peak area 
change with the temporal resolution of NEX = 2 in a single fMRS paradigm was 
found to be significant; this was however not the case with the metabolites. 
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Secondly, there was a significant difference in the BOLD response of cerebral 
water between NEX = 2 and NEX = 8 in the single, but not repeated, paradigm. 
It was noted that the origin of the water signal from both intra- and 
extravascular compartments of the brain might have aided in the significant 
response to sustained (i.e. single) visual stimulation; the metabolite signals 
originate from only the extravascular compartment as they are confined in 
brain parenchyma.     
 
Novel findings from the fMRS studies were that: a single activation paradigm 
generally gives higher BOLD changes in both water and metabolite peaks; 
regardless of the fMRS paradigm used, NEX = 2 results in higher BOLD changes 
compared to NEX = 8; only the BOLD changes recorded with NEX = 8 compare 
directly with literature values [246, 247, 255, 256]. The reason for this might 
be that NEX = 8 is the default temporal resolution on most MR scanners (at 
least on the GE scanner used in this thesis) and so researchers are more likely 
not to change the NEX value prior to the fMRS experiments. This thesis 
therefore has revealed that differences in the NEX values used in various 
studies could be a potential source of discrepancies in their results, in addition 
to other sources of discrepancies discussed in chapter 8. The results have 
further shown that BOLD changes could either be significant or not, depending 
on the paradigm design and temporal resolution (i.e. NEX value) of the MRS 
data.   
 
Through its novel in vivo relaxation time, water content, absolute metabolite 
and BOLD response measurements, this thesis has improved upon the accuracy 
and precision of previous MRS studies. In respect of its general objective, this 
thesis has also corroborated the suitability of cerebral water as a reference 
concentration in absolute quantitative MRS. Where necessary, the possible 
sources of the discrepancies between the results presented here and those 
previously published have been explained. These novel techniques can now be 
added to the body of knowledge in MRS, and are now ready to serve as tools for 
future MRS brain studies, both diseased and non-diseased.  
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  9.2 Methodological Limitations and Recommendations 
 
 
The limitation of the external reference calibration method developed in this 
thesis was the time taken to acquire all the unsuppressed-water data across 
the entire FOV of the eight-channel head coil. Future studies may develop and 
implement quicker MRS pulse sequences to record all the required 
unsuppressed-water data. On the other hand, a proton-density MRI of a brain 
phantom may be acquired and used for the same purpose of obtaining the 
reference signal. The MRI-based method of deducing the reference signal would 
be possible if there is a way of localising the in vivo voxel in the image of the 
phantom as has been done in this thesis (chapter 4).  
 
The standard equations representing the sensitivity maps of the head coil 
presented in this thesis may be validated and used for purposes of referencing 
in future studies. The validation process would require future studies to 
perform similar measurements on a similar or different scanner type using the 
eight-channel head coil or a different coil design (e.g. the quadrature head 
coil). Similar polynomial equations could then be deduced using the 
unsuppressed-water data. Cerebral water content could then be quantified 
using the derived reference signals from the different coil designs or 
experiments. If the results are comparable, it would mean that future studies 
may not have to perform the RF sensitivity mapping measurements again; and 
could thus directly use the in vivo voxel coordinates substitution method of 
deriving the reference unsuppressed-water signal.          
 
In the absolute quantification of cerebral water and metabolite concentrations, 
their respective signals were corrected for T1 and T2 relaxation effects using 
relaxation time estimates from a different set of experiments performed on a 
separate group of healthy volunteers. Even though this is normally the case in 
MRS studies [58], errors arising from ROI selections that do not exactly contain 
the same tissue type as that in the MRS voxel could lead to inaccuracies in the 
final concentration estimates. Secondly, the health conditions of the two 
groups of volunteers may vary significantly which may affect the results. With 
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the techniques developed in this thesis, it is possible to include the TE and TR 
of choice for the metabolite acquisition in the T1 and T2 measurements; this 
will allow for the relaxation times and concentrations to be estimated from the 
same voxel position within the same volunteer, within the same examination 
session.  
 
For the work on cerebral water quantification and assessment of regional 
variations (chapter 6), the left and right hippocampal data were only for 
males. It was necessary to investigate whether hippocampal water content 
varied by gender; moreover, combining that data set with the hemispheric data 
set could have introduced some degree of error in the explorative analysis for 
regional variation in water content. Nevertheless, the hippocampal work in 
chapter 7 showed that gender was not an issue; neither did regional water 
content vary significantly as long as the tissue types are the same. However, 
only data for the left hemisphere was available for the regional water variation 
in chapter 6. As a recommendation, future studies should take advantage of 
the shorter acquisition times of the techniques developed in this thesis, and 
perform the measurements in all the possible voxel positions when assessing 
regional variation in cerebral water content. This applies to the assessment of 
regional variation in the metabolite concentrations as well. Regional 
metabolite concentrations were assessed in only three brain regions (i.e. 
prefrontal, left and right hippocampi) in this thesis; which is not sufficient for 
a rigorous test to be done on regional variation in the metabolite 
concentrations.  
 
Even though the focus of this thesis was not to measure those peaks in the Glx 
complex, acquisition parameters were carefully selected to ensure that at least 
the spectral peaks of Glu and Gln were well resolved. The success of the choice 
of acquisition parameters in this regard was further aided by the higher SNR of 
the 3 T (compared to 1.5 T) clinical magnet which was equipped with an eight-
channel head coil used for all experiments in this thesis. Nonetheless, it was 
possible that GABA still contributed to the successfully resolved Glu and Gln 
peaks since no further spectral editing was done to completely resolve those 
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three components of the Glx complex. Advanced MRS localisation sequences 
are now available, tailored for the acquisition of the individual components of 
the Glx complex [271]; spectral editing and even higher field strengths (up to 7 
T) are also promising ways of acquiring Glu, Gln and Glx separately [255, 256, 
266, 272-274].  
 
In the PsA study, the availability of some important data about the volunteers 
could have clarified some of the MRS findings. Such data as the BDI scores of 
the healthy volunteers, comparative MRS data of healthy volunteers at follow 
up, patient data on disability scores, length of illness and blood cytokine levels 
(to mention but a few) were crucial to a better understanding of the outcomes 
of the experiments. Subjects’ intake of fluids/water or dehydration status was 
not accounted for in the estimates of cerebral water content. These pieces of 
information and some of those discussed in chapter 7 should be included in 
future studies of cerebral water content in both psoriatic (or any other disease 
when necessary) and healthy subjects.  
  
9.3 Suggestions for Future Medical Applications 
  
  
The MRS measurement of absolute metabolite and water concentrations in the 
human brain in vivo can be applied in the study of any disease that has a 
relationship with the brain. However, one limitation of applying the water 
content method (described in this thesis) to investigating disease is that the 
technique assumes that the water content is the same in the intra- and 
extracellular spaces. In the case of edema or tumor, extracellular water 
content increases while the intracellular component may remain unaffected. In 
such a situation, the water signal (and for that matter the water content) 
attributable to intracellular tissue would be overestimated, and the metabolite 
concentrations would be underestimated using the water referencing method. 
 
The techniques developed in this thesis can be used in a number of medical 
applications but the following were the projects of interest to the author and 
research supervisors during the period of the work presented in this thesis.    
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9.3.1 Water Measurements in Brain Inflammation and 
Tumors 
  
In chapter 7, water content and absolute metabolite concentrations were 
estimated in the brains of patients diagnosed with psoriatic arthritis, PsA (a 
peripheral inflammatory condition). The technique was sensitive to record 
subtle changes in cerebral metabolism following anti-inflammatory medication. 
The technique could therefore even be more sensitive if the condition affects 
the brain directly, such as tumors and multiple sclerosis, MS (a brain 
inflammatory condition). T1 and T2 corrections for the PsA study were done 
using T1 and T2 estimates from healthy subjects, assuming that the condition 
did not change the tissue and metabolite T1 and T2 relaxation times 
significantly. However, in the case of direct brain involvement, such as in MS, 
this assumption may not hold true. Relaxation time corrections are therefore 
likely to be the challenge in this case. Nonetheless, as proposed in sections 9.1 
and 9.2, the quantification technique in this thesis is rapid, and could be 
combined with relaxation time measurements in the same subject, thus 
avoiding the need to use T1 and T2 values from another study. 
 
  
9.3.2 Brain Temperature Measurements in fMRS Studies 
  
In section 1.4.2, the application of MRS in brain temperature measurements 
using the water and NAA peaks was discussed. No human study of fMRS has 
monitored/measured brain temperature changes resulting from neural 
stimulation during the experiments. With the spectral processing technique 
presented in this thesis, it is possible to calculate brain temperature and BOLD 
changes, simultaneously during neural activation. This could provide an insight 
into the effect of temperature on the amount of BOLD signal, and also the 
minimum amount of stimulation that will cause significant temperature rise 
which may be harmful to a patient. This application can be implemented 
without the need for any correction to the data since only the displacement 
between the NAA and water peaks are used to estimate temperature, whereas 
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the BOLD changes are calculated from the peak height, area and linewidth 
obtained from the fitting routine described in section 2.3.1.2. 
 
 
9.3.3 MT Spectroscopy of Cerebral Water Content 
  
Magnetisation Transfer Spectroscopy (MTS) pulse sequences are now available 
and have been used in previous human studies [275-278]. The MTS method 
provides the MT ratios of the metabolites in tissue. Only one of these studies 
used the MTS technique in the quantification of the MT effect on cerebral 
water content in normal subjects [276]. It would be interesting however to use 
a normal water-suppressed MTS sequence to acquire both MT on and MT off 
spectra. Processing these spectra and fitting them in the same way as done in 
this thesis, it is possible to obtain the unsuppressed-water and metabolite 
spectral peaks and subsequently calculate their respective MT ratios. This will 
be advantageous over performing MT imaging and MRS separately on the same 
subject because the MTS of water and metabolites together will allow for the 
same voxel position to be used, and will maximise time and equipment. Such a 
technique could also be used in the assessment of regional water content 
where MT imaging was used, and has been suggested, to validate the MRS 
results (chapter 6). Subsequently, such an MTS method could be applied in 
studies of many disease conditions that impact on brain metabolism, such as in 
peripheral and CNS inflammation. The calculation of the MT ratios in this case 
will require only the spectral peak areas which do not need further corrections 
after spectral fitting.    
 
 
9.3.4 Cerebral Water Content in Brain Tumor 
Classification  
 
In fact, this particular project had begun during the preparation of this thesis. 
The Neurology and Histology Departments of the Southern General Hospital are 
currently collaborating to undertake the study. Retrospective MRS, radiology 
and biopsy reports between the years of 2000 and 2010 of 121 tumor patients 
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have been collected. The MRS data for all patients will be processed using the 
techniques of this thesis to obtain the unsuppressed-water and metabolite peak 
areas. While ensuring that the biopsy and radiology reports are blinded to the 
MRS physicist, the metabolite peak areas will be used in a spectral classifier 
program, INTERPRET [279], to classify the brain tumors. The metabolite peaks 
are usually expressed as ratios, relative to either the Cho or Cr peaks [280, 
281] (in fact, some other studies [282, 283] have used the water peak for 
referencing but not in the INTERPRET program). However, in another set of 
analysis, the default reference peaks will be replaced by the water peak in 
order to observe any effect this might have on the classification outcomes.  
 
Both classification schemes (i.e. with and without the water peak) will be 
evaluated for classification accuracy (using ROC curves) by comparison to the 
biopsy reports (which contain the actual tumor classes). Thus, the water peak 
will be used in this case, for the first time, to establish a threshold at which 
brain tumors may vary by classes.  
 
In conclusion, this thesis documents a group of interrelated experiments that 
have measured and quantified changes (under selected experimental 
conditions) in the human brain tissue water signal using the single-voxel 1H-MRS 
technique. These experiments involved the development of novel methods for 
the quantification of cerebral water and metabolite concentrations, 
simultaneously. Generally, the findings of this thesis are in support of the use 
of the endogenous water signal for referencing in absolute quantitative 1H-MRS 
of the human brain. The developed quantification methods on the other hand 
do not have subject tolerance issues (as spectral acquisition times are not 
prolonged), provide accurate results and could therefore be applied in future 
MRS brain studies involving both patients and healthy subjects.  
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Appendix 2.2: The General Health Questionnaire-12 
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Appendix 2.3: The MRI Safety Checklist 
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Appendix 2.4: Ethical Approval for the Psoriatic Arthritis 
Study 
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Appendix 4.1: Polynomial fitting of the unsuppressed- 
water signal intensities acquired along the principal 
axes of the RF coil 
 
Inclusion of water signal intensities recorded at voxel position –55 mm from the 
isocentre along the RL and SI axes resulted in poor polynomial fits. These 
points were far underestimated compared to the rest of the plotted points. 
  
 
 
           
 
Removal of those plotted points at -55 mm from the isocentre resulted in 
better polynomial fits. 
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Appendix 7.1: The 21-item Beck’s Depression Inventory 
(BDI) used for Mood Assessment 
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